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ABSTRACT 
A wealth ofresearch has reported posstble nsk and predictive factors for dementia, the vanance 
across populatwns and the posstble reasons for thts vanance Thts thesis attempts to descnbe 
demographic and modtfiable nsk factors for dementia, wtth the emphasis on the associatiOn 
between (phyto) estrogens and cogmtive function 
The thests descnbes our observatiOnal dementia screenmg study, m whtch we atmed to 
assess the percentage of elderly wtth possible dementia m Indonesia, whtch IS currently 
unknown The estimated dementia prevalence m those over 60 years old was 4 I% Estimated 
Alzheimer's dtsease (AD) percentage was 3 1% (over 60 years of age), wtth all other dementias 
(mcludmg Vascular Dementia, possible secondary dementia and other non-assessed sub-types) 
estimated to be 54% (age range 52-98 years) Thts IS reflective ofprevwus literature reportmg 
a lower prevalence of AD m Astan compared to Western countries We also assessed non-
modifiable demographic nsk factors m Indonesia An older age, low educatiOn, havmg a blue-
collar professiOn and hvmg m a rural area were all mdependent nsk factors for cogmtive 
tmpamnent 
Secondly, the thesis refers to modifiable nsk factors and treatments for dementia and 
cogmttve tmpamnent Our meta-analysts of estrogen treatment randomtsed controlled tnals 
(RCT) explored the role of estrogen as a treatment for dementia Thts meta-analyses suggested 
small effects whtch were also not consistently reported among studtes The thesiS also descnbes 
the findmgs from our assessment of hormone therapy use m Indonesia reflects current trends 
assoctatmg a negative effect of hormones wtth cogmllve functiOn m women over the age of65 
years Phytoestrogens have been hatled as the natural alternative to estrogens We mvesllgated 
the relatiOnship between phytoestrogen levels and consumptiOn and cogmttve tmpatrment m our 
Indonesian populatiOn, who are htgh phytoestrogen consumers Our results showed that htgh 
tofu and low tempe consumptiOn was associated wtth cogmtive Impairment, specifically m 
women over the age of 68 years A novel findmg from thts study IS that the effects of 
phytoestrogens on cogmtive functiOn are modtfied by the form of soy consumed Thts could be 
due to the processes used to make these soy foods To our knowledge, thts IS the first study of 
thts kmd m thts populatiOn In ]me wtth the estrogen studtes reviewed, our ptlot RCT reported a 
positive 24 hour effect ofphytoestrogen supplementatiOn on semantic memory (verbal fluency) 
m postmenopausal women younger than 65 years of age Overall, we concluded that the 
relatiOnship between hormones (sex hormones or plant hormones) was modtfied by the 
demographic vanables of age and gender RecommendatiOns for future studtes are dtscussed 
Keywords:- dementia, cogmllve tmpatrment, age, educatiOn, estrogen, phytoestrogen 
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CHAPTER 1 -GENERAL INTRODUCTION 
1.1 Author's contribution to the work discussed in this thesis 
The author ofth1s thes1s was acl!vely mvolved m many aspects of the Indonesia 
proJect Th1s screemng survey was earned out m 2005 and was planned (m part) by 
the author ofth1s thes1s m collaboratiOn w1th Professor Tn Bud! Rahardjo, Professor 
EefHogervorst (EH) and the staff at the Umverslty oflndones1a Centre for Health 
The author ha1sed w1th EH as well as all collaborators both m the UK and m 
Indones1a m the study concept and des1gn of the project The author played a maJor 
part m obtammg fundmg for the proJect wh1ch mvolved ethiCal apphcatwns and 
drafting full proposals for the sponsors Due to the language barn er, the author 
could not acl!vely test or questiOn partiCipants However, at the onset of the study, 
the author was mvolved in presentmg the a1ms and methods of the proJect to 
collaborators and mvesl!gators at the Umvers1ty of Indonesia, observmg testmg and 
feedmg back observations to all mvesl!gators In March 2005, the author tramed 
field assistants and superv1sors to use the questwnnmres and cogml!ve tests she 
combmed for use specifically in Indonesia, provmg feedback on procedures and 
methods from the p1lot study The author ofth1s thes1s played a maJor part m 
comp1lmg the quesl!onna1re pack that was subsequently used m data collection and 
gave further adm1mstral!ve, techmcal and matenal support throughout the duratiOn 
of the proJect The author conducted all analyses whiCh mvolved data cleanmg and 
preparation, choosmg appropnate statistical methods, runnmg analys1s, as well as 
presentmg results for d1scusswn to EH and other mveshgators The author of the 
thes1s also played a maJor part m the draftmg of manuscnpts as well as cnl!cal 
revJswns for 1mp01tant mtellectual context for JOurnal pubhcatwn. 
For the Random1zed placebo-controlled tnal at Loughborough Umvers1ty, the 
author was respons1ble for the concept of the project as well as the des1gn and 
comp1lmg of study matenals The author sourced the 1soflavone supplements that 
were used m the study from a pharmaceul!cal company The RAs mvolved m data 
collectiOn were tramed and managed by the author Data analyses and reportmg the 
prehmmary results were lead by the author ofth1s thes1s 
1.2 Introduction 
Across the world, the percentage of the populatiOn that IS elderly has shown an 
mcrease over llme, as has life expectancy at buth (W1mo, Wmblad, Aguero-Torres, 
& von Strauss, 2003) In the 1950s the world's populatwn of elderly people was 200 
m1lhon (8% of the populatwn) Just over half a century later m 2006, th1s figure had 
more than tnpled to 688 m!lhon people w1th 11% of the populatwn aged 60 years 
and above The number of elderly people IS esllmated to nse even further to 1.968 
b1lhon (22% of the populatwn) by the year 2050 (Umted Natwns: Department of 
Economic and Soc1al Affmrs, Populatwn DIVISIOn, 2007) To add to th1s, the World 
Health Orgamsatwn (WHO) pred1cts a trend towards an mcrcase m life expectancy, 
specifically m developmg countnes, as well as a reductwn m fertility rates (World 
Health Organ1satwn, Rev1sed September 1998) It IS believed th1s declme w1ll be 
even more apparent m the fifty least developed countnes where fertility 1s pred1cted 
to reduce from 4 6 ch1ldren per woman m 2005-2010 to 2.5 ch1ldren m 2045-2050 
(Umted Natwns Desa Populallon DIVISIOn, 2006) 
Differences can be found between developmg and developed countnes m the 
number and proportiOn of older people In developed countnes, a fifth of the 
populatwn 1s currently over 60 years of age wh1ch 1s pred1cted to mcrease to nearly 
a th1rd by 2050 However, m less developed countnes, the old account for JUSt 8% 
of the whole populatwn, w1th an mcrease to a th1rd expected by 2050, reachmg the 
same stage m populatwn strata currently seen m developed countnes but showmg a 
marked nse and faster pace of growth Th1s 1s a potential future problem as the 
econom1es of these developmg countnes may not have the resources and time to 
deal w1th the consequences of a rap1dly agemg population, espec1ally when th1s 
mcrease 1s h1gher in the lower soc1o-econom1c levels (Umted Natwns Department 
ofEconom1c and Soc1al Affmrs, Populatwn D1v1s1on, 2007) 
As our populatiOn ages, the InCidence and prevalence of age-related cogmtlve 
declme and dementia IS also expected to show an mcrease Consequently, th1s 
mcrease w11l put a greater stram on soc1ety, from the fam!l1es, carers and health 
professwnals, to the w1der problem of the cost-burden placed on the economy as a 
whole 
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Prevwus research has documented that as well as there bemg cross-cultural 
differences m the proportwn of the elderly, there are also vast d1fferences m the 
prevalence and mc1dence of age-related d1seases, such as demenlla (Fern et a!, 
2005) It IS therefore worrymg that data on age spec1fic d1seases m developmg 
countnes are sparse but seem to md1cate large vanance m the prevalence of these 
d1seases, for example, demenlla (Natwnal Instltute ofMedJCme, 2001) What causes 
th1s vanatwn has been well debated but IS sllll uncertam Cross-cultural vanance 
could be attnbuted to a number of reasons rangmg from fundamental non-
modifiable factors, such as genet1cs and demograph!Cs, to mod1fiable vanables such 
as hfestyle ch01ces and health. 
Our study m Indonesm 1s the first part of a screemng process assessmg demenlla 
prevalence and nsk factors for age-related cogmtlve 1mpamnent and dementla m 
Indones1a w1th a focus on non-mod1fiable demographic and modifiable hormone-
dependent nsk factors. 
F1rstly, the methodologJCa! mm of th1s screemng phase was to assess questwns and 
cogmtlve measures for the1r rehab1hty and vahd1ty and compare these w1th a test 
battery w1th good spec1fic1ty and sens1t1V1ty to be used for formal demenha 
dmgnos1s m the second wave ofth1s study Due to tlme 1ssues, that second part of 
the study could not be mcorporated m th1s thes1s 
Secondly, the thes1s descnbes the assessment of dementla prevalence m Indonesia 
Data on dementla prevalence currently do not ex1st m Indonesia, but there are 
estlmates based on research m Ind1a wh1ch has a s1m1lar demographic profile The 
thes1s explores poss1ble dementla prevalence and sub-types of dementla across the 
world usmg an algonthm developed and vahdated at Oxford m d1fferent cohorts 
(Folstem, 2007, SchnJnemaekers, de Jager, Hogervorst, & Budge, 2006, De Jager, 
Hogervorst, Combnnck, & Budge, 2003, Hogervorst et a!, 2002) 
The thes1s then d1scusses non-mod1fiable demographic nsk factors associated w1th 
tillS algonthm The hterature rev1ew suggests poss1ble reasons for cross-cultural 
differences m dementla prevalence. Poss1ble non-modifiable demographic nsk 
factors were mvestlgated m order to 1dent1fy a demograph1c profile of people who 
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may be at nsk of possible dementialcogmtive 1mpmrment m Indonesia Indonesia IS 
espeCially appropnate for this work as It has great vanatwn m the demographic 
make-up across Its urban and rural areas The mam nsk factors discussed are age, 
educatiOn, sociOeconomic status (SES) and gender, as well as urban and rural 
differences m these demographic vanables 
Prevwus research has suggested that women are at a higher nsk of dementia (Lobo 
et a! , 2000) and this gender difference has been attnbuted (m part) to sex hormones 
(see Kimura, 1996 for a review) Consequentially, the followmg part ofth1s thesis 
focuses on hormone related factors Fmtly, the role of estrogen (E) (a female sex 
hormone) m cogmtive functiOn IS evaluated A meta-analys1s ofprevwus 
random1zed controlled tnals (RCTs) assessmg the effects of hormone replacement 
therapy (HRT) on vanous cogmtive functions IS reported, and the conflict 
surroundmg the role of E m cogmtwn discussed Hormone therapy use m Indonesia 
IS evaluated and the relatiOnship tor cogmtive functiOn m this sample statistically 
assessed 
Due to the recent reported potential detnmental effects of synthetic E on cogmtive 
functiOn, a shift has occurred to more natural hormones such as phytoestrogens, a 
naturally occumng plant hormone that mimics the effects ofE (Murkles, WI!cox, & 
Dav1s, 1998, Setchell, 1998, Adlercreutz & Mazur, 1997, Kurzer & Xu, 1997, Pnce 
& Fenwick, 1985, Bradbury & White, 1954) The role ofphytoestrogens m 
cogmtive functiOn IS currently unclear and appears to show similar effects on 
cogmtwn as that ofE (modified by demographic vanables such as age and gender) 
Phytoestrogen consumptiOn IS very h1gh m East Asian countnes such as Indonesia 
and Chma and much lower m Western populatwns such as the USA and Europe 
(Murk1es et a! , 1998, Bames, Peterson, & Coward, 1995) It has been suggested 
th1s vanatwn m the amount of phytoestrogens consumed may account for some of 
the vanance observed between East As1an and Western countnes m cogmhve 
Impairment and dementia 
Th1s thesis mveshgated phytoestrogen consumptiOn m Indonesia and 1ts associatiOn 
with possible dementialcogmtive 1mpmrment Demographic mediators ofth1s 
relatiOnship such as age, gender and m ban/rural hvmg were controlled for m 
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analyses and analyses were also stratified for these factors Furthem1ore, the 
possible effects of different doses ofphytoestrogens were assessed via a pilot RCT 
phytoestrogen treatment m a sample of post-menopausal women m the Umted 
Kmgdom and prehmmary results are descnbed and discussed 
Lastly, m the discussiOn, a cntlcal synthesis of the thesis IS presented as well as 
recommendatiOns for future studies 
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CHAPTER 2- LITERATURE REVIEW 
2.1 Dementia Prevalence and Types of Dementia 
2.1.1 Differentiating between normal ageing, mild cogmtive impairment and 
dementia 
In normal agemg, changes m the bram are hypothesized to result m ncurocogmtlve 
declme, such as decreased bram vasculansatwn, reductwn and change m central 
nervous system (CNS) neurotransmitter levels, and atrophy of the cortical gyn (Van 
Petten et al, 2004) Prevwus research has estabhshed that the most vulnerable 
cogmhve processes at nsk are executlve processes (1 e mh1b1t1on, schedulmg, 
plannmg, workmg memory, actwn, and coordmatwn of perceptwn) wh1ch are 
medmted by the frontal and prefrontal regwns of the bram (West, 1996) 
Conversely, there are some areas of the bram, and hence cogmhve functwns, that 
remam relatlvely mtact desp1te mcreasmg age (Hatfield, Spaldmg, Appanes, 
Haufler, & Santa Mana, 2003) The occ1p1tallobe and motor cortex, for example, 
wh1ch affect v1sual and motor processmg ab1h!Jes, s!Jll funct1on effic1ently even 
w1th mcreasmg age However, changes mduced by age vary greatly for some 
mdiVIduals What determmes th1s vast vanab1hty m cogmhve function m the elderly 
IS uncertam (Jolles, Verhey, R.ledel, & Houx, 1995, Poon, 1993) 
There has also been great mterest m the trans1t1onary stage between normal agmg 
and demen!la, of which Alzheimer's d1sease (AD) 1s the most common (Petersen, 
1995) (sub-types of demen!Ja are d1scussed m sectwn 2 1 3). Th1s trans1t10nary 
stage has been g1ven numerous names w1th the most common and well known bemg 
'M1ld Cogmtlve Impa1rment' (MCI) (Petersen et al, 1999) Th1s group of elderly do 
not functwn cogmt1vely w1thm the normal range and are by defimtwn below 1 5 
Standard Dev1at1ons (SD) of the mean perfonnance ofthe1r age-group Hence, they 
cannot be class1fied as havmg normal age-related cogmt1ve declme, but are not 
chmcally 1mpmred enough to be dmgnosed as havmg a pathological cogmt1ve 
d1sease such as AD (Hughes, Berg, Danz1ger, Coben, & Martm, 1982, Re1sberg, 
Ferns, de Leon, & Crook, 1982) 
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Cortical atrophy as well as medial temporal lobe atrophy and hypo-metabolism have 
been Implicated m the conversiOn from MCI to AD (Chetelat et al, 2003) Previous 
research has shown that some, but not all MCI cases show pathology similar to AD, 
e g the presence ofneurofibnllary tangles and neuntic plaques (see below) 
(Bennett, Schneider, B1emas, Evans, & W1lson, 2005, GUIIIozet, Wemtraub, Mash, 
& Mesulam, 2003, Rlley, Snowdon, & Markesbery, 2002) However, this vanation 
can range from no evidence of the type of neuropathology that usually md1cates 
AD, to a full range of neuropathologiCal markers that could warrant diagnosis of 
AD, with some cases showmg pathology of Vascular Dementia (V aD) or Dementia 
With Lewy bodieS (DLB) (Bennett et al , 2005, Gmllozet et a! , 2003, Rllcy et al , 
2002) (sub-types of dementia are discussed m sectiOn 2 1 3). To add to the lack of 
clearly defined neuropathology for MCI, some 'normal' cases show neurofibnllary 
tangles and neuntlc plaques (Gmllozet et al , 2003, M1tchell et al , 2002, Rlley et a! , 
2002, Dav1s, Schm1tt, Wekstem, & Markesbery, 1999; Haroutuman et al, 1998; 
D1ckson et al., 1992) makmg It difficult to be certam about defimt1ve 
neuropathological md1cators ofMCI. 
The presence of AD pathology m MCI raises conf!Ictmg views With some behevmg 
that all MCI cases have AD neuropathology (Moms, 2003) Others have md1cated 
that this may not be the case, as not all MCI cases progress to c!Imcal AD 
Furthermore, not all AD cases begm with MCI (Petersen, Wanng, Smith, Tangalos, 
& Th1bodeau, 1996, Petersen et a!, 1995) Individuals With amnestic MCI (aMCI) 
usually expenence problems with short term and prospective memory, but do not 
have Impairments m other functiOns, and do not expenence significant Impairment 
m daily occupatiOnal and social hvmg (Petersen, 2000; Petersen et al, 1999) In a 
sample companng normal elderly partiCipants to those With MCI and mild AD 
(Petersen et al , 1999), memory was the cognitive functiOn that showed the greatest 
difference between aMCI cases and mild AD cases, with less difference between the 
groups seen for other cogmtive functiOns When companng all three groups, the 
memory performance for MCI cases was closer to that of mild AD cases However, 
memory Impairment IS not always present, which has lead to problems m diagnosis 
(Lms, Loewenstem, Acevedo, Barker, & Duara, 2003) An additional problem IS 
that not all MCI cases are Identified at screenmg as some do not fall mto the three 
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broad categones of normal, MC! or demenl!a and hence may be at h1gh nsk of 
bemg undetected (Stephan et al , 2008) 
Prevwus research has suggested between a 1% and 25% mcreased nsk of 
developmg demenl!a for cases With mlid memory 1mpmrment (see Dawe, Proctor, 
& Ph1lpot, 1992 for a review) The reason for such a large vanatwn m reported 
percentages has been attnbuted to d1agnosl!c cntena, assessment tools as well as 
sample s!Ze vanatwns (Dawe et a! , 1992) 
It IS of vital Importance that these mdividuals w1th MC! who are at nsk of 
progressmg to AD are 1den!lfied as early detectwn could enable support and 
treatment regimes to be put mto place to m1mm1se the Impact of cogml!ve 
detenoratwn on the mdividual and their careg1vers However, although numerous 
classificatwn systems have been developed, no gold standard umform class1ficatwn 
system exist, wh1ch has lead to problems with mcons1stent diagnoses (see Stephan 
et a!, 2008; Vellas et a!, 2008 for recent reviews) Th1s must be taken mto 
cons1derat10n when evaluatmg the results of dementia prevalence and mc1dence 
studies as not all research accounts for MC! cases, and If they do, they are hkely to 
be classified usmg different cntena 
2.1.2 Definition of Dementia 
Demen!la was firstly descnbed as a syndrome called 'mcoherent or semle demenl!a' 
m 1835 by James Cowles Pnchard and charactensed by 'forgetfulness of recent 
1mpresswns wlule the memory retams a compara!lvely firm hold of 1deas laid up m 
the recesses from limes long past' (Pnchard, 1835) More than 70 years later, the 
term 'demen!la' was later ascnbed vanous neuropathology as well as the poss1b1hty 
of earher onset than the common age of 65 years (Alzheimer, Stelzmann, 
Scluutzlem, & Murtagh, 1995). 
Demen!la 1s usually diagnosed by usmg an expert consensus based set of cntena In 
Canada and the Umted States of Amenca (USA), the D1agnos!lc and Stahstical 
Manual of Mental Disorders (DSM) IS used. Vanous revlSlons have been published 
over the years and DSM 1s currently on 1ts fourth ed1t10n (DSM-N) (Amen can 
Psych1atnc AssociatiOn, 1994) DSM cnteria for demenl!a d1agnos1s require an 
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1mpamnent m long or short term memory, as wen as at least one other cogmtJve 
disturbance m aphas1a (language disturbance), aprax1a (1mpmred ab1hty to carry out 
motor actiVities despite mtact motor functwn), agnosia (fmlure to reorgamse and 
identify objects desp1te sensory functwn), and disturbances m executive functwmng 
(plannmg, orgamsmg, sequencmg, abstractmg) In addition, 1mpmrment m soc1al or 
occupatiOnal functwnmg, and a declme from a higher level of functwnmg IS 
reqmred for dmgnos1s wh1ch should not occur exclusively dunng the course of 
dehnum or wh1ch IS not better explamed by other morb1d1ty ( e g systematic 1nness 
or psych1atnc disorders such as depresswn) 
The other, and most w1dely used classJficatlon system for disease, IS the 
Intematwnal ClassJficatlon ofD1seases (ICD) published by the World Health 
Orgamsatwn (WHO) The ICD IS constantly rev1sed and IS currently on 1ts tenth 
series The I CD-I 0 dementia diagnosis IS more strmgent than, but compatJble w1th 
DSM-IV. I CD-I 0 reqmres memory declme, declme m other cogn1tJve abJhtJes 
wh1ch 1mpa1r actJv1tJes of da1ly hvmg, preserved awareness of the environment (no 
delinum), and a declme m emotwnal control and motJvatwn or a change m soc1al 
behavwur. An symptoms should have been present for at least six months for a 
pos1tJve dmgnos1s (World Health OrgamsatJon, 1992) 
2.1.3 Types of Dementia 
DementJa can be associated w1th a vast hst of over s1xty cond1tJons, the two most 
common bemg Alzheimer's d1sease (AD) and vascular dementJa (V aD) (also known 
as mult1-mfarct dementJa -MID) (Lobo et al , 2000, OlafsdottJr, Skoog, & 
Marcusson, 2000; Fenm-Stramb1 et a! , 1997) Other mam types of dementJa, wh1ch 
are neuropatholog1cany different from each other, are Frontotemporal dementJa 
(FTD), mcludmg P1ck's disease, DementJa w1th Lewy Bod1es (DLB), dementms as 
a result ofmfectwn such as Creutzfeldt-Jakob disease or HIV, and dementJas that 
are genetJcany mhented, for example, Huntmgdon's d1sease The fonowmg scc!ions 
d1scuss AD and V aD as wen as g1ve a bnefmtroductwn to FTD and DLB 
2.1.3.1 Alzheimer's disease (AD) 
AD IS the most common type of dementJa, and IS chmcany charactenzed by a slow 
and progressive declme ofcogmtJve functiOn, m particular of memory (De Jager et 
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al, 2003) It IS neuropatholog1cally charactenzed by plaques and tangles m the bram 
(Nelson, Braak, & Markesbery, 2009, Behl, 1999, Jellmger & Bancher, 1998) AD 
IS a degenera!lve disease of the bram from wh1ch to date no recovery has been 
found Nerve cells m subcortical regwns of the bram are slowly and gradually 
affected, resultmg m the md!v!dual's mab1hty to perform bas1c tasks, such as 
governance of emotwns, movement, coordmatwn, and recogmsmg errors and 
patterns (Husband & Worsley, 2006) In AD, the pnmary cogm!ive 1mpmrment 1s 
usually memory loss (long or short term) w1th other cogmhve defic1ts following 
EpisOdic memory loss followed by semantic memory loss are usually first affected 
m AD (De Jager et al, 2003) AD ulhmately results m complete loss of memones 
and many cogm!ive funchons (Husband & Worsley, 2006) As the d1sease 
pathologically develops, other affected cogmt1ve functiOns mclude executiVe 
functiOn, attentwn and workmg memory, dysphasia and aprax1a, as well as 
visuospahal skills, perceptual ab1lity, attentwn and concentratiOn (De J ager et al , 
2003) By DSM-IV diagnoshc cntena, semle demenha of the Alzheimer's type 
(SDAT) IS very Similar to the diagnosiS of general dementia However, AD spec1fic 
demenha should have gradual progressiOn and worsen steadily over lime, as 
opposed to a sudden or abrupt declme m functwn In add! !ion, symptoms must not 
be due to other CNS cond1!ions that could cause problems w1th cogn1lion and 
memory (e g Parkmson's d1sease, Huntmgton's d1sease, bram tumour, subdural 
haematoma, normal-pressure neurosyphilis), or be caused by systemic cond!lions 
known to cause demenha ( e g. HIV mfectwn, hypothyrmd1sm, v1tamm B-12 or fohc 
ac1d deficiency, macm deficiency, hypocalcaemia) Man1festatwns must also not be 
a d1rect result of another Ax1s I disorder such as DepressiVe D1sorder or 
Sch1zophrema and must not occur exclusiVely dunng the course of delinum 
(Amencan PsychiatriC AssoCJatwn, 1994) 
The NINCDS-ADRDA1 (McKhann et al, 1984) cntena for AD are also commonly 
used for the chmcal dmgnos1s of AD For the dmgnos1s of 'probable AD', the 
cntena reqmre episodiC memory 1mpa1rment wh1ch IS confirmed by 
neuropsychological testmg, and 1mpmrment wh1ch has been progressive and 1s 
1 Nattonal Instttute ofNemologJca\ and Comrnumcat1ve D1sordcrs and Stroke and the Alzheimer's D1sease and Related 
D1sorders Assocmt10n 
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present m at least two areas of cogmhon Impamnent m soc~al or occupatwnal 
functwmng 1s not reqmred, but onset of AD should be msJdJOus and there should 
not be any other systematic or bram d1seases that could have caused the cogmtlve 
1mpa1rment The dJagnosJs of 'defimhve AD' Js not made w1thout hJstopathologJcal 
confirmatiOn The NINCDS-ADRDA diagnostic cntena have been found to be 
re!Jable and accurate m d1agnosmg AD (Biacker et a!, 1994) has been shown to 
have 'moderate' mter-rater rehabJhty (Hogervorst et a!, 2000) However, Jt has also 
been reported that the NINCS-ADRDA cntena may not accurately deferenhal 
between AD and FTD (Varma et al , 1999) Hogervorst et al (2000) also found that 
the sensitiVIty and specJficJty could be Improved by usmg a computenzed 'demenha 
diagnosis system'. 
A new set of cntena by the same work group was proposed w1th the mm of 
1mprovmg the specJficJty and sensitiVIty of dJagnosJs usmg the NINCDS-ADRDA 
cntena for AD (Dubois et a! , 2007) Accordmg to these new cntena, to be 
d~agnosed w1th 'probable AD' the participant must present evidence of core 
d1agnoshc cntena w1th ep1sodJC memory 1mpmrment that IS gradual and progressive 
reported over a m1mmum of6 months Th1s IS objectively tested usmg 
neuropsychological tests and can be Isolate or associated w1th other cogn1hve 
changes at onset of AD or as AD progresses New supportive features mclude the 
presence of certam supportive bwmarkers of AD (at least one) These are presence 
of med1al temporal lobe atrophy, abnormal cerebrospmal flmd bwmarker, specific 
pattern on functwnal neur01magmg With posJtron-emJssion tomography (PET), the 
presence of at least one abnormal bwmarker as Jdenhfied by structural 
neuro1magmg usmg Magnetic Resonance Imagmg (MRI), molecular neur01magmg 
usmg PET, or proven AD autosomal dommant mutahon w1thm the JmmedJate 
fam1ly (genetic ev1dence) Excluswn cntena for dJagnosJs of 'probable AD' are 
sudden onset, early occurrence of gmt disturbances, seizures or behavwural 
changes, focal neurological features (mcludmg hemiparesis, sensory loss, visual 
field deficits), early extrapyramidal s1gns, non-AD dementia, maJOr depresswn, 
cerebrovascular d1sease, tox1c and metabohc abnomiahtles, and abnormal! ties m the 
temporal lobe that are mdJcatJVe of mfectwus or vascular problems (Dubo1s et a! , 
2007) 
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2.1.3.2 Vascular Dementia (V aD) 
Multl-mfarct dementia (MID) JS considered the mam type of V aD and IS dementla 
resultmg from multlple Ischemic, haemorrhag1c cerebrovascular leswns or Ischemic 
leswns (Levmoff, 2007) It IS caused by blood clots m the small blood vessels of the 
bram resultmg m reduced blood supply to bram tissue and resultmg m damage to 
bram cells V aD tends to present more suddenly than AD, and Is the result of either 
a smgle cerebrovascular event or will develop over tlme as a result of several 
cerebrovascular leswns (Levmoff, 2007) As suddenly as V aD can appear, Jt IS also 
usually lived with for a relatlvely short penod oftlme, as these patients tend to die 
of cardiOvascular or cerebrovascular complicatiOnS usually Withm 4- 5 years of 
diagnosis The pathological disease onset and progression of V aD typically result m 
1mpamnent m the cognitive functions of executive functwn, selectlve or divided 
attention and processmg speed (De Jager et al, 2003) 
The diagnosis of V aD IS not as clear-cut as for AD Firstly, the nammg of the 
disease has not been straightforward due to the overlap with cerebrovascular disease 
and difficulty m diagnosis (Verhey et al , 1993). Secondly, there are currently 
several different publicised defined cntena for the diagnosis of V aD which all focus 
on different endpomts In bnef, the most commonly used methods of classificatiOn 
of V aD mclude the Hachmski Ischemic Index (Hachmsk1 et al., 1975) as well as Its 
modified verswn (Rosen, Terry, Fuld, Katzman, & Peck, 1980) The Hachmsk1 
Ischemic Index gives a score on 13 subscales thought to be able to Identify MID (or 
V aD) This method does not reqmre memory or other cognitlve 1mpamnent No 
structural neur01magmg IS used, and the causal relatiOnship between bram m Jury 
and cognitive functiOn IS not exammed DSM-IV (Amen can Psych1atnc 
AssociatiOn, 1994) reqmres memory Impamnent as well as one other cogmtlve 
1mpamnent for V aD diagnosis It mcludes bram mJury due to acute Ischemia or 
bram haemorrhagmg and excludes cases of delmum Furthermore, the causal 
relat1onsh1p between cogmtlve functiOn and bram mJury can be assessed by climcal 
JUdgement alone (e g his.tory, climcal presentatiOn) and does not require bram 
scans. Another set of cntena whiCh 1s relatlvely recent 1s the NINDS-AIREN2 
2 Nat1onal Institute ofNeurologJcal DJsOJders and Stroke and Assoc1at!on lnternat1onale pour la Rechc1che et J'Ense1gnement 
en NeuroscJences 
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cntena (Roman et a!, 1993) It reqmres memory tmpmrment plus tmpmrment m at 
least two other cogmtive domams, and bram m Jury caused by acute Ischemia or 
bram haemorrhagmg. It also excluded cases of delmum, aphasia, psychosts, AD or 
other bram m Jury Structuraltmagmg IS used to dtfferentiate between probable V aD 
and possible V aD, and a causal relatiOnship between bram m Jury and cogmtive 
functiOn IS defined as occurrence wtthm 3 months, abrupt onset or stepwtse 
progression (probable V aD) If these cntena are not met, the case 1s thought to be 
possible V aD 
The NINDS-AIREN and DSM-IV have been found to have poor vahdJty and mter-
rater reliability for V aD (Hogervorst, Bandelow, Combnnck, Iram, & Smith, 2003) 
as well as low sensttlVlty (Hogervorst et a! , 2003) which could be partly because 
these cntena reqmre memory tmpmrment whtch Is not always present m V aD 
(Hogervorst et a! , 2002) A new set of vascular cogmtive Impmrment (VCI) cntena 
(Hachmski, 1994) that are data dnven, as opposed to the consensus dnven NINDS-
AIREN and DSM-IV has been developed It reqmres cogmtive Impatrment that has 
declmed from a htgher level and a mm1mum of two climcal features whtch suggest 
vascular on gm, sudden onset, a course that IS stepwtse or plateaus, and the presence 
of focal neurologtcal symptoms or patchy cogmtive deficits VCI can be dtagnosed 
wtth or m the absence ofleswns, has been reported to have good reliability and 
vahdtty (Wentzel, Darvesh, MacK.mght, Shea, & Rockwood, 2000), and suggested 
to be a better dtagnostic method than both DSM-IV and NINDS-AIREN cntena 
(Hogervorst et a! , 2003) 
The Oxford ProJect to Investtgate Memory and Agemg (OPTIMA) recommended 
the use of the State of Cahfomta Alzheimer's Disease Diagnostic and Treatment 
Centres (ADDTC) which reqmres two or more cognt!Ive tmpatrments (whtch are 
not limited to memory), uses structuraltmagmg to classify 'probable Ischemic 
vascular dementia' (IVD) and excludes cases wtth delmum (Hogervorst et a!, 
2003). The ADDTC was found to have good validity and reliability as well as 
senst!Ivtty and spectficity m V aD dtagnosts compared to post-mortem confirmed 
cases (Hogervorst et a!, 2003). 
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Some of these classlficatJOn methods have been developed for use m research 
studies m the quest for a defimt10n of V aD, e g the NINDS-AIREN cntena, whilst 
others were developed for chmcal use, e g DSM-IV The chmce of dmgnost1c 
cntena will affect the rates of case classtficatJOn For example, (Chm et al, 2000) 
descnbes how DSM-IV en ten a are the most liberal, whilst the DSM-III cntena (the 
precedmg DSM dtagnosts edttJOn) are more stnngent as It reqmres abrupt onset, 
stepwtse progressiOn, and an etJO!ogtc rela!ion between cerebrovascular dtsease and 
demen!ia NINDS-AIREN cntena was found to be the most ngtd and resulted m the 
lowest case classtficatJOn of V aD (Chm et a!, 2000) The areas of the contentiOn 
between classtfica!ion systems mclude exclusiOn of other systematic or bram 
dtsease (mcludes AD), assessmg the causal rela!ionshtp between bram m Jury and 
cognt!ive functiOn, as well as the presence of focal neurologic stgns (Chm et a!, 
2000) 
2.1.3.3 Overlap between sub-types of dementia 
There 1s considerable overlap between the vanous types of demen!ia which make 
dtagnosts of a pure type of demen!ia difficult For example, the mctdence of 'pure' 
vascular dtsease ts rare and most cases of V aD tend to have mixed pathology wtth 
AD-hke symptoms present (Esiri, 2000) The chmcal differences between AD and 
V aD dtagnosts seem rela!ively clear AD IS usually mt!ially mamfested as gradual 
problems with memory, whilst m V aD Imttal onset of cognitive tmpamnent, for 
example m executtve functiOns such as plannmg and orgamsmg are abrupt 
(Husband & Worsley, 2006) In AD, cogntttve dysfunctiOn IS usually gradual, slow 
and consistent but the dtagnosts does not rule out eo-morbid DLB or V aD In V aD 
cognitive 1mpamnent IS usually sudden as a result of a smgle cerebrovascular event 
(e g stroke), although 1t IS some!imes progressive and stepwtse, developmg over 
lime as a result of a cerebrovascular Jes10n or a combmat10n oflestons. V aD also 
differs from AD chmcally as the milia! pnmary Impairment IS m execu!Jve functton, 
as well as stgntficant personaltty and mood changes which do usually not occur 
un!il later m AD It IS common to find AD pathology at post-mortem and m fact rare 
to find pure AD or V aD at post-mortem despite different chmcal profiles m hfe 
(Esm, 2000) 
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Rtsk factors for AD and V aD also show substantial overlap (Levmoff, 2007, 
Kalana, 2003) It has been proposed that at least 40% of AD cases also have V aD 
(Brayne, 2009) Therefore, a new term 'm1xed dementia' has been comed wh1ch 
refers to AD w1th cerebrovascular symptoms (see Levmoff, 2007, Kalana, 2003, 
Kalana, 2002 for a rev1ew) Although no diagnostic cntena has been established to 
define or diagnose m1xed dementia (save for the NINDS-ADRDA and the NINDS-
AIREN), 1t has been proposed by some as a vahd class1ficatwn that addresses the 
overlap between AD and V aD especially (Levmoff, 2007, Kalana, 2003, Kalana, 
2002, Roman, 2001, Rockwood et al, 2000) M1xed dementia IS beyond the scope 
of the current thes1s 
AD also has been found to have some overlap w1th other less prevalent types of 
dement1a such as FTD and DLB FTD appears earlier than other dementlas (mean 
age of onset approximately 52 years) and features ms1dwus onset and gradual 
progresswn of cognitive 1mpa1rment (Harc1arek & Jodzw, 2005) In the earlier 
stages, memory and mtellect are relatively unaffected and the patient presents 
pnmanly neuropsych1atnc symptoms, such as personality changes wh1ch mclude 
mood swmgs, loss of mh!bltlon and mappropnate behavwur Language disturbances 
also occur m most cases (Harc1arek & Jodz10, 2005) The presentation of memory 
problems first and neuropsych1atnc symptoms second m AD d1fferenhates FTD 
from AD, as memory IS usually mm1mally affected m the early stages ofFTD 
(Husband & Worsley, 2006) The charactenstlcs that define FTD (e g behavwur 
disturbances, aphasia problems) are also found m AD Similarly, memory 
disturbance mtegral to AD diagnosis can also be seen m FTD 
Another type of dementia to take mto cons1deratwn IS DLB D1stmctive m1croscop1c 
features are found m DLB; namely a pathology known as Lewy bod1es (wh1ch 
causes neuronal loss due to 1ts msoluble complexes affectmg memory and motor 
control) Amyloid plaques m subcortical and cort1cal bram regwns are also found, 
w1th less mc1dence ofneurofibnllarytangles than m AD (Husband & Worsley, 
2006) The core symptoms mclude hallucmahons and spontaneous Parkmsomsm3 as 
well as iluctuatmg cognition (McKei!h et al , I 996) DLB IS not fully understood 
'DLB could not be assessed m thts sample because Its overlaps m symptoms wtth AD would make 1t extremely dtfficult to 
dJfferentmte between the two It can only really be categonsed separately by assessmg the presence ofhallucmatmns and 
spontaneous Parkmsomsm, for whtch no data was avallable Thts w11l be assessed m second phase of th1s study 
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and appears to fall somewhere m between AD and Parkmson's disease m Its 
symptomatology, hence people with DLB are often misdJagnosed as havmg V aD 
This may also be due to the neuropatholog1cally substantial overlap between V aD 
and DLB (Harc1arek & Jodzw, 2005, Kalana, 2002) Furthermore, the course of 
dechne IS similar between AD and DLB (Haroutuman et al , 2000) Pathological 
similanties are also found as some AD patients have an excessiVe amount of Lewy 
bodies m their brams (Serby & Alm1ron, 2005) However, DLB differs from AD as 
It does not pnmanly mamfest as memory Impmrment, but memory Impmmient can 
develop with progressiOn of the disease Furthermore, the extent of visual 
hallucmatwns found m DLB makes It more d1stmctive from other dementias 
(Armstrong, 2003) 
2.1.3.4 Conclusion 
In sum, defimng dementia beg~ns at a more basic level, 1 e bemg able to 
differentiate between normal age related cogmtive declme, MC! and pathologically 
based dementias ( e g AD) However, substantial overlap appears to ex 1st between 
the varwus types of dementia both chmcally and at post-mortem Fmdmg pure AD 
or V aD or mdeed FTD or DLB at post-mortem IS uncommon, and It IS plausible that 
the maJonty of dementia cases are mdeed 'mixed' dementia m hfe. Hence, this new 
category warrants further exploratiOn It IS of great Importance to categonse patients 
mto the vanous sub-types correctly Incorrect classificatiOn IS dangerous, as patients 
could be given drugs that are not appropnate to their conditiOn ( e g for vascular 
conditiOns) Furthermore, m dementia prevalence and mCidence research, 
misdiagiiosis could result m maccuracy m research findmgs leadmg to a poor 
understandmg of the vanous types of dementia 
2.1.4 Cross Cultural Dementia Prevalence 
2.1.4.1 Introduction 
It IS of Importance that not only the aetiOlogy of dementia IS studied extensively 
usmg vanous basic science methods, but also that cmrmmmty-based mves!Iga!Ions 
are conducted to assess actual prevalence and mc1dence of dementia m different 
countnes and different commum!Ies (Keskmoglu, G1ray, Picakciefe, Bilgic, & 
Ucku, 2006) Such research provides an overview across the world and allows 
deliberatiOn over differences m prevalence and mc1dence rates as well as the 
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possible reasons for these differences Although dementia prevalence and mc1dence 
has been studied extensively m the maJonty of developed countnes, evidence of the 
number of people livmg with dementia particularly m developmg countnes IS 
mcomplete or unrepresentative, and IS often not generalisable as these figures tend 
to be region-specific and not applicable to the demographic vanatwns across the 
country as a whole (W1mo et al, 2003, Pnnce, 1997) This can be seen clearly m the 
h1stoncal context of prevalence studies of dementia Surpnsmgly, unti1!986, there 
had been no dementia prevalence studies m the developmg world, and prevalence 
data had only been collected from Japan and western countnes Furthermore, no 
mternationally standardised diagnostic cntena for dementia were used m studies up 
to that time (Henderson, 1986) 
In an attempt to rectify some of the problems raised above, a group ofmternational 
experts was formed by Alzheimer's disease InternatiOnal (an umbrella orgamsatwn 
ofnatwnal Alzheimer's disease orgamsatwns around the world). The group mmed 
to provide up-to-date prevalence estimates across a wide vanety of countnes and 
regions of the world (Fern et a!, 2005) The systematic review of evidence from 
prevalence, remission and mortality rates used a Delphi consensus approach (a 
structured way of gammg consensus between a panel of experts) This allowed for 
analyses of a wide vanety of studies usmg different designs and ofvanous qualities, 
With educated-estimates made usmg comparable contexts when mformatwn was 
m1ssmg (Fern et a!, 2005) Results reported Chma and Its Western-Pacific 
neighbours as havmg the highest number of people livmg with dementia (6 million) 
Second was Western Europe (4 9 million), followed by North Amenca (3 4 
m1lhon) The group also predicted that although 60% of all people with dementia 
resided m developmg countnes, this figure had begun to nse and was estimated to 
reach 64 5% by 2020 and 71 2% by 2040 (Fern et al, 2005) Wl1en this IS broken 
down to country level, m 2001 global dementia prevalence figures were reported for 
Chma (5 0 million), the European Umon (EU) (5 million), USA (2 9 million), India 
(1 5 m1lhon), Japan (I I million), Russia (I 1 m1lhon) and Indonesia (1 0 m1llion)4 
However, although a high level of consensus was achieved m this collaborative 
effort, like other studies, estimates were based on scant epidemwlogical evidence 
4 These figures are d1fficult to duectly compare due to large vanat10ns m the s1ze of the vanous populat10ns 
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This IS parl!cularly the case for developmg countnes wh1ch have few studies, 
leadmg to problems ofvahd1ty, 1 e the results may not be generalisable to the whole 
populatiOn On the whole, many prevalence eslimate studies have reported age-
specific prevalence w1th no allowance for geographic vanatwn (W1mo et al , 2003, 
Pnnce, 1997) This can not been seen more clearly than by lookmg at differences 
both w1thm and between developed and developmg country prevalence rates wh1ch 
are descnbed m the followmg sect10ns 
2.1.4.2 Developed World 
The Med1cal Research Council Cogmtive FunctiOn and Agemg Study (MRC-
CFAS) (Y1p, Brayne, Matthews, & MRC Cogmtive FunctiOn and Agemg Study, 
2006, Matthews, Brayne, & Medical Research Council Cogmt1ve Function and 
Agemg Study Investigators, 2005) IS the largest United Kmgdom (UK) based multJ-
center study mvestigatmg the cogmtive and functiOnal health of the UK elderly 
populatiOn w1th mms to prov1de reliable eslimates of dementia prevalence and 
mc1dence The study estimated that m 1998, 550,000 people over the age of 64 
years m England and Wales were affected by dementia (MRC CFAS, 1998), and 
th1s figure was predicted to mcrease by 180,000 new cases every year (Matthews et 
a! , 2005) On a w1der scale, there are currently an estimated 5 1 million people 
livmg w1th dementia across the EU (W1ttchen & Jacob1, 2005) w1th a pred1cted nse 
to approximately 11 9 million dementia cases w1thm the next 50 years (W1ttchen & 
Jacob1, 2005) 
Another recent rev1ew restncted to EU countnes (Berr, Wancata, & R!tch1e, 2005) 
reported crude5 dementm prevalence rates usmg populatwn-based stud1es In 
participants over the age of 65 years, there was vanatwn of between 5.9% m the 
Italian Consehce Study (Ravagha et a! , 2007, Ravagha et a!, 2002) and 25 1% m 
Sweden (von Strauss, Vntanen, De Ronch1, Wmblad, & Fratighom, 1999), w1th 
prevalence rates of other countnes bemg between these figures M eta-analyses of 
studies m the developed world have reported prevalence at approximately I 5% at 
age 65 years, doublmg every four years to 30% at 80 years of age (R1tchJe & 
Kildea, 1995; Hofman et a!, 1991, Jorm, Korten, & Henderson, 1987) 
sA percentage of the populatiOn sampled 
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Lobo et a! (2000) compared dementia prevalence figures (all causes) m those over 
65 years of age across European counties as a whole and report prevalence at 6 4%, 
wh1ch IS similar to the 6 6% m the 1998 MRC-CFAS study UK findmgs (MRC 
CFAS, 1998) The report also descnbed an mcrease m dementia prevalence w1th 
mcreasmg age, and a 4 4% AD spec1fic prevalence across Europe However, there 
may be regwnal vanab1hty For mstance, prevalence rates of dementia (all types) as 
well as AD have been found to be h1gher m rural Northern Italy than m urban 
Central Italy Fenm-Strambi et a! (1997) reported all types dementia prevalence m 
Vescovato, North-Italy to be 9 8% and 52% for AD Ravagha et a! (2007) and 
Ravagha et a! (2002) reported a prevalence figure for demenlia (all types) to be 
59%, w1th 50% of tins bemg AD m Consehce, Northem-Italy (a rural area until two 
decades ago) In App1gnano, Central Italy all types demenlia prevalence was 
reported to be 6.2%, and 2 6% for AD (Rocca et a! , 1990) Tognom et a! (2005) m 
Tuscany, Central Italy SJmJ!arly found all types dementia prevalence to be 6 2%, but 
a h1gher AD prevalence of 4 2% 
Desp1te regwnal vanat10ns m prevalence rates, analogous mcrease m prevalence 
between the ages of 65 and 85 years has been found m most stud1es [for example 
see Jorm et a! (1987) or Berr et a! (2005)] Dementia prevalence rates m the oldest 
old are noticeablyh1gher (e g ::::72 years for Pamplona study and:::: 75 years for 
Kuop10, LEILA and the Kungsholmen ProJect) (Rahkonen et a! , 2003, RJedel-
Heller, Busse, Aunch, Matschmger, & Angermeyer, 200lb, von Strauss et a!, 1999, 
Manubens et a! , 1995) AD prevalence 1s believed to be h1gher than 50% m 
indiVIduals above 95 years of age (Vasto et a!, 2007) Furthermore, Early Onset 
Alzheimer's D1sease (EOAD) (1 e before the age of 60 years) although rare, 
accounts for 6-7% of all AD evaluatiOn (Aronson et a!, 1991). 
2.1.4.3 Developing World 
South-East As1a IS widely diverse m geographic, socweconom1c and cultural 
dynam1cs. Cit1es such as Smgapore and Hong Kong can be charactensed as 
developed and are classed as maJor financ1al centres Conversely, Indones1a and 
Thailand, for example, are slill developmg countnes With less developed public or 
soc1al care networks In fact, an 1ssue m th1s part of the world 1s the lack of access to 
serv1ces for the elderly 111 many countnes across South-East Asw (Philhps, 1995) In 
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additlon to this, an unexpected pattern of m creased hfe expectancy and decreased 
fertihty rates, and the trend towards nuclear famihes and hence less traditlonal 
family support of the elderly have lead to a worry that mcreases m dementia 
prevalence rates could be a maJor health, social and financial burden m South-East 
Asia (Philhps, 1995) 
The Delphi consensus (Fem et a!, 2005) reported dementla prevalence rates for the 
South-East Asia regwn, which mcluded Indonesia, Thmland and Sn Lanka 
Dementla prevalence for those aged 60 years and above m this regwn was estlmated 
to be 2 7%, compared to, for example, North Amenca (6 4%) or Western Europe 
(54%) Similarly, Lobo et a! (2000) reported dementla prevalence m Europe at 
6 4% m persons aged 65 years and over South-East Asia, however, IS also predicted 
to show a tremendous proportwnate mcrease of325% by 2040 m the number of 
people With dementla, which IS high m comparison to North Amenca (172%) and 
Western Europe (102%) Therefore, although developed countnes start from a 
proportwnately high base prevalence percentage, the expected mcrease m dementla 
prevalence IS lower, as compared to developmg countnes which start at a much 
lower percentage but show much greater expected mcrease m dementla prevalence 
rates This findmg IS qmte remarkable, and will have a marked Impact on the health 
care systems and costs m the less developed regwns 
In an excellent summary of22 cross-contmental studies assessmg prevalence of AD 
and V aD, Zhao & Bnnton (2007) report that overall prevalence of all-cause 
dementla for Japan and Chma IS similar to North Amenca, but lower than m 
Europe However, m Japan and Chma, AD prevalence rates are lower, while V aD 
rates are Similar to North Amenca and Europe In Japan and Chma AD prevalence 
rates were reported to be 1 5% and I 8% respectlvely, compared to North Amenca 
and Europe prevalence rates of 3.1% and 5 1% Conversely, V aD prevalence rates 
for Japan (2.3%), Chma (1 2%), North Amenca (1 3%) and Europe (2 5%) are more 
comparable Therefore, although the prevalence of V aD IS Similar for Western and 
Asian populabons, AD is -2 5 fold more prevalent m Western populatwns (Zhao & 
Brmton, 2007) 
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In some developmg countnes, such as parts of West Afnca, dementla prevalence IS 
either very low or m fact rare To add to th1s, vanatwns m dementia prevalence and 
mc1dence can be seen between people of the same ethmc1ty hvmg m different 
commumtles One example of th1s 1s the companson of dementia and AD 
prevalence and mc1dence rates between Afncans (specifically N1genans) and 
Afncan-Amencans, usmg the same methods of assessments (the same research 
group) m both populatwns (Hendne et a!, 2001, Ogunmy:t et a!, 2000) Results 
from these commumty based companson stud1es reported a marked difference m 
age-adjusted prevalence and mc1dence rates between Yorubas m lbadan, N1gena 
and Afnca-Amencans res1dmg m IndJanapolis, lnd1ana, w1th lower rates m the 
former I 15% and 2 52% respectively) (Hendne et a!, 2001, Ogunmy1 et a!, 2000) 
2.1.4.4 Possible reasons for differences across the world 
As can be seen, there 1s a worldwide difference m dementia (and dementia sub-
types) prevalence and mc1dence rates It IS possible that methodologJcal differences 
m collectmg dementia prevalence data 1s respons1ble for the vanatwn seen across 
the contments and there are numerous reasons why th1s could be the case For 
example, different demenha d~agnostlc cntena are used, as well as vanous dementia 
assessment scales and cognJtlve tests Other md1cators of cognitive 1mpa1rment such 
as self-report or the mformant/careg1ver report are also sometimes used but are not 
always avaJlable, as well as a WJde vanety of questwnnmres available to record 
subjechve reports Furthermore when eo-morbidity IS tested, the use ofbram 
1magmg scans and blood tests also vanes between stud1es, as does the use of 
functwnal ab1hty assessment tests. 
On a fundamental bas1c level, different diagnostiC en ten a have been used between 
stud1es to assess dementia prevalence, rangmg from DSM-III-R m the maJonty of 
cases, to the recent DSM-IV m some of the latest stud1es or by usmg ICD-10 It has 
been suggested that different dJagnostlc systems can result m d1fferent prevalence 
rates (even m the same populatwn) (R1edel-Heller, Bus se, Aunch, Matschmger, & 
Angermeyer, 200lb) One study, (ErkmJunttl, Ostbye, Steenhms, & Hachmski, 
1997), assessed dementla prevalence rates accordmg to SIX different algonthms 
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(DSM-III, DSM-III-R, DSM-IV, ICD-9, I CD-I 0 and CAMDEX6) Usmg the same 
partiCipants, dementia prevalence vaned from 3 I% (ICD-10) to 29 I% (DSM-III), 
control!mg for age, sex, educatiOn and mstltutwnalisatwn, with only 20 out of 1879 
partiCipants (less than I%) bemg diagnosed as havmg dementia by all SIX 
classificatiOn systems Most conflict exists between DSM and ICD Use of the ICD 
classificatiOn system results m lower prevalence rates than DSM cntena. Th1s 1s 
possibly due to the more stnngent aspects of the ICD classificatiOn system, which 
also reqmres a decline m emotwnal control or motivatiOn (aspects that are also more 
difficult to validate m commumty based samplmg due to the dependence of reliable 
mformatwn from carers or mformants (Henderson et a! , 1994), as well as presence 
of symptoms for at least 6 months Lower prevalence rates usmg the ICD compared 
to DSM cntena have been reported m vanous studies For example, m the Leipzig 
Long1tudmal Study of the Aged (LEILA75+), despite usmg the same assessment 
methods to classify cases (1 e. cognitive testmg etc), Rledel-Heller et a! (200la) 
reported lower prevalence rates m Mumch (m the same sample) usmg I CD-I 0 
classificatiOn than when usmg DSM II-R cntena Prevalence usmg DSM-III-R was 
17.4% and was 12 4% usmg ICD-10 Similar findmgs have also been reported also 
m Mumch (F1chter, Meller, Schroppel, & Stemkirchner, 1995) as well as m 
Austraha (Henderson et a!, 1994) 
The number of assessment factors used across various studies causes further 
discrepancy For example, the mcluswn of both rural and urban populatwns, usmg 
of computenzed tomography (CT) scans, the non-use of the Hachmski Ischemic 
Score (a codificatiOn of features associated With cerebrovascular disease), usmg a 
non-random sample rather than the total populatiOn, and no adjustment for false 
negal!ves (Corrada, Brookineyer, & Kawas, 1995) Also, some studies relate to 
pomt prevalence, whilst others are over months or years of prevalence (Henderson, 
1986) and as mentioned before, some take 111to consideratiOn MCI whilst others do 
not 
The possJbJhty of methodological differences accountmg for vanab1hty can be seen 
111 the find111gs of a six-fold difference 111 AD prevalence rates between two similar 
6 The Cambndge Mental D1sorders of the Elderly ExammatJOn ts descnbed m sectton 2 1 5 
22 
commum!Jes a distance of only 30 miles apart (Bachman et al , 1992, Evans et a! , 
1989) However, as much vanance m results can be attnbuted to methodological 
and d1agnos!Jc differences, exact prevalence cannot be ascertamed unless all studies 
are performed Identically Furthermore, the cut-off pomts that d1stmgmsh between 
normal agmg, very early AD and AD are difficult to Iden!Jfy (Petersen, 2006) and 
affected by educa!Jon, as well as bemg subjective (Vellas et a!, 2008), meanmg that 
dementia mc1dence studies may be maccurate Therefore, Vellas et a! (2008) 
recommend measunng change over time m cognitive functiOn m assessmg the 
conversiOn from normal agmg, to MCI and finally to dementia or AD They 
recommend usmg cognitive declme as an md1cator mstead of conversiOn to 
dementia, and assessment of the slope of cogmtive tests as the pnmary outcome m 
tandem with changes m mstrumental actiVIties of daily hvmg (discussed m sectiOn 
2 1 5) as a co-pnmary outcome This bnngs about another potential methodological 
Issue as the choice of cogmtive assessment may be responsible for some of the 
difference seen between studies 
2.1.5 Dementia Assessment Tools 
2.1.5.1 Cognitive Assessment 
The exam for the chmcal diagnosis of dementia should mclude a detailed family 
history, a measure of functional ability, a full medical exammatwn, 
neuropsychological evaluatiOn, neurological and psych1atnc exammatwn, blood 
tests and bram 1magmg (Roth, Huppert, Tyrn, & Mountjoy, 1988) However, a 
fundamental reqmrement IS cognitive function testmg which IS used m both a 
chmcal scttmg as well as m epidemiOlogical studies which aim to provide 
prevalence and mc1dence estimates Vanous cogmtive tests and cognitive test 
battenes have been h1stoncally used m research to assess cogmtive functiOn for 
dementia diagnosis Tests used to screen for possible dementia m the general 
populatiOn need to be qmck, easy to admm1ster, reliable and have high levels of 
sensitiVIty and predictive value This sectiOn descnbes some (but not all) of the 
most commonly used cognitive tests to aid dementia diagnosis 
The Mm1 Mental Status Exammatwn (MMSE) IS a popular and widely used tool 
that has been established as an accurate and valid test of cognitive functiOn 
(Folstem, Folstem, & McHugh, 1975) The MMSE IS a measure of global cognitive 
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functiOn assessmg vanous cogmtJve aspects such as memory, attentwn and 
language and JS typically used m stud1es to assess 1f an mdivJdual has severe 
dementia The MMSE 1s w1dely used m chmcal practiCe and has long been 
established as a vahd and accurate test ofcogmt1ve functwn (Folstem et a!, 1975) 
It JS a bnef screenmg method that IS non-mv as1ve, reqmres a m1mmal amount of 
time, and has the advantage of assessmg spec1fic facets of cogmtwn (Small, Herhtz, 
Frat!ghom, Almkv1st, & Backman, 1997) 
The MMSE has been cntlcJsed for not bemg sensitive enough for those w1th m1ld 
dementia (Feher et al, 1992, Tombaugh & Mcintyre, 1992), those who have a h1gh 
level of education, (Huppert, Brayne, G1ll, Paykel, & Beardsall, 1995, Crum, 
Anthony, Bassett, & Folstem, 1993), and a h1gh IQ (Cullum et al, 2000), as well as 
those m vanous cultures where the educatiOn levels are low and partiCipants may 
fail to respond correctly to spec1fic 1tems (Iype et al , 2006, Lm et al , 1994; 
Katzman et al, 1988, Escobar et al, 1986) Due to th1s, 1t 1s necessary (and often 
practised) to amend and adJUSt aspects of the MMSE m order to mcrease 
apphcab1hty to a particular cultural settmg For example, a Hmd1 verswn of the 
MMSE, the Hmd1 Mental Status Exammatlcm (HMSE) (Ganguh et al, 1995), was 
des1gned to address some of the cultural problems w1th the MMSE and make 1t 
more applicable to an Ind1an cultural settmg 
Although the MMSE should not be used by 1tself as a way of d1agnosmg dementia, 
because of 1ts ce1lmg effect, for example Ho gervorst et al (2002), 1t has h1gh 
sensJtJVJty for moderate to severe cognitive 1mpamnent, and sahsfactory rehab1hty 
and construct vahd1ty (Tombaugh & Mcintyre, 1992), w1th adequate d1scnmmate 
vahd1ty wh1ch 1mproves w1th adJustments for age and educatiOn (Chum, Anthony, 
Bassett, & Folstem, 1993; K1ttner, Wh1te, & Farmer, 1986) Therefore, 1t serves 1ts 
purpose as a bnef screenmg tool for cognitive 1mpmrment, as well as for foiJowmg 
up changes m cogmtive status over time and has been deemed useful for pred1ctmg 
mc1dent dementm (Brayne, Best, Mmr, RI chards, & G11l, 1997, Small, V1tanen, & 
Bachman, 1997, Monsch et al, 1995) The MMSE was used m tillS thes1s to assess 
global cognJtJve funchon m an Indonesian populatiOn (see methods sectiOn 
4 1 4 2 1) 
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The Hopkms Verbal Leammg Test (HVLT) (Brand!, 1991) IS commonly used to 
assess verbal episodic memory It mvolves the participant bemg presented a hst of 
words and havmg to recall them The design of the HVLT allows the partiCipant, If 
able, to use categones during recall as a way of remembenng the mdividual words 
as the words each fit mto one of three categones As AD pathology progresses and 
the mdividual has greater Impairment m executive functiOn, the ab1hty to orgamse 
the words m this way may be affected (De Jager et a!, 2003) Memory IS typiCally 
one of the first functions to show a declme m the cognitive aspect of some 
dementias (SchriJnemaekers et a!, 2006, De Jager et a!, 2003) and IS therefore a 
useful md1cator of possible cognitive Impairment Furthermore, verballeammg 
ability IS commonly Impaired m those with mild dementia (Frank & Byme, 2000) 
Importantly, previOus research found no associatiOn between performance on the 
HVLT and age (Rasmusson, Bylsma, & Brandt, 1995; Petersen, Smith, Kokmen, 
Ivmk, & Tangalos, 1992, Brand!, 1991) Therefore, this lack of associatiOn IS 
Important as It md1cates that the HVLT should be able to differentiate between 
normal agemg and possible dementia (Frank & Byme, 2000) The HVLT IS not as 
lengthy (12 words) or labonous as other verbal memory tests but IS sensitive to the 
different forms and the early stages of dementia (Hogervorst et al , 2002, Brand!, 
1991) 
The specificity and sensitlVlty of the HVLT for AD IS very high (Shap1ro, Bened1ct, 
Schretlen, & Brandt, 1999, Brandt, 1991) and the HVLT has been well validated 
(Brandt, 1991) Fmdmgs demonstrating 94% sensitlVlty and 100% specificity for 
mild to moderate AD, and accurate differentiatiOn between 'patients with dementia' 
and 'healthy controls' with 87% sensitlVlty and 98% specificity (Hogervorst et a!, 
2002) support this assertiOn Furthermore, the HVLT has been found to accurately 
differentiate between cases With MCI and controls (De Jager et a!, 2003, Petersen et 
a!, 1999) The test-retest rehab1hty has been found to be similar to other tests of 
verbal memory, such as the California Verbal Leammg Test and the Logical 
Memory subtest of the Wechsler memory Scale (Rasmusson et a!, 1995) 
Furthermore, the HVLT has six other alternative word lists, and IS therefore 
appropnate for longitudmal studies, as different lists can be used each time m order 
to ehmmate any possible leammg effects Many studies have assessed and provided 
support for the test-retest rehabihty of the vanous versiOns of the HVLT (BenediCt, 
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Schretlen, Gromnger, & Brand!, 1998) Although the MMSE has a ce1lmg effect, 
the HVLT has been reported not to, makmg 1t extremely smtable for demenlla 
screenmg as 1! 1s also not sensJ!ive to educatiOnal attamment (Hogervorst et a! , 
2002) (low educalion as a nsk factor for demenlia 1s discussed m sect10n 2 2 3) It 
has also been found to accurately differentiate between demenlia cases and controls 
as well as between MCI cases and controls (De Jager et al, 2003) The HVLT 1s 
also able to d1stmgmsh between possible/probable AD cases and patients With 
depresswn who scored h1gher on the test (Hogervorst et a!, 2002) De Jager et a! 
(2003) reported that the HVLT has h1gh sensltlVlly (82%) and specJficJty (75%) m 
d1stmgmshmg between AD and V aD cases The HVLT 1s also used to assess verbal 
memory m th1s thes1s (see methods sectiOn 4 I 4 2 2) 
Another popular screenmg tool1s the Alzhe1mer D1sease Assessment Scale-
cogmhve subscale (AD AS-Cog) (Rosen, Mohs, & Dav1s, 1984) whiCh 1s a battery 
of tests that assess memory, language, onentahon and prax1s and IS pnmanly used 
to measure changes m cogmlive funclion over lime However, the ongmal vers10n 
of the AD AS-cog d1d not salisfactonly assess execulive functiOn and was therefore 
amended approximately ten years later to mclude some executive functwn 
measures, changmg 1t from an 11-1tem to a 13-Jtem scale (Mohs et a! , 1997) 
A newly developed test battery measunng a w1de vanety of cogmlive domams IS 
the NeuropsychologiCal Test Battery (NTB) (Hamson et a! , 2007) wh1ch mcludes 
tests that measure attentwn, workmg memory and execu!Jve functiOn It was 
developed to be use to identify mild to moderate cases of AD, but has also been 
found to 1denlify some subtle changes m cogmlive functiOn not Jdenlified by the 
AD AS-cog m a tnal assessmg 1ts sens1liVJiy (G1lman et al, 2005) Due to th1s, 
Vellas et al. (2008) believe 1t may be used more often m future dementia tnals 
In the Umted Kingdom, the Cambndge Mental D1sorders of the Elderly 
Exammation (CAMDEX) (Roth et al , 1988) 1s often used It consists ofthree parts 
1) a structured chmcal mterv1ew w1th the participant to obtam mformahon about the 
present and past, as well as fam1ly h1story, n) a neuropsychological cogmlive test 
battery, and m) a structured mterv1ew wh1ch takes place w1th a relalive or mformant 
to substanliate the participants report and obtam any other necessary addJt!Onal 
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mformal!on The authors reported that the CAMDEX JS acceptable to patients, has 
h1gh mter-rater reliability, and has h1gh sensitiVity and specJfic1ty (Hogervorst et a! , 
2000, Roth et a!, 1986) The Cambndge Cogml!ve Exarnmatwn (CAMCOG) 1s a 
part of CAMDEX and JS the neuropsychological test battery used to assess cogml!ve 
function specifically (Huppert et a!, 1995, Roth et a!, 1986) An advantage of 
CAM COG (unlike the MMSE) JS that Jt has been found to have no ceJlmg effect 
However, Jt has been found to be h1ghly sensitive to educatwn and socweconom1c 
status (SES) and hence should be used w1th some cautwn (Huppert et a! , 1995), 
especially m poorer populatwns w1th low SES and/or educatwnal attamment 
The Cambndge Neuropsychological Test Automated Battery (CANTABf IS a 
computer based non-verbal (v1sual) test battery wh1ch assesses vanous cogml!ve 
functiOns governed by frontal and med1al temporal bram regwns (Robbms et a! , 
1994), namely Visual memory, attentiOn and plannmg The CANT AB has been 
reported to be sensJ!ive to the progressive cogml!ve declme found m AD (Sahakian 
et a! , 1990, SahakJan et a! , 1988), w1th the pa1red associates leammg task bemg 
especially sensJ!ive to AD (Sahakian & Owen, 1992) However, the graded nammg 
test Js not cross-culturally apphcable, and computer tests are not smtable for 
screenmg, particularly m developmg countnes 
The 10/66 Demenl!a Research Group test battery (Pnnce et a! , 2003) has been used 
successfully m Ind1an, Chmese and Latm Amencan countnes and validated cross-
culturally, correctly JdentJfymg 94% of demenl!a cases (Pnnce et a!, 2003) The 
10/66 Group use a number ofcogml!ve tests, an mformant mterv1ew, as well the 
Consortmm to Establish a Registry for Alzheimer's D1sease (CERAD) as part of the 
test battery Therefore, 1t IS qmte lime mtens1ve, takmg 2-3 hours to complete, as 
well as requmng tramed medJCa! staff It IS therefore unsmtable for the dementia 
screenmg process 
Another cogmt1ve screenmg test, the Row land Umvers1ty Demenl!a Assessment 
Scale (RUDAS) (Storey, Rowland, Basic, Conforti, & Dickson, 2004), was 
designed With the a1m of reducmg the effects of cultural and language differences m 
7 For the hst of tests that make up CANT AB see http 1/www cantab com/science/cantab-tests-all asp 
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cogmtive testmg It assesses language, memory, praxiS, JUdgement, drawmg and 
body onentation However, although the RUDAS has been found to have high 
sensitiVIty and specificity (Storey et a! , 2004), and has been reported to be as 
accurate as the MMSE (Row land, Basic, Storey, & Conforti, 2006), m South India It 
was found to be sensitive to the effects oflow education (Iype et a! , 2006) and 
hence may be unsmtable for testmg those With low educational attamment unless 
different appropnate cut-offs are used 
Across vanous dementia mcidence and prevalence studies, a wide vanety oftests 
have been used for cogmtive assessment, but when compared to the MMSE, they 
are not always as easy to admmister, reliable and sensitive For example, Burkart, 
Heun, Marer, & Benkert, (1998) reported that the 'Structured Interview for the 
Diagnosis of Dementia of the Alzheimer-type, Multi-mfarct Dementia and 
Dementias of other Aetiologies accordmg to ICD-10 and DSM-III-R' (SIDAM) and 
the AD AS-cog did not perform better than the MMSE m differentiatmg between 
dementia, mild dementia and non-demented participants Furthermore, some of 
these tests tend to be laborious and complex (unlike the qmck and non-mtrusive 
MMSE), as well as reqmre extensive trammg of medical staff(Lm et a!, 1994, 
Katzman et a!, 1988) This may make them less applicable or useable for dementia 
screemng m developmg countnes 
Regardless of how cognitive functiOn IS measured, a key cntenon of dementia 
diagnosis mvolves bemg cognitively Impaired to the pomt of disabrlity and resultmg 
m socral and functionalrmparrment In fact, dragnostic cntena (both DSM-IV and 
ICD-1 0) reqmre some mdication of detenoration of functional abrlity (Amen can 
Psychralnc Assocration, 1994, World Health Orgamsation, 1992) Therefore rt rs 
believed that functional abihty should also be measured when screenmg for 
dementia (Barberger-Gateau et a! , 1992) 
2.1.5.2 Functional Ability Assessment 
Many studres have shown a hnk between cognrtive dechne and consequent dechne 
m functiOnal abihty wrth dementia (Perry & Hodges, 2000, Mitmtskr, Graham, 
Mogilner, & Rockwood, 1999, Green, Mohs, Schmerdler, Aryan, & Davrs, 1993, 
Stern et al., 1992, Kramer-Gmsberg et a! , 1988). For example, m a retrospectrve 
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study assessmg the relatiOnship between cogmtive function (as measured by the 
MMSE) and functional ability, Mok et a! (2004) found that the two aspects we1e 
significantly correlated In those With a high level of educatiOn, who may score 
higher on tests of cognitive functiOn (see sectiOn 2 2 3 for discussion concemmg 
education as a nsk factor for AD), assessmg more mstrumental or complex 
functiOnal ability m particular may be an mvaluable tool to Improve the specificity 
of cogmtive screemng tests (P1sam, Inouye, MeN I coli, & Redlich, 2003, Morales, 
BermeJO, Romero, & Del-Ser, 1997) However, hnks do exist with age, as the older 
the age, the higher the chance that functional limitatiOns are due to other eo-morbid 
diseases or organic detenoratiOn (Castiila-RI!o et a! , 2007) Therefore, It IS harder 
to defimtively suggest that limitatiOns m functiOnal ability are as a result of 
cogn1!Ive declme, mdependent of agemg 
Although functiOnal Impairment IS not suggested as a nsk factor for development of 
dementia or AD, It usually occurs alongside dementia pathology (Ofstedal et a! , 
2007). Furthermore, diagnostic cntena of dementia reqmre some level of functiOnal 
Impairment FunctiOnal Impairment IS also of mterest as disability and functional 
Impairment IS on the nse across Asia (Ofstedal et a! , 2007) This mcrease does not 
appear to be the case m Western countnes such as the Umted States (Ofstedal et a!, 
2007) Trends m functiOnal status seen m Asia are similar to those seen m the 
Umted States m the 1970s and early 1980s This suggest that Asia may be at the 
cusp of a health transitiOn, makmg new research addressmg functiOnal status m Asia 
of high pnonty and the use of functional scales m assessments vital The two most 
common functiOnal ability measures are Barthel's ActiVIties of Daily LIVmg (ADL) 
(Mahoney & Barthel, 1965) and Lawton and Brody's Instrumental ActiVIties of 
Dmly LIVIng (IADL) (Lawton & Brody, 1969) Both the ADL and IADL were used 
to assess functiOnal ability m our Indonesian saiUple (see methods sectiOn 4 1 4 2 4) 
2.1.5.3 The Informant Report 
Recordmgs of memory complamts from the mdlVldual may be mdicative of an 
awareness of a degradatiOn of cogmtive processes (Barnes, Schneider, Boy le, 
B1emas, & Bennett, 2006) However, although useful as validatiOn of already 
recognised cognitive Impairment and good for giVIng an mdicatiOn of the Impact of 
cognitive Impairment on quality of hfe ( e g social and occupatiOnal functwnmg and 
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functiOnal ab1lity), due to the very nature of d1sease, self-reported cogml!ve 
complamts may not be the most reliable source of mformat10n Therefore, the 
careg1ver or mformant plays a v1tal role m the treatment and progress of demenl!a 
patJents as an mvaluable source of mformat10n 
Several measures have been developed to obtam standardised mformant reports 
The two most w1dely used are the Demenl!a Questwnna1re (DQ) (Sllverman, 
Bre~tner, Mohs, & Dav1s, 1986) and the Climcal Demenl!a Ratmg (CDR) (Hughes 
et a! , 1982) The DQ prov1des mformat10n for the d1agnos1s of demenl!a, but also 
assesses the specific cause of cogn1t1ve and funct10nal1mpmrments It 1s a semi-
structured mformant mterv1ew wh1ch does not measure cogn1t1on d1rectly but asks 
quest10ns of the mformant or careg1ver It thus places a great deal of emphas1s on 
the Importance of the mformant report as well as a collecl!on of fmmly h1story from 
a range ofmformants usmg standardised mstruments (S1lverman et a!, 1986) The 
DQ has been found to be a sens1t1ve and reliable measure of demenl!a screemng 
(Kawas, Segal, Stewart, Corrada, & Thai, 1994) It detects m1ld cases of demenl!a 
and d1scnmmates between demenl!a and other neurologJCa! disorders wh1ch are 
causmg funct10nal1mpmrment (Ellis et a! , 1998) 
The CDR scale IS a test developed for use specifically m AD and has been u!Jhsed 
m many stud1es mtematlonally (Hughes et a! , 1982) It has the advantages of 
measunng everyday changes m an md1v1dual's functlonmg, m h1s/her own settmg 
and w1thm the1r own cultural context It has estabhshed mter-rater rehab1lity, 
concurrent vahd1ty, and neuropathologic correlatiOn, as well as bemg robust agamst 
cultural b1as and prediCtive valid1ty (Berg et a!, 1998, Moms et a!, 1995, Welsh, 
Butters, Hughes, Mohs, & Heyman, 1992; Burke et a!, 1988, Berg et a!, 1984) 
Therefore, 1! 1s understandable why the CDR has been used m many As1an stud1es, 
in both urban and rural settmgs (FUJIWara et a!, 2003, Chandra et a!, 2001, Vas et 
a!, 2001, Chandra et a!, 1998, Graves et a!, 1996), and has been found to be 
compatible w1th DSM-IV for dementia dmgnos1s (L1m, Chm, Lam, L1m, & 
Sahadevan, 2005) However, the CDR does have a few disadvantages, wh1ch 
m elude rehance on an mfom1er (the 1mplicat10ns of th1s m an Indonesmn settmg, for 
example, wlll be d1scussed), rehance on chmcal JUdgement of the CDR rat er, length 
of admmtstrat10n, and relal!ve insenstl!vtty as a global measure of change 
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Furthermore, although 1ts reliability and validity have been confirmed m many 
studies, 1t IS not directly applicable to all Aswn settmgs and still reqmres some 
mod1fical!ons to the cultural settmg 1t 1s bemg used m (L1m, Chong, & Sahadevan, 
2007) 
It 1s possible that some non-cogml!ve symptoms may be unnoliced by the careg1ver 
and hence goes unreported, or when reported, the careg1ver burden may result m 
errors m Jdenl!fymg the symptoms (Zanetli, Gero!dJ, Fnsom, Bianchetli, & 
Trabucch1, I 999) It must be taken m to consideratiOn that reports from careg1vers 
may be maccurate and subjecl!ve, based on the expenences and stresses of carmg 
for someone w1th AD (T!emey, Szala1, Snow, & Fisher, 1996) When reportmg the 
patient's symptoms, Mangone et a! (1993) found that careg1ver burden mcreased 
w1th the number and seventy ofbehavwural symptoms, as well as cogmlive 
dysfunctiOn (Mangone et a! , I 993) Also, the careg1ver d1d not accurately report the 
palient's functwnal abihty, and palients showed better functwnal performance m 
direct assessment m aspects such as shoppmg, feedmg, dressmg and ambulatiOn. 
Th1s suggests that the burden may result m undereslimatwn of functwnal ability 
Similar Issues have been found m other studies (Zanett1 et a! , I 999) Hence, 
careg1ver's reports, particularly m sJtualions where behavwural symptoms are nfe, 
should be v1ewed w1th some cautwn 
Non-cogmlive disturbances have an 1mpact on functwnal 1mpa1rment and are also 
associated w1th mcreased careg1ver burden (Chenoweth & Spencer, 1986) 
Suspected AD cases may be able to perform bas1c self-care needs, but due to other 
Issues e g psychmtnc problems such as pacmg, ag1tatwn or deluswns, they may 
need some superviSIOn to carry these out safely and effiCiently The behavwural and 
psych1atnc symptoms, as well as the functwnal lim1tatwns often cause more distress 
for careg1vers than the memory 1mpa1rment (Rabms, Mace, & Lucas, I 982) 
Therefore, 1t is possible that mterventJOns which address these non-cogmt1ve 
problems may result m better quality of life for the AD pal!ent as well as less 
burden for the careg1ver Regardless of all th1s, 1t has been found that the mcluswn 
of an mformant's ratmgs w1th use of a cogmtJve measure such as the MMSE, can 
Improve the accuracy m pred1ctmg probable AD (T~emey, Herrmann, Geslam, & 
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Szala1, 2003) and even more so when additionally mcludmg the patient's own 
perceptwns oftheu cogmhve function (T1emey et a!, 1996) 
2.1.5.4 Conclusion 
Bemg labelled as havmg demenlia as a result of these assessments could result m 
more extensive climcal exammahon and diagnosis However, 1f a positive dwgnos1s 
1s reached m error, th1s could lead to embarrassment and sligmalisatwn of the 
mdividual, as well as mformmg future policies and practices We need to be able to 
trust and rely on compansons of dementia mc1dence and prevalence both w1thm and 
between countnes Therefore 1t IS essential that dmgnoslic cntena and tools are 
standardised across the world (as much as can be, accountmg for cultural vanatwn) 
When evaluatmg and companng findmgs from different countnes, populatwns and 
studies, we must take mto account what diagnostic cntena was used, how cognitive 
functwn was measured and other methods used to validate cognitive 1mpmrment, as 
well as other methodological Issues addressed m th1s review However, as has been 
seen m prevalence and mc1dence rates descnbed above, there IS great vanatlon 
between different countnes and populatwns m dementia prevalence, especially m 
the prevalence of different sub-types of dementia across the world. It IS possible, 
and mdeed probable, that other Issues or nsk factors are the cause ofth1s R1sk 
factors for the vanous demenhas are vaned. Th1s thesis discusses possible 
demographic nsk factors as well as modifiable nsk factors w1th a specific focus on 
the role of sex hormones and phytoestrogens (whiCh have a Similar structure and 
perhaps function as sex hormones) 
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2.2 Demographic Risk Factors for Dementia 
2.2.1 Introduction 
In the prevwus few sectiOns, diagnostic cntena, assessment methods as well as 
possible prevalence and types of dementia have been descnbed and discussed Of all 
types of dementia discussed, cross-culturally, AD has been found to be the most 
common, but also showmg the greatest vanatwn m prevalence cross-culturally 
(chapter 2 I 4) This could possibly be due to the greater number of nsk factors for 
AD that have been Identified In the early 1980s, although many nsk factors for AD 
were suggested, none were conclusively demonstrated, and It was consequently 
thought that age or agemg may have been the only viable nsk factor for AD 
(MortJmer, Schuman, & French, 1981, Sluss, Grunberg, & Kramer, 1981) Smce 
then, a wealth of research has provided a hst of potential nsk factors for the 
development of dementia, although an m-depth focus on specifically AD has 
Yielded hm1ted results with only a few nsk factors showmg strong evidence of any 
mdependent associatiOn Age, genetics (specifically the epsilon 4 allele of the 
Apohpoprotem E (APOE) gene), and dementia m a close family member are the 
only non-modifiable confirmed nsk factors (Stnttmatter & Roses, 1996, R1tch1e & 
Klldea, 1995; Hofman et al., 1991; Jorm et a!, 1987) However, previOus research 
has lead to the suggestion of a wealth of potential non-cognitive nsk factors, 
mcludmg some demographic, genetic, neuropsych1atnc, health, and lifestyle factors 
Potential demographic nsk factors for AD are discussed m this sectiOn 
2.2.2 Age 
A contmually growmg body of research suggests that at the forefront of these nsk 
factors IS age, or agemg, and the changes which are associated with mcrcasmg age 
As we age, there are pathological changes Withm the bram that result m varymg 
levels of cognitive declme (from age-related cognitive declme to full-blown AD) as 
well as differences m general health and wellbemg 
Scannmg processes such as MRI allow us to mvestigate anatomical changes m the 
bram' s structure and processes These could be markers for the subsequent declme 
that IS seen m cognitive functiOn and that are consequently displayed m behaviOur 
These changes could be possibly reflective of deeper cellular and neurochemical 
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transformations Furthermore, m those with a history of cerebrovascular disease, 
MRI shows white matter hypermtensitles m middle-aged adults (Krmt et a], 2004) 
Changes m the density of frontal cortex grey matter can also be Identified at an early 
age (Small, Tsm, DeLaPaz, Mayeux, & Stem, 2002) as well as atrophy of sub-
regions of the hippocampus as seen usmg MRI (Sowell et al, 2003) which was 
found to be a good marker for AD (Smith & Jobst, 1996) 
A wealth of research findmgs supports this notiOn that age, or agemg, IS one of the 
mam mdependent risk factors for dementia development (Keskmoglu et a] , 2006, 
Ogunmy1 et al , 2006, Zhang et al , 2006, Zhou et al , 2006; Herrera, Caramelh, 
S!lve1ra, & N1tnm, 2002, Lobo et al, 2000, Rocca et al, 1990, Jorm et al, 1987) 
For example, the MRC-CFAS report an mcreased nsk of dementia development 
with mcreased age With an odds ratio of 1 8 m people aged 70-74 years to 25 6 
those 90+ m companson to those aged 65- 69 years old (Y1p et al, 2006) It has 
been reported that overall dementia mc1dence mcreases with age at a rate of 1% per 
year (Rltch1e & Lovestone, 2002). Not only does AD mc1dence double every four 
years between the ages of 65 to 80 years (Hebert et al, 1995), dementia prevalence 
on the whole mcreases drastically after the age of 80 years (Hebert et al , 1995) 
When takmg these pomts m to consideratiOn, one must note that 'age-related' 
diseases begm before they are chmcally evident (Launer, 2005) In fact, It has been 
suggested that the chmcal symptoms of AD can be seen m the brams of sufferers as 
young as 40 years old (Braak, de V os, Jansen, Bratzke, & Braak, 1998) Most 
studies exammmg age as a nsk factor for cogmtlve declme (with var)'lng extremes) 
mclude mamly participants 65 years or older. However, the Imtlal pathological 
changes that lead to the degeneratiOn of healthy bram processes and the 
neurogeneratlve processes that may directly or md1rectly cause age-related changes 
are hkely to have already begun before the age of 65 years (Launer, 2005) 
Therefore, It IS of Importance to mvestJgate nsk factors m m1d-hfe, the old and the 
very old over time m order to map the rate and pathology of changes that occur as 
age mcreases 
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2.2.3 Education 
Both a high and low educahon have been suggested as factors which may mfluence 
the development of demenha, but this relationship between educatiOn and dementia 
IS a controversial one, w1th m1xed findmgs both across and wl!hm vanous cultures 
A low level of education has been associated With higher demen(la nsk (Zhou et a! , 
2006, Herrera et al., 2002, Callahan et a!, 1996, Katzman, 1993) For example, an 
epidemiOlogical study assessmg dementia prevalence across rural and urban Chma, 
Zhang et a! (2006) found a higher prevalence of demenHa m the Illiterate 
uneducated parts (36% ofthe sample) than those who had higher levels of 
educatiOn V ar1ous epidemwlogJCa! studies have reported th1s same m verse 
relationship between dementia and educatiOn (Fratighom et al., 2000; Letenneur et 
a!, 2000, Letenneur et a!, 1999, Ott et a], 1995, Katzman, 1993) However, this 
findmg has not been supported m several other populatiOn-based or case-control 
studies (Beard, Kokrnen, Offord, & Kurland, 1992, Fra!Jghom et a! , 1991, Chandra, 
Ph1hpose, Bell, Lazaroff, & Schoenberg, 1987, Shalat, Seltzer, P1dcock, & Baker, 
1987) In the Frammgham Study, an evaluatiOn of level of educatiOnal attamment as 
a nsk factor for dementia mc1dence found that unadJusted mc1dence rates for 
demenha and AD specific demen!Ja were higher for the least educated However, 
once this was adJusted for age, educatiOn was no longer a significant nsk factor for 
dementia or AD Interestmgly, an associatiOn was seen between level of educatiOn 
and non-AD types of demen!Ja 
PreviOus research has attempted to explam the mteractiOn between educatiOn and 
cognitive ab1hty by assessmg AD pathology It has been suggested that educatiOn 
may encourage dendntic growth m the bram and hence a lugh level of educatiOn 
would therefore have a protective effect agamst AD (Mort1mer & Graves, 1993) 
Another study mves!Jgatmg the mteractwn between AD pathology and cogmtive 
functiOn reported that AD pathology (neuntic plaques and diffuse plaques only) was 
related to cognitive functiOn performance, and this relatiOnship differed by years of 
formal educatiOn (Bennett et a! , 2003). Further evidence comes from the results of 
an an1mal study which suggests that an enriched envuonment encourages an 
mcrease m cortical thickness as well as the number of synapses (Diamond, 1988) 
Research such as th1s has led to the theory of 'bram reserve' BwlogJCa! evidence 
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suggests that educatiOn may thus prov1de a reserve (the bram or cogmtlve reserve 
hypothesis) wh1ch affects the chmcal and consequently diagnosable mamfestat10n 
of dementia In other words, educatiOn protects agamst the chmcal mamfestatwn of 
dementia, or educatiOn g1ves a greater capac1ty to better manage the 1mpmrment 
caused by progressive neurodegeneratwn (Satz, 1993; Stern, Alexander, Prohovmk, 
& Mayeux, 1992, Mortlmer, 1988) 
RegiOnal cerebral blood flow (rCBF) reduc!ions are present from the early stages of 
AD (Prohovmk et a!, 1988), d1scnmmatmg AD from normal agemg, maJor 
depress1ve d1sorder, multnnfarct dementia, and P1ck's d1sease (see Prohovmk, 
Alexander, Tatem1ch!, & et a!, 1991; Sacke1m et al., 1990, Sacke1m, Prohovmk, 
Mayeux, & et a!, 1990; Rlsberg & Gustafson, 1988) rCBF reductions are also 
correlated w1th post-mortem histological diagnosis m AD patients (R1sberg & 
Gustafson, 1983), as well as disease seventy, showmg an mcrease With disease 
progressiOn (Foster et a! , 1984) If a h1gh level of educatiOn mcreased the threshold 
for the chmcal mamfestatwn of AD, one would expect more severe pathological 
changes m those w1th h1gher educatiOn (reduced perfuswn m the panetemporal 
cortex), 1 e greater panetemporal flow deficit In those diagnosed w1th dementia, 
rCBF data did find a nega!ive correlatiOn between educatiOn and cerebral perfuswn 
(Stem et a! , 1992) Patients w1th more education had the greatest perfuswn defic1ts 
m AD affected flow areas This thus provides evidence that h1gh levels of educatiOn 
could result m a reserve agamst the chmcal expressiOn of AD These findmgs do not 
clmm that educatiOn IS necessanly protective agamst AD, but that educatiOn delayed 
the chmcal mamfestatwn of AD pathology, and the d1agnos1s of AD m patients w1th 
h1gher educatiOn may not be until there 1s a declme m functiOnal ab1hlies 
The theones presented by the bram reserve hypothesis represent a double-edged 
sword Although a high level educatiOn clearly has beneficial effects on cogn1t1ve 
function, 1t also mcreases bram reserve and may mask AD pathology necessary to 
diagnose and treat possible AD Therefore the questiOn that begs to be asked 1s how 
these mdlVlduals who have a h1gh reserve can be 1den!ified and treated at an early 
stage The focus needs to be on AD pathologiCal biomarkers that are mdependent of 
bram reserve, and usmg these bwmarkers to identify mdividuals With AD pathology 
before 1t IS mamfested chmcally One possible bwmarker IS hippocampal atrophy 
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Some studies have reported that hippocampal volume IS strongly correlated to 
Braak's neurofibnllary stage (Gosche, Mor!Imer, Smith, Markesbery, & Snowdon, 
2001) and IS a reliable as sensitive mdiCator of AD pathology (Gosche, Mort1mer, 
Smith, Markesbery, & Snowdon, 2002) Hippocampal volume can be measured 
usmg CT or MRI, both post- and ante-mortem, and has been shown to have the 
ability to track very early stages of AD and may therefore feasibly Identify 
mdiVIduals at nsk possibly decades before the chmcal symptoms appear (Jack et al , 
2002) However, hippocampal atrophy alone IS unlikely to Identify these at nsk 
mdividuals. Other md1cators such as global atrophy measures and the mvestigatwn 
of volumes of other regiOns are needed to reliably show AD neuropathology 
(Mort1mer, Borenstem, Gosche, & Snowdon, 2005) As well as functiOnal MRI 
markers, others such as PET markers of amyloid~ (A~) pathology, plasma A~ 1 -42 , 
antibodies to A~, olfactory loss and serum protems need to be considered for early 
diagnosis of AD (Mort1mer et a! , 2005) 
Reflectmg the bram reserve hypothesis, some studies have suggested a relatiOnship 
between early hfe (from childhood nght up to mid-life) and later hfe cognitive 
functiOn For example, m a study analysmg data from nuns (Snowdon et al , 1996) 
low lingmstic ability m early life was a strong predictor for poor cognitive ability 
and subsequently AD m later hfe Whalley et a! (2000) reported that late onset (and 
not early onset) dementia was associated with cognitive ability m childhood, which 
becomes stronger at later ages of onset Whalley et al. (2000) suggest that childhood 
mtelhgence IS hence a reliable proxy for cognitive reserve In support of this, 
R.Ichards et al. (2004) reported that cognitive decline between the ages of 43 and 53 
years was partly explamed by ch1ldhood mtelhgence (mdependent of educatiOnal 
atta1mnent) 
A similar concept was fonnd m a study of US armed forces wh1ch showed that 
cogn1t1ve performance m later hfe was associated with cogmtive ability measured 
earlier on m their adult lives (Plassman et a! , 1995) This Idea that AD can be 
expressed via different cognitive functwns m early hfe has been supported by bram 
Imagmg studies assessmg the relationship between cerebral blood flow and 
educatiOn (Stem et a! , 1992), as well as cerebral metabolism and premorb1d 
measures of mtelhgence (Alexander et al , 1997) These stud1es fonnd that m 
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patients with similar levels of climcally diagnosed dementia, greater cerebral 
metabolic deficits were assoCiated With premorbid ability or higher levels of 
educatiOn which would suggest that AD was more advanced m these subjects 
Additionally, It may be beneficial to view the mteractwn between educatiOn and 
dementia nsk as one that IS either quantitative (I e the number of years of 
educatiOn) or qualitative (I e. obtammg a certam standard m educatiOnal 
assessment) A qualitative view focuses on reachmg a certam level of mtellectual 
ability and may be more reflective of cogmtive ability than a quantitative view. For 
example, statmg that an mdividual had 'X' number of years of education does not 
portray what level they attamed, for example did they take and pass the test for a 
high school qualificatiOn and what grade/level was achieved? This also provides a 
problem when companng and contraslmg different studies which assess educatiOn 
m one way or another and should be considered when evaluatmg the results of 
studies mvestigatmg the relatiOnship between educatiOn and cogmtive functiOn 
Although observational evidence provides data on the link between educatiOn and 
dementia, the wealth of mformatwn has been disappomtmg and It IS unknown If It IS 
educatiOn Itself that affects bram development and consequently cogmtive functiOn, 
or If a higher level of educatiOn results m a selectiOn of healthy participants Thus 
an mcreased awareness and use of early detection mformatwn, as well as better 
access to healthcare could result m combatmg dementia development at an early 
stage. Furthermore, It IS possible that associatiOns seen between low levels of 
educatiOn and higher dementia prevalence could be explamed by reasons other than 
the effect of educatiOn on cognitive functiOn A poor educatiOn could result m 
poorer performance on the screenmg tools used to diagnose dementia, and therefore 
higher detectiOn rates This could lead to false-positives m those with low levels of 
education and m turn false-negatives m those with higher levels of educatiOn 
(Kittner et a! , 1986). Therefore educatwnal attamment must be considered when 
mvestigatmg cognitive function and decidmg on assessment tools m populatwns of 
both high and low educational attamment 
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2.2.4 Socioeconomic Status (SES) 
Social and cultural factors mfluence our development as people, but also our 
expenence of health and agemg SociOeconomic development vanes both between 
and Withm cultures and countnes, and has direct links With environmental factors 
such as access to healthcare. Differences between cultures and societies m 
healthcare are apparent, which could be attnbuted to socio-economic status (SES), 
makmg SES a 'fundamental cause' ofhealth (Link & Phelan, 1995) Therefore 
those with higher SES may have better understandmg of diseases and their 
symptoms through better access to health care mformation, and can address 
symptoms earlier through better access to treatment This group may also better 
understand lifestyle behaviOurs, which would encourage good health and may also 
have lower levels of stress, higher quality of social support and greater feelings of 
control over their lives Interestmgly, m a non-demented Swedish sample, Karp et 
a! (2004) reported that although a combmatiOn of low educatiOn and low SES 
mcreased the nsk of dementia, well-educated partiCipants with low SES were not at 
high nsk of AD, 1 e the effects of high education overruled the effects of low SES 
However, research mto this association has been limited especially m developmg 
countnes. What has been found IS that this associatiOn IS more profound m non-
western societies, perhaps due to the vast extremes of poverty seen m these societies 
compared to the developed world (Z1mmer & Kwong, 2004, L1ang, Liu, & Gu, 
200 I) Another important pomt to note when focusmg on the developmg world, 
such as parts of East Asia, IS the Impact of the family umt and family support It IS 
not uncommon for the elderly to live With sons, daughters and grandchildren, and 
although the elderly may be charactensed as from a lower SES, these younger 
generations have more access to education and healthcare which may extend the 
resources avmlable to older people (Hermahn, Ofstedal, & Chang, 1996) 
2.2.5 Profession 
Some studies have suggested that lifetime occupatiOn may mfluence cogmtive 
functiOn For example, a populatiOn-based, case-controlled study found a significant 
assoCiation between havmg a manual professiOn and a higher prevalence of 
dementia (Bonamto et a! , 1995) This Is mmored by (Zhang et al , 2006) who 
found high dementia prevalence m farm labourers and housewives compared to 
officials and professiOnals 
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Educatwn can affect the professwn choice of an mdividual m later life, and these 
two vanables have thus been linked to each other m rclatwn to AD nsk A lower 
level of educatwn may result m a more manual and less cogmtively demandmg 
profession m adult life Some studies have suggested that m creased levels of mental 
stimulatwn throughout one's lifetime can result m alterations m bram physiOlogy, 
e g the production of greater synaptic mterconnectiv1ty among neurons (Diamond, 
1990, Greenough & Green, 1981) Those who have not reached a certam level of 
mtellectual achievement m early hfe by fa~hng (mdicative oflower mtellectual 
ability) as opposed to not takmg a test (does not necessarily reflect lower 
mtellectual ability), may then go on to have Jobs or futures with less cogmtive 
stimulatwn and therefore less bram reserve It IS also possible that the roles these 
subJects then take m later life, for example, m a rural settmg where It IS the nonn to 
go mto the fannmg or labounng professwn, may lead to greater exposure to toxms 
and chemicals that may have a degenerative effect on the bram and mcrease the nsk 
of developmg AD Therefore, It seems unlikely that professwn, m Itself, can be 
Identified as an mdependent nsk factor for dementia and It may be modified by 
other vanables such as educatiOn or livmg m an urban or rural area 
2.2.6 Urban/Rural Living 
In Chma, rural livmg status has been assocmted With higher AD prevalence than 
urban areas (crude and age-adjusted analysis, which was did not remam significant 
when all other demographic vanables were added to analyses) (Zhang et a! , 2006) 
However, this does not tie m With Western studies which do not report a rural and 
urban difference m AD prevalence (Y1p et al., 2006, Keefover et a!, 1996, 
Fratigliom et al, 1991; Rocca et a!, 1990) Interestmgly, m a twist to this theory, 
Hall et al (2000) report that livmg m a rural area m childhood, combmed with less 
than or equal to 6 years of educatwn was associated with an mcrease nsk of AD m 
Afncan-Amencans Along similar hnes, Ogunni)'l et a! (2006) found that rural 
hvmg before the age of 19 years of age was a significant nsk factor for mc1dent AD 
m Afucan-Amencans The mfluence ofrura1 livmg could be attnbuted to other 
environmental factors, such as less access to health care and educatiOn and greater 
likelihood of poverty, or the environmental exposures that come With more time 
spent domg rural-type manual actiVIties (Hall et a! , 2000) 
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2.2. 7 Gender 
Gender differences m dementia and also AD mc1dence and prevalence have shown 
vanatwn across studies 
2.2. 7.1 Prevalence Studies and Gender Differences 
The findmgs of The European Commumty Concerted Actwn on the Ep1demwlogy 
and Preventwn of Dementia Group stud1es, reported that women had an mcreased 
nsk of developmg AD when compared to men (Lobo et a! , 2000) In fact most 
European based dementia prevalence studies report higher AD prevalence m women 
(O'Connor, Archer, Ha1r, & Wu, 2001; Bachman et a!, 1992, Dart1gues et a!, 1992, 
Folstem, Bassett, Anthony, Romanoskl, & Nestadt, I 991, Rocca et a! , 1990), w1th 
similar findmgs m other parts of the world e g m Brazil (Herrera et a!, 2002), 
Turkey (Keskmoglu et a! , 2006), Chma (Zhang et a! , 2006, Zhou et a! , 2006; 
Zhang et a! , 1990), and the Netherlands (Heeren, Lagaay, HIJmans, & Rooymans, 
1991) The female gender has been found to be a nsk factor m Afncan-Amencans 
and N1genans (OgunnJ)'l et a! , 2000, Hall et a! , 1998) However, the same group 
later reported m further study that the female gender was not a risk factor for AD m 
Afhcan-Amencans The researchers attnbute tins earher reported gender difference 
to the women reachmg an older age, as well as the possible cultural factor of women 
havmg obtamed lower educatwnal attamment, Ieadmg to lower cogmtlve 
performance, and consequently, a h1gher chance of selectwn for second stage 
assessment (Ogunniyi et a! , 2006) 
Not all prevalence studieS have reported h1gher prevalence of dementia m women, 
w1th some findmg no difference between men and women (Y amada et a! , 1999, 
van DmJn, 1996, Lm et a!, 1995, Elby, Parhad, Hogan, & et a!, 1994, Pfeffer, Afifi, 
& Chance, 1987) and one even reportmg h1gher AD prevalence for men (Lobo, Saz, 
Marcos, D1a, & De-Ia-Camara, 1995) The reason for th1s var~atwn m findmgs 1s 
that prevalence studies face similar Issues to pooled analysis, as they usually 
mvolve collectmg a vast amount of data from different sources Another 1ssue 1s that 
prevalence IS determmed by mc1dence rates as well as the duratwn of survival post 
disease onset R1sk of d)'lng IS lower for women, therefore women, on average, hve 
w1th AD for a longer penod of time (Hebert, Scherr, McCann, Beckett, & Evans, 
2001). 
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2.2.7.2 Incidence Studies and Gender Differences 
Although the recent MRC-CFAS showed that women had a shghtly higher nsk of 
mc1dent dementia (OR= I 6) when compared to men (Y1p et al, 2006), most 
mc1dence studies have not shown any Significant associatiOns between gender and 
an mcreased nsk of AD or dementia (Aevarsson & Skoog, 1996, Hagnell et a] , 
1991, NI!sson, 1984) Although some mc1dence studies have reported associatiOns 
between the women and an mcreased nsk of dementia, they do not reach 
significance (Brayne et al, 1995; Yosh1take et al, 1995, Paykel et al, 1994, 
Aronson et al, 1991), or when reportmg h1gher dementia mc1dence m women, have 
not given the statistical Significance of the results (Rorsman, Hagnell, & Lanke, 
1986; Molsa, Martti!a, & Rmne, 1982) When the female gender has been shown to 
mcrease mc1dent dementia or AD, It appears to have an associatiOn With age For 
example, the Rotterdam and Gothenburg studieS reported no sex differences m 
dementia mc1dence even up to very old age, although AD mc1dence after the age of 
90 years was higher m women than m men (Rmtenberg et al., 2001) In some cases 
significantly higher dementia mc1dence has been found for women This has been m 
studies where the participants are over 85 years of age (Gussekloo, Heeren, Izaks, 
L1gthart, & RoOIJmans, 1995), or over the age of75 years, as well as only for AD, 
e g m the Kungsholmen ProJect (Fratighom et a! , 1997) In addition, some studies 
have reported higher mc1dence of dementia (B1ckel & Cooper, 1994) and AD m 
men before the age of75 years (Schoenberg, Kokmen, & Okazakl, 1987) and 80 
years (Letenneur et al , 1999) and a h1gher mc1dence m women after that age. One 
must note that many of these mc1dence studies were small and the number of men 
mcluded where (mc1dence levels for dementia were at their highest) was low 
Although the maJonty of population-based prevalence studies have thus found 
higher prevalence of AD among women, many of these studies had small sample 
sizes or d1d not have statistiCal Significance The same can be sa1d for mc1dence 
studies, and even more so because fewer men than women survive m follow-up 
studies to the oldest age groups m which AD IS most nfe Two reports, a meta-
analysis (Gao, Hendne, Hall, & Hm, 1998) and a pooled analysis (Launer et al, 
1999) have reported higher AD mc1dence m women Results from pooled analysis 
or meta-analys1s are more robust as they address the problem of low numbers 
However, there IS such var1abihty m the methodology between studies that other 
42 
poss1ble confoundmg vanables may have an mdirect effect on the results obtamed 
Th1s IS particularly true for pooled analys1s wh1ch has hm1ted ab1hty to control for 
mter-study vanatwn, a partiCular problem when companng men and women from 
different populatwns (Hebert et a!, 2001) 
We must also note that there IS such a great vanatwn between stud1es m number of 
partJc!pants, duratwn, number of evaluatiOns, attntwn rates and most Importantly 
d1agnostJc cntena, that 1t would be unw1se to assume equal vanance between 
stud1es (Brayne et a! , 1999; D1 Ban, W!lhamson, & Pahor, 1999) It 1s Important 
that gender-specific studies are des1gned and executed m a way which controls for 
possible confoundmg variables m order to have empmcal data from wh1ch more 
confident concluswns can be drawn about gender as an mdependent nsk factor for 
AD. 
2.2.7.3 Gender, Estrogens and Dementia 
As prevwusly d1scussed (sectwn 2 2 7), research mvestlgatmg the poss1ble gender 
difference m nsk for Alzhe1mer's d1sease (AD) has reported that women may have a 
greater nsk of developmg AD than men (Launer et a! , 1999) Th1s could be 
attnbuted to the fact that women reach an older age than men, and AD shows a 
greater mc1dence w1th age. However, the age-spec1fic mc1dence of AD has also 
been reported to be h1gher m women than m men (Fratlghom et a! , 2000) 
Unfortunately, the mformatwn that Is currently available on gender as a nsk factor 
for dementia IS based on post-hoc statistical analyses for women compared to men, 
sometimes w1th unequal numbers of women and men This 1s mev1table because 
women hve longer than men and the percentage of men at the ages where nsk 1s 
more prevalent IS relatively low Also, there are differences between men and 
women m educatwn and occupatwn as well as hfestyle aspects which may mcrease 
the nsk of developmg AD 
An alternative or addJtwnal reason why gender could affect nsk of AD has been 
attnbuted to the role of sex hormones Owmg to Its bwlogJcal plausJbJhty to protect 
the bram, deficiency m estrogen (E) after the menopause has been suggested as a 
potentially Important factor m the development of dementia Therefore, It was 
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beheved that hormone therapy (HT) would be a beneficial mterventwn for treatmg 
or preventmg dementia m older women (Tang et al , 1996, Henderson, Pagamm-
Hill, Emanuel, Dunn, & Buckwalter, 1994) In this next sectiOn of the literature 
review, hormone dependent modifiable nsk factors for Alzheimer's disease and 
cogmtive Impmrment are discussed Firstly, the role ofE m cogmtJve function IS 
reviewed with the aid of a meta-analys1s ofRandom1zed Controlled Tnals (RCTs) 
assessmg the effects of hormone replacement therapy (HRT) on cogmt1ve functiOn 
m postmenopausal women Contrary to previOus research findmgs from these small 
RCTs as well as observatiOnal studies, recent research has suggested that E may not 
be protective of cogmtiVe functiOn m postmenopausal women This shift has lead to 
a recent focus of 'natural' alternatives such as phytoestrogens The role of 
phytoestrogens m mamtammg cogmtJve functiOn IS then discussed m sectiOn 2 3 2 
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2.3 Hormone Dependent Modifiable Risk Factors for Alzheimer's 
disease and Cognitive Impairment 
2.3.1 M eta-Analysis of the Effect of Hormone Treatment on Cognitive Function 
in Postmenopausal Women (the maJonty of tins section has been published 8) 
2.3.1.1 Introduction 
The relatwnsh1p between sex hormones (both endogenous and VIa HT) and 
cogmt1ve functwn has been under extensive mvestJgatwn over the last three 
decades Results of many ammal and cell culture studies have repeatedly shown 
potential protective effects ofE on the bram For mstance, synaptic plasticity was 
shown to be enhanced through bmdmg ofE to Its receptors m the hippocampus and 
nucleus basalis ofMeynert, areas that are both Implicated m AD (Levmoff & 
Chertkow, 2002) In ammal models, E has been found to mcrease dendntJc density 
m the hippocampus, which has the highest concentration of E receptors (W oolley, 
1998) In affected AD brams, the hippocampal regwn IS severely affl1cted, 
suggestmg that the bwlogJCal effects ofE m th1s area of the bram could perhaps 
preserve cogmtlve functiomng by havmg an impact on cogmtlve declme pnor to the 
onset of AD It has been found that E use preserves regional cerebral metabolism, 
protectmg agamst metabolic decline m postmenopausal women, agam especially m 
the areas of the bram found to be adversely affected m AD (Rasgon et al , 2005) 
Detmled rev1ews of the possible effects ofE m protectmg the bram are already 
avmlable (Smgh, Dykens, & Simpkms, 2006, Boulware & Mermelstem, 2005) In 
fact, It was stated that there are almost nmumerable bwlogical reasons why E could 
be protective agamst both bemgn memory loss and AD (Barrett-Connor, 1998) 
On the basis of the biological findmgs outlined above, the mne!Jes showed great 
opt1m1sm regardmg the benefits ofE therapy m the treatment of AD Th1s was 
encouraged by an mcreasmg number of pos1t1ve observatiOnal studies and a number 
of small treatment tnals, wh1ch provided evidence supportmg the potentially 
beneficial bwlog1cal effects ofE The theoretical bas1s behmd the 1dea that E could 
protect agamst AD was summed up as follows (Atwood, 2005) -
8 Yesufu, A, Bandelow, S , Hogervorst, E (2007) Meta·analyses of the effect of hormone treatment on cogmttve functton m 
postmenopausal women Women's Health mvtted revtew 3(2) 173-194 
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• There IS a pos1t1ve relationship between AD and decreasmg E levels after 
menopause, 
• A sudden ear her loss of gonadal functwn seen m postmenopausal women 
compared With men IS assoc~ated w1th an mcreased prevalence of AD m 
women; 
• There IS generally decreased mc1dence and delay m the onset of AD m 
observatiOnal stud1es of women usmg HT after the menopause (Atwood, 
2005) 
Wh1le these arguments follow a logJCal system, they have, unfortunately, not always 
supported by current research F1rst, m contrast to imtlal findmgs, several well-
controlled observatiOnal stud1es actually reported h1gher levels ofE m women w1th 
AD compared w1th controls (Hogervorst, 20 06) Second, m contrast to European 
and As1an stud1es, observatiOnal stud1es m the USA d1d not find mcrcased mc1dence 
of AD m elderly women compared w1th age-matched men (Edland, Rocca, 
Petersen, Cha, & Kokmen, 2002), and men have often been found to show faster 
age related cogmtlve dechne than women (Hogervorst, 2006) Last, more recent, but 
also several earher, observatwnal stud1es d1d not show protective assoc1atwns of HT 
use agamst AD (Hogervorst, 2006) 
2.3.1.2 Observational Studies of Endogenous Estrogen Levels in men and 
women without dementia 
A number of observatwnal stud1es have mvestigated the relatwnsh1p between 
naturally occumng E levels and cogmtlve functwn m both men and women The 
MRC Challenge Fores1ght ProJect (Hogervorst et a!, 2004) was a study of !58 
healthy, commumty dwellmg elderly men and women not usmg HT. The results of 
the study showed that h1gh levels of total estradwl (E2) had a pos1t1ve relationship 
w1th verbal memory (a sex sensitive test) m women but tillS was not found m men 
However, m men younger than 72 years of age, spatial span score was better w1th 
h1gher levels of total E2, the most potent Em the bram These results for women 
showed panty w1th the results of other stud1es (Wolf & Kmchbaum, 2002, Drake et 
a! , 2000) and poss1bly suggest that E has protective quaht1es for women w1thout 
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dementia agamst memory dysfunction However, others have not found a positive 
associatiOn between total or bwavmlable E levels and verbal memory m women 
without dementia (Barrett-Connor, Goodman-Gruen, & Patay, 1999, Polo-Kantola 
et a! , 1998) Yaffe et a! (2000) d1d find positive associatwns between bwavaiiable 
E2 and global cogmtive functiOn m healthy older women but not, m an earlier study, 
with total E2 levels (Yaffe, Grady, Pressmm, & Cummmgs, 1998) 
2.3.1.3 Observational Studies of Estrogen Levels and Alzheimer's disease 
Studies mvestigatmg levels ofE m women with dementia compared to controls 
have )'lelded Widely varymg results Fmdmgs range from higher levels of E m 
female AD partiCipants (Paoletti et a!, 2004; Cunnmgham et a!, 1994), to higher E2 
levels m controls compared to AD patients (Manly et a! , 2000, Filii! et al , 1986), to 
studies showmg no significant difference For example, Carlson et a! (2000) found 
no significant difference m E2 levels between male and female AD patients and 
controls Re-analyses ofHonJo et a! (1989) results (Hogervorst, Wilhams, Budge, 
Riedel, & Jolles, 2000) found no differences between women with AD and controls 
Cunnmgham et a! (1994) could also find no difference m E2levels, although this 
group did report higher levels of estrone (El), which IS a maJor metabohte ofE, m 
women with AD. 
Short et a! (2001) found that women with AD not usmg HT had higher levels of 
folhcle-stimulatmg hormone (FSH) and lutetmzmg hormone (LH) (two 
gonadotropms produced by the p1tmtary gland which normally regulate sex steroid 
hormone productwn) This could be a normal response to havmg lower levels ofE2 
However, their findmg was m contrast With findmgs from the OPTIMA study which 
showed that E2 was slightly, but significantly higher m women With AD, while LH 
and sex hormone bmdmg globulm (SHBG) levels were lower (Hogervorst, 2006) 
Paolett1 et a! (2004), similar to the OPTIMA study, found that women with AD had 
higher E2 and SHBG levels but reported lower bwavmlable testosterone (T) levels 
when compared to controls. 1n contrast, a recent observatiOnal study by Tsolaki et 
a! (2005) studied serum levels ofE2, progesterone (P), T, LH and FSH m a sample 
of women with AD compared to a group of somewhat younger controls Results 
showed that only E2 levels were significantly lower m the group of women With AD 
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(mean age= 72 years) compared to levels m controls (mean age= 65 years) 
Analyses were controlled for sex, age, ethmc group and educatiOn There was no 
stgmficant difference m the levels of the other four hormones An Important Issue m 
this study was the potential difference m age dtstnbutiOn between cases and 
controls, as levels ofE2 drop with age However, perhaps more Importantly, similar 
to other studies reportmg no difference or lower levels ofE2 m AD cases, was a 
lack ofE2 assay sensitiVIty Usmg quantitattve meta-analyses, Hogcrvorst, et a! 
(2003) suggested that a lack of assay sensitivity was responsible for findmgs 
suggestmg that E2 levels are lower m women With AD. 
Levels ofE2 are very low m elderly women and It IS unclear what the physiOlogtcal 
stgmficance of vanations m levels would be It IS also unclear what the associations 
between cogmtJve functwns and endogenous sex sterOid levels really reflect 
Importantly, several sources ofbtas (e g, healthy userbtas and recall btas) exist m 
observatiOnal studtes hmttmg their predictive value (Hogervorst, 2006) Ultimately 
the proof of the effect of sex stermds on bram actlVlty lays m the results of HT 
treatment studtes 
2.3.1.4 Exogenous Estrogens and Cognitive Function 
Pnor to recent findmgs, the tdea that HT could potentially reduce the nsk for 
dementia m women was wtdely credited and accepted. Well-controlled treatment 
studies ultimately provide the most compellrng evidence Most of the early 
treatment studies showed favourable effects of HT, m hue wtth biO!ogtcal 
plaustbthty studies (Hogervorst et a! , 2000) However, several of the Imtial 
treatment tnals had methodological problems (e g, stze and stattstJcal analyses), 
which had already ear her led to scepticism about their results (Yaffe, Sawaya, 
Lteberburg, & Grady, 1998) In addition, many better-controlled treatment studies 
performed m recent years have )'lelded opposmg results For example, several 
recent large, well controlled, randomtzed controlled tnals (RCT) showed that HT 
dtd not prevent cogmtive dechne or dementia and dtd not Improve cogmtive 
abthties m postmenopausal women with or without dementia (Vtscoh et a!, 2005; 
Mulnard et a!, 2000, Wang et a!, 2000) 
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The largest and best known of these RCTs to date has been the Women's Health 
lmtJatJve- Memory Study (WHIMS) (Shumaker et al, 1998) The WHIMS was a 
large, mulhcenter, random1zed, double-bhnd, placebo controlled tnal m wh1ch a 
subgroup of several thousand women from the Women's Health ImtJatJve (WHI) 
study were assessed for the effects of HT on mc1dence rate of demenha and MCI 
Part1c1pants were aged 65 or older (and were thus all postmenopausal), and rece1ved 
conJugated equme estrogens (CEE) plus Medroxyprogesterone acetate (MP A) 
versus placebo (Rapp et al, 2003) or contmuous unopposed CEE versus placebo 
(Espeland et al, 2004) The combmed tnal arm was d1scontmued m 2002 after 
concerns arose regardmg 1ts safety (mamly an mcreased nsk of breast cancer) The 
CEE and MP A tnal found, contrary to the earher wealth of sc1entific ev1dence 
(wh1ch ha!led HT as havmg a pos1t1ve mfluence on cogm!Jve functwn), that the 
w1dely used Prempro™ mcreased the nsk for demen!Ja (Shumaker et al, 2003) 
Several sc1en!Jsts concurred w1th the WHIMS authors that HT should not be 
recommended as an effec!Jve preven!Jve treatment agamst demen!Ja (Alme1da & 
Fhcker, 2005) A smaller subset of WHIMS part1c1pants rece1vmg combmed 
treatment (n = 1417) showed nega!Jve effects on verbal memory as well as some 
pos1hve effects on VISUal memory (but only after 3 years of treatment) (Resmck et 
al., 2006) Th1s demonstrates, once agam, the van able results of HT and cogmhon 
stud1es. 
In February 2004, theE-only (CEE) arm of the WHIMS (WHI) was also 
d1scontmued due to an unacceptable mcreased nsk of stroke m the treatment group 
The results were pubhshed m Apnl of the same year (Anderson et a], 2004, 
Espeland et al, 2004) S1m1lar to the findmgs of the WHIMS CEE and MPA tnal, 1t 
reported an mcreased nsk of demen!Ja onset, although 1t was of a smaller magmtude 
(Anderson et a!, 2004) 
It IS not clear why negahve effects of HT on ncurocogmhve health were found m 
the WHIMS. Lacunar mfarcts and h1gh-grade deep wh1te matter leswns are nsk 
factors for demen!Ja (Kuller et a!, 2003; Vermeer et a!, 2003; Hogervorst, Rlbe1ro, 
Molyneux, Budge, & Sm1th, 2002) It was suggested that multJ-mfarcts may have 
played a role m the results reported, as MP A has been associated w1th an mcreased 
nsk of vascular d1sease (Sarrel, 1990) However, m the WHIMS, the presence of 
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cardwvascular disease or hypertensiOn at baselme d1d not confound study analyses 
In additiOn, controllmg for mfarcts m post hoc analyses by excludmg women w1th 
stroke did not alter the assoc1atwn between HT and demen!ia, and the effect 
remamed when only AD cases were selected for analyses (Shumaker et a!, 2003) It 
remams to be mves!igated whether microvascular events could have played a 
medmtmg role m the m creased demen!ia nsk (Shumaker et a! , 2003) Recent 
analyses of the study found mcreased nsk ofbram atrophy m HT users (Resmck et 
a!, 2009). 
2.3.1.5 M eta-analysis Results 
For th1s rev1ew, we performed quantJtatJve and quahta!ive m eta-analyses of HT 
treatment stud1es usmg Revman software provided by the Cochrane library 
standardized rev1ew system, employmg both the1r mcluswn cntena and their 
sta!is!ical methods (update) (Hogervorst, Yaffe, R1chards, & Huppert, 2002a) (see 
tables 1 & 2) 
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Table I Hormone replacement therapy for cognitive function in postmenopausal women: characteristics of included studies. 
Study 
Almc1da et 
al (2006) 
Bmder et al 
(200I) 
D1tkoff et al 
(I991) 
Duka et al 
(2000) 
Methods 
Random1zcd, 
double-blmd, 
parallel groups, 
20 weeks 
Randmmzed, 
double-bhnd, 
parallel groups, 
9 months 
Random1zed, 
double-bhnd, 
parallel groups, 
3 months 
Randomt7ed, 
douhle-blmd, 
parallel groups, 
3 weeks 
Parhc1pants 
Country Austraha, n = 86, 
healthy women aged over 70 
years, mean age 73 8 years, 
natural or surg1cal menopause 
not stated 
Country USA, n =52, elderly 
healthy \\'Omen, mean age 82 
(75-91 years), surg1cal or 
natural menopause 
Country USA, n == 36, healthy 
"-Omen, mean age 53 (45-60 
years), hysterectomized, 
symptomatiC patients 
Country UK, n = 37, healthy 
\\Omen, mean age 65 (55-75 
) ears), natural or surg1cal 
menopause not stated 
Inten·enhons 
1 E2 oral (0 5 mg weeks 1-2, 
1 mg v.eeks 3-4, 2 mg weeks 
5-16, I mg weeks 17-18,0 5 
mg weeks 19-20) 
2 Placebo 
I CEEoral 
0 625 mglday +(m women 
"Jthout hysterectomy) MPA 5 
mg/day for 13 days every 
th1rd month 
2 Placebo 
I CEE oral (0 625 mg/day) 
2 CEE oral (I 25 mg/day) 
3 Placebo 
1 i 7~£2 transdermal patch 
(I mglda)) 
2 Placebo 
Outcome Measurements 
General CAMCOG, Verbal 
memory/language CVLT (IR + DR), 
Verbal fluency faces (IR + DR), 
V!suospatta\ block dcstgn 
Verbal memoallanguage PAL (IR + 
DR), fluency, Speed/concentration 
TMT (A+B), cancellatmn random 
letters and random form test 
Short-term memory/concentratiOn 
d1g1t span Speed DSST 
V1sual memon' p1cture 
recall (BETMf), VISUal recall, PAL 
Vtsuospatlal/speed mental 
rotatmn task, E:...ecut1vc funct1on 
CANT AB IDlED, Stroop test, 
random 
number generation test, Tm\er of 
London te<;t 
Results 
HRT> Placebo 1/5 tests 
(Faces- IR not DR) 
No effect CAM COG, 
verbal fluency, CVLT, 
block des1gn 
No effect HRT on 0/5 tests 
No effect HRT on 0/2 tests 
HRT >placebo memory 
(BET AM and PAL) and VISual 
rotatton speed, 3/7 tests 
(baseline dtfferences seem 
larger than effect stzc) 
Randomizatwn 
A 
A 
A 
A 
R1ndom,7ai!On key A Adequale nndom,zat,on B Uncl.,ar-randomlzahon 3MSE Mod,fied Mm1 Mental State Exammat,on BET AM BErhn Test for Assoc1at"c Memory BNT Boston Nammg Test B\ RT Benton V1sual Retention Teo;t B-W Bourdnn-\\1er;ma t~ 
CAMCOG CAMbndge demenlta exammat1on C'OGM"c tests CANT AB CAmbndge Neuropsychological Test Automated Battery CEE Con;ugated equme estrogen CRT Complex react1on tune C\'lT Cahfomnn Verbal U:m~mg Test DR ~laycd recall D'>"f 
D1agnost'c and St1t!SI!Ca1 Manual of Menial D1sordm DSST 01g1! Svmbo11'110d3htles or Substi!UIIon Test E2 Es1rad1ol E 1 Estrone E3 Estnol EO Extradm~enttonal HRT Honnone replacement therapy m lnlradlmenSior>al 1 m Intramuscular JR Immediate recall 
KVT Konn:nlral1ons Verhufs Tesl MPA Medroxyprogcsterone acelate MMSE Mm' Mental Status Examm~t1on MWT mul11ple cho1ce \\Ord test PAL Pa1red :ISsocmte learmng PASA T Paced Auditory Seflal Add!IIOn Test PMA Pnmary mental ablht,es RT 
Reaclton lime SD Slandard de\IJIIon SRT S1mple reactiOn t1me STM Space T1me Modulation T Testosterone TMT Tnal Makmg Test USTM Umtary sp;~ce-tlme modulauon \'RT v,sual reoc11on !!me \V AIS R Wcchsler Adult lnte!hgcnt Snlc- Re' 1sed \\'CST 
\\'1seons'n Card Sort1ng Test \\l!IMS Women s Heallh lmii.:U1VC Memory Study \\'MS R \\'echsler Memo!) Test- RC\1sed 
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Table I cont ••• Hormone replacement therapy for cognitive function in postmenopausal women: characteristics of included studies. 
Study 
Dun km et al 
(2005) 
Espcland et 
al (2004) 
redor-
freyberg et 
al (1977) 
Gocbel et al 
(1995) 
Orccnspan et 
al (2005) 
Methods 
Randomtzed, 
double-bltnd, 
parallel groups, 
10 weeks 
Riindomtzcd, 
double-blmd, 
parallel groups, 
7 years (mean 54 
y=s) 
Randomtzed, 
double-blmd, 
parallel groups, 
3 months 
Randomtzed, 
double-blmd, 
parallel groups, 2, 4 
and 8 months 
Random17ed, 
double-bltnd, 
parallel groups, 
3 )Cars 
Participants 
Country USA, n == 17, healthy 
women, mean age 57 years, 
natural or surgtcal menopause 
not stated 
Country USA, n = 2808, 
healthy women (WHIMS 
parttctpants), mean age 72 
(65-79 years), hysterectomized 
Country Sweden,n=21, 
women wtth many climactenc 
symptoms, mean age 57 (47-
70 years), natural or surgtcal 
menopause not stated 
Country USA, n = 87, 
elderly women, mean 
age 75 (70-88 years) 
Country USA, n = 373, 
healthy \VOmen, mean age 
71 3 years, natural and surg1cal 
menopause 
Interventions 
I E2 transdennal (0 1 
mg/day) 
2 Placebo 
CEE oral (0 625 mg/day) 
2 Placebo 
I E2 oral (2 mg/day) 
2 Placebo 
I CEE oral 0 625 mg/da; (+ 
MPA 5 mglday for 12 da) s 
every tlurd month) 
2 Placebo 
I CEE oral (0 625 mg/day) 
2 CEE oral (0 625 mg/day) + 
MPA (2 5 mglday) 
3 Placebo 
Outcome Measurements 
Verbal memory/language CVLT, 
WMS-R, PAL and log1cal memory, 
fluency of non-verbal memory, 
WMS-R vtstml reproductiOn, Rey-
Ostemeth complex figure test, speed 
processmg, Executtve functwns 
Stroop test, grooved pegboard test, 
WCST, TMT-8, digit span, DSST, 
WAIS-R picture 
arrangement 
General 3MSE 
Speed/conecntratton 
ch01ce RT, KVT (VIsual 
search), Stroop test, USTM 
(attentlOn STM, reasonmg), 
v1sual search test 
Speed TMT-il 
General MMSE 
Results 
No effect of HRT on 0/13 
tests (but trend level 
s1gmficance m attentmn and 
speed oftnformat1on 
processmg tests combmed) 
Placebo> HRT Ill test 
HR1 >Placebo 3/5 tests 
No effect HRT on 0/l test 
No effect HRT on 0/1 test 
RandomJzatmn 
B 
A 
B 
B 
B 
Random•nhon key A Adequate 11lndom17.1he>n B Unclear randomtzat1on 3MSE Mod•fied Mm1 Mental State Exammat1on BET AM BErlin Test for Asso<:tallvc Memory B}.'T Boston Narrnng Test 8\ RT Bent on \'1sua! Retentmn Test B-W Bourdon-W1er;ma test 
('AM COG CAMbndge dert~entla exammahon COGmtl\e tests CANT AB CAmbndge Neurops)Cholog•cal Test Autormtcd Battery- CEE ConJugated eqmneestrogen CRT Complex reaction t•me C\'LT Califom•an V erN.! Uammg Test DR Delayed r.-call D<;M 
D•agnost1c and <;ta!ls!lcal Manual of Mental Dtsorders DSST D•g•t Svmbol modahtu:s or Subshtut1on Test E2 Estrad1ol El Estrone E3 Estnol ED Extradnnent10nal HRT Hormone rcplacemem thn"1py ID lntrnd•mcnslonal 1 m Intramuscular IR lmrnedtate recall 
KVT Konnntrat1ons \ erl:tufs Test MPA Medroxvprogo:-stC"rone acetate MMSE Mmt-Menta! Status Examma!ton MWT mu!ttp!e ch01ce word test PAL Pmred assocmte learnmg PASAT Paced Audttory Scnal Add•hon Test PMA Pnma1J mental abt!itto:-s RT 
React ton ltme <;;D <;;tand::rrd de~muon SRT Stmple reactton tnne "™ Sp:~ce Tune Modu]a!lon T Testosterone- TMT Tnal Makmg Test USTM Umtary s:pacc-ttme modulatton VRT Vtsual reacuon lime WAIS R We\:hslCT Adult lntc!hgent Scale- ReHsed WC'ST 
Wtsconsm C'::rrd Sortmg To:-st \\'1-UMS Women s Health lnu,attve Memory Study WMS R Wechs!CT Memory Test- ReHsed 
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Table I cont ••• Hormone replacement therapy for cognitive function in postmenopausal women: characteristics of included studies. 
Study 
Hackman et 
ai (I977) 
Janowsky et 
al (2000) 
Lmzmayer 
et a I (2000) 
Plulhps et at 
(I992) 
Polo· 
Kantola et 
ai (1998) 
Methods 
Random1zed, 
double~blmd, 
parallel groups, 
6 months 
Random1zed, 
double·bhnd, 
parallel groups, 
1 month 
Random~ zed, 
double~blmd, 
parallel groups, 
3~am1 tnal, 
2 months 
Random1zed, 
double·bhnd, 
parallel groups, 
2 months 
Random~ zed, 
double·bhnd, 
cross·over drug 
(Jmonths)l ,,.ashout 
(I monthY drug (3 
months)/ washout 
Partictpants 
C'ountry UK, n = 18, healthy 
women, aged 29-68 years, 
group of natural and surgical 
menopause, many cl1mactenc 
symptoms 
Country USA, n = 13, healthy 
women, mean age 69 (61-74 
years), natural or surg1cal 
menopause not stated 
Country Austna, n ""49, mean 
age 58 (46-67 years), natural 
or surg1cal menopause not 
stated 
Incluston sleep disorder 
(DSM), menopausal> 24 
months 
Country Canada, n = 19, 
healthy women, mean age 48 
years (SD 5), all surgtcal 
menopause 
Country Fmland, n = 62, 
very healthy 
hysterectomtzed women, mean 
age 56 (47 • 65 years) 
Interventions 
I P1perazme El oral (I 5 
mg/2x) 3 weeks/month 
2 Placebo (2x day) 3 
weeks/month 
I CEE (0 625 mg/da)) 
2 Placebo 
1 E2 valerate (2 mg/day) + 
progestm dtenogest (3 
mg/day) 
2 E2 valerate (2 mg/day) 
3 Placebo 
I E2 (1 m IO mg/month) 
2 Placebo (1 m. sesame 01ll 
m I) 
1 E2 transderma\ (2 5 
mg/day) <56 years of age 
2 E2 transdemml (0 05 
mg/day) >55 years of age 
3 Placebo 
Outcome Measurements 
Verbal memory GUild memory test 
V1sual memorv workmg memory' 
task ("'1th abstract figures) 
Verbal memory Grunberger (also 
mcludes assocmt1ve, numenc and 
total verbal memory), V1sual 
memory BVRT Intelhgence MWT, 
word knowledge 
Verbal memorY/concentratiOn 
paragraph recall, PAL, d1g1t span 
V !StiOspattal memop, WMS-R 
(VRT) 
Y1sual memorvlconcentratJOn BVRT 
and d1g1t span, Speed Stroop test, 
RT, 
letter cancellat1on, PASAT, DSST, 
subtractiOn test 
Results 
No effect HRT on 0/1 test 
~No effect HRT on 0/l test 
HRT >placebo 1/5 tests E2 + 
progestm > E2 or placebo on 
as'loCiatJve verbal memory E2 
> £2 + progestm on numencal 
memory (base! me difference) 
E2 + progcstm > E2 on visual 
memory (only after 4 months 
HRT) 
No effect on mtelhgencc 
or other verbal memory 
tests 
HRT >placebo on 214 tests 
verbal memory (not d1g1t 
span), no effect VRT 
No effect HRT on 0/8 tests 
Random1zation 
B 
B 
B 
B 
B 
RandomJ73110n l.ey A Adequate rnndom17..:\hon B Uncle3T rnndomJzatJon JMSE Mod1fied Mm1 Mental State Exammauon BETA'-1 BErhn Test for AssocJa!l\'e Memory BNT Boston Nammg Tffi BVPT Bent on \ 1Su1l Retenhon Test B-W Bourdon-\'nersma lest 
CAMCOG C'AMbndge dcmenlla exammat10n COGmtlHtests CANT AB CAmbndge Neuropsychological Test Automated Satiety CEE Comug1ted CC]Uine estrogen CRT lomplex rcachon nme C\'LT Cahfommn Verbal Lcam1ng Test DR Delaved recall DSM 
Dmgnost1C and St1!1StJca1 Manual ofMent1l D1sordas OSST D1g1t Symbol modahues or Substnut1on Tr<;t F2 Estr.d1ol El Emone E3 Estnol ED Extrad1men11onal HRT Hormone Teplacemenl ther:~py ID lntrnd1menslonal 1 m lntrnmuscular IR lmmed1ate r«al! 
KVT Konzentra\lons Verlaufs Test MPA Medroxypro)!:e«terone ~cetatc MMS[ Mmt Mental Status Exammation M\VT multiple ch01ce "ord Test PAL Paired 3SSOCI:IIC lcammg PASAT Paced Auditory Serial Add1110n Test PMA Pnmary mental ab1h!1eS RT 
React1on 11me <:;O <:;11nd~rd de Ha! lOll <:;RT S1mp!e rcact10n tnno: STM Space T1me Modulat10n T Testosterone TMT Tnal Makmg Test USTM Un1tary space-11me modulatiOn VRT Vtsu'll reaction 11me W AIS R Wechsler Adult Intelligent Scale- Re1 1sed WCST 
W1scoruM Cvd Sonmg Test \\1UMS Women s Health lmt13ll\e Memory Study WMS R Wechsler Memory Test- Re,lsed 
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Table I cont ••• Hormone replacement therapy for cognitive function in postmenopausal women: characteristics of included studies. 
Study 
Rapp et al 
(2003) 
Resmck et 
aJ (2006) 
Schtffct al 
(2005) 
Shay.,.,ltz et 
al (1999) 
Methods 
Randomtzed, 
double-blmd, 
parallel groups 
7 years (mean 4 2 
years) 
Randonuzed, 
double- blmd, 
parallel groups, 
3 years (mean I 35 
years) 
Randomtzed, 
double-blmd, 
cross-over 24 weeks 
(12 weeks each 
condttwn) 
Randomtzcd 
double-blmd, 
cross-over 
drug (21 days)/ 
washout (14 days)/ 
drug (21 da)•) 
Participants 
Country USA, n = 4381, 
healthy women (WHIMS 
par1lc1pants), aged 65+ (half 
below 70 years) 
"country USA, n ~ 1416 
(subgroup WHIMS), healthy 
\'>Omen, mean age 73 7 )Cars, 
natural or surgtcal menopause 
not stated 
Country Australia, n = 19, 
healthy women aged over 60 
years, mean age 71 (62-89 
years), surg1ca\ menopause 
Country USA, n = 46, healthy 
postmenopausal women, mean 
age 50 8 (SD 5, 33--61 )ears) 
Interventions 
I CEE ornl (0 625 mg/day) + 
MPA (2 5 mg/day) 
2 Placebo 
1 CEE oral (0 625 mg/da;) + 
MPA (2 5 mg/day) 
2 Placebo 
I E2 transdcnnal (50 f.lg/24 
hrs) 
2 Placebo 
I CEE oral (I 25 rug/day) 
2 Placebo 
Outcome Measurements 
General 3MSE 
General/verbal J..nov. ledge PMA 
vocabulary, Memon'flanguage 
BVRT, CVLT (IR + DR), verbal. 
fluency (2 types), Attentwn/workmn 
memory d1g1t span forward and 
backwards, Spat1al ab1htv card 
rotatwns, rme motor skills finger 
tappmg 
Cogmt1ve drug research Verbal 
memory word hst recall (IR + DR), 
word recogmt1on, Speed tests SRT, 
CRT, d1gtt vtgtlance, Ytsual 
reco&n.W.ml. vt~ual trackmg, spatml 
memory, face recogmtwn, picture 
recogmt10n 
Memory "\\'Ord and token recall 
Results 
Placebo> HRT on Ill 
test, More women m HT 
group had substantial 
dechne 
HRT;:. placebo on 119 tests 
(BVRT) 
Placebo> HRT on 119 
tests (CVLT) 
i{RT >placebo on 1/9 tests 
(SRT only after 12 hut not 6 
weeks) 
No effect HRT on 0/2 tests 
Randomizatwn 
A 
A 
A 
A 
Randomt11!1on ~ev A Adequate mndoml7-l!lon B Unclear rnndomtzatton 3MSE Modtfied Mm1 Mental State E~ammauon BETA M BErhn Te~t for Assoc1at"e Memory BNT BostOn Nammg Test BVRT Brnton V>sual Retenuon T.-st B-W Boutdon-\\'u:rsma test 
CAMCOG C'AMbndge demenoae~nmmnlton COGmtl\e t.-sts CANT AB CAmbndgeNeuropS)cho!og1enl Test Automated Battery CEE Con;ugated equme estrogen CRT Complex react1on t1me C\ LT Callfom1an \'erball.eam1ng Test DR De!a)Cd recall DSM 
D1agnos11c and <;tat1s11eal Manual of Mental Dtsorders DSST Dtg1t Svmbol modaht1es or Subshtut,on Test E2 Estrad1ol El Estrone E3 Estnol ED Extrad1menttonal HRT Honnone repbcement therapy ID lntradnnens1onal 1 m Intramuscular lR lmmcd1ate recall 
KVT Kon7entrat>ons Verlaufs T.-st MPA Medroxyprogesterone acetate M\1SE Mm1 Mental Status Examtnat1on M\\'T multtple chotce "ord test PAL Patr<"d assoctate learnmg PASA T Paced Aud1tory Senal Add111on Test PMA Pnmary mental abtht>es RT 
Rc1c11on lime SD St1nd:n-d de\latlon SRT S1mple rc1ct1on ume STM 'ipace T1me Modulation T Testosterone TMT Tnnl Makmg Test USTM Unrtary space-tmJC: modulation VRT V1sual reactiOn ttme WAIS R Wechsler Adult Intelligent Scale- Re\t~ed WCST 
Wtscons1n Card Sortmg Test WHIMS Women s Health lmtl111\e Memory Study- WMS R_ WechslerMemoryTest- Re\tScd 
54 
I I I I 
Study Methods Parhc1pants lnten•entmns Outcome Measurements Results Randormzatwn Shcn\ln et Randomtzed, Country Canada, n =50, 1 E2 (1 m 10 mg/month), n = Memory/concentration d1g1t span, HRT >placebo on 4!4 tests B a! (1988) double-bltnd, healthy women, mean age 10 paragraph recall (not WMS) Speed 
cro<>sovcr 45 4 years, surgtcal menopause 2 E2 (1 m 8 5 mg/month) + T clenca\ speed and accuracy, 
Drug ExclusiOn psychologtcal (1 m 150 mg/monlh), n = 10 Abstract rcasonmo (3 months)!placebo problems 3 Placebo 
(1 month)/drug 
(3 months) 
Sherwm et Randomtzed, Country Canada, n = 12, I E2 (1 m I 0 mg/monlh) Verbal memory paragraph recall, HRT >placebo on 2/4 tests, B a! (1990) doublc-blmd, healthy women, mean age 47 2 Placebo PAL, dtglt span, V1suospatmJ notVRT parallel groups, )ears surgtcal menopause memory VRT (WMS) 
2 months 
Vanhul!e et RandomJ7ed, Country Belgwm, n = 26, I E3 oral (4 mg/day) Memory/concentratton BVRT, d1gtt HRT >placebo on 2n tests of n al (1976) double-bhnd, healthy postmenopausal nuns, 2 Placebo span, Lab~Ttnth ofRey, alertness and attent1on parallel group<i, mean age 57 6 years, natural SQeed'concentratJon DSST, (v1gllance and 8-\V test), not 3 months and surg1cal menopause calculat~ans, VIgtlance test, B-W test on memory and concentration 
Vtsco!J et a! Randomt7ed, Country USA, n =461, l E3 oral ( 1 mgfday) + MPA General MMSE, Memon./languae:e No effect HRT on 0/6 tests A (2005) double-blmd, women wtth recent stroke or (5 mgfl2 da~S/)ear for modtfied BNT, d1g1t span, word-hst Women w1th nomtal MMSE parallel group'>, trans1cnt Ischemic attack, mean women "•lth mtact uterus) generatiOn (fluency), spatial (28-30) at baseltne, HRT 39 months age 70 years, natural and 2 Placebo recogmt1on, BNT (DR) assocmted w1th less dechne on 
surg1cal menopause MMSE 
Wolf et al Ramloml7ed, double Country Gcnnany, n = 38, 1 E2 transdermal (0 I Verbal memory/lanouage patred No effect HRT on 0/5 te~ts n (1999) blmd, parallel healthy \\Omen, mean age 69 mglday) word recall, verbal fluency, 
groups, 2 \veeks vears (SD 6), natural and 2 Placebo VtsuospatJ:al route findmg, mental 
~urg1cal menopause rotat1on (dtffcrent from Duka), 
SQeed/coneentrat!On Stroop test 
Randorn17illlon ley A Adequate random1za!lon B Unclear random1ni10n 3MSE Mod1ficd Mm1 Mental Slate Examma110n RETAM BErlm Test for Assoc1at11'e Memorv BNT Boston Namrng Test B\ RT Benton V1sual Retentton Te~t R-\\' Bourd"n \\ 1ersma t~t 
C'\MlOG CAMbndge d.-menlm exammat1on COGmt11e tests CANT AB CAmbndge Neuropsvchologl<'al Test Automated Batterv CEE ConJugated equme estrogen C'RT Complex reacuon t1me {\LT Cahft'>rman \ crba! Uammg Te~l DR Dd'l)cd rec31l D'>M 
Dngnost1c and '>t1hsucal M1rmal of Mental DJ~ orders DSST D•g1t <;vmbol modal m~ or Substrtuuon T~t E2 l:strnd1ol El Estrone E3 Estnol ED E'\tr.ldlmentlonal HRT Honoone replacemelll ther1py ID lntrad1mens1onal 1 m lntranmscubr JR Jmmed11te ree1ll 
KVT Konzcntnuons Verhufs Tr'St MPA Medro~yprogesterone acetate MM<;E Mmt Mental Status E~ammat1011 M\\ T mult1ple chmce 110rd test PAL Pa1red assocLate leammg PASAT Pace-d Audnon Senal AddltiOII Test PMA Pnm'IT) mental ah1h11es RT 
Rc1ct1nn tnne <;D St1nd.vd dc11a\1on SRT S1mple react1011 \1n~e ST~I Space-T1me Modubt1on T Testosterone- TMT Tna! Makmg T~t USTM Unnary space~t1me moduhuon VRT \ 1sual react1on ume \V AJS R Wechsler Adult Jmelll!!ent Scale~ ReviSed \\'C'ST 
\\ ~<consm C'1rd Sortmg Te<l WliiMS Women s !lea!th lnttla\1\C Memo\') Study WMS R \Vechsler Memory Test~ Rcv1scd 
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2.3.1.5.1 Verbal memory 
Tables 1 and 2 show that of all studies, only 23 of the tests used (22% out of 106 
cogmtive tests used over all studies) showed a positive effect, while three tests had a 
negative result Of these positive effects, a quarter of tests used (n = 6) reflected a 
positive effect of HT on verbal memory, but 12 verbal memory tests used could not 
show this and one study (WHIMS data) showed that CEE with MP A had a negative 
effect on verbal memory after treatment over a longer penod of several years 
Qualitative analyses usmg Table I shows that the positive effects on memory were 
only seen m four studies after treatment for a short duratiOn (2-3 months) This was 
seen m a study usmg oral E2 m younger postmenopausal women reportmg msomma 
(average age 49 years) (Lmzmayer et a!, 2001) and m studies usmg bolus InJections 
ofE2 m surgically menopausal women aged on average 48 [82], 45 [83], and 47 
(Sherwm, 1988) years of age In contrast, several other studies, usmg transdermal E2 
m younger women (average age 57 years) (Dunkm, Rasgon, & Parker, 2005) and 
transdermal or oral E2 m older women (average age: 71 (Schiff, Bulprtt, Wesncs, & 
Rajkumar, 2005) and 74 years (Almeida et al, 2006) respectively, 70 years wrth oral 
E2 {VIscoli et a!, 2005), and 69 years with transdermal E2 (Wolf et al, 1999) did not 
reflect these effects Studies wrth CEE did not report positive effects on verbal 
memory m younger (51 years) (Shaywitz et al, 1999) or older (82 years) (Bmder, 
Schechtman, Birge, Williams, & Kohrt, 2001) women, although one study (sub-study 
of the WHIMS) reported a negative effect of CEE and MPA on verbal memory m 
older women (74 years) (Resmck et al, 2006) These qualitative analyses were earned 
out usmg the reports of the mvestigators Quantitative analyses showed an overall 
posrtive effect on only one test, the verbal parred associates Immediate recall (z = 
2 40, p < 0 05, effect size I 02,95% confidence mterval 0 19-1 85) (Lmzmayer et 
al , 2001; Phrlhps & Sherwm, 1992), but not on the delayed recall or recall of word 
lists or stones or on verbal fluency (which also tests language and executive 
functiOns) These analyses may be hmited as standard deviations (SD) of the mean 
difference often had to be recalculated, whrch, m smaller studies, could lead to an 
overestimate of the SD, makmg these analyses vulnerable to type II error. However, It 
does mdicate that effects, If present, are small 
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2.3.1.5.2 Visual memory 
In v1sual memory tests (where verbahzatwn may occur), pos1hve effects ofE2 were 
seen on the memory of faces m women aged 74 years (after 5 months of oral E2) 
(Aime1da et a! , 2006), on p!Cture recall and v1sua! pa1red assoc1ates m women aged 
65 years (3 weeks E2 transdermal) (Duka, Tasker, & McGowan, 2000), and also on 
figure recall after 3 years ofCEE and MPA therapy m women aged 74 years (Resmck 
et a! , 2006) A total of 15 stud1es reported no effects on visual memory regardless of 
age or type of treatment (V1scoh et a!, 2005, Janowsky, Chavez, & Orwoll, 2000, 
Polo-Kantola et a!, 1998; Vanhulle & Demo!, 1976) D1fferences m tests could 
explam the vanance between stud1es, but quanhtatlve meta-analyses showed no 
s1gmficance for tests ofheterogene1ty These analyses also revealed no overall 
s1gmficant effect of HT on v1sual memory Trad1l!onally, effects ofE have been 
thought to be most apparent on verbal memory tests (Sherwm, 1994) 
2.3.1.5.3 Tests of Speed of Information Processing 
Several stud1es reported pos1t1ve effects of HT on speed of mformatwn processmg 
(found on a thud of all tests used m stud1es) Th1s was the case m five stud1es usmg 
transdermal E2 m women aged 65 years (Duka et a! , 2000), transdennal E2 w1th 
women aged 57 years (Dunkm et a!, 2005), oral E2 w1th women aged 57 years 
(Fedor-Freyberg, 1977), transdermal E2 w1th women aged 71 years (Sch1ff et a!, 
2005); and bolus E2 w1th women aged 45 years (Sherwm, 1988) Although several 
other tests used m stud1es w1th transdermal E2 could not reflect t!us (Dunkm et a! , 
2005; Sch1ffet al, 2005, Duka et a!, 2000, Wolf et a!, 1999, Fedor-Freyberg, 1977) 
Three stud1es usmg CEE reported no effects on these tests (Bmder et a!, 2001, 
Goebel, B1rge, Pnce, Hanson, & F1shel, 1995; Janowsky, Ovwtt, & Orwoll, 1994) 
Quantltal!ve m eta-analyses found overall trends on s1mple tests (Trml Makmg Test 
[TMT] Part A and Speech Recepl!on Threshold test, p = 0 06) and more complex tests 
(TMT Part B and Stroop test; p = 0 I 0) Surpnsmgly, for s1mple speed, these analyses 
mvolved stud1es w1th CEE and MPA for 9 months (Bmder et a!, 2001) and 
transdermal E2 for 24 weeks (Sch1ff et a!, 2005), both m older women For complex 
speed, pos1l!ve effects were seen m quanl!tal!ve m eta-analyses, agam w1th CEE and 
MPA (Alme1da et a!, 2006), after transdermal E2 m older women for 2 weeks (Wolf 
et a! , 1999) and 3 weeks (Duka et a! , 2000), and also after oral E2 m younger women 
for a duratwn of I 0 weeks (Dunkm et a!, 2005) Other tests, such as the cogml!ve 
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reflectiOn test and the Digit VIgilance and Digit Symbol SubstitutiOn tests were not 
affected by HT 
2.3.1.5.4 Other 
Several other tests showed positive effects, but only after bolus InJeCtiOns of E2 m 
surgical menopausal women For example, (Sherwm, 1988) reported effects on 
executive functiOns (abstract reasonmg) and accuracy and similar effects were seen 
after oral E2 111 symptomatic young women (Fedor-Freyberg, 1977) On the other 
hand, meta-analyses showed that there was no overall Significant effect of HT on 
these types of tests (p = 0 14, p = 0 16) Three studies showed no overall effect of HT 
on the MMSE or the cogmtive and self-conta111ed part of the CAM COG (Almeida et 
a!, 2006, VIscoh et a!, 2005, Ditkoff, Crary, Cnsto, & Lobo, 1991) and negative 
effects were reported twice after HT on the modified MMSE 111 the WHIMS 111 that 
less of a learn111g effect was seen 111 HT users (Espeland et a! , 2004, Rapp et a! , 
2003) However, 111 sub-analyses (VIscoh et a!, 2005), elderly women Without stroke 
who had a normal MMSE score (28-30) were found to decline significantly less after 
E2 treatment compared with placebo after 3 years (z = 2 37, p < 0 005) 
Our meta-analyses of the Modified M111I-Mental State Exam111ation (3MSE) showed 
an overall effect m favour of placebo (z = 2 04, p < 0 05, mean difference -0 15, 95% 
confidence 111terval [ CI]. -0 29 to -0 0 I for the comb111ed tnal and z = 2 49, p < 
0 0005, mean difference -0 38, 95% Cl -0 60 to -0 17 for CEE alone) However, 
when we performed 111dividual analyses per year, this showed 111consistencies m nsk 
over time 111 both the WHIMS studies While the effect of the comb111ed tnal only 
showed a significant difference 111 favour of the placebo group at year 4 (z = 2 26, p < 
0 05), th1s was seen after CEE alone only at year 1 (z = 2 25, p < 0 05) when takmg 
111to account the number of women who dropped out each year. 
Importantly, none of the meta-analyses showed significant heterogeneity and the more 
conservative standardized mean differences with random effects (rather than weighted 
mean differences with fixed effects) were used throughout 
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Table 2. Qualitative mcta-analysis of effed of hormone therapy on different aspects of cognitive function in postmenopausal women. 
Author Cogmt1ve test 
Verbal memory Fluency Language Visual memory Speed Spatial ConcentratiOn Executive MMSE 
Ph•lhps et al (2+)12 (IX)/1 (IX)/1 
Sherwm et a! (1988) (!+)/! (1+)/1 (1+)/1 (I +)/1 
Sherwm et a! ( 1990) (2+)12 (1X)/1 (1X)/1 
Hackman et al (IX)! I* 
Vanhu!le et a1 (2X)I2 (2+,1X)/3 (1X)/1 (lX)/1 
Fed or et al (3+)13 (2+)/2 
Lmzmayer et al (1+, 2X)/3 (lX)/1 (IX)/l (1X)/1 
Dunkm eta! (3X)/3 (IX)/1 (2X)/2 (4X)/4 (1X)II (IX)/ I (lX)/1 
Polo-Kantola et al (IX)/ I (4X)/4 (IX)/ I (2X)I2 
Alme1da et a! (IX)/ I (IX)/1 (!+)/! (IX)/J (IX)/! 
V1scoh et al (IX)/ I (IX)/ I (IX)/! (IX)/! (IX)/! 
Duka et al (2+)/2 (l+)/1 (IX)/! (IX)/ I (2X)/2 
Scluff et a! (2X)/2 (3X)/3 (l +,IX)/2 (IX)/! (IX)/1 
Wolf et al (IX)/ I (IX)/ I (IX)/ I (IX)/ I (IX)/ I 
D1tkoff et a! (IX)/ I (IX)/! 
ShayWJtz et al (IX)Il (IX)/1 
Bmder et a! (IX)/1 (IX)/! (I+, 2X)/3t (IX)/ I 
Espeland et al (1-)/1 
Goebel et al (IX)/! 
Greenspan et al (IX)/ I 
Janowsky et al (IX)/! 
Rapp et a! (1-)/1 
Resmck et al (1-)/1 (IX)/ I (IX)/ I (1+)/l (IX)/ I (IX)/ I (lX)/1 (IX)/ I 
Total +ve (+) 6 0 0 4 9 0 3 I 0 
Total-ve (-) 0 0 0 0 0 0 0 2 
Total tests 19 6 2 19 25 7 14 9 5 
Kev + Posn•~e re~ult - Neg3t"e result X No effect For eumple (2+ I \:)_'3 means there "ere 1\>.0 pos•t1~e results and one no effect found out oftl1rce testS (lXVI means that one test found no effect c>ut of one test •This authors repmt found one po>•ll'e 
effect 1\hl!e our me1a-analysrs found none :This author's report found no po<;•t•ve cffects wh1le our meta anal}s•s found one, lv1MSE Mmt-Menr:al State Exarmnauon 
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Table 2 cont Quahtatwe meta analys1s of effect of hormone therapy on dtffercnt aspects of cogmt,~c funcllon m postmenopausal "'omen. 
Author Outcome 
Tests 
Treatment Age DuratiOn 
(n) PoSith e Outcome l\Iode of admm1stration El, E2, E3 CEE <65 )ears >65) ears 
Ph1lhps et a! 4 2 Bolus mJeCtion • • 2 montl1s Sherwm et a! (1988) 4 4 Bolus mJectwn • • 3 months CO Sherwm eta! (!990) 4 2 Bolus InJection • • 2 months Hackman et al l 0* El • • 6 months Vanhulle et a! 7 2 E3 • • 3 months Fedor et al 5 5 Oral • • 3 months Lmzmayer et a! 5 Oral • • 2 months Dunkm et a! 13 0 Transdermal • • 2 5 months Polo-Kantola et a! 8 0 Transdermal • • 3 months CO Alme1da et a! 0 Oral • • 5 months V1scoh et al 6 0* Oral • • 39 months Duka et a! 7 3 Transdetmal • • 0 75 months Schiff et al 9 Transdennal • • 3 months CO Wolf et a! 5 0 Transdennal • • 0 5 months D1tkoff et a! 2 0 
• • 3 months Shayw1tz et a! 2 0 
• • 0 75 months CO Bmder et al 6 I:t • • 9 months Espeland et al 0 
• • 54 years Goebel et al 0 
• • 8 months Greenspan et al 0 
• • 3 years Janowsky et al 0 
• • l month Rapp et a! 0 
• • 4 2 years Resmck et al 8 
• • 3 years Total~ 23 
Total tests 106 
Ke\- + Pos!ll'e rcsul! Ncg:att•e result '\ No effect For example (2+ IX) 3 means there ''ere No posnn-c results and one no effect foundoutofthree tests (IX)'! means that one test found no effect out of one test •nns authors report found <>ne posnt•e 
effect "htlc our met a analYStS found none :nus authors report found no poS1II\e effects "hlle our met a analysts found one MMSE Mmt-Mental State Examtnauon 
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2.3.1.6 Discussion of Results 
Our m eta-analyses shows that E2 given orally or as a bolus InjectiOn (but not 
transdermally) was mamly effective m Improvmg verbal memory, but only m very 
recently menopausal younger symptomatic or surgically menopausal women This 
could be explamed because these highly symptomatic women had fewer hot Dashes, 
and better sleep and mood after treatment, wh1ch could have affected their 
performance However, 1f th1s were the case, perhaps overall better cogm!Ive 
performance would be expected on a broad range of cogmtive domams (LeBlanc, 
Janowsky, Chan, & Nelson, 2001) By contrast, 1t seems that only some domams are 
affected by HT In addition, this positive effect on verbal memory m these women 
was only tested for up to 3 months Several earlier studies suggested that the effects of 
E2 on memory actually reversed after 6-12 months of treatment (Hogerv01st, 2006) 
and one study (File, Heard, & Rymer, 2002) found worse short-tenn verbal memory 
m surg1cal menopausal women who had been usmg E2 for 10 years than surg1cal 
menopausal women who had not used E2 In meta-analyses, the pos1tJve effect was 
also small, as It only held up for one aspect of one test of verbal memory. 
For VIsual memory, the effects were not clear and m1ght also be modified by age 
Some pos1tive effects on VIsual memory after E2 and CEE and MPA were seen, but 
only m older women Th1s may argue agamst the 'wmdow of opp01iumty' theory (see 
below) Similarly, the results for tests of speed of mformatwn processmg mdicated 
that the successful type of E treatment could depend on age where the younger 
symptomatic group seemed to profit most from an oral or bolus injectiOn ofE2 on 
these tests, while the older women could poss1bly profit from transdermal E2 or CEE 
and MPA, wh1ch both render lower levels ofE (Hogervorst, 2006) Effect on accuracy 
and abstract reasonmg were reported m stud1es (Sherwm, 1988, Fedor-Freyberg, 
1977), but this was not found to be sigmficant m meta-analyses 
It has often been suggested that the effects of HT are limited to particular aspects of 
cogmtive functiOn, winch could be an alternative reason for some stud1es not findmg 
any effects It 1s likely that not all cogmtive domams are affected equally by sex 
ster01ds However, results from stud1es show mconsJstenCJes m findmgs One meta-
analysis found that the most common cogmtive domam found to be affected by HT 
was memory, specifically verbal memory (LeBJanc et al, 2001) Data from many 
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cross-sectiOnal studtes suggest thts mdeed to be the case (Resmck, Makt, Golskt, 
Kraut, & Zonderman, 1998, Szklo et a], 1996, Ktmura, 1995, Kampen & Sherwm, 
1994, Robmson, Fnedman, Marcus, Tmklenberg, & Yesavage, 1994), although RCTs 
and cohort studtes report confhctmg results (Hogervorst et al, 2000) and our m eta-
analyses suggest that thts ts not the case for all tests or all functiOns related to verbal 
memory 
Dtfferent treatments may also show dtfferent cogmttve effects, whtch may m addttiOn 
be modtfied by age of parttctpants tested (Hogervorst, 2006) The WHIMS, as the 
largest study that mcluded older women, reported that women who used CEE and 
MPA and CEE alone had less Improvement on the 3MSE and a greater nsk of 
dementia, after 2 and 3 years respectively, although the effects were small (Anderson 
et al., 2004, Shumaker et al., 2003) However, as also mentioned, whtle a decrease m 
verbal memory was seen, the WHIMS sub-study actually reported Improvements m 
vtsual memory after combmed HT at the same time pomt (Resmck et a] , 2006) 
It has been argued that there may be some tmportant reasons for the negattve results 
found m the WHIMS, as well as some ratwnale behmd the general dtscrepancy seen 
m the field as a whole It has been suggested that dtfferences m the age of parttctpants 
[resultmg m the 'wmdow of opportumty' theory (Pmkerton & Henderson, 2005)], 
type, form and route of treatment, and type of menopause that parttctpants had 
undergone (surgtcal or natural) are mostly responstble for the lack ofumformtty m 
results These factors shall be addressed m more detatl below 
2.3.1.7 Possible factors explaining the variability in outcomes between studies 
2.3.1. 7.1 Age 
A current theory ts that Es could exert a combmatlon ofbenefictal and harmful effects 
and thts may be modtfied by age (Resmck et al , 2006) Some researchers have argued 
that the negattve results found m the WHIMS were parttally due to the age of 
parttctpants (Bhavnam, 2003) The advanced age (65+ years of age) and obestty of 
parttctpants m thts study was deemed not representative of the populatwn that HT ts 
mmed at The maJonty ofparttctpants may have been beyond the scope of help m 
avertmg most ofthe negative outcomes ( e g , stroke and dementta) However, that 
would not explam the 'negative' effects seen m the WHIMS Another revtew reported 
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little support for beneficial effects ofE (both alone and m combmat10n with 
progesterone) m women older than 65 years of age and It was noted that potentially 
beneficial effects on specific cogmtive functiOns were mamly seen m younger and 
more recently menopausal women (Maki, 2005) In a recent study, the relatiOnship 
between HT use and a lowered nsk of developmg AD m 971 postmenopausal women 
showed a protective associatiOn, but only m women of the youngest age tertile (50-63 
years) (Henderson et a!, 2005) This findmg IS m !me With ammal studies suggestmg 
protective bram effects m young, but not older, mice (Gibbs, 2006b) 
2.3.1. 7.2 Window of opportunity theory 
Several authors have thus suggested that there IS a cntical penod for HT treatment m 
order to obtam positive effects on the bram It IS hypothesized that Imhatmg or 
contmumg HT beyond this cntical penod would have httle effect on the bram and 
cogmtive functiOn (Gibbs, 2006b, Henderson et al, 2005, Pmkerton & Henderson, 
2005). The 'wmdow of opportumty' theory suggests that tl1ere IS a cntical time for the 
InitiatiOn of HT and could explam why no protective effects were seen m the 
WHIMS Results from ammal studies suggest that the longer the delay between 
ovariectomy and onset of treatment, the less chance there IS of detectmg the 
favourable effects of HT on the bram (Gibbs, 1994). 
However, the strongest argument agamst this theory IS that m RCTs of women with 
AD, both Premarm and E2 were also seen to have positive effects, but only up to 2-3 
months (Hogervorst, Yaffe, RIChards, & Huppert, 2002b) These women with AD (of 
whom the maJonty were aged over 65 years) were at least 15-20 years older than the 
recently menopausal women (with a mean age of 48 ycms) m the successful E2 tnals 
descnbed m another m eta-analysis (Hogervorst, 2006) 
This meta-analysis suggested that positive effects ofE2 m women Without dementia 
were also time-limited, resultmg m an mcrease m memory, accuracy and abstract 
reasonmg functiOns, but agam only up to 2-3 months For both older and younger 
more recently menopausal women, a possible reversal of positive effects was seen on 
some cogmtive functiOns after I year of treatment (Hogervorst, 2006) Therefore, It 
seems more hkely that positive effects, If they were found, are only short-lived, 
regardless of age These findmgs also tie m with the WHIMS data 
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2.3.1. 7.3 Treatment form, route & duration 
Whether HT given for a longer penod of time to older women could actually m crease 
dementia nsk has been reviewed by others and several possible mechamsms for this 
relattonshtp were suggested (Baum, 2005) These mechamsms were based on the 
theory that a longer hfe span, a lower prevalence of vascular dementia and lower 
levels ofT m women may contnbute to the higher prevalence of AD The 
mechamsms that may have been active m WHIMS and potentially responsible for an 
mcrease m dementia could be 
• Use of MPA and El may have different effects on neuronal and cerebrovascular 
functiOn than progesterone and E2 (the most potent E), 
• A greater nsk of stroke m HT users (caused by the use of MPA (Sarrel, 1990) or 
through accidental mcluswn of those at nsk for stroke) leadmg to dementia, 
• Last, a decrease ofbwavmlable T (through the mcrease m SHBG, which CEE 
mduces to a greater extent than E2 does (Senn et al, 2001)) T can, directly or 
through conversiOn mto E2, protect agamst AD (Toran-Allerand et al , 1992) 
However, the role ofT on cogmtive functiOn IS beyond the scope ofth1s thesis See 
(Yesufu, Bandelow, & Hogervorst, 2006) for a rev1ew 
Arguments agamst these mechamsms mclude the followmg FJrSt, as we saw m the 
meta-analyses that while on verbal memory only E2 had positive effects m relatively 
younger postmenopausal symptomatic women, small positive effects of CEE w1th or 
without MP A were seen on some cogmtJve tests, but only 111 older women 
In addition, exclusiOn of women With stroke 111 the CEE alone or CEE With MPA tnal 
did not substantially alter the negative effect of HT on the overall Improvement on the 
3MSE in all arms (Espeland et al , 2004) 
Last, wh1le SHBG may mcrease With CEE, so would the amount ofE when treatmg 
With CEE The role ofbwavmlable T and E2 (and the ratiO ofT.E2) on cogmtJve 
functiOn m elderly women 1s not well understood and reqmres further mvestigatwn It 
1s unclear whether CEE metabohtes would have worse effects than E2, but bram E 
receptors are more sens1tJve to E2 than El (O'Connell, 1995) In addition, m a recent 
RCT focusmg on event related potentials (ERP) m women w1th an average age of 60 
years, a posJtJve effect of CEE was found (Anderer et a! , 2005) The results showed a 
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shortemng of P300 latency, which JS consistent with normalization of cogmtJve 
functiOn This result casts further uncertamty mto the understandmg of the role of 
CEE m cogni!Jve treatment One observatiOnal study reported that h1gher E I levels 
were associated with detnmental effects on cognition In the Study of Osteoporotic 
Fractures, women m the highest El quartile showed worse scores than women m the 
lower El quartiles on two cognitive tests (Yaffe et a!, 1998) 
As mentiOned above, CEE (similar to E2) has also shown positive effects on cogmtwn 
m women w1th dementia (Hogervorst, Yaffe, Richards, & Huppert, 2002a) and, as our 
most recent meta-analyses suggest, also on some tests m older women Without 
dementia Snmlarly, the maJonty of observatiOnal studies showed a protective 
association of HT use. Most women m the USA based studies would have used CEE 
(m the form ofPrempro and Premann) and would have thus been exposed to high 
levels of El metabohtes. Importantly observatiOnal studies could be vulnerable to 
several potential confounds, such as the healthy user b1as (Hogervorst, 2006), 
meanmg the type of women who may use HT are likely have a better health profile, 
e g cardiOvascular, blood pressure etc, due to a healthy lifestyle mvolvmg exercise 
and a healthy d1et 
Taken together, these findmgs suggest that, as well as the form of HT, the route of 
admmistratwn may also be of Importance and may depend on the age of the woman 
Where oral and bolus inJections ofE2 w1th or without P may be more smtable for 
relatively recently menopausal women, transdermal E2 and possible CEE could be 
more smtable for older women m mamtammg cogmt1ve functiOn for up to 3 months 
However, Jt JS not clear whether and which positive effects, If they exist at all, reverse 
after longer periods of usage 
2.3.1.7.4 Cyclical versus continuous administration 
Followmg on from the mfluence of duratiOn of treatment, It has also been suggested 
that contmuously elevated levels ofE could potentially have long-term negative 
effects on cognition A Similar pattern has been seen mE studies, suggestmg that 
effects were positive up to 3 months of HT, stabihzed at 6 months and then showed a 
declme after I year (Hogervorst, 2006) Addmg P does not seem to substantially alter 
these results (see also Hogervorst, 2006) A possible reason for the negative effects of 
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contmuous h1gh-level E treatment m elderly women (Espeland et al, 2004; Rapp et 
al, 2003) could be downregulatwn ofreceptors (Toran-Allerand, 2004) A potentlal 
way to prevent th1s could be by usmg an altered treatment reg1men (Hogervorst, 
2006) Ammal stud1es have shown that mterm1ttent (2 days/week) or low-dose E 
treatment IS more effectlve than contmuous normal-to-h1gh dose treatment (G1bbs, 
2006b) It IS also a poss1b1hty that these reg1mens may prevent reversal of 
hippocampal sproutmg, wluch IS a by-product of contmuous (> 2 days) elevated E 
levels (Woolley & McEwen, 1993) We hypothesized that tlus may m1m1c the natural 
E fluctuatwns seen m the female reproductlve cycle and hence may prevent the 
reversal of pos1hve effects on the bram (Hogervorst, 2006) 
2.3.1. 7.5 Surgical menopause 
QuantltatJve meta-analyses of women w1thout dementla (Hogervorst, Yaffe, R1chards, 
& Huppert, 2002a) and the current updated meta-analyses md1cated that s1gmficant 
effects of HT were strongest m women who had undergone surg1cal menopause A 
s1gmficant drop m cogmhve functlon after ovanectomy has been shown (Farrag, 
Khedr, Abdel-A1eem, & Rageh, 2002, Napp1 et a!, 1999, Sherwm, 1988) Risk of 
dementla was mcreased m women who had undergone surg1cal menopause but had 
not rece1ved HT up to the natural age of menopause (Hogervorst & Bandelow, 2007, 
Rocca et al , 2007) By contrast, researchers could not find any ev1dence suggestmg 
that natural menopause causes a drop m cogmt1ve functwn (Henderson, Guthne, 
Dudley, Burger, & Dennerstem, 2003) Therefore, one concluswn that could be drawn 
from these results IS that surg1cal menopause m 1tself IS a nsk factor for accelerated 
cogmtlve 1mpa1rment and that E therapy would be particularly md1cated for th1s 
group However, m an observatwnal study (File et al , 2002) surg1cally menopausal 
women who had an E2 Implant for approximately 10 years had worse long-term 
ep1sod1c memory and mental flex1b1hty, and more psychologiCal and somatlc 
menopausal symptoms, than untreated surg1cally menopausal women These negatlve 
results are m lme w1th other findmgs of an assoc1at10n between better verbal fluency 
and HT use m younger (<58 years) surg1cally menopausal women, but not m older, 
surgiCally or younger, naturally menopausal women (Szklo et al , 1996) These 
findmgs also t1e m w1th an observatwnal study that md1cated that former- but not 
current- users of HT were protected agamst AD (Zand1 et a], 2002) However, 
mteractwns of duratwn of use and protechve effects were not always found For 
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e"ample, surg1cally menopausal women usmg HT compared With surg1cally 
menopausal women who were not usmg HT had better verbal memory and 
constructiOnal abJh!ies at the age of 65 years (Verghese et al , 2000) As duratwn of 
treatment was not reported m this study, 1t IS poss1ble that the majonty of women m 
th1s study had only used HT for a hm1ted penod of lime 
It must be kept m mmd that several chmcally 1mportant questwns remam unanswered, 
such as the effect of duratwn of use and the generahsab1hty of the WHIMS to women 
for whom HT 1s an md1catwn 1 e penmenopausal women who have menopausal 
symptoms (Cra1g, Maki, & Murphy, 2005) Tl11S questwn; Will be answered when 
results ofKronos Early Estrogen Preventwn Study (KEEPS) (Wharton et al, 2008, 
Harman et a] , 2005) While our quanlitalive meta-analyses Jdenlified surg1cally 
menopausal women as those most effec!Jvely treated for cogmlive deficiency by HT 
(Hogervorst, Yaffe, Rlchards, & Huppert, 2002a), other reviewers suggested that 
women who were h1ghly symptomatic (wh1ch would mclude most surgically 
menopausal women) showed largest treatment effects (LeBlanc et al, 2001) 
Although when sta!Js!Jcally tested, menopausal symptoms did not explam 
improvement on cogmlive funclion, these 1ssues need to be further elucidated 
(Hogervorst, 2006). 
2.3.1.8 Conclusion 
There 1s no doubt that the findmgs of these tnals have had and w11l contmue to have a 
huge mfluence on the mdustry and the use of HT Furthermore, more controlled 
studies need to be done m order to fully understand and support or refute the findmgs 
so far The general confuswn and conflicts seen m th1s area are worrymg, particularly 
for postmenopausal women who are plagued by symptoms, such as hot flushes, mght 
sweats and cogmlive and affec!Jve complamts However, JUSt as history has shown a 
sh1ft m perspec!Jve over the last I 0 years, what the next I 0 years bnng Will hopefully 
result m the clanfication of the effects that HT has on cogmtwn m menopausal 
women w1th and w1thout demenlia The future lies m more RCTs that take mto 
cons1derat10n the van abies that have been seen to mfluence the 1mpact of HT on 
cogmtwn and that have been listed above A change m perspeclive IS needed to focus 
on which vanables result m a pos1!Jve effect of HT, mstead of just those aspects that 
may result m nega!Jve findmgs The mcluswn and exclusiOn cntena used m future 
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studies should take m to consideratiOn factors such as the mfluence of age, wmdow of 
time, treatment form/route, surgical versus natural menopause and (although It IS not 
discussed m this thesis) possibly genetics (Hogervorst, Henderson, Bnnton-D1az, & 
G1bbs, 2009) 
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2.3.2 Phytoestrogens and Cognitive Function 
2.3.2.1 What are phytoestrogens? 
Phytoestrogens, a phytohormone or plant hormone, are naturally occurnng 
polyphenohc molecules found m plants and are abundant m frmts, vegetables, grams, 
legumes, clover and soy based products (Kurzer & Xu, 1997) They are consideied to 
be 'natural hormones', as they are very Similar toE m their physiochemical and 
physwlogical properties, and when consumed, display Similar effects on the body as 
naturally occurnng E (Murkres et a!, 1998, Setchell, 1998, Adlercreutz & Mazur, 
1997, Kurzer & Xu, 1997, Pnce & Fenwick, 1985, Bradbury & White, 1954) The 
Food Standards Agency (FSA) define a phytoestrogen as 'any plant substance or 
metabohte that mduces biological responses m vertebrates and can mimic or modulate 
the actions of endogenous E usually by bmdmg toE receptors' (FSA, 2002) 
Phytoestrogens can be classified mto three mam categones; hgnans, coumestans, and 
ISoflavones Isoflavones are the phytoestrogens mvestrgated m the current thesis and 
are found m large quantities 111 the soybean The most potent Isoflavones, and also the 
Isoflavones discussed 111 the current thesis, are dardze111, gemste111 Further 111formation 
on other phytoestrogens, bwavarlabihty, mteractrons With endogenous sex hormones, 
and effects on general health are descnbed m detail m appendix 8 
2.3.2.2 Safety & Availability 
Dietary phytoestrogens are a billion dollar busmess at least partly accounted for by the 
findmg that four out of five middle-aged women use herbal remedies and dietary 
supplements, With or Without prescnptron drugs, on a regular basiS m order to treat 
health problems associated with agemg Therefore, I so flavone supplemental! on IS 
gettmg more and more popular and available either over the counter or as mgredients 
111 the development of fortified foods (Bloedon et a!, 2002, Setchell et a!, 2001) 
With specific reference to phytoestrogens, the US Food and Drug Admmistratron 
recently allowed the food mdustry to state that soy piotem can protect and promote a 
healthy heart, focusmg on Its Isoflavone and protem content (US Food and Drug 
Admimstratron, 1999) Inevitably, !Ius has resulted m a floodmg of the food markets 
With soy products and supplements as well as an expected mcrease 111 the sale and use 
ofthese soy foods and supplements This IS worrymg as the fullimphcatrons of soy 
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manufactunng processes or efficacy are not fully understood In fact, the scarce and 
confltctmg mformatton regardmg the metabolism and bwavatlabthty of 
phytoestrogens m Itself should be enough to cause concern over Its' promotwn as a 
'health food' Furthermore, a trend towards manufactured tsoflavone supplements as 
opposed to tsof!avone m a more natural form, through 1soflavone-nch foods, may 
have additional further reachmg 1mphcatwns (see append1x 8) 
2.3.2.3 East vs. West Demographic Differences in Soy Consumption & 
Phytoestrogeu Levels 
Soy foods have been eaten m Astan soc1et1es for over 1000 years and are an Important 
part of everyday d1et thus consumption IS much h1gher than m western countnes 
Populatwns m Japan, Tmwan and Korea are estimated to consume approximately 20-
150 mg/day of 1soflavones, usually from a vanety of soy food sources (Murktes et al , 
1998), compared to the average Amencan who consumes 1-3 mg/day (Bames et a! , 
1995) In Japan, soy foods and supplements are heav1ly promoted as a "natural" 
source ofE w1th beneficial effects for women and a pos1tive 111fluence on healthy 
agmg, therefore soy 111take 111 that part of the world IS espec1ally lugh K1m1ra et a! 
(1998) found that total1soflavone mtake of a female Japanese sample was on average 
39 46 mg/day (rangmg from 7 80-87.73 mg/day) More specifically, 111take of 
dmdze111 was 4 62 mg/day on average, and 52 12 mg/day on average of gemstem Arat 
et a! (2000) reported s1m1lar dmdzem and gemste111 intake for Japanese m1ddle-aged 
women (16 4 and 30 1 mg/day/cap1ta respectively). The most common types of soy 
food eaten 111 Japan are tofu, m1so, natto (Arm et a!, 2000) and fned tofu (Wakm et 
a!, 1999) Amongst the Ch111ese, Chen et a! (1999) found that the maJonty (96 7%) 
of women 111 the Shanghm sample (n=60) ate soy foods at least once a week (medtan 
mtake of soy foods= 100 6 g/day)9 Although many of these samples are small111 s1ze 
(less than 100 part1c1pants) the same findmg IS reported across the board, assoc1at111g 
h1gh phytoestrogen 111take wtth East As1an commumties 
The 1soflavone 111take 111 these Western countnes ts low compared to East As1an 
countnes For example, 111 F111land average 1soflavone mtake (although mtake vaned 
across the population) was 0 788 mg/day (S D = 0 673) consumed from mamly 
9 Please note the mvest1gators assessed the quantity of soy foods eaten, and th1s was measured m grams per day and not 
m1lhgrams as IS common for assessmg levels of ISOflavones 
70 
processed meat products and sausages which contam soy (Valsta et al., 2003) This 
was reflected m low plasma levels of dmdzem and gemstem found m another Fmmsh 
sample (Wang et a], 2000) In another cohort (n=447) ofnon-As1an hvmg m the USA 
of mixed ethnicity (Afhcan-Arnencan, Latma, and White), the mean mtake of 
1soflavones was 1 483 mg/day gemstem, and 1 281 mg/day da1dzem mamly from tofu, 
doughnuts, soy milk, white bread, pancakes/waffles, and canned tuna Coffee was also 
a mam contnbutor to dmdzemlevels m this group (Horn-Ross, Lee, John, & Koo, 
2000) In a Dutch sample (Boker et a! , 2002), the mam source of 1soflavones was 
peas and beans, followed by coffee, tea, nuts and grams, and to a lesser extent 
tradJ!Jonal soy foods winch only accounted for 6 5% of total dmly mtake of gemstem 
and dmdzem Most of the phytoestrogens consumed were hgnans (-70%), which IS 
reflective of other Western populations (de KleiJn et a!, 2001, Hom-Ross, Lee et a!, 
2000) 
Lower Isoflavone levels have also been found m Portuguese and Bntish men 
compared to Chmese men hvmg m Hong Kong (Morton et a! , 1997) Low 
phytoestrogen m take can be seen m other Asian Western-country based populations 
For example, Bhakta et al (2006) reported mean Isoflavones and hgnans mtake at less 
than 1 mg/day m both migrant and native Bntish South Aswn women ongmatmg 
from India and Pakistan, with the m am source of Isoflavones bemg bread and 
vegetables and bread for hgnans Similarly, m aUK population cohort study, 
Mulhgan et a! (2007) found that average I so flavone mtake for men and women 
(n=11,843) was less than 1 mg/day and mostly from bread However, self-reported 
soy-consumers had higher mtake with 8 6 mg/day for women and 7 5 mg/day for 
men, mostly from vegetable dishes and milks Agam this IS much lower than seen m 
South-East Asian populatwns In other western societies, this same low mtake has 
been found, for example m Arnencan Caucasian women (de KleiJn et al, 2001) 
The culturalmfluence on the differences observed between East Asian and other 
commumt1es can be seen clearly when companng mdividuals of the same ethnic 
ong111 hvmg 111 different commum!Jes For example, a study assess111g dietary soy 
111take and breast cancer m South Asians hvmg m Ch111a and Aswns hv111g 111 Amenca 
found that soy 111take m Chma (S111gapore, Chma, and TwnJm) ranged from 20 to 141 
mg/day, whereas for Arnencan-Asians (San Francisco, Los-Angeles, or Hawan), soy 
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consumptiOn was a much lower 0 9- 10 mg per day (Wu et al , 1998) Rice et al 
(2001) reported that Japanese-Amencan women, a sub-sectwn of the longitudmal 
Kame ProJect (Graves et al., 1996), (n=274 women, aged 65 years or above) 
consumed tofu at least once a week, With miso and aburrage (fned tofu puffs) a close 
second at 90% of the cohort For tl11S sample the mean soy Isoflavone mtake was 10 2 
(S D =12 4) mg/day, wh1ch could be spht mto 3 8 (S D =4 8) mg/day dmdzem and 
6 4 (S D =7 6) mg/day of gemstem, and although not as high as a 1 apan-based 
Japanese cohort, It was stlll higher than non-Asian western samples Furthermore, the 
mvestigators found that language spoken at the mterview was a Significant predictor 
of Isoflavone m take, with those who spoke Enghsh havmg much lower mean 
1soflavone mtake (7 8 ± 8 9 mg/day) compared to those who spoke Japanese (23 1 ± 
19 5 mg/day) This suggest that those women who spoke Japanese may have been 
more hkely to eat a traditlonal Japanese diet and therefore consumed more dietary soy 
Isoflavones than those who were more 'westernised' and hence spoke Enghsh This 
amount ofphytoestrogens consumed was double the amount consumed by Caucasians 
also hvmg m Hawan (6 9 mg/day) (Maskannec, Smgh, Meng, & Franke, 1998) 
2.3.2.4 Different Soy foods and their composition 
In order to accurately mterpret the effect of soy foods on health, one must first 
understand the vanatwn m composiilon of different soybean based products On a 
basic level, 01l and protem account for approximately 60% (weight) of the soybean 
(40% protem and 20% 01l), with the remamder consistmg of35% carbohydrate and 
approximately 5% ash The maJOnty of the soybean IS heat-stable (Mohamed & Xu, 
2003) whlch makes the soybean smtable for high temperature cookmg producmg tofu, 
tempe, soymilk, and textured vegetable protem 
Many databases have been developed hstmg the Isoflavone content of soy foods 
(Beecher, Bhagwat, Haytowitz, Holden, & Murphy, 2000, Hom-Ross et al , 2000) 
The maJonty of soybean products, for example mature soybean, roasted soybean, soy 
flour and textured soy protem are nch m Isoflavones, providmg approximately 5 1-5 5 
mg tota!Isoflavone/g soy protem Followmg this, the green soybean and tempe 
provide approximately 3 3 mg/g and 3 I mg/g respectlvely Tofu, Isolated soy protem, 
and some types of soy milk provide 2 mglg. Food types providmg approximately 
40mg ofisoflavones (similar to the average dmly quantltles eaten m a traditiOnal 
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Japanese d1et Kmma et a! (1998) mclude 120g uncooked tofu, 73g uncooked green 
soybeans, 456 (2 cups) ofsoYJmlk, 20g (1/4 cup) soy flour and 20g of roasted 
soybeans (Anderson, Sm1th, & Waslmock, 1999) 
Table 3- Soy Food Isoflavone Content 
Aglvcon (microgram per gram) 
Product 
Trad1t10nal ~~~" Fond'i 
Roasted Soybeans+ 
Tofu+ 
Tempe+ 
M1so (Soy Be.1n Paste)+ 
Natto (Fem1ented Soybeans)O 
Soy m1\k (hqu•d from bmled 
pureed soybeans)O 
Soy SauceO 
Second-oenerratwn 'iOY foodo;: 
Soy Hotdogt 
Soy Bacon+ 
Tempe Burger+ 
Flat Noodle+ 
Soy Parmesant 
Foods Contammg Sov Flour or 
l•rott•m & Other Foods 
Wh1te BrcadO 
\Vholegram BreadO 
Canned TunaO 
DoughnutsO 
PancakesO 
Soy/"Vegg1e" BurgersO 
CoffceO 
"Power"-type BarsO 
P1zzaO 
563 
146 
273 
272 
50 
2 
34 
28 
64 
9 
15 
7 
2 
4 
20 
13 
30 
05 
18 
2 
Gcm'itcm 
869 
162 
320 
245 
63 
6 
82 
69 
196 
37 
8 
8 
7 
32 
14 
20 
tr 
33 
2 
tWang & Murphy J Agnc Food Chcm 1994,42, 1666-1673 
0 Hom-Ross et a! Cancer Causes and Control 2000, 11, 289- 298 
m = not stated 
193 
20 
32 
77 
ns 
ns 
34 
24 
30 
39 
41 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
tr =trace defined as~ 25 ~tgll OOg (the authors 1mmmum level of rch<1ble dctcctton) 
1615 
337 
625 
593 
ns 
ns 
!50 
122 
289 
85 
65 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
The soybean IS the nchest source of 1soflavones (m both the aglycones and glucoside 
form) With the fennentatwn process mcreasmg the aglycones levels On the whole the 
processed soy products of cooked soybeans, textured soy protem, and soymllk powder 
contam more than 95% of1ts 1soflavones m the fom1 of glucos1des However, m 
fermented soybean products, such as tempe, a greater proportiOn of Its Isof!avones are 
m the form of aglycones ( 40%) whereas m non-fermented products of soy such as soy 
mllk or !So flavone extract supplements, the !so flavone form tends to be glucoside 
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(Wang & Murphy, 1994, Coward, Barnes, Setchell, & Bames, 1993) Soy 1s the 
nchest source of gemstem, IS abundant m dmdzem and IS the only source of glyc1tem 
(Zhao & Bnnton, 2007) The estrogemc effect of soy has been attnbuted to gemstem 
and dmdzem as well as the newly added dmdzem metabohte, equol (see appendix 8) 
CompositiOn of soy foods can vary m further ways that affect the types and quantities 
of the molecnles that make them This begms With the nul! a] growth process and 
response to external stlmuh wh1ch may cause the molecules of the soy plant to 
develop m certam ways that result m more complex phytoestrogen profiles (Zhao & 
Bnnton, 2007) For example, a stressful growmg condition could result m mcreased 
productiOn ofJsoflavonOJd phytoalexm compounds glyceolhns (antlbwtlcs that are 
produced by plants under attack wh1ch are tox1c to the orgamsm), and can form as 
much as 56% of the tota]Jsoflavone content (Burow et al, 2001) The stress caused 
by freezmg and fermentation can also result m a bmld-up of glyceollms (Burow et al., 
2001) Other vanables such as locatiOn, season, mfectlon and fungal d1seases affect 
the phytoestrogen content (Eldndge & Kwolek, 1983) Furthermore, the 1soflavone 
content and form of different soy foods can have a s1gmficant effect on 1soflavone 
avmlab1hty Vanatlons m aspects such as aglycone or glucoside form, sohd or hqmd 
all need to be taken mto consideratiOn when assessmg the pharmacokmet1cs and 
pharmacodynamics of Jsoflavones For example, consumptiOn of tempe, wh1ch 
contams approximately 50% aglycone, as an example, resulted m h1gher serum peak 
levels of gemstem than 15% aglycone textured vegetable protem Furthermore, 
soym1lk ("=' 15% aglycone) was absorbed qmcker and reached peak plasma levels 
faster than both tempe and textured vegetable protem (Cass1dy et al., 2006) 
Soy IS processed m different ways to make products from 1ts different components 
and th1s processmg can affect the 1soflavone content as well as result m the add! lion of 
other products and compounds For example, alcohol extraction and ac1d preCJp!tatwn 
reduces the 1soflavone content of soy protem and the soybean can be altered m 1ts 
levels of fibre, fat, phyt1c ac1d, and saponm content by the processmg methods used to 
make the end-product (Oakenfull, 2001; Potter, 1995) The vanatwn m food-
processmg of soy also alters the proportwns of glucos1des and aglycones (de Pascual-
Teresa et al , 2006, Coward et al , 1993). 
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Tofu and tempe contain varying amounts of isoflavones in the four chemical forms 
(aglycones, glucosides, acetylglucosides, and malonylglucosides). However, the 
aglycone form is the most common type of isoflavone found in traditionally made soy 
foods with tempe containing approximately two times the amount of aglycone 
isoflavones (daidzein, genistein, glycitein) as tofu (Wang & Murphy, 1994). See table 
3 for the total aglycone content in tofu and tempe. 
Tofu is of Chinese origin, although the exact origins and discovery have not been 
confirmed. It is made by coagulating soy milk from soy bean curd using salt or acid 
coagulants. This is then formed into blocks and processed in a variety of ways to form 
different types and textures. It is relatively bland in taste and therefore picks up 
flavours easily. Due to this, it is used in Asian cooking in a wide variety of ways 
which include soups, stews, stir-fries, eaten raw or stuffed with other fillings. 
Although originating in China, the spread ofBuddhism (which places high 
importance on proteins and has a strict vegetarian diet) meant that tofu was then 
introduced into the diet in Korea, Japan, and other parts of East Asia, such as 
Indonesia, in the late eighth century. However, in Western countries, tofu was not 
well known and used until the middle of the 201h century with increased popularity of 
vegetarian diets. Consequently, although very popular amongst the vegetarian 
constituent of western populations and promoted more and more as a 'healthy 
superfood', it is not eaten widely, and still remains very much a niche food. 
Figure 1- Soft Tofu 10 Figure 2 -Fresh tempe at the market in 
Jakarta, Indonesia 11 
~ .. 
Tempe, or tempeh, is made by ferm.enting the whole soybean using a mild acidulent 
such as vinegar with the mould Rhizopus oligosporous. The mould forms a mycelium 
which binds the soy beans together, resulting in a 'bean cake' like form. Unlike tofu, 
tempe actually originated from the Indonesian Javanese and is still an integral part of 
10 Source : http://www. wingyipstorc.co.tk/d isp lay-product. php?rcf= 82095&currcnlpagcrc F I 052 
11 Source: hllp://cn.wikipcd iaorglwikiffcmpch 
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the Javanese d1et Due to the differences m processmg, tofu and tempe have different 
nutntlonal compositiOns The fermentatiOn of the whole soy bean means that tempe 
retams more of the nutntious components of the soy bean that tofu, 1 e It has higher 
protem, fibre and v1tamms than tofu and hence IS commonly used as an alternative to 
meat due to Its meaty texture and d1stmctive flavour (Golb1tz, 1995) Addmg to Its 
nutntwnal value, v1tamm B 12 IS a by-product of the fermentation process used to 
make tempe (Gmtmg & Arcot, 2004, L1em, Stemkraus, & Cronk, 1977) Tempe was 
mtroduced m Europe through the Dutch who colomzed Indonesia Therefore the first 
Western tempe compames were started m the Netherlands by Dutch Immigrants fwm 
Indonesia The mterest m tempe by the Dutch goes back to the early 1900s However, 
m the USA, tempe was only known m 1946 and was first commercially made m 1975 
(Tempeh mfo, 2008) It IS still not as popular as tofu m Western countnes 
Although the more 'traditional' soy foods, tempe, soym1lk, soy sauce, and m1so, eaten 
m Asian countnes are made m traditional ways usmg on ental techniques (Golb1tz, 
1995), soy foods such as tofu and are becommg more popular m Western countnes 
and hence are largely mass produced in large processmg plants Furthermore, the 
West has also developed some 'second-generatiOn' soy based foods, which are not so 
popular m Asian countnes For example, Amencans have developed products, such as 
tofu Ice cream, tofu hotdogs, vegg1e burgers, tempe burgers, soym1lk yoghurt, 
soym1lk cheese and a wide vanety of other soy based foods manufactured usmg non-
traditiOnal methods (Golb1tz, 1995) Recent technologies and techmques have been 
developed to m crease the saleability of soy products m the west For example, tofu IS 
pasteunsed to mcrease Its self-hfe and ab1hty to market It as 'fresh' tofu for as long as 
30-60 days, and aseptic packagmg IS used so that tofu can be stored at room 
temperature for up to one year (Golb1tz, 1995) What causes this difference IS purely 
speculatiOn at this pomt, but the method of makmg the food product (whether 
traditional or mass productiOn) could be a factor to consider Is It possible that those 
who eat tofu made m a traditional way (such as m South-east Astan countnes) may be 
consummg not JUSt more soy, but also a greater quantity of phytoestrogens due to the 
methods ofpreparatwn? 
It must be noted that soy IS added to a multitude of foods and beverages m Western 
countnes and therefore 1soflavone mtake may be underestimated m studies assessmg 
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these parts of the world However, most studies ask extensive questiOns covenng a 
wide vanety of soy contammg foods Furthermore, It IS unlikely that the East vs West 
difference observed can be attnbuted to simply this confounder, as other studies 
assessmg a w1de vanety of foods contammg different types of soy have also found 
low Isoflavone mtake m Western populatwns from different ethnic backgrounds 
The general consensus from previous research thus appears to be that South-East 
Asian countnes (on average) consume a much greater quantity of soy than western 
countnes Furthermore, m South-East Asia, soy consumed IS m the form of 
'traditiOnally' made products such as tofu, tempe, m1so, and soymilk, as well as a 
higher m take of the phytoestrogen 1soflavone through these sources, whilst m the 
West, more mdustnally produced foods contammg some soy are frequently consumed 
as are high quantities of lignans rather than 1soflavones Furthermore, some studies 
have found different Isoflavone concentratiOns usmg plasma and unne samples, With 
those eatmg a more traditiOnal Asian diet havmg higher levels of gemstem and 
dmdzem However, It must be noted that w1thm these studies there IS great vanab11Ity 
Furthermore, when mterpreting findmgs from studies assessmg Isoflavone levels, the 
bwavarlabiiity of phytoestrogens can vary between mdiVIduals and can be mfluenced 
by a multitude such as habitual diet, duratiOn of soy consumptiOn, gender, and 
genetically determmed metabolism rates, as well as bactenal flora (Boker et a! , 
2002) 
2.3.2.5 Effects on endogenous sex hormones levels in postmenopausal women 
In postmenopausal women prevwus research assessmg the effects of phytoestrogen 
consumption on endogenous sex hormones have not been as unswervmg as for 
premenopausal women (see appendix 8) For example, Persky et a! (2002) found no 
effect oflong-term (up to 6 months) daily mgestwn of moderate or h1gh 
concentrations of Isoflavone on serum or unnary E, DHEAS or FSH m 
postmenopausal women (mean age 59- 61 years across the treatment groups) In 
support of this, Petrakis et a! (1996) also found no change m plasma E concentrations 
after 6 month of38 g soy protem/day Isoflavones Furthermore, Duncan et a! (1999) 
reported significant (although small) reductiOns m E2 and El concentratiOns and an 
mcrease m SHBG concentratiOn m postmenopausal women on a 3 month high 
Isoflavone diet 
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Even m low E environments, such as that of the postmenopausal woman, some 
research has mdJCated that dietary Isoflavones can additionally disrupt the funct10mng 
ofE2, possibly due to Its competitiOn for ER sites (E agomst) Boettger-Tong et a! 
(1998) found no uterotrophic effect ofE2 treatment after ovarectomized female rats 
were feed high amounts of gemstem and dmdzem suggestmg that the response had 
already been over-stimulated by the Isoflavones and therefore estrogemc actiVIty of 
excessive Isoflavone mtake affected the funct10nmg ofE2 
2.3.2.6 Biological Effects on the Brain 
Although a great deal of attention has been paid to the rela!Jonship between 
phytoestrogens and the penpheral systems, research IS limited concemmg the 
mfluence ofphytoestrogens on the nervous system and cogmhve functiOn (Lephart, 
Rhees, Setchell, Bu, & Lund, 2003, Lmford & Dorsa, 2002, Lund, Rhees, Setchell, & 
Lephart, 2001; Ha!breJch & Kahn, 2000, Pan, Anthony, Watson, & Clarkson, 2000) 
Phytoestrogens have been found to regulate cholme acetyltransferase, nerve growth 
factor, and bram-denved neurotrophic factor m the hippocampus and frontal cortex of 
female rats (Pan, Anthony, & Clarkson, 1999a, Pan, Anthony, & Clarkson, !999b) 
Phytoestrogens have also been found to demonstrate a neuroprotective effect by 
attenuatmg tau protem phosphorylat10ns, whiCh are associated with AD pathology 
(Kim, XIa, L!, & Gewm, 2000) Further neuroprotec!Jve effects ofphytoestrogens 
have been found on hippocampal (Zhao, Chen, & Diaz Bnnton, 2002) and pnmary 
cortical cultures m vitro (Lmford & Dorsa, 2002) Isoflavones, extracted from over-
the--{:ounter supplements, have also been found to antagonize ER~ via an!Jestrogemc 
effects m the female rat bram and hence alter reproductive behaviOur (although no 
sigmficant effects were found on ERa) (Pa!Jsaul, Melby, Whitten, & Young, 2002; 
PatJsaul, Dmdo, Whitten, & Young, 200 I) 
Soy 1soflavones could Impact on other processes such as neurotransmitter systems 
known to be necessary for cogmtJve functiOn For example, gemstem can modulate 
the dopammergic system (Ferguson, Flynn, Dele! os, Newbold, & Gough, 2002), 
mhibits GABA-act1vated currents m HEK293 cells (Huang, Fang, & D!llon, 1999), 
and mhibit glycme receptors (Zhu, J~ang, KrnjeVIC, Wang, & Ye, 2003, Huang & 
D!llon, 2000) Soy Isoflavones also may affect ChAT expressiOn and actJVJty (Pan, 
Anthony, & Clarkson, 1999a) 
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Appendix 8 g1ves a more detailed rev Jew of phytoestrogen research It discusses the 
classilicatwn of phytoestrogens, h1story of phytoestrogen research, bwlogJcal 
mechamsms, pharmacokmelics and pharmacodynamics both m v1tro and m v1vo, 
bwavaJ!abJhty, effects on endogenous hormones m h1gh estrogen states 
(premenopausal women) A very bnefsumrnary of the effects ofphytoestrogen on 
health 1s mcluded However, tlus portwn of the thes1s focused on the possible effects 
of phytoestrogen consumptiOn on cogmlive fun cl! on m postmenopausal women and 
men and the findmgs of the few observatwnal and RCTs assessmg this are discussed 
below 
2.3.2.7 Human Studies Assessing the Effects ofPhytoestrogens on Cognitive 
Function 
2.3.2.7.1 Observational studies investigating phytoestrogens and cognition 
ObservatiOnal studies assessmg the relalionshlp between !So flavone and cogmlive 
functiOn have been few and far between, and have also reported conf11ctmg results 
These stud1es have mvesligated the relatwnsh1p between phytoestrogen consumptiOn 
and vanous aspects of cogmlive funclion m Western countnes w1th postmenopausal 
women of non-East As1an decent (Krc!Jkamp-Kaspers et al, 2007, Franco et al, 
2005), older men and postmenopausal women of East As1an decent (Rice et al., 2000, 
White et al , 2000), as well as mulli-ethmc populatwns younger than 50 years of age 
(Ostatnikova et al , 2007, Huang et al , 2006; Celec et al , 2005) 
Kre!Jkamp-Kaspers et al (2007) assessed the effects ofhab1tual mtake oflow 
quanlilies ofphytoestrogens through d1et The sample cons1sted of301 Dutch 
postmenopausal women aged 60- 75 years. These were volunteers from an ongomg 
cohort study assessmg nutnlion and cancer, as well as a breast screenmg program, 
who had a w1de range of phytoestrogen m take A Food Frequency QuestJOllllaJre 
(FFQ) was ulihsed to compile mfonnatwn of phytoestrogen contammg foods eaten 
Furthennore, to evaluate approximate levels of phytoestrogens consumed, the 
researchers ass1gned a value to the vanous phytoestrogens (m1lhgrams per IOOg of 
food!dnnk) The foods were then dlVlded mto seven groups based on th1s 
phytoestrogen 'score' (see de Kle!Jn et al (2001) for methods used) and a med1an 
phytoestrogen content was ass1gned to each group to avmd over or under eslimatwn 
of phytoestrogen consumptiOn In th1s sample, med1an m take per day of hgnans 
ranged from 0 65- 2 29 mg/day, whereas for 1soflavones this was 0 18- 14 64 
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mg/day, although the middle two quartiles were significantly lower than the highest 
(0 34 & 2 99 mg/day) The researchers report no Significant differences between the 
vanous levels of Isoflavone m take on cognitive tests of memory, processmg speed, or 
executive functiOns However, a significant associatiOn was found between high 
l!gnan mtake and processmg capacity and speed as well as executive functiOn 
In the same Dutch sample, Franco et al (2005) aimed to assess the effects of 
Isoflavones and hgnans of the levels found m a typical western diet on cognitive 
performance usmg only the MMSE However, m these analyses, the mvestigators 
were mterested m a longer (20- 30 years) vs a shorter (8- 12 years) postmenopausal 
time span They also mcluded natural menopause as a factor that might have affected 
the relationship between phytoestrogen mtake and cognitive functiOn No significant 
associatiOn was found between Isoflavone mtake and cognitive functiOn as measured 
by the MMSE However, and more pronounced m women with longer 
postmenopausal lime span, a significant association was found between higher hgnan 
mtake and better cognitive performance The authors speculated that this stronger 
associatiOn m women With longer postmenopausal time span could be due to the older 
age, or other age-related mechamsms which could be mediatmg the relatiOnship 
However, It must be noted that mean Isoflavone mtake was very low (0 14 mg/day) m 
this sample and IS substantially lower than that observed m Japanese and Chmese 
samples 
Two large scale epidemiOlogiCal studies have assessed the relatiOnship between 
phytoestrogen consumption, specifically tofu, and cognitiVe functiOn m Asian-
Amencan's hvmg m Western commumties These are the Honolulu Asm Agemg 
Study (HAAS) (White et al , 2000) and the Kame ProJect (Rice et al , 2000) 
The largest study of the effect ofphytoestrogen on cognitive functiOn, mclusive of 
men, has been HAAS, consistmg of 3734 J apanese-Amencan partiCipants aged 70-90 
years l!vmg m Hawau, USA (White et al , 2000) The mvestigators reported that 
contrary to the1r own and others expectatiOns high soy consumptiOn had a negative 
associatiOn w1th cognitive function The study found that men aged 71 and over, as 
well as their w1ves, who had consumed tofu more than twice a week m midl!fe had 
higher nsk of dementia, lower bram weight and ventricular enlargement, and lower 
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cogmt1ve functiOn than those who consumed less tofu For example, for men With the 
lowest tofu mtake, cogml!ve 1mpmrment was Identified as 4% compared to men with 
the highest tofu mtake figure of 19% Also, m the low tofu mtake group low bram 
weight was seen m 12% of cases compared to 40% of men m the highest category 
This suggests that there IS a dose-dependent effect of tofu consumpl!~n, 1 e that 
mcreasmg levels of tofu consumptiOn was associated with poorer cogml!ve functiOn 
As previously discussed, mterest m dementia development has partly focused on 
antioxidant mfluences However, this study which has shown a negative assocm!Jon 
between h1gh tofu mtake and cogmtive 1mpmrment suggests It may be w1se to move 
away from antioxidants and supplements and focus on dietary factors that could 
mfluence cogml!ve functiOn (Grodstem, Mayeux, & Stampfer, 2000) 
A strength of the HAAS study hes m Its ability to cover a wide lime-span of dietary 
assessment (data was collected vm two assessments up to nme years apart) Also some 
data was collected m m1dhfe, approximately 20 years before cogml!ve eva1uation and 
MRI scans However, and as with studies usmg this methodology, It IS unclear If tofu 
consumptiOn Itself was responsible for cogml!ve 1mpmrment or If tofu mtake IS 
simply an mdicatwn of some other unfavourable exposure For example, the men With 
high tofu mtake, and hence a more traditional diet, were more likely to come from 
1mpovenshed backgrounds and may have expenenced more childhood depnvatwn 
which could be related to bram development and later hfe cogm!Jve functiOn In 
addition, a high tofu d1et could be an md1catwn of a specific dietary pattern which 
may be harmful to the bram and separatmg the elements of this d1et m order to Isolate 
the contnbutmg factor may prove very difficult Although these results are of great 
mterest, one must note that they are prehmmary, as relatively few subjects consumed 
very high levels of tofu and confidence mtervals around the estimates of effect 
presented were wide, md1catmg the hm1ted precisiOn of these results (Grodstem et a!, 
2000) 
The Kame Project (Rice et a!, 2000) consisted of Japanese-Amen can men (n=634) 
and women (n=767) hvmg m Washmgton State, USA, aged 65 years and older 
Cross-sectwnally, the results showed an associatiOn between lower cogm!Ive score, as 
measured by the Cogml!ve Abilities Screemng Instrument (CASI), and high tofu 
consumption(> 3 limes a week) as opposed to moderate (1-2 times a week) or low 
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consumption (<I time a week) In stratified analyses this remamed significant only for 
women who were hormone replacement users (but not for those who were not 
hormone users, elderly men or those who consumed moderate to low amounts of 
tofu) The mvestJgators also found that longitudmally, although no overall associatiOn 
was found between tofu consumption and 2 year change of CASI score, those with 
modest tofu consumptiOn showed the greatest improvements m CASI scores These 
data suggest that there may be optimal levels of phytoestrogens, perhaps mteractmg 
with age, gender and E levels It must be noted that the Investigators d1d not assess 
tota!Jsoflavone exposure, but only estimated tofu mtake This may be problematic as 
tofu accounted for only approximately half of soy based Jsoflavone consumed by the 
populatiOn 
Some observatiOnal studies have assessed the relatiOnship between phytoestrogen 
consumptiOn and cogmtive functiOn m premenopausal women In the Study of 
Women's Health Across the NatiOn (SWAN) (Huang et a!, 2006) a sub-group of 195 
Japanese and 185 Chmese women hvmg m the USA between 42 to 52 years of age 
were assessed for this relatiOnship Vanous tests of episodic memory, workmg 
memory and processmg speed were used to assess cognitive functiOn However, the 
mvestigators found no association between gem stem mtake (as calculated from the 
Food Frequency QuestiOnnaires or FFQ (Boker et a!, 2002, de KleiJn et a!, 2001) and 
cognitive functiOn The authors surmised that the effects might only be present m 
women who are m !ow-E states and hence who were postmenopausal Furthermore, 
although the participants were of Japanese and Chmese on gm, with higher 1soflavone 
mtake than other Western non-Asmn populatwns, mean gemstem and daJdzem mtakes 
were still only 6,788 and 4 678 Jlg for Japanese women and 3,534 and 1,739 Jlg for 
Chmese women Approximately 45,000 Jlg of 1soflavones IS needed to significantly 
affect folhcular phase and menstrual cycle length m premenopausal women (Cass1dy, 
Bmgham, & Setchell, 1995, Cass1dy, Bmgham, & Setchell, 1994, Ph1pps, Martm1, 
Lampe, Slavm, & Kurzer, 1993) See appendiX 8 for more mformatwn Therefore, It 
IS possible that the findmg of no associatiOn m th1s study could m part be due to the 
levels of 1soflavone not bemg suffiCiently high enough to have an Impact on cogmtJve 
function Th1s could also explam a lack of significant findmgs m the KreiJkamp-
Kaspers study 
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It 1s poss1ble that the lack of s1gmficant assoc1at10ns found m stud1es assessmg 
trad1t10nal Western (Caucas1an) populatwns IS due to the very low levels of 
1soflavones consumed m these populatwns The part1c1pants m Kre!Jkamp-Kaspers 
observatwnal study (Kre!Jkamp-Kaspers et al, 2007) had at the most a d1etary mtake 
of 15mg/day of soy 1soflavones Th1s IS only a quarter or half of that consumed by 
Japanese women hvmg m Japan, but 1s stlll substantlally h1gher than Caucaswn 
women hvmg m Western countnes e g (Franco et a], 2005) Furthermore, a 
s1gmficant assocwtwn (whether th1s was pos1t1ve or not) has been found m 
populatwns that consume much h1gher quanhtles of 1soflavones m the1r d1et but are 
also hvmg m Western commuml!es Th1s suggests there may be a dose effect or an 
effect ofhab1tual mtake, and that the lack of s1gmficance m the Dutch stud1es may be 
due to the very low levels of 1soflavones consumed 
In !me w1th prevwus suggeshons and theory, the findmgs from observatwnal stud1es 
(whether the assoc1at1on IS a pos1hve one, negal!ve one or no assoc1at10n found) 
suggest that an optlmallevel ofphytoestrogens may be needed m order to mamtam 
cogml!ve functwn m the m1ddle-aged but not the old (>65 years of age) after wh1ch 
h1gh soy consumptiOn could be negatlvely assocwted w1th cogml!ve functwn 
However, these stud1es rehed on self-reported FFQ which may not be the most 
rehable smgle md1cator of soy m take ( espec1ally m samples w1th very low 
phytoestrogen mtake) Furthermore, there 1s a potentlal problem when companng 
stud1es due to the d1fferences between them m the type ofFFQ used For example, 
some use d1etary self-report methods (recall vs acl!ve food d1ary) causmg a problem 
m d1stmgmshmg between cause and effect as well as mtroducmg bwses such as the 
"healthy-user" bms Lastly, no actual endogenous phytoestrogen levels were 
measured 
2.3.2.7.2 TreatmenUintervention Studies with Postmenopausal Women 
See Table 4 for a summary of all human phytoestrogen treatment stud1es 
There have been nme long term random1zed placebo-controlled mtervent10n stud1es, 
or Randomized Controlled Tnals (RCTs), assessmg the effects of soy 1soflavone 
supplementatiOn on vanous aspects of cogml!ve functwn Of these, e1ght have 
assessed postmenopausal women only,(Fourn1er et al, 2007, Cas1m et a!, 2006, F!le, 
Hartley, Elsabagh, Duffy, & W1seman, 2005, Howes, Bray, Lorenz, Smerdely, & 
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Howes, 2004, KreiJkamp-Kaspers et al, 2004, Duffy, W1seman, & F!le, 2003) of 
wh1ch seven were m Western populatwns (Fourn1er et al, 2007, Casm1 et al, 2006, 
F1le et al, 2005, Howes et al, 2004, Kreljkamp-Kaspers et al, 2004, Duffy et al, 
2003, Kntz-S1lverstem, V on Muhlen, Barrett-Connor, & Bressel, 2003), and one m a 
Hong Kong sample (Ho et a! , 2007). The nmth study has been w1th premenopausal 
women and young men m aUK sample (F1le et al, 2001) Furthermore, two short 
term (1 week) prospective mterventwn stud1es, also w1th premenopausdl women and 
young men, have been conducted (Ostatnikova et al, 2007, Celec et al, 2005) 
Four of the stud1es assessmg postmenopausal women reported beneficml effects of 
1soflavone treatment on cogml!ve functiOn (Casm1 et al, 2006, F1le et a! , 2005, Duffy 
et a!, 2003, Kntz-S1lverstem et al, 2003; F!le et al, 2002) Two were from the same 
group of mvesl!gators and separately assessed the effects of 60 mg total1soflavones 
per day on cogmtlve function, usmg the same cogmtlve test battery w1th 
postmenopausal women aged 50- 66 years m the Umted Kmgdom (UK) for a 
duratiOn of 6 weeks (F1le et al, 2005) and 12 weeks (Duffy et a!, 2003) 
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Table 4- Human Intenention Studies of Soy Isoflavones and Cogmtive Function 
Stud) Locahon 
Ho, 2007 !long Kong, 
Chma 
Fourmer, 2007 Pullman, 
USA 
Cac;m1. 2006 Mdan & 
Rome, Italy 
r,J!', 2005 London, UK 
Des1gn Durahon 
RDI3P, P 6 months 
RDBP 16 \\eeks 
RDOP, 6 months 
eo 
RDilP, P 6 weeks 
PartiCipant Vanables 
* n - 176 (168 completed) healthy 
PMW 
• Mean Age: 63 5 years (55 - 76 
)ears) 
* ExclusiOn Cntena liT m 
prev10us 6 months 
* n = 79 healthy PMW 
• Mean Age: 561 years (48- 65 
years), 1-35 years beyond 
menopause (mean 7 7 )Cars) 
* Exc!us10n C'ntena -HT m 
prev10us 6 months 
• n = 76 PMW 
• Mean Age= 49 5 years, > 
1 year of menopause (mean 57 
)ears) 
• Excluston Cntena HT use m 
pre\-IOUS 8 weeks, presence or 
htstory endocnnologtcal dl'>orders, 
use of psychoactn e medtcatton 
* n =50 healthy PMW 
• Mean age 58 years (51 - 66 
years),> I year beyond 
menopause (mean= 9 1 years, 
66% > 5 years) 
* ExclusiOn Cntena HT m 
pre\lous 12 months 
Interventmn 
I Soy Supplement- 80 mg total 
tsofla,ones/day 
2 Placebo 
I Soy Milk -72 mg total 
tsoflavone/day (37 mg gemstem, 
31 mg datdzem, 4 mg glycttem) 
2 Soy Supplement- 70 mg total 
!So flavone/day (33mg gent stem, 
30 mg datdzem, 7 mg gl)Citem) 
3 Placebo 
1 Soy Supplement- 60 mg total 
tsoflavonelday (40-45% 
gem<>tem, 40-45% daidzem, 10-
20% gi)Citem) 
2 Placebo 
I Soy Supplement- 60 mg lobi 
t'>oflavone/day 
2 Placebo 
Cogmtn e Measures 
• Leammg & Memory Tests -Hong Kong Leammg Ltst 
Test, Rey-Ostemeth Complex Ftgure Test, 
WMS-R 
* Executt\e FunctiOn- Tratl-Makmg Test, Verbal 
Fluency Test 
• Verbal Fluency- Boston Nanung Task 
• Attentton & Concentratton - Dtgtt Span Test 
• Motor Control - Fmger Tappmg Test 
• Language- Boston Nammg Test 
• Vtsual PerceptiOn - Rey-Osterneth Copy Tnal 
• Global Cogmtton & Dementm- MMSE 
* Workmg Memory- D1gtt Ordermg Colour Matchmg 
• Memory Recall & Rccogmt10n -Ben ton V1sual 
RetentiOn Test, V1sual Pattern Recogmtwn 
*Memory Span (\\orkmg memory)- Fon\ard D1g1t 
Span, Corst Block-Tappmg 
• Selecllve Attention- Stroop Test 
• Psychomotor Performance- Dtgtt Symbol Test 
* Immediate audttory attentron & mental flextbthty-
Dtgtt Span Te~t 
* Drstracttb1hty & Visual lnattentn eness - Vtsual 
Scannmg Test 
* Other Non-Cogmttve Mea<>urcs- Mood, P'trttc•pant 
CondtttOn Preference 
• Short-term Non-Verbal Memory- CANT AB 
* Short & Long-term Verbal Memory- Log1cal memory 
& Recall \Vechsler (re\ tsed) 
* Long-term Eptsod•c Memory- Ptcture Recall 
* Verbal Fluency & Semanttc Memory- Category 
fluency 
• Sustamed AttentiOn· PASAT 
*Mental Flextbthty (s•mple & complex rule rever~al)­
IDED-CANT AB 
* Planmn Abthty- SoC CANT AB 
Outcomes 
0/15 measures ''ere 
Slgmftcantly Improved 
0/16 measure~ \'ere 
stgntficantly 1mpr0\ ed 
t 6/8 measures of all 
three eognttt\ e aspect<> 
f se! f-rated mood 
f Preference to 
tsofla"one t1eatment 
(n~49) 
f short-term nom crbal 
memory, mental 
flex1btltty, plannmg 
nbthty 
- short & long term 
"erbal memory, 1ong-
tell11 eptsodJC memory, 
verbal fluency&. 
'>emanttc memory, 
sustamed attentwn 
• = Full P~I'CT could not be :u:ce~~cd onh abd~ad I = lmp~oH•nlent m prrrorm~nce ....... tloo cl11nge m performance Ct\t'o TAB- (ambndge Neuropn cholog•cal Tn1 AutomRitd Ballel') (BLC' • Commuml\ BJ~I'd Longrtudmal Cohort Stud1, CO· ( ros~nHr Dc~rgn l.S • 
Cro~• ,_...,,,on'! lJC = ()tgol Omccllahon TM'C ()MTS • D~I~•NI r'>htchmf: to Sample Tr~t {part of CANT AB) DSS,. D•g•t-S)mbol Subst1tutron, IIAD .. Hosprtal Anxtet) & Dep~css1on Scale, HT~ Hormone Thcnp1 ,IDEO. Attenllonal Set Sblftmg 1\JMSE • M•nl J\lentlll ._tatn1 
E~Pmlnahou NART R,. Natlrmal Adull Rudrng Ted reu<ed .ers10n P- l'anllel Dedgn PASAT- Paced Audtton Serial Addrtron Test, I'J\1\\. Postmenop:m~:d Women, I'Rl\IW ~ Premenop!nsal \\omen RDBP. Randoml<ed douhle--bhnd placebo-controlled RP-
R:ondonu~ed plactbc.-.controllcd "oC ="locking~ ofCambndge STPI- Short Term Prosr..cthe lntcnentlon Stud1, \\ l\1S R • Wcchsler Memory Scale -Reused 
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Krt•IJkamp-
Kaspcr'i, 2004 
Dufh. 2003 
Ktltl'-
SII' cr..tcm, 
2003¥ 
I ocat1on 
Utrecht, 
Netherlands 
New South 
Wale'i, 
t\u<;traha 
London, UK 
San Dtcgo, 
USA 
RDBP 
RP 
RDBP, P 
RDBP 
Duration 
12 
months 
6 months 
12 v..ecks 
6 months 
Part1c1pant Van abies 
*n-175PMW 
* Mean age 66 6 years (60- 75 
years),> I year of menopause 
(mean 18 )'Cars) 
* E'i:cluswn Cntena HT m 
prevtous 6 months, estrogen 
related health condtttons 
• n=30 PMW 
*Age> 60 years 
* n = 33 healthy PMW 
* Mean Age = 57 8 years 950 - 65 
year;),> I year of menopause 
(mean 8 I years) 
* ExclusiOn Cntena HT m 
prevtous 12 months, use of 
anttbwncs m prevwus 3 months, 
use ofpsychoacttve medtcatton, 
smokmg 
* n = 53 healthy PMW 
• Mean Age= 60 7 years 955-74 
years), >2 years of menopause 
(mean 10 9 years) 
• Exctus10n Cntena current HT 
users 
In ten entwn 
I Soy Protem Supplement - 99 
mg totaltsoflavone/day (52 mg 
gem stem, 41 rng da1dzem, 6 mg 
glycllem) 
2 Placebo 
1 Aglycone Isoflavone e'i:tract 
from red clover (25 mg 
formonenetm, 2 5 mg b10charnn, 
< 1 mg da1dzem & gemstem) 
2 Placebo 
1 Soy Supplement- GO mg total 
I So flavone/day 
2 Placebo 
1 Soy Supplement- 110 mg 
total1soflavones/day 
2 Placebo 
Logmtn e Measures 
*Verbal EpiSodic Memory- Rey Auditory Verbal 
Leammg lest 
* Y1sual Memory- The Doors Test 
* Short-term/Workmg Memory- D1gtt Span Test 
• Verbal Fluency- Boston Nammg 1 ask 
*Global Cogmt!On & Dementia- MMSE 
• Complex AttentiOn Tra!l Makmg Test, D1g1t Symbol 
SubstitUtiOn Test 
• Other Non-Cogmt1ve Measures - Depress1on 
(Genatnc Depression Scale), Verbal Intelligence (Dutch 
Adult Readmg Test), Bone Mmeral Density, Plasma 
Ltp!ds 
• V1suo-spat1al Intelligence -Block Des1gn 
* Verbal Memory 
• D1g1t Recall 
*Short Tenn Verbal Ep1Sod1c Memory- Log1cal 
Memory & Recall WMS-R 
* Short Term Non.Yerbal EpiSO<hc Memory- DMTS-
CANTAB 
• Long Term Eptsod1c Memory- P1cture Recall 
• Verbal Fluency & SemantiC Memory- Category 
Generation 
*Frontal Lobe Functwnmg (mental flexJblhty & Simple 
rule reversal)- IDEO- CANT AB 
• frontal Lobe Functtonmg (planmng abthty)- SoC-
CANTAB 
• Sustamed Attentwn- PASAT 
• Other Non-Cogmt1ve Measures- Mood (Bond & 
Lader Mood Questlonnmre) 
*Short & Long-Term Memory- Logtcal memory & 
recall Wechsler 
* Verbal fluency & SemantiC Memory- Category 
fluencv 
• V1suomotor Trackmg & Attention - Halstcad-Re11an 
Tra1lsA & B 
Outcomes 
- on 16 cogmtn e 
measures 
-on all cogm!Jve 
measures 
- Short-Tcnn Verbal & 
Non-Verbal Memory 
Verbal fluency & 
Semantic Memof) 
j Long-Term Fptsodte 
Memory, Sustamed 
AttentiOn, Mental 
flexlblilty, Plannmg 
Ab1l1ty 
-Short & Long Term 
Memory, Trail A 
j Verbal fluency & 
SemantiC l\1emory, lratl 
B 
•- Full hptr could not ht accc<<cd onlv ah<ln~cl f lmprovtmtnt•n pcrformlnct ---+ 1\o changc m performancc CANT AB • Cantbndgc r>.turop5\ dtolog•cal T~l Autom~trd B1t1try CBI C- Commumt\ Bucd Longotudmal Cohort <;rud' CO- Crosso• n De<ngn CS-
Cro<s-StCTtonal DC•Il•g•t CanctUahon Ttsl DMTS- Dtl:ntd Malchmg to Samplc Trsl (part of CANT AB) DSS= D•gll-5\mbol Subsltlut•on HAD'"' Hospital An~•ch & Dtprcsslon Scale, HT"' llormoncTherap' lllFD- Alltntmnal <;tt Shlf!mg M\ISE- Mont Mental <;talus 
E'~""n11ton 1\i\RT R ~ Natoonal Adult R<'adong Tf"'t rcuscd \trs10n P- Pan~llel Dcs•gn PAS\ T ~Paced Audotor) <;<'nal Add1tlon Ttsl I'!\ lW- Postnunopausal \\ omtn I'R!\1" .. Prfmtnopausal \\ omrn RDBP- Randomo~d douhll'-bhnd placeho--conlrolltd RI'-
Randonu<td pbccbo C1lnlrol!cd, SoC ~ Stocl..mgs of C:ambndgc STI'I -Short Tcrm Pro~pcclttc lntenention Stud\, \\ MS-R .. \\ fchslcr Memo!') Scalf - RtHSfd 
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Study 
0'1tatn1kO\a, 
2007 
Celec. 2005 
File, 2001 
l ocahon 
Bratt'llava, 
Slovak 
Republic 
Rrattc;lava, 
Slovak 
Republic 
London, UK 
STPI 
STPI 
RP 
Durat1on 
I week 
I \\CCk 
10 weeks 
Participant \'anables 
* n 86 PRMW & young men 
(54 females & 32 males} 
* Age Range 18 - 25 years 
* Fxc\uswn Crttena use of 
hormonal contraceptives 
*n""16PRMW 
*Mean Age"" 23 4 years 
* n = 27 PRMW & young men 
(15 males & 12 females) 
* Mean Age= 25 years 
In ten t'ntJOn 
1 2 glkg per day soybeans 
I 900 g soybean to be eaten 
With one \\eek (1 ,080 0 - 3,780 0 
mg tsoflavones) 
I H1gh Soy Dtet (I 00 mg total 
1soflavones/day 
2 Low Soy D1et (0 5 mg total 
isoflavoneslday 
CogmtJve Measures 
*Mental Rotation- sub-section of Amthauer Intelligence 
test (non-verbal) 
* Spatial V1suahzat10n -sub-sectiOn of Sm1th & Whetton 
mtel11gcnce scale (non-verbal} 
"'Other Non-Cogmh\e Measures- Salt vary Testosterone, 
Plasma Estrad10l 
* Mental RotatiOn- sub-<;ectton of Amthauer lntelhgence 
test (non-verbal) 
* Spatlal VJsuahzat!On- sub-sect10n ofSm1th & Whetton 
mtelhgence scale (non-\crbal) 
Other Non-Cogmtive Measures- Sail\ ary and Plasma 
Testosterone & Estradwl 
* Attent10n- DSS, DC test, PASAT 
* Immediate EpisOdic Memory- short story (WMS-R) 
*Short-Term Non-Veibal Memory- DMTS-CANTAB 
*Long-Term EptsOdiC Memory- Picture Recall 
• SemantiC Memory- Catcgot) GeneratiOn Task 
* Mental FlexJbihty (<;imple & complex rule reversal)-
IDED-CANTAB 
* Frontal FunctiOn -Letter fluencv 
"' Planmng Abthty- SoC CANT AB 
* Intelligence- NART-R 
• Other Non-Cogmttve Measures- Deprco;swn (HAD) 
Mood (Bond & Lader Mood Questwnna1re) 
Outcomes 
T Mental RotatiOn & 
Spatial VisuahzatJon 
T Mental RotatiOn & 
Spatial VJsualtnt!On 
T Short-Tenn Non-
Verbal Memory, Short-
Tenn Verbal Memory, 
Long-Tem1 fptsodiC 
Memory, Mental 
flexJbiittv 
remales only t frontal 
function, Plannmg 
Abtllt~ 
- Verbal fluency & 
<;emanttc Memory, 
Sustamed Attcntton 
"' • Full p,fiiT could not hc uc~<ed on I) 11hstnct, I = lmpro1cmrnt m prrformancc - ~ !l.o chlnge •n prrformance, CAll. TAB"' Cambndgc !l.curops}cholog•cal T~t Automated 8a!ltl') ("BLC • Communtt\ Based Longttud,nal Cohort Stud1 CO· Cro<s<Hcr De«1:n CS· 
Cros~<;cto~mnal f)(' .. f),~,, Cancclhlllln Tcst, 01\ITS • r>ei:ncd 1\fatchmf: to Sa m pit Tc<t (part of CANT AB) DSS = Dlglt-S1 mbol Subsututton HAD .. Ho<ptlal Anxltt) & Ocprcmon Scale, liT -Hormone Therap) IDED- Atltnhonnl Set Shlft,ng MM<;E- 1\tml Mcntol Status 
[nmlnunn N,\RT R "'N~Ilonlll Adult Rudmg T~t rc•Jstd Hrsoon, P- Pal'l\lld Des1gn, PASAT .. Paerd AudJtOn Senlll Addttlon T~l, PMW. Postmenopausal \\·omen, PRM\'t'., PrtmenOf13USal Women RDBP- Random!<td double bhnd piac .. bo-controlled RP-
Randomo<td Jlhrt'bo controlled SoC"' Stockings ofCambndJ:t'• STPI· Short Trrm Prospecthr lntcnention Stud\,\\ 1\IS-R = "tchslcr Mcmon Suit- R<'l1•td 
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The 111vest1gators found that 60 mg/day 1soflavone eqmvalent was beneficial for 
cogmtlve functwn as assessed by memory tests as well as on tests of frontal lobe 
functiOn, mental flexibility and planmng ability Duffy et a! (2003) found no effect of 
isoflavone treatment on menopausal symptoms, such as self-rated mood, s!eep111ess or 
bodily symptoms, but d1d find beneficial effects for susta111ed attentwn, as well as 
long-term epiSOdic memory, mental flexibility and plann111g ability, which was not the 
case 111 the 6 week study (File et a! , 2005), suggest111g that duratiOn of !So flavone 
111take may have consequences for health benefits 111 postmenopausal women 
Around the same hme as the UK stud1es, the Soy and Postmenopausal Health In 
Ag111g Study (SOPHIA) (Kntz-SJ!verste111 et a!, 2003) 111 the USA was be111g 
conducted, also w1th postmenopausal women aged 55- 74 years of age. However, a 
higher dose (110 mg/day) of1soflavones was used and for a much longer duratiOn of6 
months Although a leam111g effect was observed over time w1th both the placebo and 
1soflavone treatment group show111g improvements 111 all five cogmtlve tests used 
Th1s Improvement was larger 111 the 1soflavone groups for four tests, and sJgmficantly 
greater (23% as opposed to 3%) for the verbal memory test of category fluency even 
after controll111g for age and educatwn Furthermore, 111 analysis stratified by age, 
those 111 the younger age group (50-59 years) tak111g the 1soflavone supplement 
showed a greater Improvement than placebo on a test of vJsuospatJal track111g and 
attentwn (Trmls B) Th1s effect was not observed 111 the older group (60-74 years), 
suggest111g that not only could 1soflavones have a beneficial effect on verbal memory 
in postmenopausal women, but also that the effect of 1soflavones may be greater for 
penmenopausal women than those who are older and have already expenence 
menopause. 
Casim et a! (2006) reported that postmenopausal women (with a mean age of 49 5 
years and 5 7 years s111ce menopause) who were g1ven 60 mg/day iSoflavone as 
aglycone for a duratwn of 6 months, showed an improvement 111 cogmtlve ability, as 
measured by three cogmtlve tests, as well as improved mood When asked, the 
participants also generally showed a preference for phytoestrogen over placebo 
(64%). This study has particular value because 1t prov1des support for the possible 
role of phytoestrogens 111 allevmt111g or revers111g psycholo peal mlments assocJated 
With menopause, such as mood and quality of life 
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However, four stud1es fmled to show any s1gmficant effect of 1soflavone 
supplementatiOn on vanous aspects of cogmtl ve function w1th postmenopausal 
women (Foum1er et a!, 2007, Ho et a!, 2007, Howes et a!, 2004, Kreljkamp-Kaspers 
et a!, 2004) 
Usmg aglycone 1soflavone extract from red clover, Howes et a! (2004) mvestlgated 
the effects ofpredommantly bwchanm A (25 mg per day) w1th less than 2 mg 
da1dzem and gemstem for a duratwn of 6 months and found no s1gmficant effects of 
1soflavone supplementatiOn on tests of v1suospat1al mtelhgence and verbal memory m 
postmenopausal women However, these women were all dbove the age of 60 years of 
age 
In a study of the longest duration of all RCTs earned out m th1s top1c area, 
KreiJkamp-Kaspers et a! (2004) mvestlgated the effects of 12 months of soy protem 
contammg 99 mg (52 mg gemstem, 41 mg da1dzem, 6 mg glyc1tem) totaltsoflavone 
per day on cogmtive function (and other health md1cators) m postmenopausal women 
aged 60 to 75 years m the Netherlands No effects of1soflavone supplementatiOn were 
found on a multitude of cogmtive tests (see table 4 for full hst) However, 1t must be 
noted that compared to the other stud1es, these partiCipants were much older on 
average (66 years of age), had been menopausal for longer (mean of 18 years), and 
19% were also usmg cholesterol-lowenng and anti-hypertensive medication 
Similarly, Ho et a! (2007), studymg the effects of 6 months supplementatiOn w1th 80 
mg/day soy 1soflavones on quahty of hfe as well as vanous cogmtive functwns usmg 
a neurological test battery on postmenopausal women (mean age 63 5 years, 13 8 
years smce menopause on average), found no s1gmficant Improvements m any of the 
test measures m this Hong Kong based Chmese sample Interestmgly, tl11S IS the only 
study of this nature which has been conducted m a populatwn who habitually eat soy 
as part ofthe1r dmly diet and had a mean dietary mtake of20 mg/day 1soflavones It IS 
possible that no effect was found m th1s study due to the habitual mtake of soy m the 
sample and that there were possibly beneficial effects of supplementatiOn, even m the 
placebo group Therefore group differences would have been reduced (Ho et a! , 
2007) 
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In a recent USA based study of postmenopausal women With a mean age of 56 1 years 
and 8 years smce menopause, Fourmer et al (2007) assessed the possible effects of 
two different forms of Jsoflavone However, the researchers found no s1gmficant 
effects of e1ther 72 mg/day total1soflavones (from soy m1lk) or 70 mg/day total 
Jsoflavone (v1a a soy 1soflavone supplement) on vanous cogmtlve abJhties, mcludmg 
selective attentiOn, workmg or vJsuospatJal short or long term memory A large 
varJabihty m age smce menopause m th1s group may have been responsible for lack of 
findmgs (Zhao & Bnnton, 2007) 
2.3.2.8 Explaining differences between Phytoestrogen Studies 
Human phytoestrogen tnals have evaluated many health Issues ( e g menopausal 
symptoms, cardiOvascular markers, cancer, bone density and cogmtlve functwn), but 
chmcal data remams hm1ted and a d1screpanc y can be seen between stud1es m Vitro 
and m VIvo, as well as across vanous m v1vo chmcal tnals. Focusmg on the 
association between phytoestrogens consumptiOn and cogmtJve functiOn, there are a 
number of possible reasons for the discrepancies m result findmgs. For example, the 
methodological Issues of lack of standardisatiOn across stud1es m aspects such as the 
charactenst1cs of the study populatiOn, the outcome measures, 1 e the range and type 
of cogmtlve tests used, and the mterventwn used, 1 e the type of soy product used and 
hence the composition of the product, the dose used, as well as duratiOn of 
mterventlon In order to have the ability to meanmgfully compare the findmgs of 
different studies, 1t 1s Imperative that the Issue of standard1satwn across chmcal 
studies IS addressed 
2.3.2.8.1 Characteristics of the study population 
Vanatlons m some charactenstJcs of the study partiCipants may mfluence the effect of 
1soflavones on cogmtlve functwn Similar to the findmgs w1th E, 1t IS possible that age 
and hormonal h1story may have an Impact on the effect of soy 1soflavone on cogmtJve 
functiOn (Zhao & Bnnton, 2007) There IS a possibility that beneficial effects of soy 
1soflavones can only be seen for the younger menopausal women w1thm 10 years of 
the onset of menopause Interestmgly, bar Foum1er et al. (2007), most RCTs findmg 
no associatiOn between 1soflavone mtake and cogmtlve functwn had on average older 
participants (Ho et al, 2007; Howes et al, 2004, Kre!Jkamp-Kaspers et al, 2004), 
wh1lst those findmg positiVe effects were, on average, With younger participants 
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(Casm1 et a!, 2006, File et a!, 2005, Duffy et a!, 2003, Kntz-Silverstem et a!, 2003) 
The findmgs from the HAAS and Kame studies also lie m w1th this age-dependent 
theory (Rice et a! , 2000, Wh1te et a! , 2000) There are also marked differences 
between premenopausal women and postmenopausal women, as well as between men 
and women However, most studies have focused on postmenopausal women and 
hardly any research has been earned out w1th men ofvanous ages and premenopausal 
women 
Another factor causmg vanatwn between mdJvJduals that has recently been 
recognised IS equol (see appendix 8 for detmls pertammg to the importance of equol) 
In bnef, equol has the ab1hty to bmd to both the Estrogen receptor alpha (ERa) and 
Estrogen Receptor beta (ERPJ s1tes but w1th greater affimty for ERP Furthermore, as 
well as greater bmdmg abJh!ies, equol also has greater transcnptwnal abJh!ies than 
da1dzem (Monte et a!, 2001) Inter-mdJvJdual differences ex1st m the ab1hty to 
produce equol, w1th only approximately 20-35% of the human populatiOn havmg the 
ab1hty (W1seman et a!, 2004, Setchell, Brown, & Lydekmg-Olsen, 2002, Row land, 
W1seman, Sanders, Adlercreutz, & Bowey, 2000, Lampe, Karr, Hutchms, & Slavm, 
1998; Morton, W!lcox, WahlqvJst, & Gnffiths, 1994) Of further mterest IS the theory 
that the proportiOn of equol producers also reduces With mcreasmg age (Frankenfeld 
et a!, 2004). Therefore equol1s a maJor player m the effect of soy consumptiOn m the 
human body and fa1lure to account for this by human mterventwn studies could result 
m marked differences m mdJvJduals' responses to soy consumptiOn 
2.3.2.8.2 Intervention Type/Composition 
Vanous compositiOn and structural make-up differences between different types and 
sources of soy Jsoflavones may affect their m VIVO pharmacodynamics m the human 
body (see appendix 8) Th1s 1s especwlly a problem as the mterventwn stud1es to date 
have used vanous sources and type of soy 1soflavones Some studies used Isolated 
Jsoflavones wh1lst others used mtact soy protem As can be seen from table 4, 
phytoestrogen tnals vary m the make-up ofthe1r admm1stered phytoestrogens For 
example, the study by KrelJkamp-Kaspers et a! (2004) used soy protem (99 mg/day 
1soflavone), wh1lst Casm1 et a! (2006) used 60 mg/day 1soflavones as aglycone m a 
tablet form Soy protem contammg phytoestrogens are considered "mtact" soy protem 
and have an abundance of gemstem and da1dzem When soy protem1s washed out 
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with alcohol and extracted, the alcohol extract IS the part that contams the 
phytoestrogens This extract IS then dned-down, encapsulated and sold m a capsule or 
tablet as Isolated phytoestrogen (F1tzpatnck, 2003) Vanab11Ity m composition of the 
soy used leads to the Issue ofbwavaiiabi!Jty differences between studieS m the way m 
which the phytoestrogens are mteractmg with the mtemal environment of the human 
body and hence differences m the overall effect on health This degree of vanatwn 
needs to be taken m to consideratiOn when companng and contrastmg stud1 es as well 
as when formmg conclusiOns based on the findmgs of these studies 
2.3.2.8.3 Dose 
As previOusly mentiOned soy Isoflavones may have different estrogemc effects which 
are dose-dependent but the effective dose has not been found Zeng et a! (2004) 
report that the neuroprotective effects of gem stem are mediated by two mechamsms 
dependent on dose The first one 1s at a nonmolar level m wh1ch gemstem protects 
neurons v1a an ER-mediated pathway The second mvolves a m1cromolar level m 
which gemstem behaves as an antiOxidant However, Lmford & Dorsa (2002) have 
found (like others) that high concentratiOns of gemstem are tox1c to neurons 
Treatment w1th 50 J.tmol/L d1d not attenuate neuronal apoptosis mduced by the 
endoplasmic reticulum calcmm-ATPase mh1b1tor thapsigargm and actually enhanced 
apoptosis of cells, whilst low concentratiOns of gemstem ameliorated apoptos1s of 
neurons. In contrast, another study found that the same dose of gemstem protected 
HCNl-A and HCN2 cells from death (Sonee, Sum, Wang, & MukherJee, 2004) 
These stud1es all suggest that soy 1soflavones can affect the viability of neurons and 
cogmtive functiOn by actmg as an estrogemc agomst and can also utilise d1fferentml 
distnbutwn and regulation of ERa. and ERP m the bram Furthermore, the dose 
adminiStered could greatly mfluence the efficacy and safety, by either bemg too low 
to have a noticeable effect on cogmtive functiOn, [ e g m the SW AN study (Huang et 
a!, 2006)] or by bemg too high over a long exposure penod and resultmg m possible 
safety Issues (e g effects of high doses of soy 1soflavones on endometnal hyperplasia 
(Unfer et a! , 2004) as opposed to a low dose where no adverse effects on the 
endometnum were found (Temp fer et a! , 2007) ) These RCTs all tended to use large 
quantities of daily admmistered 1soflavones which exceed the amount of da1ly 
Isoflavone consumed m food m a typical Asian diet No gmdelmes exist to ass1st m 
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th1s dec1S1on and the reasons for th1s are not at all clear as they are not based on any 
known pharmacokmet1cs As the RCTs to date, although few m number, ail vary m 
the amount of 1soflavone admm1stered, the poss1ble effect of dose on the efficacy of 
soy 1soflavone needs to be taken mto cons1derat1on 
2.3.2.8.4 Other factors that may explain discrepancies between studies 
Other factors that need to be cons1dered when companng stud1es and drawmg 
concluswns from the results ofRCTs are the duratwn of the study and the cogm!lve 
aspects measured As can be seen, the RCTs descnbed ail have varymg mterventwn 
dura!lons rangmg from I week to 12 months. It 1s poss1ble that, m combma!lon w1th 
the methodolog!cal!ssues d1scussed above, duratwn of mterventwn may have been 
too short or too long Or even more complex, short-term effects may be mamfested m 
d1fferent ways and for d1fferent cogm!lve aspects compared to long term 1soflavone 
intake Furthermore, and as appears to be the case when assessmg cogmtlve functwn 
m human part1c1pants for a w1de range of 1ssues rangmg from healthy cogmtlve 
functwn through to AD (see sectwn 2 3 2 7), the pubhshed RCTs have not ail 
assessed the same cogmtlve ab1ht1es, or when they have, d1fferent cogmtlve tests have 
been utlhsed (see table 4) Th1s also needs to be taken mto cons1deratwn when 
companng and contrastmg findmgs from d1fferent stud1es 
2.3.2.9 Conclusion 
To date most stud1es assessmg the health effects of soy 1soflavones have run mto 
confl1ct and d1sagreement They have generaiiy been smaii and lackmg m statlstlcal 
power However, the vast methodological d1fferences between the stud1es would 
result m prac!lcaiiy meamngless compansons m meta-ana!ys1s 
Of great Importance 1s the fact that RCTs evaluated cogmtlve performance at fixed 
pomts ofllme In contrast, most epldemwlog!cal stud1es find 1t d1fficult to estlmate 
soy consumptwn over a long pcnod oftlme Therefore, soy mtake may be estlmated 
maccurately Furthermore, cogmtlve dechne 1s often a gradual process over !!me As a 
socwty we are concerned w1th preventmg cogm!lve declme and hence may benefit 
from researchmg more long1tudmal processes to poss1bly d1scover an earher marker 
for nsk of CI (Grodstem et a! , 2000) 
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As well as RCTs admmistenng soy iSoflavones m different forms and doses, 
observallonal studies assessmg the health effects of isoflavones also tended to 
measure endogenous isoflavone levels vta a number of different methods such as 
unne, plasma, sahva, or faeces However, the measured bwavailabihty of different 
iSoflavones maybe dependent on the method of measurement (Setchell et a!, 2003) 
To our knowledge and With best endeavours, at this pomt m llme, no study to date has 
assessed iSOflavone mtake as well as endogenous isoflavone levels m relat10n to 
cogmllve funcllon 
94 
CHAPTER 3- STUDY AIMS & HYPOTHESES 
3.1 Introduction to Indonesia 
Indonesia's soctal, economic, and cultural differences make 1t an tdeallocatwn for 
agemg research Culturally, Indonesia consists of over 300 dtfferent ethmc groups of 
predommantly Muslim fatth, IIVlng m both urban and rural areas The ethntc and 
soctoeconomJC diVersity of Indonesia IS stmtlar to many countnes m Southeast Asta 
Indonesia IS mhabtted by over 234 million people, makmg 1t the fourth most populous 
natwn m the world Ofthts number, 57% (13 mtllion) are over 65 years of age (2 5% 
men I 3 2% women) (Central Intelligence Agency, 2007), and tlus ts expected to nse 
to 13 5% by 2025 (Wtbowo et a!, 2004) It IS predtcted that the number of the oldest 
old (those over 75 years of age) Will mcrease to 6 3 mtllion m 2020, showmg an 
annual m crease of 6% (Adlakha & Rudolph, 1994) In conJunctiOn wtth thts, life 
expectancy at btrth IS 66 years for men and 69 years for women {World Health 
Orgamsa!ion, 2009) The percentage of people over 65 years of age has also mcreased 
m the last 10 years Earlier estimates (Chm et a! , 1997) stated that the percentage of 
the populatiOn over 60 years was 6 9%, reducmg to 4 0% over the age of 65 years 
Ltke many countnes m the South-East Asta region, Indonesia ts not known for Its 
general use of 'western medtcme' Chm et a! (1997) reported that m 1997, there were 
no psychtatnsts who specialized m psychogenatncs and that there was no systematic 
teachmg of psychogenatncs m the undergraduate cumculum Therefore, It ts not 
surpnsmg to find that a survey conducted m the rural Leuwtliang sub-dtstnct ofBogor 
West Java {populatiOn 177,454) reported that there were only 249 health care 
provtders, of whtch only 6 8% were qualified allopathic phystctans {prac!Jce standard 
"western" medtcme) Of the other 232 health care providers, 4% were mdtgenous 
health workers (tabtb, shmshe, acupunctunst, and reflexologist), 15 3% were 
paramedtc {mtdwtves and nurses) and a staggenng maJonty (73 9%) were traditiOnal 
and spmtual fatth healers (WHO, 2005) 
Wtth the growth m the populatiOn of Indonesta and the vast m crease m life 
expectancy of73 6% m Just over 50 years (WHO Regwnal Office for South-East 
Asta, 2006), 1t ts not surpnsmg that Indonesia, amongst other countnes m South-East 
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Asia, has m1l!ated development of mental health legJslal!on In 1993, Bogor and 
Semarang were the first two commuml!es to p1lot State Mental Hospitals m a b1d to 
develop psychogenatnc serv1ces (Chm et a!, 1997) Followmg on from th1s, the 
C1ptomangunkusumo General Hosp1tal has commenced a Similar proJect With rollouts 
planned for Jakarta, Pedang (m West Sumatra) and Lawang (m East Java), With plans 
to Implement th1s natwnally (Chm et al, 1997) However, although there has been a 
strong emphasis on hospital-based psychiatry, th1s focus needs to shift m order to 
pnonl!se an mcrease m commumty-based mental health programmes w1th experts and 
workers who are tramed m bas1c dJsabJhty work imd pracl!ce of allopathic medicme 
w1thm the commumty (WHO Regwnal Office for South-East Asia, 2003) 
3.2 Dementia Screening, Estimated Dementia Percentage and Types and Possible 
Demographic Risk Factors in an Elderly Indonesian Sample 
Th1s first sectiOn has descnbed demenl!a diagnosis cntena and measurements and 
how demenl!a prevalence and types vary across the world Furthermore 1t goes on to 
d1scuss possible 1ssues surroundmg methodological differences m demenl!a 
prevalence and mc1dence research as well as poss1ble demographic nsk factors that 
may explam some ofth1s cross-cultural vanance Usmg a sample of elderly 
Indonesian men and women, th1s thes1s mmed to assess some of the 1ssues discussed 
F1rstly, the rehab1hty and sensitiVIty of our test battery for use m populatwns w1th a 
similar demographic to Indonesia was assessed A part ofth1s mvolved vanous 
assessments of the usefulness of the caregiver and mformant report 111 dementJa 
screemng Careg1ver or 111formant reported cognJl!ve problems are a part of dementia 
dmgnos1s and are used 111 chmcal diagnosis of dementJa (secl!on 2 I 5 3) 
AddJl!onally, self-reported cogn1l!ve compla111ts may also have some confirmatory 
value 111 screen111g for dementia12 The 111ter-rater rehabJhty of the careg1ver and 
partiCipant report 111 th1s Indonesian sample was assessed Furthermore, the validity 
and accuracy of the careg1ver report 1111dentJfy111g Cl cases were also statJsl!cally 
analysed 
12 See sect1on 4 2 2 for a descnptton of caregtver and self-reported responses to quest10ns regardmg partiCipant cogmt1ve 
complamts 
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Secondly, the reported figures of dementia prevalence m IndonesJa from 1997 (Chm 
et al , 1997) are the last known reliable rates Therefore, dementia prevalence m 
Indonesia and w1thm the vanous regwns ofindonesJa IS currently unknown and needs 
further mvestlgatwn Takmg the dementia d~agnost1c cntena and assessment methods 
discussed m th1s literature rev1ew mto cons1deratwn, th1s thesis descnbes analyses 
assessmg the percentage of participants w1th possible dementia/cognitive 1mpmrment 
as well as the possible types of dementia m Java, Indonesia 
Furthermore, a w1de vanety of potential non-modifiable demographiC nsk factors for 
dementia have been discussed through this literature rev1ew Takmg these mto 
cons1deratwn, th1s thes1s then addresses how they may apply to an elderly Indonesian 
populatiOn. The elderly m Indonesia, Similar to other developmg countnes, have 
significantly lower levels of educatwnal attamment than those m the developed world 
Th1s 1s even more apparent for women, for whom opportumtles were very hm1ted 
when growmg up Kaneda & Z1mmer (2007) reported that only 6% of older 
Indonesian women had more than a pnmary school educatwn Colomsatwn by the 
Dutch and h1stoncal mfluences have had a marked effect on the educatwnal profile of 
the country, With the mmonty group of the prlVlleged and elite usually bemg the only 
ones to have access to educatwn (Oey-Gardmer & Suprapto, 1996) In the world of 
employment, Indones1ans also rece1ve lower returns from the1r educatwn m reference 
to earmngs and occupatiOnal status than m developed countnes. The elderly 
population we see today m Indonesia are from a lime where educatiOnal attamment 
was not common or necessary, and the maJonty of work was found m the agrJCultural 
sector Therefore, m the chmce of cogmtJve 1mpmrment screenmg tools, m sp1te of 
the1r d1scussed lim1tatwns, functwnal status measures are a good screenmg method, as 
they are not mfluenced by the detnmental effects of poor educatiOn that could be seen 
m th1s populatiOn and that may mfluence results on standard cognJlive screenmg tools, 
and hence should be used m collaboration w1th these tests when possible (F1llenbaum 
et a!, 1999) 
A distinctive difference can be seen between urban and rural areas of Indones1a m the 
number of elderly people, w1th over double the percentage of elderly m rural areas 
(World Health Orgamsatwn, 2009) The reasons for th1s are unclear and could be 
attnbuted to lifestyle/nutntwnal factors and/or genelics/etlmicity factors For example, 
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m rural areas especially, 1t 1s not uncommon for the elderly to work well mto old age 
to support the fam!ly and hence physical activity m older age 1s at a h1gh level Th1s 
could have d1rect effects on surv1val rates makmg these mdlVlduals more hkely to 
survive to a greater age as they are physically fitter to survive d1seases that m1ght 
otherwise have resulted m the1r dem1se 1 e "healthy survivor bias" (Kreager, 2006) 
Furthermore, smce 1990, local health centres m the rural areas of Sumedang have 
been providmg regular opportumtles for soc1al mteractwn and physical and mental 
actlVltJes as well as regular health check-ups for the elderly It IS estimated that 30-
40% of the elderly m this area therefore take part m these events. However, what IS 
not known IS why the rest of the elderly do not take part (could be disabJhty, lack of 
will and motivatiOn to take part, clashes With other activities, workmg etc) and to 
what extent similar activities are run m rural areasll 
Rural areas tend to have a greater maJonty of mhabitants from one ethnic group (for 
example, the Sundanese m Sumedang or Javanese m Borobudur) whilst urban areas 
such as Jakarta tend to have a more ethnically diverse mixture of people (as was found 
m the current sample) as well as a strong Chmese element An mvestigatwn such as 
tl11S, assessmg potential demographic nsk factors that might affect cogmtive functiOn 
may help m the quest to understand the vanatwn seen cross-culturally m prevwusly 
reported dementia prevalence across the world 
Hypotheses 
Due to the similar geographic pyramid structure, Similar life-expectancy, and the same 
estimated dementia mcidence percentages, IS 1t feasible to pred1ct that dementia 
prevalence w!ll be Sim!lar to that m India (B1swas, Chakraborty, Dutt, & Roy, 2005), 
wh1ch estimates approximately 5% of people aged over 60 years with dementia 
Furthermore, based on pnor research assessmg nsk for possible dementia, 1t IS 
hypothesised that when compared to controls, participants With cogmtive Impmrment 
(CI) m th1s Indonesian sample Will be more hkely be older, have lower educatiOn 
attamment, be a blue-collar worker, and hve m a rural area 
13 Source Integrated commumty post m Cltengah Elderly actlVlttes m C!tengah, Sumedang and tts constramts 
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3.3 Hormone Therapy Use in an Elderly Indonesian Sample 
Research mvestlgatmg HT or HRT use IS Indonesia IS very hm1ted What has been 
reported 1s that the use ofHRT by women m Indonesia 1s not very htgh (Baztad & 
Mangunkusumo, 2008) and IS much lower than other Western countnes For example, 
a multt-natwnal survey ofnme countnes, (Hememann, Rubtg, Strothmann, Nahum, & 
Hememann, 2008) reported that assessmg 'ever use' 14 of HT was 1 8% m Indonesia 
compared to developed countnes such as France (50%) and the USA (43%) Thts low 
use of HT m Indonesia could be for a number of reasons As suggested by the Geneva 
FoundatiOn for Medical Educatwn and research, Indonestan women, hvmg m both 
rural and urban areas, generaiiy vtew menopausal symptoms as a part of normal 
agemg For example, 1t was reported that only 29% ofn=70 women expenencmg 
menopausal symptoms reported 1t to their physician (Baztad & Mangunkusumo, 
2008) Furthermore, psychosomatic symptoms such as depressiOn, Imtabihty and 
sleep disorders are usuaiiy treated by doctors prescnbmg sedatives However, the 
mam reason for the low use ofHRT m Indonesia IS mistrust, as both physicians and 
menopausal women still beheve HRT mcreases the nsk of breast cancer (Baz1ad & 
Mangunkusumo, 2008) While there IS m deed an m creased nsk of this, that nsk IS 
very smaii ( e g Shumaker et a! , 2003) However, while HT was regarded as one of 
the most prom1smg treatments for age-related cogmtive declme and dementia 
(Hogervorst et a! , 2000), the results of large tnals actuaiiy mdJCated an m creased nsk 
for dementia (Shumaker et al., 2004, Shumaker et a! , 2003) Some researchers 
bel! eve the effect of HT IS modified by age (Resmck & Henderson, 2002) and that an 
mcreased nsk of decline only confers to those over 65 years of age whereas positive 
effects are seen m pen and recently postmenopausal women Others (Hogervorst et 
a! , 2009) hypothesize that the nsk IS m creased w1th a longer duration of treatment 
which IS substantiated by meta-analyses and some observatiOnal studies We assessed 
the relatiOnship between HT use and cogmtive function and 1ts mteract10n With age m 
a sample of middle-aged and elderly women res1dmg m both urban and rural areas of 
Indonesia Not much IS known about the regular use of HT m older men m the 
populatiOn (e g testosterone) and this was also explored m these prehmmary analyses 
14 Have you ever used hormone therapy" 
99 
3.4 Phytoestrogens and Cognitive Function in an Elderly Indonesian Sample 
There are substantial differences between East As1an countnes, such as Japan or 
Chma, and Western populatwns, such as the USA or Europe m the prevalence of 
cogmt1ve disorders and dementia See sechon 2 I 4 for an extens1ve d1scuss10n This 
difference IS not JUSt for all-cause demenha, wh1ch IS Similar across Japan, Chma and 
the West, but for AD and V aD AD rates are lower m Japan and Chma, and the 
prevalence IS -2 5 limes h1gher m Western populal!ons And whereas AD IS more 
prevalent m Western socJehes than V aD (-2 2 fold), AD and V aD rates m Japan and 
Chma are more similar. The d1fference between East and West countnes could be 
attnbuted to a number of factors as previOusly descnbed However, It has also been 
suggested that an 1soflavone (a category ofphytoestrogen) nch d1et may be a 
contnbutmg factor for the lower prevalence rates of AD m Japan and Chma compared 
to the USA and Europe 
This next porhon of the thes1s therefore contmues tl11S debate by mvestigatmg the 
relatwnsh1p between phytoestrogen consumptwn and cogmtive functiOn, takmg mto 
account the relationship between modifiable hormone-dependent vanables and 
demographic vanables which may mod1fy the relationship between hom1ones and 
cogmt1ve function 
Indonesia IS an 1deal study Site for mvest1gatmg the relationship between 
phytoestrogen consump!Ion and cogm!Jve 1mpmrment (Cl) nsk for a number of 
reasons relatmg to Its demographic smtab1hty boastmg a m1xture of urban and rural 
areas and vanous ethmcJ!ies (for general demographic mformation about Indonesia 
please see sectwn 5 1). Furthermore, Isoflavone consumptiOn 1s generally very h1gh m 
Indonesia, as m other East Asian countnes, as soy foods are an mtegra1 part of the 
Indoneswn d1et The two mam forms of soy eaten by Indonesians specifically are tofu 
and tempe 
Assessmg the relatwnsh1p between soy consumptiOn and cogmtive functiOn m a 
populatwn w1th hab1tual high mtake of soy allows a more d1rect compansons with the 
findmgs of the HAAS study (Wh1te et a!, 2000) as well as the Kame Project (Rice et 
a!, 2000). Few observatiOnal stud1es have assessed tl11S relatwnsh1p or focused on 
lifelong, habitual high m take of !so flavone nch foods Therefore, the poss1ble effects 
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of1soflavone mtake on later hfe cogmt10n are largely unknown Due to the fact that a 
typ1cal lndoncsmn d1et contams phytoestrogens wh1ch are consumed m vanous soy 
forms, 1t was expected that th1s Indonesian sample would show greater mter-subject 
vanab1hty m the quanl!ty and type of soy consumed, g1vmg better resolutwn m data 
analyses 
In th1s arm of the Indonesia study, we mmed to mvest1gate the assoc1at10n between 
soy mtake (amounts and type), actual endogenous aglycone 1soflavone levels of 
dmdzem, gemstem, and glyc1tem assessed usmg a sahvary assay and Cl nsk m an 
elderly lndonesmn sample of men and women from m1xed ethmc1ty and demographiC 
backgrounds Analyses controlled for other foods eaten, wh1ch may contam low levels 
of phytoestrogens, as well as assessed the mfluence of age and gender Add1!1onally, 
because different types of soy are eaten m d1fferent areas m rndones1a, hvmg d1stnct 
was also mcluded m analyses All analyses also controlled for educatwn as 1t has been 
found to be associated w1th cogml!ve functwn m th1s study (see sectwn 5.6) as well as 
m a wealth ofprevwus research (see sechon 2 2 3) To our knowledge, th1s 1s the first 
study that assesses actual phytoestrogen levels m the body as well as soy mtake m the 
same sample Furthermore, usmg 1denhfied stahst!Cally s1gmficant poss1ble 
demographiC nsk factors for er (see chapter 5 6), the effect of soy consumphon on er 
nsk was assessed when controlhng for these other nsk factors 
Hypothesis 
Based on the findmgs of prevwus research assessmg the relat10nsh1p between Es and 
cogmhve functwn as well as phytoestrogens and cogmhve functwn, 1t was 
hypothesised that age and gender may med~ate the relat10nsh1p between soy mtake 
and Cl m th1s rndones1an populatwn. More spec1fically, h1gh soy 1soflavones may be 
assoc1ated w1th er m those over approximately >65 years of age as well as havmg 
stronger effects m women (due to mteractwn With endogenous E levels). 
3,5 Previously published work in this sample 
Some results from th1s study have been prevwusly pubhshed (Hogervorst, Yesufu, 
SadJimlm, Kreager, & RahardJo, 2009, Hogervorst, SadJimlm, Yesufu, Kreager, & 
RahardJo, 2008) (m press) However, there were d1fferences between these 
pubhcat10ns and the current thes1s 
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Although the current thes1s descnbes and assessed all participants (n=719), the book 
chapter (Hogervorst et a! , 2009) to be published as a chapter m Hogervorst et a! 
(2009) was based on participant data collected between Apnl and June 2006 (n=297) 
The chapter descnbed analyses pertammg to assoc1atwn of soy mtake and salivary 
1soflavone levels of gemstem to both verbal memory (as assessed by the HVLT-IR) 
and cogmtlve 1mpa1rment (Cl) or poss1ble dementJa, as defined by the cogmtJve 
algonthm usmg HVLT-IR and MMSE cut-offs It also assessed salivary 1soflavone 
levels m separate analysis to soy foods 
In the published JOurnal article (Hogervorst et a! , 2008) the relatwnsh1p between soy 
mtake and verbal memory alone (usmg the HVLT-IR) was assessed (see appendix 9) 
However, m the current thes1s, possible dementia/Cl usmg the cogmtlve algonthm 
was used as a main outcome vanable. Furthermore, the current thes1s also mvestJgates 
the assocJatJOn between salivary phytoestrogen levels and Cl m the same analyses as 
soymtake 
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CHAPTER4-METHODLOGY 
4.1 Project Design and Data Collection 
4.1.1 Testing Areas 
We measured cognitive function and risk factors for possible dementia in Indonesia. 
Participants were studied in rural sites Sumedang (West Java) and Borobudur (Central 
Java) and in urban sites Central and South Jakarta (North-West Java). The study was 
carried out between April and June 2006 in Jakarta and between December 2006 and 
February 2007 in the rural areas ofBorobudur and Sumedang. Ethical approval 
(University oflndonesia, Jakarta and Loughborough University, UK), governmental, 
and local permits had all been obtained before study onset. 
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Figure 3- Areas assessed in Indonesia included rural Borobudur (approximately 26 mi les rrom 
Yogyakarta), rural Sumedang (approximately 23.5 miles rrom Bandung), and both Central and South 
Jakarta 
4.1.2 Participants 
In this study, participants included were between 52 to 98 years of age, and resided in 
the selected urban and rural areas. Participants had varying education and 
socioeconomic backgrounds as these variables .were not used as selection criteria. In 
West Java, in the Sumedang site (approximately 23.5 miles from Bandung), all elderly 
who resided in the village of Citengah and surrounding smaller villages were invited 
to come to the community health center. A total of207 participants were tested there 
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after they had given mformed consent (appendix 2) Similarly, m the rural Borobudur 
Site (approximately 26 miles from Yogyakarta) all elderly covered by the Borobudur 
commumty health center were mv1ted to come to the local health centre to be tested 
PartiCipants (n=214) whom were able attended the sesswn and were tested after they 
had given mformed consent Those With lm1Ited mobility were VISited at home (n=2) 
at a time they had prevwusly agreed to be VISited For Central and South Jakarta, a 
convemence sample of 298 elderly was mcluded after glVlng mformed consent These 
participants were attendmg the local communlty health centers, or were VISited at the 
mstitute m which they hved (n=49) or at home (n=l) 
Pnor to the study all village elders and staff at local commumty health centres or care 
mstitutes had been mformed of the study and subsequently forwarded this mforma!Ion 
to potential partiCipants Interested partiCipants were asked to bnng thetr caregiver (If 
applicable) and to amve m the mommg between 8- 11 am at the local health centers 
at agreed dates for potential participatiOn m the study None of the elderly approached 
refused participatiOn after they had been given mformatwn about the study by tramed 
research assistants (RAs) and hence all signed the mformed consent forms. If a 
caregiver was present, they also signed the mformed consent form No monetary 
mcentive was offered, but participants at the commumty health centers were given 
lunch and participated m actiVIties organized by commumty center volunteers for the 
rest of day Furthermore, all partiCipants were given multivitamm supplements upon 
completiOn of the study 
4.1.3 Clinical Interviewer Training 
In collaboration with the Indonesian scientists from the Umve1s1ty of Jakarta, and the 
Centre for Health Research, four RAs and two expenenced Field Coordmators were 
fully tramed m all aspects mtegral to the process oftestmg partiCipants dunng a 
prehmmary sesswn on a pnor VISit by Professor Hogervorst This mcluded how to 
properly obtam mformed consent, background knowledge about the vanous testmg 
measures used and how to use them, sconng methods, and saliva samplmg Trammg 
was repeated at study onset by the author ofth1s thesis whom had been tramed by 
Professor Hogervorst At study onset, the author of this thes1s presented the aims and 
procedures of the study to all research staff and collaborators at the Umversity of 
Indonesia Followmg this, she re-1terated the procedures for testmg and RAs were 
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able to use the measures and questwns on dummy participants m a pre-pilot testmg 
sesswn, with amendments to the procedures made as appropnate after this Dunng 
pilot testmg, detmled observations were recorded by the author and feedback to the 
research team with further adJustments made as necessary. 
4.1.4 Procedure 
4.1.4.1 Translations & Testing Procedure 
To ensure that the correct meanmg of words was not lost when translatmg questwns 
from English to local languages (e g Javanese, Bahasa and Sundanese) multiple 
forward and backward translatiOns were performed and the test pack was proof-read 
by a number of scientific staff m both Indonesia and England Back-translation was 
done successfully for tests and questionnaires, which were all well tolerated m this 
study 
Test sesswns were announced beforehand m general commumty meetmgs Testmg 
was done by the tramed and supervised RAs between 8-11 am to av01d Circadian 
mterference and the effects of heat Participants and their carers were gathered and 
communally talked to by the supervisor and told about the study, 1ts mms and 
procedures, as well as lime and other commitments reqmred for participatiOn Any 
questwns were answered, and partJcipatmg mdividuals and carers were then allocated 
to a RA whom explamed the details of the study once agam usmg the standardised 
'InformatiOn for Volunteers' (appendix 3) If the mdlVlduals were Willmg to 
participate, they (and their carer, If applicable) were read the mformatwn for 
volunteers clearly and slowly, the mformed consent sheet was signed and the 
participant allocated a participant number This study was the first part (Wave I) of a 
two part mvesl!gatwn mto demenl!a prevalence and nsk factors m Indonesia Consent 
and contact details were then requested from the partiCipants for any follow-up 
contact and possible participatiOn m Wave 2 ofth1s study See General Discussion 
(sectwn 7.7) for details of the second stage of this study 
After the maJonty of the questJmmaire was completed assessmg demo graphics, mood, 
health, lifestyle, and cogml!ve complamts, the cognitive measures usmg the Hopkms 
Verbal Learnmg Test (HVLT)- Immediate Recall (IR) (Brand!, 1991) and the MMSE 
(Folstem et a!, 1975) were completed, followed by functiOnal ability assessment 
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usmg the ADL (Mahoney & Barthel, 1965) and IADL (Lawton & Brody, 1969), and 
general health usmg the Short Form-36 (SF-36) (Ware & Sherbourne, 1992) The 
partiCipant was then asked to recall the word hst from the HVLT for the delayed recall 
(DR) score, approximately 30 mmutes after Imtial exposure Fmally, after a mouth 
nnse with clean water, partiCipants were asked to deposit a saliva sample mto a 
labelled and stenhsed tube which was Immediately stored m dry Ice for later analysis 
Each test sessiOn lasted between 50 mmutes and 1 5 hrs dcpendmg on the cogmtlve 
ability of the participant and whether a carer was present or not 
4.1.4.2 Questionnaire Test Pack 
The questwnnaue and test pack consisted of four sections which the RA followed m 
the pre-defined order. The questions assessed m this thesis mcluded demographic, self 
and careg1ver reported health and cognitive complamts as well as objective cognitive 
and functiOnal assessment measures All questwns and measures were presented 
verbally by the RA See appendix 1 for questiOnnaire test pack which IS descnbed m 
more detail below 
4.1.4.2.1 Mini Mental Status Examination (MMSE) 
The afore mentwned Mm1 Mental Status Exammatwn (MMSE) (Folstem et a!, 1975) 
consists of a senes of questions designed to measure change m cogmtive status and to 
differentiate between normal age-related cogmtive declme and the pathological 
cogmtive declme that occurs m dementia It measures onentatwn, registratiOn 
(1mmed1ate memory), short- but not long- term memory, attentwn and calculatwn, 
and language A score of 17 or less IS considered to be severe cogm!Ive 1mpamnent, 
18- 24 mild to moderate Impairment, and 25 - 30 normal or borderline 1mpau111ent 
Not all Items m the MMSE were easy to understand or applicable to the Indonesian 
cultural settmg. Therefore, for this study the MMSE was slightly adapted for local 
Circumstances usmg some aspects of the HMSE but makmg others specifically 
culturally applicable to Indonesia Changes mcluded seasons of the year scored as 
correct for simply wet or dry season, which IS similar to the HMSE The nammg and 
remembenng of three objects were amended to objects the participants would all be 
familiar with (house, nee, and child) Some aspects of the 'Attention and Calculatwn' 
questiOns were considered too difficult for an Illiterate mdividual, for example, 
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countmg backwards by three and spellmg 'world' backwards Therefore, as for the 
HMSE, these participants were asked to say the days of the week backwards mstead 
See sectiOn 2 I 5 I for a cntical review of the MMSE 
4.1.4.2.2 Hopkins Verbal Learning Test (HVLT) 
The HVL T (Brandt, I 99 I) was used to assess memory functiOn This IS a word 
Jeanung test measunng verbal episodic memory, which consists of 12 words from 3 
low frequency categones (for verswn A which was used m this study 'human 
shelter', 'ammals' and 'precwus stones') These words were all repeated 3 times to 
obtam a total Immediate recall (IR) measure ('leanung ab1hty') After approximately 
20-30 mmutes, delayed recall (DR) of the words was assessed Without cues or 
promptmg See sectiOn 2 I 5 I for a cntical review of the HVLT. 
4.1.4.2.3 Possible dementia/cognitive impairment in the current study using a 
cognitive algorithm 
Accordmg to DSM IV diagnostic cntena, diagnosis of dementia must mclude 
Impaired cognitive functiOn, which IS usually assessed by a cognitive measure In 
order to Identify mdividuals who may have possible dementia or cognitive 
Impairment, established performance cut-offs based on previOus research (see below) 
for the MMSE and HVLT (IR) were used By usmg a combmatlon ofthe MMSE and 
HVLT (IR), the sample was then spht mto three groups cons1stmg of a cogmtlve 
1mpmrment (Cl), possible cogmtlve Impairment (possible Cl), and control groups 
This combmatwn was shown to have good sensitivity and speclfic1ty for dementia 
(Folstem, 2007, SclmJnemaekers et al, 2006, De Jager et al, 2003, Hogervorst et al, 
2002) and both tests have been found to be effective for detectmg dementia m an 
ethmcally diverse population (Kuslansky et al , 2004) PreviOus research on the 
sensitlVlty and speclfic1ty of the MMSE and HVLT has lead to the suggestiOn that the 
MMSE IS better at rulmg out dementia, whilst the HVLT IS better at detectmg 1t 
(Lawlor, 2001, Frank & Byme, 2000) Folstem (2007) also recommends a 
combmatwn of the MMSE and HVLT (IR) m assessmg AD symptoms, as "It g1ves 
reasonable sensitivity and speclfic1ty and IS bnef and mexpens1ve" (Folstem, 2007) 
Frank & Byme (2000) stated that a cut-off score between 25 and 26 (88% sensitive 
and 93% specific) on the MMSE and between 18 and 19 (96% sensitive and 80% 
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spec1fic) on the HVLT would detect m1ld dementJa m an elderly populatwn The 
OPTIMA group reported that a cut of score of 14 5 on the HVLT (IR) had 87% 
sensJ!JVJty and 98% specJfic1ty for dementJa and 95% and 77% respectJvely for a cut-
offscore of 19.5 Furthermore, usmg NINCDS-ADRDA15 cntena for diagnosed 
dementJa patJents, the HVLT cut-off of 14 5 had 91% sensJtlVlty and 98% specJfiCity 
(Hogervorst et al, 2002) AdditiOnally, no adjustments had to be made for age, 
gender, educatwn or depressiOn Based on prevwus stud1es (SchnJnemaekers et al , 
2006, De Jager et a], 2003, Hogervorst et al, 2002), Cl was therefore considered 
when performance of the HVLT-IR was less than 14 5 and MMSE total score was less 
than 24 516 Controls were 1dentJfied as havmg an HVLT-IR greater than or equal to 
19 5 and an MMSE score greater than or equal to 24 5 (SchriJnemaekers et al , 2006, 
De Jager et al, 2003, Hogervorst et a], 2002) 
The stratJfied sample also m eluded a group of participants sconng m between these 
cut-offs, wh1ch were labelled as possible Cl Th1s last group was purely for the 
purpose of descnplive analyses and mcreased power For further analysis, the 
'possible Cl' group was excluded and analyses are thus spec1fic to the 'Cl' as defined 
by the cogmtJve algonthm, and 'control' groups only to obtam max1mum contrast 
between groups Th1s was to reduce heterogeneity and remove borderlme cases 
Further analysis assessmg only the extreme groups of cogmtJve functwn ensured the 
groups contamed participants who were e1ther probably m all likelihood Cl cases (and 
hence at h1gh nsk) or had little or no cogmlive 1mpmrment (and thus could be used as 
controls) 
Although no formal diagnostic measure was used to categonse dementJa and the 
vanous types that could be prevalent, the methods used and data gathered were 
chmcally validated m prevwus stud1es and were systematiCally chosen, With previous 
literature m mmd, m order to mvestJgate the percentage of people w1th poss1ble 
dementia m urban and rural parts ofJava, Indonesia It must be noted that although 
speculatJve assessment was performed to mvestJgate the possible types of dementia m 
th1s sample, no climcal sub-typmg of the dementJas was attempted Further validatwn 
15 Nattonal InstJtute ofNeurologJcal and Commumcat1ve D1sorders and Stroke and the Alzheimer's D1sease and Related 
D1sorders AssocJatwn -nO\\ known as the Alzheimer's AssocJatwn 
16 As can be seen, these cut-offs are lower than those suggested by Franl.. & Byme (2000) Titerefore, they should Jdent1fy cases 
WJth poss1ble and probable dementia and not those With MC! or even m1ld dementia 
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of the cut-offs used to assess possible dementia and poss1ble dementla sub-types m 
Indonesia IS currently underway In add1hon, although the cogn1t1ve algonthm has 
been vahdated m an Enghsh populatwn, the cross cultural apphcab1hty has not yet 
been estabhshed Testmg It m a settmg such as Indones1a allows for some msight mto 
1ts use m a more d1verse settmg. 
4.1.4.2.4 Functional Ability Measures 
Functwnal ab1lity was measured usmg two scales The bas1c 'act!Vllles of dmly livmg' 
(ADL) (Mahoney & Barthel, 1965) and the more m-depth 'mstrumental act!Vllles of 
da1ly livmg' (IADL) scale (Lawton & Brody, 1969) Although functiOnal measures 
such as the ADL and IADL can be accurate m 1dent1fymg clear and more advanced 
cases of cogmtlve d1sab1lity, they lose sensltlvlty when cases are m1ld or borderlme 
cogmuvely 1mpa1red (Juva et al, 1997, Rubenstem, 1995, Green et al, 1993) 
However, 1! has been suggested that functiOnal status be used as a cntena for 
d1agnosmg cognitlve 1mpamnent m part1c1pants w1th a low level of educahon as well 
as those who score between 18 and 23 on the MMSE (Murden, McRae, Kaner, & 
Bucknmn, 1991) Conversely, some have argued that these functwnal measures, 
part1cularly the IADL, are culturally specific and not applicable to non-western 
settmgs and that the IADL spec1fically has been found to be sens1t1ve to the effects of 
educatwn (Kaneda & Zimmer, 2007) Therefore, certam 1tems of the IADL were 
changed to fit m to the socml climate of rural and urban Indones1a FirStly, the pomt 
system was adapted to score between 0-2 mstead of0-1 (to g1ve a greater range m 
ab1lity assessment) and score descnptlons were made clearer and more defimllve 
Th1s was done to create clearer d1stmctwns between the extremes of those w1th 
defimte functwnalimpmrment, defimte funct10nal mdependence, and those m 
between. The first Item of the IADL was changed from 'use of the telephone' to 'the 
ab1hty to extend messages or use the telephone' to ensure that the cogn1!IVe ab1lity 
behmd usmg the telephone was assessed but with a questwn that was apphcable to 
those m Indonesia who may have never used a telephone, e g those m rural areas 
ADL was cons1dered to be Impmred 1fthe part1c1pant scored between 1-19 (out of a 
poss1ble 20) and classlficahon of Impaired IADL was based on a score of 0- 8 (out of 
a poss1ble 16) as used by Mok et al. (2004) m a Hong Kong sample to 1dent1fy the 
early stages of functwnal1mpa1rment m demenha 
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4.1.4.2.4.1 Activities of Daily Living (ADL) Assessment Scale 
The self-reported ADL scale (Mahoney & Barthel, 1965) assesses the ability to 
complete the basic day-to-day needs of an adult such as personal hygiene, eatmg, 
mobility etc Accordmg to current diagnostic cntena, MCI IS associated w1th mtact 
ADL (Petersen et al, 1999) and therefore the consequent Impaument of these basic 
functional abilities IS used m the categonsatwn of dementia, I e. ADL IS not Impaired 
until a certam level of cogmtive detenoration has been reached Therefore, ADL 
scales are used as a method of detectmg when there IS a shift from MCI to dementia 
Of the few studies attemptmg to differentiate between healthy participants and those 
with cognitive functiOn limitatiOns (both MCI and dementia), significant differences 
have been found between groups on ADL and MMSE score (Doble, Fisk, & 
Rockwood, 1998, Ebly, Hogan, & Parhad, 1995), with the group showmg cognitive 
dysfunctiOn bemg more likely to also have Impmred ADL (Perneczky et al , 2006) 
4.1.4.2.4.2 Instrumental Activities of Daily Living (IADL) Assessment Scale 
The self-reported IADL scale (Lawton & Brody, 1969) IS pnmanly split mto two 
parts, questions that measure physical aptitude, and those that assess aspects of 
cognitive functiOn It has the advantage ofbemg fast and easy to admmister. The 
cognitive Items of the IADL focus on aspects such as onentatwn and procedural 
memory skills which are cogmtive functiOns Impmred early on m dementia 
(Barberger-Gateau, Dartigues, & Letenneur, 1993) NeurologiCal tests do not provide 
detmls of functional ability, nor do cogmtlve measures alone However, the IADL, to 
some extent, measures both and has been found to have a strong associatiOn with 
cognitive functiOn tests (Wemtraub, Baratz, & Mesulam, 1982) This has been 
reported m cross-sectional studies for both demented and non-demented populatwns 
(Cromwell, Eagar, & Poulos, 2003, Juva et al , 1997), and has been found to be cross-
culturally applicable across ethnic groups m Asian populatwns (Ng, Nit!, Ch~am, & 
Kua, 2006) 
It has been suggested that certamitems of the IADL can be used to predict possible 
mcidence of dementia and Identify mdiVIduals who reqmre further 
neuropsychological evaluatiOn (Barberger-Gateau et al, 1993), mdependently of age 
and MMSE score (Barberger-Gateau et al, 1993) More specifically, certam Items of 
the IADL, labelled as 'complex self-management' are believed to be mdicative of 
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cogmhve ability, such as handling money, telephone use, and self-medJcatwn 
(Cromweii et a!, 2003; Thomas, Rockwood, & McDoweii, I 998) Further study has 
added the transport 1tem and found assoc1at10ns between these four 1tems and scores 
on the MMSE w1th demenha pahents (Barberger-Gateau et a! , 1992) Therefore, 1t 
has been proposed that because the spec1fic areas ofbehavwur and functwnmg 
measured by these four 1tems are not m fact covered by the MMSE and are 
mdependently assocmted w1th mc1dent dementia, the IADL should always be used m 
add1hon to the MMSE (Barberger-Gateau et a! , I 993). Th1s assert10n has also been 
vmced by (Veiias et a! , 2008), espec1a1Iy m the early dmgnos1s of demenha 
4.L4.2.5 Demographics and Health Questions 
General demographic mformat10n obtamed about the part1c1pant covered a w1de 
vanety ofbas1c mformatwn (e g age, sex, educatwn, professwn) and other 
mformatwn wh1ch has shown an assocmhon w1th cogmhve functwn m prevwus 
research Th1s mcluded hvmg d1stnct, as weii as urban or rural res1dence, whom the 
partiCipant lives w1th (by themselves/with ch!ld/mshtutwn etc ), home ownership 
(own/rent/hvmg w1th others/mshtutwn) and parents' race (separately for mother and 
father) Educatwn was categonsed mto s1x categones, rangmg from "no formal 
educatwn" to "umvers1ty/academy educahon". Furthermore, mformatwn was 
obtamed about professwn (before rellrement) wh1ch was d1V1ded mto nme separate 
categones, e g no employment, c1vll servant, doctor/lawyer, and fanner and labourer 
Further analyses combmed these categones mto "blue-coiiar", "wh1te-coiiar" or "no 
professwn 17" 
Foiiowmg from th1s, health questwns were completed, w1th some confirmatory 
queshons for the carer Health assessment mcluded the SF-36 (Ware & Sherboume, 
1992). The SF-36 1s a self-reported health survey des1gned to assess vanous aspects of 
health, mcludmg phys1cal, neuropsychologJCa! and soCJal health problems and how 
these hm1t everyday life Questwns mvolve bod!ly pam, mental health and weiibemg 
(broadly), hm1tahons due to emotwnal problems, v1tahty (energy and fahgue), as weii 
as self-perceptwns of general health. It 1s w1dely used by health care professwnals, 
pohcy makers and populatwn surveys around the world SF-36 score ranges from 0 to 
17 
"No profess !On" would mclude housew1ves as well as men whom were not m any profess10n before retirement age 
I I I 
I 00 w1th an mcreasmg score md1catmg better health The cntenon rehab1hty and 
vahd1ty of the SF-36 has been established m both general populatwns (Jenkmson, 
Wnght, & Coulter, 1994) and palient samples (Ruta, Abdalla, Garratt, Coutts, & 
Russell, 1994) Further questwns wh1ch both the partiCipant and careg1ver answered 
assessed health complamts measured categoncally and dichotomously (yes/no) 
Questwns mcluded current med1catwn use and consultmg a doctor, as well as longer 
term health assessed by consultmg a doctor, attendmg a hosp1tal outpalients 
department, and admittance to hosp1tal w1thm the last two years 
PartiCipants were also asked 1fthey had used any form of hormone therapy m the last 
6 months wh1ch mcluded HRT for women, testosterone or other androgens for men, 
or any other supplements With (plant) hormones PartiCipants answered w1th 'yes' or 
'no'. 
4.1.4.3 Phytoestrogen assessment and assay method 
Participants provided a sahva sample, wh1ch was used to measure the levels of the 
most aclive phytoestrogen metabohtes, gemstem, da1dzem, and glyc1tem Samples 
were then refugerated for up to 4 weeks, at wh1ch pomt they were frozen at -20°C 
before bemg assayed by the Umvemty of Indonesia usmg coulometnc array detectiOn 
w1th H1gh Performance L1qmd Chromatography (HPLC). The HPLC method has 
vanous advantages over other ana!ytJcal mstruments m 1ts sensJ!iVJty and selec!JvJty 
when dealmg With very low levels of phytoestrogen (Gamache & Acworth, 1998) 
Vanous stud1es companng different methods of assessmg phytoestrogen levels m 
bod1ly flmds have been published (for a rev1ew see Wu, Wang, & S1mon, 2004). The 
HPLC coulometnc array detechon method has been compared w1th a GC-MS 
technique and has been found to be "a praclical, affordable means ofphytoestrogen 
determmatwn smtable for metabolic, pharmacokmehc and !issue d1stnbutwn stud1es" 
(Gamache & Acworth, 1998) Furthermore, 1t has the advantages ofhavmg s1mple 
sample preparatiOn, higher sensitiVIty and specJfic1ty than the ultravwlet or dwde 
array detectiOn HPLC methods, and a w1de analytical range (Wilkmson, Wahala, & 
Wilhamson, 2002) The coulometnc array detectiOn method was thus smted to th1s 
study as 1t ehmmates the need for sample re-extractiOn because large peaks oflugh 
concentratiOns do not saturate the detector (Laboratorytalk, 2003) 
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When choosmg a samplmg method for phytoestrogen measurements, vanous methods 
could be used Unne, for example, IS a good reflectiOn of the presence of secreted 
compounds and would be useful m simply detectmg whether or not phytoestrogens 
were present Blood samplmg fmiher adds value by prov1dmg mformatwn on 
cuculatmg compounds However, we were mterested m the levels of phytoestrogens 
Hence unne would be madequate, and blood sampling would be too mvas1ve m this 
pilot sample Therefore, sahva samplmg was used because It IS a qmck, mexpensiVe, 
and non-mvas1ve way of assessmg the biOavmlabihty of soy 1sof1avones Furthermore, 
Franke, Custer, Wang, & Sh1 (1998) report that w1thm an mdlVldual, Isoflavonmd 
levels m plasma and m other bodily flmds are sigmficantly correlated, and therefore 
sahva levels would be an accurate level of blood plasma 1soflavone concentratiOn 
4.1.4.4 Food Frequency Questionnaire (FFQ) 
To control for neglect m eatmg a proper overall diet due to memory problems or 
demenlla symptoms, questiOns based on the Food Frequency QuestiOnnaire (FFQ) 
(Frankenfeld et al., 2003) about dietary mtake were calculated Participants were 
asked If they consumed certam foods and If they d1d the frequency of consumptiOn 
and whether this was on a dmly, weekly or monthly basis The foods mcluded the soy 
foods, the mam vanables ofmterest, 1 e. mtake oftempe, tofu or tahoe, as well as 
other foods contammg 1soflavones (a type ofphytoestrogen) 18, such as soy milk 
These foods are frequently consumed m an Indonesian population and hence were 
mcluded m the FFQ Other foods assessed mcluded frmt (whole or as JUICe), orange or 
red vegetables, green vegetables and fish In this study, soy mtake was calculated as 
weekly total food mtake (calculated from dmly, weekly or monthly mtake For 
example, m take of a food once monthly would be calculated as 0 25 times a week, 
and mtake of three times a day would be calculated as 21 times a week Tins was 
calculated pot-hoc with the aim ofhavmg a weekly amount ofmtake for all 
participants Unfortunately, data on mtake of other protems and other foods were not 
mcluded due to time constramts as well as bemg outside the scope of this thesis which 
focuses on the relatiOnship between hormones/plant hormones and cogmtwn 
18 See appendix 8 
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The soy FFQ has been shown to have excellent rehab!IJty and vahd1ty m es!Jmatmg 
soy mtake m both East-Asian and Western populatwns (Frankenfeld, Lampe et a!, 
2004, Frankenfeld et a! , 2003) and has been found to be reproducible when 
admm1stered at two lime pomts, 2 weeks apart (Kuk, Patterson, & Lampe, 1999) 
Dietary assessment m large populatwns can be a costly venture, therefore population-
based studies ut1hse the FFQ as It IS lime-efficient and prac!Jcal (Jaceldo-Siegl, 
Fraser, Chan, Franke, & Sabate, 2008) The vahd1ty and rehab1hty of the FFQ IS 
supported when assessmg phytoestrogen mtake m populatwns which consume large 
amounts of soy (Chan et a! , 2008, Huang et a!, 2000, Wakm et a!, 1999) 
AddJ!Jonally, vahda!Jon has been further confirmed when asscssmg the correlatiOn 
between soy mtake, as reported by the FFQ and biOchemical md1ctors of 
phytoestrogen levels, usmg blood or plasma samples This has been the case m high 
phytoestrogen consummg East-As1an populatwns (Jaceldo-Siegl et al., 2008, Lee et 
a!, 2007; Chen et a!, 1999), mull!-ethmc popula!Jons with varymg levels of 
phytoestrogen mtake (Maskannec et a!, 1998), as well as m Western populatwns with 
relatively low mtake (Heald, Bolton-Smith, Ritchie, Morton, & Alexander, 2006, 
R1tch1e et a!, 2006) Although correlatiOns m Western popula!Jons have been lower, 
this IS possibly due to the low quanti lies of phytoestrogens consumed m these 
populatwns (Jaceldo-Siegl et a! , 2008) FFQs have therefore been found to be vahd, 
rehable and reproducible m the assessment of phytoestrogen m take m populatiOn-
based epidemwlogJcal studies (Yamamoto et a!, 2001) 
4.1.4.5 Informant and Self Reported Cognitive Impairment 
In addition to the cogmtive algonthm, questiOns to both the participant and careg1ver 
were added to assess vanous other aspects ofDSM-IV cntena for dementia diagnosis 
(Amencan Psych1atnc Association, 1994) The careg1ver questiOns are also similar to 
those asked m the mforrnant based DQ, which IS commonly used to screen for 
dementia (Kawas et a! , 1994) As an mtegral aspect of a demenl!a questwrma1re, 
questiOns were asked about the participant's memory and other cognJ!Jve problems 
(history, progressiOn and possible causes) The questiOns were asked of both the 
participant and the careg1ver as a means ofvahdatmg the self-reported cogn11Ive and 
behavwura!Impmrments, as well as assessmg the vahd1ty of a careg1ver's report m 
dementia diagnosis Additionally, these questiOns could perhaps vahdate cognitive 
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assessment usmg the cogmttve algonthm and hopefully asstst m dtfferentiatmg 
between posstble dementia types m thts populatiOn 
Types of dementia and their symptoms have been descnbed m detml m thts thesis m 
sectwn 2 1 3 However, the cogmtive algonthm, although gtvmg an mdtcatwn of 
posstble dementia, gave no mdtcatwn of the type of dementia the cases were 
presentmg In our follow-up, these DSM-IV based caregtver and partiCipant reported 
questiOns allowed for further analysts mvestigatmg the posstble subtypes of dementia 
m thts populatiOn usmg a fom1al dementia dtagnostic model. As can be seen m table 
5, on the basis of the mdtvtdual consensus based cntena (see mtroductwn) certam 
questions were assumed to gtve a greater mdtcatwn of the type of dementia present 
Our follow-up study wtll allow further validatiOn of these self-report and mformant 
questwns 
Composite scores that formed the DSM-IV based categones for dtagnosts were 
formulated usmg the questiOns m table 5 Answers to questwns were dichotomous 
(yes or no) m most cases for both the participant and the caregtver However, m some 
caregtver specific questions participants answered wtth 'always', 'sometimes' or 
'seldom'. Most questiOns were asked of both the participant and the caregtver 
Separately, participant and caregtver composite scores were computed to assess 
problems wtth long/short term memory, agnosia, aphasia, apraxia, and executive 
problems Another composite score was also computed based on a senes of caregtver 
obtained questions about memory problems Each question answered was gtven a 
score of '0' or' 1' and totals made from these scores, hence rendenng an overall 
composite score whtch would gtve an mdtcatwn of problems wtth long/short term 
memory, agnosia, aphasia, apraxia and executive functiOn, as well as a score based on 
spectfic mformatwn from the caregtver A low score mdtcated greater cognitive 
problems. 
Table 5- Participant and caregiver reported cognitive complaints used to compute DSM 
IV based composite scores 
The table shows the questiOns answered by the partiCipant and ca~egiver which were used to compute a 
composite score that mdtcated 'problems with long/short term memory', 'agnosta', 'agnosia', 
'aphasia', 'apraxia', 'e:x.ecuttve functiOn' and 'mformatwn from the caregtver' 
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Table 5 
Quest•on An~v.ered 8\ Dementia Sub-T)pes 
Participant Carer AD V aD FTD 
Problems with long&. short term memon . • •I • . 
Forget names of people ) ou ha\e JUS! met 
Forget names of people you know a httle (al.quamtances) 
Forget names of people you know well (cousmslnephev.s) 
Forget names of people .. erv close to you (cluld'panner) 
Forget names ofthmgs (amm,ds/grocery 1tem) 
Forget the way home/v.av to shopslwav to fnl.ll(is 
Forget thmgs you bought from the last tnp to the grocery 
Remember where you put thmgs 
Remember wlaat vou had for breal..fast 
Remember what you d1d Ja~t week 
Remember what you did last year 
Remember whJt you did I 0 vears ago 
Remember your childhood 
Other 
AgnoMa (F.ulure to recogm~c or Jdenhfv objects and Jleoplc de~p1tc intact sensory • . . • . 
functiOn) 
Problems 111 recogmzmg faces of people you know a hule 
Problems m recogmzmg faces of people you know very well (cluld/spouse) 
Problems 111 recogmzmg your way home 
Problems m rccogmzmg thmgs 
Other 
Aphas1a (language disturbance) . . • . •I 
Problems m speakmg 
Word findmg problems 
Problems spcakmg m understandable sentences 
Problems readmg 
Other 
Aprax•a (•mJJaired ab! hi' to carry out motor activities desp1te mtact motor . • • • . 
functiOn 
Problems combmg lm1r, washmg dressmg, gettmg up from a cha1r, eatmg usmg 
the tOilet, mdoor v.alhm.e: 
Problems takmg med1cme regularly 
Problems cookmg sl10ppmg and cleamng 
Executive Function Impa1rmenl (planmng, or~amlmg, sequencmg, abstractmg) . . • •I . 
Problems plannmg (e g a tnp, to do somethmg) 
Problems Countmg (e g bank affa1rs) 1--Problems handhng money 
Aggressmn problems r-----;-
Womed par.tnmd or susp•c•ous r-;-
Otl1er 1--
D1d These problems start • 
Slowly • . . 
Suddenly (e g after a Strohe) . 
Have the\ been getlmg \\Orse" . 
y" . • . 
No 
Do memory problems occur cons•~ tenth" . 
y" . 
No . . 
Do these problems make lt difficult for vou to funchonsocJalh, at v.ork or In 
• • • . splntual/mental!suclal actlvJh" 
InformatiOn from the Careg1ver (mcmor\ problems) . . • • 
Does the elderly you care for have memory problems I • 
Does the concerned remember and mcnt!OII some events b 
Is the concerned able to name some thmgs (c g shoppmg h~t) b 
Do Ins/her memory problems affect da1ly aCiiVII!es'l • 
Does the concerned forget b1g or important events m a fey. Y.eeks since they took 
_p_lace (e g a wcddmg)b 
Does the concerned forget deta1ls ofm1portant events~ 
Does the concerned fully forget ALL llllportant e\ ents m the past 1 b 
AD"' Alzheimer's d•sease V aD '"" Va.~cuiar Dement1a FTD- Frontotemporal Demenua 
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4.2 Statistical Analyses 
The followmg sectwn descnbes the statisllcal methods used to assess the areas of 
mterest descnbed so far m this thesis For all analyses, a p-value ofless than 0 05 was 
considered sigmficant and analyses were performed m SPSS verswn 15 0 
4.2.1 Descriptives 
4.2.1.1 Whole Sample Demographics, Cogmtive Function, Functional Status & 
Health 
Descnptive analyses were performed for the whole group giVIng frequencies and 
percentages for demographic vandbles The demo graphiCS vanables were gender, age 
(both as a contmuous van able and age groups), distnct, urban or ruralhvmg, 
educatwn and professiOn, ethnicity and hvmg status (whom the partiCipant was hvmg 
with and whether this was m an mslltutwn or the commumty) The sample was 
descnbed for cogmtive scores on the MMSE and HVLT (IR & DR) as well as 
functiOnal status (ADL & IADL) and health, as measured by the SF-36, and proxy 
measures (medicatiOn use, seemg a doctor, and hospital use) 
4.2.1.2 Cognitive Groups Demographics, Cognitive Function, Functional Status, 
Health & Participant and Self Reported Cognitive Complaints 
Usmg the cogml!ve algonthm (see sectwn 4 I 4 2 3) partiCipants were then diVIded 
mto three cogmtive groups, controls, possible Cl cases and Cl cases The groups are 
descnbed for the vanables above, usmg AN OVA analysis (for contmuous data) and 
Chi-square analysis (for categoncal data) to assess differences between cogmtive 
groups for vanables 
Cogmhve groups were also compared for self & caregiver reported complamts for 
compound scores for agnosia, aphasia, apraxia, execullve problems (see sectwn 
4 I 4 5 for questiOns that were used to form composite) Groups were also compared 
for partiCipant responses for questiOns related to problems With "aggressiOn", 
"paranma", "If cognitive problems started suddenly or slowly", "If they have been 
gettmg worse", and "If they make It difficult to funcllon" (socially, at work or m 
spmtual/mental/social acllvity) Caregivers' responses assessmg a range of cognitiOn-
related Issues, as well as a composite score for caregiVer mformatwn about memory, 
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were also compared between cognitive groups Agam, Ch1-square analysis was 
performed for categoncal vanables and ANOV A for contmuous data were used to 
assess the differences between cognitive groups for these vanables 
4.2.2 Analyses of the Caregiver and Participant Report 
Spearman's correlatiOn analyses were used to mvestigate the mter-rater rehab1hty 
between the participant and care giver reports Spearman's correlatiOnal analysis was 
used as the data (although hnear m nature) d1d not meet assumptwns ofparametnc 
tests and data was based on composite scores from different questwns not measured 
on the same scale Analyses dssessed the correlatiOn between the participant and 
careg1ver reports on composite scores (using the questwns m sectwn 4 I 4 5) that 
make up DSM diagnostic cntena-based cogmt1ve complamts of problems with long 
and short term memory, agnosia, aphasia, apraxia, and executive functwn problems, 
1 e whether they were both reportmg the same type of problems 
Cohen's Kappa was used to assess the mter-rater agreement between the carer and 
self-reported responses to the mdlVldual component questwns of the DSM diagnostic 
cntena based composite scores Kappa IS the coefficient of agreement for nommal 
scales and measures the level of significant agreement between two raters of the same 
vanable on nommal or ordmal scales (Cohen, 1960) It IS an appropnate method m 
this Situatwn as participants and carers were asked Identical dichotomous questwns on 
Identical scales 
Spearrnan's correlatwnal analysis (for contmuous data) and ch1-square analysis (for 
categoncal data) were also used to mvestigate the vahd1ty and accuracy of the 
careg1ver m reportmg Cl by assessmg the correlatiOn between Cl (based on the 
cogmtive algonthm groupmgs- see sectwn 4 1 4.2 3) and careg1ver reported 
cognitive problems With long/short term memory, agnosia, aphasia, apraxia, executive 
functwn, and the composite score for general 'InformatiOn from the careg1ver' about 
memory problems (see table 5 for the questwns used to compute this composite 
score) 
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Receiver Operatmg CharactenstJc (ROC) curve analyses were used to assess the 
sensitivity and specificity of the composite scores from the careg1ver report usmg the 
cogmtlve tested based Cl algonthm as established cases and controls ROC analyses 
are an objechve way of assessmg the true positive (sensJtlVlty) and false positive 
(speclfic1ty) d~agnost1c accuracy of the careg1ver and participant report It also g1ves 
'cut-off levels m scores which could be used to objechvely Identify cases and 
controls. This method has been used m many studies assessmg cogn1live measures m 
dementia research 
4.2.3 Possible Dementia in Indonesia 
4.2.3.1 Estimated Dementia Percentage 
In order to estimate possible demenlia percentage m th1s Indonesian populatiOn, 
frequencies and percentages of participants w1th possible dementia were Identified 
based on a number of factors that based on DSM-IV cntena (Arnencan Psych1atnc 
AssocJatJOn, 1994) 
The cntena used were as follows·-
1 Cogmhve 1mpaument based on the cogmhve algonthm (CD 
HVLT score less than 14 5 and MMSE score less than 24 5) 
2 Functwnallmpamnent (Fl) 
IADL <9 19 
3. Confinnatwn by the care giver or self report of at least one cognilive 
disturbance such as aphasia, apraXIa, agnosia, executive functwn, problems 
With long/short tenn memory, and cogmhve problems have gotten worse over 
lime (participant report) 
19 For th1s exploratory analysts, Cl ''as detenmned usmg the cogmtwe algonthm alone as well as wtth FI usmg the IADL 
(wtthout ADL) Although a stgmficant dtfference was observed between the Cl, posstble Cl and control cases (see descnpttve 
table 4}, the dtfference m group means was very small for the ADL Whereas the group means for the IADL had a greater 
dtstnbut10n Therefore, 11 was dectded that for thts sample, the IADL mtght have better d1scnmmatory ab1hty 111 tdenttfymg 
posstble/probable dement1a cases by screemng out control and poss1ble Cl cases Although both the ADL and IADL had a ceilmg 
effect as some partiCipants d1d score the max1mum score poss1ble on both measures, for the ADL 82% of the sample had the 
max1mum score of 20 (the cutMofffor unpamnent was hence <=19), wh1lst a much lower 43 5% scored the max1mum on the 
IADL 
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4.2.3.2 Estimated Percentages of Possible Dementia Types 
It was of interest to assess if, as has been descnbed in section 2.1.4 and reflecting 
other East-Astan populations, AD would be less common in Java, Indonesia. Without 
formal diagnosis and using the cnteria outlined above for dementia, the estimated 
dementia percentage above did not give any indication of the different possible types 
of dementia in this population. In order to assess this, various questions were asked of 
both the participant and the carer that would indicate different possible sub-types of 
dementia (table 5). Questions were based on DSM-IV diagnostic cnteria for the 
dementia sub-types of AD, V aD, or other possible dementia types. 
Figure 4 - Diagnosis Criteria for Alzheimer's disease and Vascular/Other 
Dementias 
Dementia Criteria 
•Cogm!ive algonthm alone (HVL T<l4 5 & MMSE <24 5) 
•Jmpatred functiOnal abthly using the IADL (<9) 
•At least one other cogmtive dtsturbance (aphasta, apraxta, agnosta, 
executtve function, problems With long/short term memory) 
confirmed by the caregtver or parttctpant 
+ + 
Alzheimer's Disease Vascular or Other Dementias 
•Gradual onset of cognittve problems (assessed) •Abrupt onset OR cogmtlve problems are fluctuatmg 
•Contmumg decline •Poor health (secondary dementtas) 
•Gettmg worse 
•Not caused by other morbidity (not established here) 
4.2.3.3 Factor Analysis to Assess Possible Dementia Types 
4.2.3.3.1 Research Questions and Areas oflnterest 
Pnncipal Component Analysis (PCA), a particular method of Factor Analysis (FA) 
was used to explore the way in which variables20 correlated with each other, how they 
grouped together and what these groupmg could imply about the psychological 
constructs, or factors21 behind them. In this sample, we assessed whether participant 
and caregiver reports of cognitive complaints clustered together in a way that allowed 
20 See table 5 and sect10n 4 1 4 5 for an extensive descnpt10n of the vanab1e~easured and the methods of obtatmng compostte 
scores 
21 NB m ANOVA the tenn •factor' refers to the Independent Vanabte However, m factor analysts, the tenn •factor' means a 
'd1mensmn' (a psychological constru::t) that underlies several measured variables (F1eld, 2005~ 
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mferences about possibly different sub-types of dementia and Cl PCA was used to 
assess the d1scnmmatory value of these vanables, 1 e not simply 'Cl/dementia' as a 
component, but sub-types of Cl/possible dementia As already discussed (sectiOn 
2 I 5 3) carer corroboratiOn IS usual practice m dementia diagnosis as the care giver 
report serves the purpose ofvahdatmg and confirmmg the findmgs of obJective 
cognitive measures PCA also allowed assessment of the value of the care giver report 
m this sample. 
4.2.3.3.2 Nature of the Sample 
The portwn of the total populatiOn whom met the basiC cognitive cntena for Cl usmg 
the cognitive algonthm (see sectwn 4 I 4 2 3) were Identified, hence assessmg this 
proportiOn of the sample m IsolatiOn, as opposed to the entire sample which would 
mclude possible Cl and control cases, allowed more sensitive mvestlgatwn of the 
possible components (or types) of dementia the vanables measured22 
4.2.3.3.3 Assumptions 
In order to be able to JUStifiably use any method ofF A, the data must meet certam 
assumptions (Field, 2005) -
data must be of at least ordinal level measurement 
11 variables should be normally d1stnbuted. 
Ill relatiOnships between vanables should be hnear (1 e the van abies must be of a 
contmuous nature) 
IV at least I 00 participants (preferably 200) should have been tested. 
v there should be more participants than extracted components (at least 2 1), but 
as this IS exploratory analysis, this was not known until after the analysis was 
performed 
This data set met all above assumptiOns and therefore FA was applicable 
22 Th1s was checked usmg prehmmary analys1s w1th the whole sample (n:7J9) Prehmmary factor analys1s e\tracted four factors, 
a h1ghly loadmg first factor, With a very h1gh e1genvalue, and three other' anables v.htch explamed much less of the total 
vanance (the last tv.o components were espec~ally weak The analySJS was therefore not d1scnmmatory enough for the nature of 
the data Th1s could have been due to the mclus10n of eo gm lively mtact, poss1ble Cl as well as Cl cases seen m the ent1re sample, 
and hence the analys1s was not sens1t1ve enough to Jdenttfy poss1ble sub-types of dementia 
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4.2.3.3.4 Suitability of data for FA (preliminary analysis) 
4.2.3.3.4.1 Sample Size 
To assess the smtab11Ity of the data for FA, prehmmary analys1s was performed The 
sample was of adequate s1ze However, due to the nature of the data, not all questiOns 
were answered by all partiCipants and a careg1ver was only present for approximately 
40% of the Cl sample Therefore, although the preferable method of excluswn of 
m1ssmg cases IS 'exclude cases 1Istw1se', th1s method would have resulted m a 
dramatic and s1gmficant reductiOn m the sample s1ze Therefore, cases were excluded 
pa1rw1se Although th1s meant the sample sizes of the vanables vaned, they were 
greater than 200 whiCh IS adequate for exploratory FA23 
4.2.3.3.4.2 Normality of data 
D1stnbutwn histograms were plotted to check the data were not skewed and were 
nom1ally d1stnbuted. 
4.2.3.3.4.3 Correlations between variables 
MultJColhneanty and smgulanty were checked usmg the determmant (a cntical value 
which g1ves an mdJcatwn of the correlalion between vanables) The determmant 
should be greater than 0 00001 as If this value 1s zero, a solutwn could not be reached 
and FA 1s not appropnate. Checkmg for smgulanty, assesses 1ftwo vanables are 
perfectly correlated, was checked by cons1denng the removal of vanables wh1ch 
correlate too h1ghly w1th each other and hence have very h1gh absolute values (r > .9) 
Different absolute value cut-offs have been suggested for the mm1mum absolute 
values for correlatiOnS between vanables (F1eld, 2005, Pallant, 2005b) The more 
stnngent rule mvolves cons1dermg the removal of absolute values below r = 4 Tl11S 
would result m analyses that narrow down the vanables and the components they load 
on to However, m prehmmary checks, an absolute value cut-off of 4 resulted m most 
vanables only loadmg onto one component. The nature of the top1c studied means that 
there IS often overlap between different symptoms that can be seen m more than one 
type of dementia It was dec1ded that an absolute value cut-off ofr = 4 would not 
allow the natural shanng of some vanables between different components, or different 
21 Barr the composite score of caregtver m formatiOn about memory complamts \\h1ch had n=48 cases m the analysis 
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possible dementia sub-types Therefore, as Pallant (2005b) suggested, an absolute 
value cut-off of r = 3 was used m further analysis 
4.2.3.3.4.4 Factorability of the data 
The factorab1hty ('whether It IS hkely that there are any factors underlymg the 
vanables that are measured' (Brace, Kemp, & Snelgar, 2006)) was assessed via two 
standard methods -
a Bartlett's test of sphenc1ty tests the null hypothesis, for which the correlation 
matnx would be an Identity matnx and all correlatiOn coefficients would be zero 
Bartlett's test of spheric1ty needed to be statistically significant (p<O 005) to mform 
that the R-matnx was not an Identity matnx and that there was actually a relationship 
between vanables. 
b Ka1ser-Meyer-Olkm (KMO) (values range from 0- I) IS a measure of samplmg 
adequacy. It tests the amount ofvanance Withm the data that can be explamed by the 
components Gmdehnes (Tabachmck & Fidell, 2001) state that a value of 61s 
considered to be the m1mmum value for a good FA24 
4.2.3.3.5 Criteria used to determine number of extracted components 
Component extractiOn was used to determme the smallest number of components that 
could best be used to account for the mter-correlat10n between vanables The mm was 
to find a Simple solution with as few factors as possible (speCificity) but still 
explammg as much of the vanance m the data as possible Several methods were used 
to determme the number of components to be retamed after prehmmary analysis and 
before factor rotatiOn. 
Fustly, the proportiOn of total vanance and the vanance due to each of the extracted 
factors was exammed Usmg Kaiser's cntenon (Kmser, 1974) only components with 
an e1genvalue over I were retamed for further analysis However, this method has 
been cnticJsed for retammg too many factors and therefore Kaiser's cntenon needed 
to be used m additiOn to other methods The shape of the scree plot (plots component 
e1genvalues) was then exammed Cattell (1966b) recommends retammg components 
above the elbow or break m the plot (sometimes there IS more than one) This has 
24 Kmser (1974) reports that 5 to 7 = medJocre, 7 to 8 =good, 8 to 9 =great, 9 and above= superb 
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been suggested to be a good method for sample stzes greater than 200 (Brace et a!, 
2006) Furthermore, the component matnx was scruhmzed to assess whtch vanables 
load onto the extracted components and the strength of the loadmg 
For further confirmatiOn of the number ofretamed components, parallel analysts was 
employed. In parallel analysts the s1ze of the e1genvalues are compared w1th those 
randomly generated from a data set of the same s1ze Only e1genvalues exceedmg the 
randomly generated e1genvalues were retamed. Monte Carlo PCA for FA25 (Watkms, 
2000) was used for the randomly generated dataset The use of parallel analys1s 
mcreases confidence m results and reduces subjechve mterpretat10n of an obJeCtive 
analytical method (Frankhn, Gtbson, Robertson, Pohlmann, & Frahsh, 1995) 
Fmally, exammation of the reproduced correlatiOns allows compansons between the 
observed correlatwns and the pred1cted ones for the correlahon between the vanables, 
under the assumphon that FA IS appropnate The smaller the res1duals, the smaller the 
dtfference between the observed and predicted values, the more hkely 1t 1s that FA 
gave a good explanatiOn of the data and the extracted components do actually explam 
the vanance m the data There were less than 50% ofresiduals over 0 05 whtch 
mdtcate that FA was an appropnate and good method for the dataset 
4.2.3.3.6 Factor rotation 
RotatiOn maximises the loadmg of each vanable onto one extracted component whtlst 
mmtmismg the loadmg on the others It allows a clearer md1catJon ofwh1ch spectfic 
vanables are more strongly related to wh1ch component Rotatwns performed are 
either orthogonal rotahons (Vanmax method), wh1ch assume that the underlymg 
constructs are mdependent or uncorrelated, or obhque rotatwns ( dtrect obhm method), 
which allows for the underlymg constructs or components to be correlated 
Theorehcally, the nature of the data would assume that the components may be 
related as there IS some overlap between the symptoms of the dementJas and hence 
some components could be correlated Therefore, as suggested by stattstlC!ans (Brace 
et a!, 2006, Field, 2005, Pallant, 2005a, Pallant, 2005b), both types ofrotatJon were 
2 ~ Go to- http /I\\\\\\ ,tlkn,mdum\Jn t.om'"r~.,. <;tudcntlurth..r html - to downlo.td Monte Carlo PCA Parallel Analysts tool 
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run If the output of oblique rotat10n did not show significant correlatwns between the 
components, then orthogonal rotation could safely be used 
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4.2.4 Demographic Risk Factors 
In sectiOn 5 I participants, measures and procedures for th1s study sample are 
descnbed m more detail The current sectiOn descnbes how poss1ble demographic nsk 
factors for cogmt1ve 1mpmrrnent m an lndones1an sample were mveshgated 
4.2.4.1 Correlations between Demographic Variables 
Vanous literature dnven assoC!alions between demographic vanables were assessed 
usmg AN OVA (for contmuous, mtervallevel data) and Ch1-Square (for categoncal 
data wh1ch IS e1ther ordmal or nommal). D1stncts were compared for age, educalion, 
professiOn and gender d1fferences Furthermore, professiOnal groups were compared 
for educahonal and gender differences, and lastly the relatwnsh1p between education 
and gender was assessed 
4.2.4.2 Logistic Regression 
Bmomal Log1slic RegressiOn was used as 1t IS able to stat!slically predict category 
membership based on groups of partiCipants However, th1s 1s only the case for two 
groups not three m SPSS. For these analyses only the Cl and control groups and not 
the poss1ble Cl cases (as defined by the cogmt1ve algonthm) were used Log1st1c 
regressiOn was used as th1s part of the study mmed assess whether certam 
demographic vanables could predict cogmlive status, 1 e the odds of a part1cular 
outcome Furthermore, the cogmlive status measurement was catcgoncal (Cl or 
control) and not contmuous, hence lmear regresswn could not be used for these 
analyses 
Log1st1c Regresswn analyses were used to find nsk factors for Cl as defined usmg the 
cogmlive algonthm w1th 'control cases' as the reference category, and 'Cl cases' as 
the dependent vanable Demographic var1ables of age, gender, educatwn, ethmc1ty, 
and professiOn were added mto the regression equal! on usmg the 'Enter' method 
whiCh some beheve m the most appropnate methods for theory testmg where prevwus 
research ex1sts and 1s not as mfluenced by random vanatwn or as un-rephcable as 
stepw1se methods (F1eld, 2005) Hosmer & Lemeshow ch1-square test of goodness of 
fit was used wh1ch g1ves an md1cat10n of agreement between the observed and 
predicted outcomes Lastly, s1mple (first) contrasts were apphed to categoncal 
vanables The s1mple (first) method meant that Cl category was compared to the 
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control category (the reference category) Thts could be used because for vanables 
wtth more than two groups ( e g educatwn) the categones were ordmal Secondly, 
dtstnct was entered mto the analyses to assess whether 1t modtfied the relatwnshtp 
between CI and other demographic nsk factors In the final step of analyses, 
functional abthty as measured by the IADL (a measure ofposstble dementia) and 
health as measured by the SF-36 were added to assess whether functwnal dtsabthty or 
1ll health medtated the assoctatwns found m the first and second stages of analyses 
Analyses were then re-run as above but stratified by dtstnct wtth the demographic nsk 
factors of age, gender, educatiOn, professiOn and ethmctty entered, and the vanables 
of health and functional abthty were controlled for 
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4.2.5 Hormone Dependent Modifiable Risk Factors for Alzheimer's 
disease and Cognitive Impairment 
4.2.5.1 Hormone Therapy Use in an Indonesian Sample 
Hormone Therapy (HT) was assessed by self-report and mcluded a wide range of 
treatments (estrogens, testosterone, plant based hormone treatments etc) Participants 
simply answered yes or no to currently usmg HT However, as the types of HT used, 
reasons for HT use and possible effects of HT on cogmtive functiOn vary greatly 
between men and women, all analyses were run separately for men and women 
4.2.5.1.1 Descriptive Analyses 
Descnptive analysis used x2 for categoncal data (hence cannot be normally 
d1stnbuted) and Independent T Test (used to compare the difference m means 
between two mdependent groups) for contmuous data was used to assess the 
differences between HT users and non-HT users for a number ofvanables This 
included the demographic vanables of age (both contmuous and as age-groups), 
gender, educatiOn, professiOn and house ownership (as md1cators of SociOeconomic 
Status (SES), and area of residence (urban vs rural and d1stnct) Cognitive function 
scores were also compared between groups for the MMSE and the HVLT (both IR 
and DR) (see sectiOn 4.1 4 2 for a descnpt1on of all tests) usmg non-parametnc Mann-
Whitney U Mann-Wh1tney U was used because although the data was on mterval 
level, It was not normally d1stnbuted between the HT groups, hence a parametnc 
method of analyses would have been mappropnate Furthermore functional ab1hty (as 
measured by the ADL and lADL), health (SF-36 and self reported medicatiOn use, 
currently seemg a doctor and attendmg an outpatients department) and mood (feelings 
ofhappmess, sadness, stress, nervousness, and full ofhfe) were also assessed 
4.2.5.1.2 Linear Regression Analyses 
Lmear regressiOn analyses were performed to mvestJgate the relatiOnship between HT 
use and cognitive functiOn as measured by participant score on the MMSE, HVLT-lR 
and HVLT-DR. Lmear regressiOn allows prediction of a score on a linear scale based 
on other vanables (e g HT or not) Logistic regressiOn analyses were also used to 
assess the relatwnsh1p between cognitive 1mpmrment (Cl) as defined by the cognitive 
algonthm, 1 e 'Cl case' or 'control case' (see sectiOn 4 1 4 2 3) In the first step of 
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analyses, the relatiOnship between HT use and cogmtwn (HVLT, MMSE or Cl) was 
assessed In a second step, demographiC vanables (age and educatiOn) were entered as 
covanates followed m a third step by SES (home ownership) and distnct In a fourth 
step, mood and health (m a fifth step) were entered as covanates to assess whether 
these medmted the associatiOn The vanables that assessed mood were feelmgs (or 
lack of) stress or sadness, feeling full of hfe and nervousness The vanables assessmg 
health that were added to the lmear regressiOn analyses were SF-36 score, self-
reported current use of mediCatiOn, currently seemg a doctor and attendmg a hospital 
outpal!ent department m the last two years These analyses were run separately for the 
HVLT-IR, HVLT-DR and MMSE scores Step I and 2 were entered while step 3-5 
used stepwise backward ehmmatwn To assess the mteract10n between age and HT 
use, analyses were rerun usmg GLM (ANOV A) GLM allowed us to test formam 
effects and mteractwns, entenng age and HT as mam effects and as mteractwn term 
If the mteractwn was sigmficant analyses were stratified by age Analyses were 
stratified for sex to mvesl!gate differences between men and women. 
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4.2.5.2 Phytoestrogens and Cognitive Function in Indonesia 
Please see sectiOn 4 1 for details of assessment procedures and methods For these 
analyses, the m am assessments of relevance were the cogmtive assessment methods 
used to determme CV control classlficatwn, FFQ to assess soy consumptiOn, and 
saliva samplmg m order to assay aglycone !so flavone levels of gemstem, daidzem, 
and glycitem. Possible dementra!CI cases (and controls) were Identified usmg the 
cogmtive algonthm extensively descnbed m sectwn 4 I 4 2 3, and refers to the same 
sample used to assess possible demographic nsk factors for dementia m sectiOn 5 I 
4.2.5.2.1 Descriptive Analyses 
Descnptive analyses were performed for the whole sample to assess demographic and 
other vanable frequencies The sample was then stratified for several vanables I) Cl 
vs control groups (usmg the MMSE and HVLT cut-offs descnbed), 11) d1stnct 
(Jakarta, Sumedang, Borobudor), m) gender (men and women), and 1v) by medmn 
split for age (less than or greater than 68 years of age) Chi- square ( categoncal) and 
umvanate ANOV A were used to explore the differences between these stratified 
groups for a mulhtude of vanables as descnbed m chapter 5 I 2 Furthermore, 
stratified groups were also compared for soy and other food mtake as well as salivary 
Isoflavone levels. 
4.2.5.2.2 Correlation between salivary phytoestrogen levels and self-report on soy 
FFQ in the current study 
Pearson's correlatiOn coefficient analysis was performed as descnbed above to assess 
the relatwnsh1p between self-reported soy mtake (tofu and tempe only), as measured 
by the FFQ (number ofhmes the food Item IS consumed m a week), and salivary 
Isoflavone levels of gemstem, daidzem and glyc1tem (parts per million- ppm) 
Pearson's correlatwnal analyses were used as data was parametnc 
4.2.5.2.3 Associations between Demographics, Food intake, Isoflavones and 
Cognitive Function 
Spearman's rank correlational analyses was performed to assess the relatwnsh1ps 
between cogmhve functiOn (MMSE and HVLT IR and DR score, and Cl), food mtake 
(tofu, tempe, frmt, vegetables and fish), 1soflavone levels (gem stem, dmdzem, and 
glycitem), and demographic vanables (age, gender, education and urban or rural 
130 
hvmg) Spearman's analyses were used here as not all vanable bemg correlated were 
lmear and data was non-parametnc 
4.2.5.2.4 Soy Food Intake, lsoflavone Levels and Cognitive Impairment (Logistic 
Regression) 
Bmomiallogtslic regressiOn analyses was used to tdenlify whether mtake oftempe, 
tofu as well as sahvary phytoestrogen levels of gemstem, dmdzem and glycttem26 
were mdependently assoctated wtth an mcreased nsk CI (based on the cogmttve 
algonthm usmg the 'control cases' as the reference group, and the 'CI cases' as the 
dependent vanable) Tofu and tempe mtake were entered as etther lmear weekly 
amounts or, m separate analyses, as a dtchotomous van able 'dmly or above' mtake or 
'less' (median spht)27 The vanables were analysed usmg the 'Enter' method, Hosmer 
& Lemeshow cht-square test of goodness of fit was assessed and categoncal vanables 
were contrasted usmg the stmple (first) method28• The vartables entered m the first 
step of analyses were those of mterest, namely tofu and tempe (weekly amount) and 
sahvary levels of gemstem, datdzem and glycttem Addtl!onally, demographtc 
covanates were added mto the analyses These were age, gender, educatiOn, and 
hvmg dtstnct In the second step of analyses, mtake of other foods was also entered as 
covanates These vanables were frmt (or frmt JUtce) orange/red coloured vegetables, 
green coloured vegetables and fish, all as a weekly amount 
Analyses, as above, were re-run stralified by h vmg dtstnct, median age (less than or 
greater than 68 years), and gender Furthermore to assess the combmed posstble effect 
of these vanables, analyses were further stralified by medtan age and hvmg dtstnct, 
medtan age and gender, and lastly, gender and dtstnct 
26 Levels of glycttem dtd not show any stgmficant dtfference between posstble cases and controls m ear\ter ANOV A analyses, 
although 11 was posttJvely correlated wtth posstble dementta m Spearrnan's analyses Therefore, although 1t \\as added mto 
logtsttc regresswn analyses (as a control), 11 1s not descnbed 
27 Analyses usmg tofu and tempe consumpt10n as defined by d1chotomous med1an spht of dmly or more ytelded similar results to 
that oftofu and tempe as a contmuous weekly amount and therefore, to avmd repetttwn, only an<Jlyses usmg weekly tempe and 
tofu m take are descnbed 
2& See section 4 2 5 2 for reasons for methods u~ed 
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CHAPTER 5 - RESULTS 
5.1 Descriptives of the Whole Sample and Cognitive Groups Based on 
the Algorithm 
5.1.1 Cognitive Function Scores (see table 6) 
The mean score, SDs, and mimmum and maxtmum scores for the whole group on the 
MMSE and HVLT (IR & DR) can be seen m table 6 
Cut-offs on the bas1s of the cogmtive algonthm from OPTIMA (Hogervorst et al, 
2002) were used to form groupmg vanables to detennme whether participants could 
be considered as CVposs1ble dementia, poss1b le Cl or control cases (hkely to have no 
dementia) (see sectwn 4 I 4 2.3 for cutoffs) Of the whole populatiOn, 52% scored 
less than the cut off for the Cl group of 14 5 on the HVLT (IR), and 40% scored less 
than the MMSE Cl cut off of24 5 At the other end of the scale, 25% on the whole 
populatiOn scored greater or equal the control group HVLT (IR) cut-off of 19 5 and 
60% of the populatiOn scored equal to or greater than the MMSE cut-off of25 5. A 
combmation of these extremes rendered the Cl and control groupmg, with all other 
participants havmg questwnable cogmtive status ( e g possible Cl or other) Usmg the 
cogmtive cutoffs, 30% of the total populatwn were categonsed as the Cl group, and 
24% as the control group, and the remammg 47% were classified as possible Cl cases 
Table 6 Cognitive Score Descriptives for the Whole Sample and Cognitive 
Groups Based on the Algorithm 
Table 6 shows the mean, SD, nummum and maximum •cores for the MMSE and HVLT AN OVA 
analySis showed a Sigmficant difference (p<O 001 for all cogm!Ive tests) between cogmtive groups for 
the MMSE (F~376 67), HVLT-IR (F~723 63) and HVLT-DR (F~461 23) 
MMSE HVLT(IR) HVLT(DR) 
N('Yu) 
Mean {SD) Mm M" Mean (SD) l\1m Max Mean {SD) M in l\1ax 
Whole Group 719 (lOO) 24 18 (5 59) 0 30 14 74 (7 73) 0 34 489(335) 0 12 
Cl (.ases 215 (30) 1834(534) 0 24 738(468) 0 14 I 84 (I 87) 0 8 
Poss1ble Cl Cases 335 (47) 25 85 (3 54) 4 30 14 56 (4 47) 0 31 493(243) 0 12 
Control Cases ]69 (24) 28 28 (I 61) 25 30 24 40 (3 68) 20 34 8 64 (2 07) 0 12 
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5.1.2 Demographics (see tables 7 and 8) 
5.1.2.1 Whole Group 
Partrcrpants m the study were from vanous areas comprismg of one urban settmg 
(Jakarta) and two rural settmgs (Sumedang and Borobudur) The maJority of 
partrcrpants had both a mother and a father who were Javanese or Sundanese, 
although rural areas drffered wrth 100% of those m Borobudur bemg Javanese and 
I 00% of those m Sumedang, Sundanese The average age of the whole sample was 
69 4 ± 7 9 years (age range 52- 98 years) and 65% were women The maJOrity of 
partrcrpants were hvmg m the commumty as opposed to an mstrtutron The largest 
proportron ofpartrcrpants (39%) strll hved wrth a spouse and at least one chrld, 21% 
were hvmg wrth a chrld only, 18% wrth a spouse only, and I 0% hvmg alone The 
maJOrity ofpartrcrpants were Mushm and owned therr own home If the partrcrpants 
had chrldren, the average number of chrldren per household was 5 2 ± 2 6, wrth an 
average of 4 3 ± I 9 chrldren strll ahve and 2 3 ± 1.5 chrldren hvmg close by and able 
to vrsrt A carer was present for 47% of the whole sample. 
A greater proportron of partrcrpants had recerved primary school or elementary 
(fimshed or unfimshed) level education or no formal education, followed by a hrgh 
school level educatron, wrth only a small number of the sample obtammg umversrty 
level educatron Of the whole cohort, 31% drd not have a professron before retrrmg, 
and of those who drd the most common professrons were that of a fanner or labourer 
(43%) whrch would be consrdered blue collar professrons, whrlst 23% of the cohort 
worked m whrte collar professrons ( e g c!Vll servant/entrepreneur etc) before they 
retrred 
Interestmgly, and a srmrlartrend to prevrous findmgs (Adlakha & Rudolph, 1994), a 
srgmficant drfference was found between males and females m lrvmg arrangement, 
wrth a greater proportron of women than men hvmg alone, or wrth a chrld and no 
spouse On the other hand, more men than women hved wrth therr spouse and a chrld 
or a spouse alone Thrs rs also reflective of other data m Central Java (Chen & Jones, 
1988) Furthermore, a srgmficant drfference was found between genders Irvmg m an 
mstrtutron or wrthm the commumty, wrth more women than men lrvmg m an 
mstrtutron. 
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5.1.2.2 Cognitive Groups 
A s1gmficant difference was seen between groups m the age of part1c1pants With 
part1c1pants m the Cl group more hkely to be older There was a s1gmficant d1fference 
m the number of men and women m each group, w1th the CI group havmg 67% 
women, the poss1ble CI group 58% and the control group 75% of women 
A s1gmficant d1fference was found between groups for ob tamed level of educatwn. 
The h1ghest percentage of part1c1pants w1th no formal educal!on was observed m the 
CI group Furthermore, the poss1ble CI group had the lughest proportwn of 
part1c1pants w1th elementary level educatiOn and the control group w1th h1gh school 
and umvers1ty level educatwn 
Although a h1gher percentage of part1c1pants m the control group were not workmg 
before retJrement age, there was a s1gmficant d1fference between the groups m 
professiOn before rel!rement Th1s can be attnbuted to the frequencies ofpart1c1pants 
domg 'wh1te collar' ( c1v!l servant, entrepreneur, army/pohce, employee m a pnvate 
company, doctor, or lawyer) JObs as opposed to 'blue collar' JObs (farmer, fisherman 
or labourer) Of part1c1pants m the dcmenl!a group, only I 0% were employed m wh1te 
collar JObs and a vastly h1gher percentage (68%) m blue collar JObs In the poss1ble Cl 
group, proportiOns were more evenly spread but there was a s1gmficantly h1gher 
proportwn of part1c1pants w1th blue collar professiOn before rel!rement On the other 
hand, m the control group, 40% of part1c1pants were 'wh1te-collar' employees, wh1lst 
only 15% were in 'blue-collar' employment 
A s1gmficant difference m s1te tested was observed between groups, With those m the 
control group and poss1ble CI group bemg more hkely to hve m Jakarta, wh1lst the Cl 
cases were more populous m Sumedang and Yogyakarta A s1gmficant difference was 
also Seen m urban/rural residence With partiCipants m the CJ and pOSSible CJ groups 
bemg more hkely to hve m a rural (Sumedang and Borobudur) area than an urban 
(Jakarta) area 
A s1gmficant d1fference was observed between groups m father's and mother's 
ethmc1ty, w1th Cl cases havmg a greater proportiOn of Sundanese part1c1pants wh!lst 
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the poss1ble er cases and controls cons1sted mamly of Javanese ethmc1ty (both 
mother's and father's ethmc1ty). 
S1m1lar proportwns of part1c1pants m all groups were st!ll hvmg m the commumty 
(approx1mately 91 - 95%) and there was no s1gmficant d1fference between the groups 
There was also no S1gn1ficant d1fference between groups when assessmg whom the 
part1c1pant hves w1th However, reflectmg the findmgs of Adlakha & Rudolph (1994), 
a h1gher proportwn of women than men hved alone Furthermore, a h1gh proportwn of 
all three groups owned the1r own home , A small but s1gmficant d1fference was 
observed m house ownersh1p/hvmg status, poss1bly due to the a h1gher percentage of 
those m the er group than the poss!ble er or control groups hvmg m someone else's 
home 
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Table 7 - Descriptives of Demographic Vanables (Part 1) 
Table 7 reports demographic vanables for the whole sample as well as stratified by cogmttve group To 
assess the differences between groups, the cnt1cal values and s1gmficance level (p Value) IS shown 
Ch1-square (x2) analyses were used for categoncal van abies and ANOV A (F) for contmuous data NB 
+Urban~ Jakarta, Rural ~ Sumedang & Borobudur, 0 Blue CollaP (fisherman or labourer, White 
Collar= ctvll servant, army/pollce, entrepreneur, employee m a pnvate company, doctor, or lawyer, ¥ 
percentage reported IS vahd percentages, N (%)~frequency and percentage 
Dcmograpluc Vanablu Whole Cl Cases Poso;1blc (I (.ontrol Cr1t1cal p Value Group Cases Cases Value 
N 719 215 335 169 
Age, mean ± ~D 69 38 72 15 (8 33) 69 24 (7 75) 66 14 (5 95) 30 02 <0001 (7 85) 
Age Groupl>, 1"1 (%) 
< 65 \ears 285 (39 6) 60 (27 9) 131 (39 1) 94 (55 6) 
65-70 vcars 169 (23 5) 43 (20 0) 85 (25 7) 40 (23 7) 50 35 <0 001 
71 -80 \Cars 196 (27 3) 77 (35 8) 88(263) 31 (18 3) 
>80 \ears 69 (9 6) 35(163) 30 (9 0) 4 (2 4) 
Living Area, N ("loo)+ 
Urban 246 (38 4) 28 (13) 130 (38 8) 118{698) 129 17 <0001 
Rural 443 (61 6) 187(870) 205 (61 2) 51 (30 2) 
LIVIng D1stnct, N (%) 
Jakarla 298 (41) 34 (15 8) 140 (4l 8) 124 (734) 
129 38 <0001 
Sumedang 207 (29) 88 (40 9) 98 (29' 3) 21 (12 4) 
Borobudur 214 (30) 93 (43 3) 97 (29- 0) 24(142) 
Women, N (%) 464 (64 5) 143 (66 5) 194 (57 9) 127 (75 I) 15 11 0 001 
Educatwn, N (%) 
J'l.o Formal 175 (24 6) 98 (46 0) 69 (20 8) 8 (4 8) 
E1ementar) 396 (55 6) I 11 (52 I) 219 (66 0) 66 (39 5) 
236 68 <0001 
High School 93 (13 I) 4 (I 9) 32 (9 6) 57 (34 I) 
Academy/ 48 (6 7) 0 (0 0) 12 (3 6) 36 (21 6) 
lJmverSit) or higher 
Professwn, N (%) 0 
None 226 (32 I) 47 (22 4) !04 (31 5) 75 (45 7) 
11077 <0001 
Blue Collar 312 (44 3) 143 (68 I) 145 (43 9) 24 (14 6) 
While Collar 139(197) 20 (9 5) 81 (24 5) 65 (39 6) 
ProfessiOn, N (%) • 
I'. one 226 (32 I) 47 (22 4) 104 (31 5) 75 (45 7) 
Ch 11 Ser\ ant 49 (7 0) 2 (I 0) 20 (6 I) 27 (16 5) 
Entrepreneur 62 (8 8) 13 (6 2) 35(106) 14 (8 5) 
149 18 <0001 
Emplo\ ee m a private 28 (4 0) I (0 5) 9(2 7) 18 (11 0) 
eompaO\ 
Arm,/Pohce 27 (3 8) 4 (I 9) 17 (5 2) 6 (3 7) 
Farmer 258 (36 6) 111 (529) 128 (38 8) 19 (11 6) 
Labour/no P£'rmanent job 54 (7 7) 32 (15 2) 17 (5 2) 5 (3 0) 
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Table 8 Descriptives of Demographic Variables (Part 2) 
Table 8 reports demographtc vanables for the whole sample as well as strattfied by cogmttve group 
To assess the dtfferences between groups, the critical values and stgmficance level (p Value) ts shown 
Cht-square (X2) analyses were used for categoncal vanables NB ns =not s1gmficant, 'I percentage 
reported ts vahd percentages, N (%)~frequency and percentage 
Whole Possible Control Cnt1cal Demographic Vanables Group Cl Ca!.e~ Cl Cases Valut p Value Cases 
L•vmg Place, N (0/co) • 
lnshtuhon 49 (6 8) 11 (5 I) 30 (9 0) 8 (4 7) 4 69 
"' 
Commumn 667(932) 204 (94 9) 302 (91 0) 161 (95 3) 
WJth whom tlo vou hve? N ("/o) 
Alone 74(103) 25(116) 34 ( 10 1) IS (8 9) 
Spouse 128 (17 8) 34 (15 8) 67 (17 0) 37 (21 9) 
Spouse & Ch•ld 279 (38 8) 73 (34 0) 135 (40 3) 71 (42 0) 
16 63 
'" Child (no spouse) 1 so (20 9) 60 (27 9) 60 ( 17 9) 30 (17 8) 
Relahve 29 (4 0) 8 (3 7) 14 C4 2) 7 (4 I) 
lnstltuhon 46 (6 4) 11 (5 1) 28 cs 4) 7 (4 I) 
Others 13 (I 8) 4 (I 9) 7(2 1) 2 (1 2) 
Mother's Ethmclty, N (%) 
Ja, anese 356 (49 5) 99 (46) 162,48 4) 95 (56 2) 
Sundanese 258 (35 9) 95 (44 2) 121{36 1) 42 (24 9) 
Mala) an 7 (I 0) 2 (0 9) 3 (() 9) 2 (I 2) 39 92 <0001 
Batak 3 (04) I (0 5) 2 (() 6) 0 (0) 
Mmang 16 (2 2) 0(0) 4 9 (I 2) 12 (7 I) 
Other 79 (I I 0} 18 (8 4) 43 (12 8) 18(107) 
Father's Ethmcll), N (%) 
Javanese 355 (49 4) 99 (46 0) 161 (48 I) 95 (56 2) 
Sumlanese 258 (35 9) 93 (43 3) 123 (36 7) 42 (24 9) 
Malaun 6 (0 8) 2 (0 9) 3 (() 9) I (0 6) 41 92 <0001 
Balak 2 (0 3) 0 (0) 2 (06) 0(0) 
Mmang 1 ~ (2 I) 0 (0 0) 3 (0 9) 12 (7 I) 
Other 83(115) 21 (9 8) 43 ( 12 8) 19 (I I 2) 
House 01merslup, N (%) 
Ov.n Housr 596 (82 9) 182 (84 7) 274 (81 8) 140 (82 8) 
Rentmg 27 (3 8) 6(28) 14 (4 2) 7 (4 I) 
34 19 <0001 
Ll\e In other's house 25 (3 5) 14 (6 5) 9 (2 7) 2 (I 2) 
Soc1al lnslitui!On 29 (4 0) 6 (2 8) 21 (6 3) 2 (1 2) 
Other 42 (58) 7 (3 3) 8(24) 18 (10 5) 
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5.1.3 Functional Ability and Health (Table 9) 
For self-reported functiOnal measures (ADL and lADL) and SF-36 means for the 
whole sample, see table 9 Nearly half of the cohort self reported currently usmg 
medicatiOn and/or currently seemg a doctor Approximately half of the sample had 
seen a health provider or traditional healer m the last two years and had been to the 
hospital as an outpatient Only 13% of the sample self-reported bemg admitted to 
hospital m the last two years However, of those who had a caregiver present, much 
lower frequencies of use of medication, seemg the doctor and hospital 
attendance/admittance were reported by the carer (tables I 0) 
A significant difference m functional ability was observed between cognitive groups 
m both the ADL and the lADL measures of functiOnal status, with the Cl cases havmg 
the lowest scores and the control cases the highest on both functiOnal measures (see 
table 9 for means, SDs, cntical values and significance levels) Furthermore, health as 
measured by the SF-36 was also significantly dtfferent between groups, agam wtth the 
control cases sconng the htghest and Cl cases the lowest A stgntficant difference 
between groups was also observed m the self-reported proxy measures of health, 
specifically for consultmg a doctor at present and admittance to hospital m the last 
two years Cl cases had stgntficantly worse health as measured by the SF-36, were 
sigmficantly less hkely to have recently consulted a doctor or to have been admitted 
to hospital m the last two years accordmg to self-report However, this group 
difference m proxy health measures were not reflected accordmg to the caregiver 
report (table I 0), with a significant difference between cognitive groups found only 
for medicatiOn use (more Cl cases reported use of mediCatiOn) Agam, as seen for the 
whole sample, caregtvers reported lower mcidence of these proxy measures than 
partiCipant self-report 
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Table 9 -Differences between Cognitive Groups in Self Reported Functional 
Ability and Health 
Table 9 and I 0 show the vanables that assessed funelle>nal ability and health as reported by the 
partiCipant self-report (table 9) and caregiver report (table 10) for the whole sample as well as the 
cogmtive groups The table shows the mean score and standard deviatiOn (SD) on the ADL, IADL and 
SF-36 A low score on the ADL, IADL and SF-36 mdicates Imparrment ANOVA (F Value) analyses 
were used to assess the difference between cogmt1ve groups for these thiee measures Frequencies and 
percentages (N(%] are shown f01 the 'yes' or 'no' r~sponses to other proxy measures Percentages 
reported are vahd percentages and dtfferences between cogmtlve groups for these questions were 
assessed usmg chi-square analyses (x2 value) 
FunctiOnal Ab1hty & Health Whole Cl Caw~ Pos'ilble Cl Control Cnt1cal p Value Measurements Group Ca'ics Casu Value 
ADL, mean± SD 19 63 (I 22) 1941 (I 63) 19 63 (I 14) 19 90 (0 52) 753 0001* 
IADL, mean ± SO 13 31 (3 86) 1139(483) 1367(343) 15 04 (I 62) so 62 <0001* 
SF36 Score, mean± SO 67 86 (15 62) 64 32 (16 91) 67 03 (16 10) 73 88(1055) 18 87 <0 001•• 
On medtcahon (at present), N(%} 
Yos 328 (45 9) 89 (42 0) !50 (45 0) 89 (52 7) 
'" "' 
No 386(541) 123 (58 0) 183 (55 0) 80 (473) 
Consultmg a doctor (at present), 
N(%) 
Yos 277 (38 7) 96 (45 3) 198(595) 88 (52 I) 10 65 o oo5• 
No 438 (61 3) 116(547) 135 (40 5) 81 (47 9) 
Altemlmg an outpalients 
department or health lClltre (m the 
last two vears), N(%) 
361 ns 
Yos 345 (48 3) 105(495) 169(508) 71 (42 O) 
No 369(517) 107 (50 5) 164 (49 2) 98 (58 0) 
Been admtlted to hospttal (In the last 
two vears), N(%) 
Yos 92 (12 8) 20 (9 3) 55(165) 17 9 (10 I) 7 52 0 023• 
No 624 (87 2) 194 (90 7) 278 (83 5) 152 (89 9) 
• S1gmficam at the 0 05 level (2-taded) •• Stgmficant at the 0 01 b·cl (2 tailed), ns =Not stgmficant 
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Table 10 -Differences between Cognitive Groups in Caregiver Reported Health 
Health Measurements Whole Cl Cases l'osstble CJ Control Cnhcal p Value Group Cases Ca'ies Value 
On medicatiOn (at present) N(%) 
Y« 24 (4 9) 13 (8 2) 9 (4 0) 2 (I 8) 651 0 039• 
No 470(951) 145 (91 8) 215(960) 110 (98 2) 
Consulting a doctor (at pre§ent) N(%) 
Ye> 26 (53) 11 (6 9) 11 (4 9) 4 (3 6) !57 
'" 
No 468 (94 7) 148 (93 I) 212 (95 I) 108 (964) 
Atlendmg an oulpahents dep.artment or 
health centre (10 the last two vears) N(%) 
Ye> 21 (4 3) 11 (7 0) 8 (3 6) 2 (I 8) 4 8 0 091 
No 470 (95 7) 146 (93 0) 214(964) 110 (98 2) 
Betn admitted to hosp1fal (m the l.t\1 two 
'ears) N(%) 
y" 9 {I 8) 4 (2 5) 5 (2 3) 0 9 {0) 2 75 '" 
No 482 (98 2) 154 (97 5) 216 (977) 112(1000) 
5.1.4 Self and Caregiver Reported Cognitive Complaints 
A significant difference was observed between the cognitive groups on some 
cognitive complamts (table 11 & 12) Fmtly, a difference between cognitive groups 
was observed for composite scores assessmg DSM-lV based cognitive problems, 1 e 
agnosia, aphasia, apraxia, executive functwn, and problems With long/short term 
memory (table 11 & 12) Accordmg to the participant report, controls had greater 
1mpmrment m these functions than Cl cases who also had better self-reported 
cognitive functiOn than the possible Cl cases However, based on the careg1ver report, 
the control cases had the highest scores, and hence had less 1mpmrment than the Cl 
and possible Cl cases The possible Cl cases were reported as havmg greater 
1mpa1rment m these functiOns than the Cl cases Possible Cl cases also self-reported 
s1gmficantly more problems With aggressiOn than the other two groups, although tins 
was not significant accordmg to the careg1ver report The careg1vers also reported 
s1gmficantly more paranma among the possible Cl cases which was not s1gmficant 
accordmg to the participant report. Significantly more Cl cases reported that their 
cognitive problems have been gettmg worse and these problems affected 
social/occupatwnal/spmtual/mental activity which was corroborated by the careg1ver 
report AdditiOnal careg1ver questiOns concemmg cognitive problems revealed that 
significant more Cl cases than possible Cl or control cases seldom remembered some 
events, and had significantly more problems bemg able to name thmgs From these 
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compansons, 1t IS ev1dent that the careg1ver and partiCipant reported cogmtlve 
complamts vary, w1th careg1ver reports appeanng to concur more With cogmtlve 
objectively measured functiOn (groups based on the cogmtlve algonthrn) than 
partiCipant self-reports 
Table 11 -Differences between Cognitive Groups in Self Reported Cognitive 
Complaints 
Tables 11 and 12 dtsplay the whole sample and cogmttve groups self reported (table 11) and caregtver 
reported (table 12) responses that mdtcate cogmttve complamts lt shows the mean and SD for the 
composite scores whtch mdtcate agnosia, aphasta, executive functiOn and problems wtth long/short 
term memory A low score mdtcated tmpmrment and dtfferences between cogmttve groups m these 
compostte scores were assessed usmg ANOVA (F value) analyses Frequenctes and percentages [N(%] 
are shown for responses to other proxy measures Percentages reported are vahd percentages and 
dtfferences between cogmtlve groups for these questwns were assessed usmg cht-square analyses (X2 
value) 
Cogmt1ve Compla1nts Whole Cl Cases Possible Cl Control Cnhcal p Value Group Cases Cases Value 
Agnosia, mean± SD 3 28 (2 50) 360(202) 331(206) 278 (441) 673 0 001* 
Aprax1a, mean± SD 2 65 (0 83) 2 76 (0 66) 2 56 (0 91) 268(082) 384 0 02• 
Aphasia Score, mean± SO 4 39 (I 05) 450(082) 4 29 (1 17) 443(107) 2 67 0 07 
Executive Functwn, mean± SO 5 10 (I 41) 538(117) 484(155) 527(131) 11 25 <0 001•• 
Problems w1th long/short term 10 71 (276) 1090(2 76) 1047(293) 1094(233) 2 23 
'" memon, mean :i: SD 
Aggression Problems, N (0/o,) A 98(137) 20 (9 3) 63 (18 9) 15 (9 0) 13 99 0 001• 
ParanOJa Problems~(%) A 96(134) 22(102) 52 (15 6) 22(133) 3 26 n< 
Problems started, N (%) 
Suddenly 30 (7 2) 10 (6 3) 17 (9 2) 3 (3 9) 26 n< 
Slowly 389 (92 8) 148 (93 7) 167(908) 74(961) 
Ha\e the) been gettmg worse" N 
(%) 
Ye< 317(724) 101 (46 9) 147 (43 8) 69 (40 8) 14 81 0001• 
NO 121 (27 6) 60 (27 9) 49 (14 6) 12 (7 I) 
Do these problems make it difficult 
for \Ou to function SOCJall), at l\ork 370 (84 9) 128(595) 166 (49 5) 76 (41 9) 10 54 ooo5• 
or 1n spLntuallmental!soclal actL\lh? 
N(%•)A 
• S1gmficant at the 0 05 level (2-tat!ed), •• S1gmficant at the 0 01 le\ e) (2-tailed) n<;"' not SJgmficant .A."' ansv.er denotes a )CS 
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Table 12 -Differences between Cognitive Groups in Caregiver Cognitive 
Complaints 
Cogmtlve Complamts Whole Cl C.ases Po~~1ble Control C.ntlcal Group Cl Cases Cases Value 
A~!nos1a mean± ~D 481(077) 485(068) 4 69 (0 97) 4 96 (0 33) 
'" Apra:oa, mean± SD 288(053) 2 92 (0 42) 2 81 (0 (•7) 297(028) 55 
A ha\la &core, mean± ~U 484(062) 484(058) 479(074) 494(035) 297 
Executive Funchon, mean± &D 5809083) 5 83 (0 77) 568(104) 597(026) 648 
Problems With long/short term memor}, 13 08 (2 84) 1325(247) 12 68 (3 39) 1362(191) 6 42 
mean±SD 
InformatiOn from the C.aregner (memory 6 63 (I 87) 596(177) 7 (I 88) 735(145) 574 problems) mean± SD ( 
A~grcss10n Problems, N ('Y,,) 6 29 (4 3) 10 (5 8) J7 (56) 2 (I 2) 5 04 
Pdranma l'rohlems N (% • 18 (2 7) 6 (2 9) 12 (4 0) 0 (0) 64 
Does the elderly ,ou care for have memory 40 (30 I) 24(453) 16 (25 4) 0 (0) 138 problems" N (%)" 
H yes, does 11 happen conSI~tentlv" N (%) 
Ye> 19 (21 8) 12 (32 4) 6 (15 0) I (10 0) 435 
No 68 (78 2) 25 (67 6) 34 (85 0) 9 (900) 
Does the concerned remember and 
mentum some events, N en;.,) 
Always 41 (31 8) 8(154) 24 (39 3) 9 (56 2) 1437 
Somet1mes 76 (58 9) 36 (69 2) 33 {54 I) 7 (43 8) 
~eldom 12 (9 3) 8(154) 4 (6 6) 0(0) 
Is the concerned able to name some thmgs 
(e g shoppmg hst), N {%) 
Always 81 (58 3) 23 (41 8) 45 (68 2) 13 (72 2) 103 
Sometimes 49 (35 3) 27 (49 I) 18 (27 3) 4 (22 2) 
Seldom 9 (6 5) 5 (9 1) 3 (4 5) I (56) 
In the last vear, has h1s/her mcmor) gotten 
worse" N (%) 217 
Ye> 22 (16 2) 12 (21 8) 8(125) 2 (I 18) 
No 114(83 8) 43 (78 2) 56 (87 5) 15 (88 2) 
Does the concerned forget b1g or 
Important events m a fev. v.eeks smce they 
took place (e g a wedthng)" N (%) 
739 
Always 24 (17 6) 8(148} 15 (22 7) I (6 3) 
<;omellmes 62 (45 6) 29 (53 7) 28 (42 4) 5 (31 3) 
Seldom 50 (16 8) 17 (31 5-) 23 (34 8) 10 (62 5) 
Does the concerned forget details of 
important events" N en;,,) 
Always 19(142) 6(113) 10(15 6) 3 (17 6) 451 
SometmlCS 70 (52 2) 33(623) 31 (48 4) 6 (35 3) 
Seldom 45 (33 6) 14 (264) 23 (35 9) 8 (47 I) 
Does the concerned fulh forget ALL 
lm]lortant e\enh m the past" 1'1 (%) 
Always 80 (58 8) 32 (60 4) 40 (60 6) 8 (47 I) 1111 
<;eldom 5-6(412) 21 (39 6) 26 (39 4) 9 (52 9) 
Do h1s/her memory problems affect d,uly 22 (16 7) 16 (30 8) 5 (7 8) I (6 2) 12 31 
actl\illes" 1\ (%)" 
• <;•rn1ficant at the 0 05 le\ cl (2-l.Hkd), •• S1gmficant at the 0 01 lt:\cl (2-t.u!cd) ns =not s1gmficant, "=answer denott.s a 'yes' 
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p Value 
0 001" 
0004• 
0 052" 
0002" 
0 002" 
0 004" 
0 08 
004" 
0001• 
"' 
o oou• 
0036• 
0 337 
'" 
"' 
'" 
0 002• 
5.2 Assessment of the Usefulness of the Caregiver and Participant 
Report 
5.2.1 Inter-Rater reliability between participant and caregiver reported cognitive 
complaints 
Participant's and carer's responses were sigmficantly positlvely correlated with each 
other for composite scores from mdlVldual questlons assessmg agnosia problems, 
aphasw problems, apraxw problems, problems with cxccutlve functlon, and problems 
with long/short term memory. As can be seen m table 13, the strongest agreement 
between the participants and caregiver report was for apraxia problems, closely 
followed by aphasw, then executlve functlon and lastly problems with long/short term 
memory The least degree of agreement was for agnosw problems, although this was 
stlll statlstlcally significant However, although correlahons are significant, cntlcal 
values for agnosia and problems with long/short term memory m particular were low 
mdicatmg a weak correlat10n. Therefore, It was Important to delve deeper by 
assessmg the agreement between the participant and caregiver report for the 
mdlVldual components which made up the composite score 
Table 13 - Correlation between participant self-report and carer report on the 
same DSM-based memory composite scores 
Spcarman's rho 
DSM-baud Memory Que.,hon Correlation p value 
Coeffic1cnt 
2I <OOOI 
11 0 OI 
40 <0 001 
49 <0 001 
36 <0 OOI 
Kappa analyses were used to assess the level of agreement between the participant 
and careg1ver reports for the mdivJdual vanables used to compute the composite 
scores (agnosia, aphasia, apraxia, executlve problems, and problems with short/long 
term memory) Table 14 shows the results of these analyses. There was significant 
agreement between the participant and caregiver report for 30 out of 33 quest10ns that 
were used to make up the composite scores (see table 5 for queshons used) Table 14 
shows the full hst ofKappa values, and significance levels However, p-values (tests 
whether the estlmated Kappa IS not due to chance, but not the strength of the 
agreement) are sensitive to sample size, and hence any Kappa above zero may be 
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significant With a sample size of over 700 this may have been an Issue Therefore, It 
was Important to consider the Kappa value Itself and not JUSt the significance level 
For mterpretatwn ofKappa values, groupmgs were used for guidance as determmed 
by (Landis & Koch, 1977) (see appendix 5 for Land1s Kappa groupmgs) 
For almost all assessed questiOns, there was significant agreement between participant 
and caregiver reports on the mdividual questiOns that were used to calculate the 
composite scores However, usmg Landis Kappa agreement groupmg the strength of 
th1s relatiOnship was further evaluated and revealed that the questions assessmg 
'problems with long and short term memory' and 'agnosia' had only "httle" 
agreement between the partiCipant and carer There was "moderate" agreement for 
'aphasia' and 'apraxia' questions and 'executive functiOn' questiOns had "moderate" 
to "fair" agreement There was moderate agreement for problems associated with 
aggressiOn, which could thus be useful m later analysis to differentiate between 
different categones of possible dementia This explams the low correlatiOn coefficient 
found for the composite scores m Spearman's analyses above 
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Table 14- Kappa Agreement Analysis between self-reported and caregiver 
reported cognitive complaints 
Cogmhve Compla1nt Kappa SJgmticance Agreement • 
Problems with Ion~ & short term memon 
Forget names of people you have Just met -06 <0 001 "'* Lit! le 
Forget names of people you know a httle (acquamtances) - 12 <0 001 "'* Little 
Forget names of people vou know well (cousms/nephews) -09 0 024"' Little 
Forget names of people very_ close to you (Child~rtner) -07 0 06 Llttle 
Forget names ofthmos (ammals/grocery Item) - 08 0 04* Little 
Forget the way home/way to shops/way to fnends -09 0 02"' Little 
Forget thmgs you bought from the last tnp to the grocery -09 0 01** Ltttle 
Remember where you put thmgs - 10 <0001** L1ttle 
Remember what you had for breakfast -08 0 03"' Llttle 
Remember what you did last week - I 3 <0001""" LJttle 
Remember what you d1d last vear - 12 <0 001** Little 
Remember what you d1d 10 years ago - 14 <0 001** Little 
Remember your ch1ldhood - 11 0 01** Little 
Other -01 <0 001 "'* Little 
Agnosia (Failure to recogmse or 1dent1fy objects and people desp1te L1ttle 
mtact ~en~;orv function) 
Problems m rec~gmzmg face~ o~op1e you know a ll!tle 13 <0 001 *"' LJUle 
Problems m recogmzmg faces of people you know very well 09 <0 001 .... L!Ule 
( ch1ld/spouse) 
Problems m recogmzmg your way home ]] <0001*"' Ltttle 
Problems m recogmzmg thmgs 10 <0 001*"' Lltt1e 
Other 00 07 No 
Aphas1a (1an~uaee disturbance) 
Problems m speakmg 41 <0 001"'"' Moderate 
Word findmg problems 47 <0 001*"' Moderate 
Problems speakmg m understandable <>entences 43 <0 001"'"' Moderate 
Problems readmg 23 <0 001""" Fmr 
Other 42 <0 001 "'* Moderate 
Apraxia (1mpa1red ab1hty to carry out motor achHtJes despite zntact 
motor funct10n 
Problems combmg ha1r, washmg, dressmg, gettmg up 50 <0 001"'"' Moderate 
from a chair, eatmg, usmg the tmlet, mdoor walkmg 
Problems takmg medicme regularly 43 <0 001 .... Modemte 
Problems cookmg, shoppmg and cleanmg 45 <0 001*"' Moderate 
Executive FunctiOn Impaument (p1anmng, organl.llng, ~equencmg, 
abstractmg) 
Problems planmng (e g a tnp, to do somethmg) 36 <0 001 *"' Fall 
Problem~; Countmg (e g bank affa1rs) 27 <0 001"'"' Fatr 
Problems handh!lg money 33 <0 001 .... Fair 
Aggress1on problems 40 <0 001"'* Moderate 
Warned paranOid Of SUSpiCIOUS 26 <0 001"'* Fa1r 
Other 00 0 911 No 
* InterpretatiOn of Kappa for an agreements based on <0 -no agreement, 0 0- 0 19 -little agreement, 0 20- 0 39- fmr 
agreement, 0 40- 0 59= mode1ate agreement, 0 60- 0 79 = substantml agreement, 0 80 - I 00 = almo<>t perfect agreement 
(UmdiS &. Koch, 1977) 
5.2.2 Reliability & Accuracy of the Caregiver Report 
The rehab1hty of the careg1ver report was then assessed by explonng the assocmt10n 
between responses and the objectlvely measured cogmtlve group of 'Cl cases' As can 
be seen m Table 15, less severe cogmtlve complamts reported by the carer were 
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s1gmficantly assocmted w1th Cl usmg the cogmhve algonthm descnbed m sectwn 
4 I 4 2 3 However, more severe problems were less hkely to be corroborated by the 
carer In th1s sample, the most rehable (as compared to the Cl estabhshed algonthm) 
md!v!dual questwns were "does the elderly you care for have memory problems?", 
"does the concerned menhon and remember some events?", and "do h1slher memory 
problems affect dmly act!Vlty" wh1ch may have added value to a screemng 
mstrument 
Table 15 - Association between cognitive impairment (Cl) and caregiver 
responses to memory questions for individual questions and composite scores 
Thts table shows the results of analyses assessmg the assoctahon between caregtver responses to 
mdtvtdual questtons (assessed usmg cht-square analyses) and composite scores (assessed wtth non-
parametric M ann-Whltney U) With the Cl group (as defined by a HL VT score < 14 5 and MMSE score 
< 24 5) A low score on the composite scores of agnosm, aphasta, apraxta, executive functiOn and 
problems with long/short term memory mdicated impairment 
Carcr Question Cntlcal Value p value 
Does the elderly you care for have memory problems'> x2- 11 12 <0 001 ** 
Does the concerned remember and mention some events" x2-1189 0 003** 
Is the concerned able to name some thmgs (e g a shoppmg hst)'l xz- 5 o5 008" 
Do h1~/her mt:mory problem~ o:~.fft .. Lt do:~.ily ac\IVJIH:s'l x2-392 004* 
Does the concerned forget b1g and important events m a week fol\owmg Jt'l x2-506 0 08" 
Does the concerned forget the deta1ls of important events'l x2-J8J ns 
Does the concerned fully forget Important events m the past? x2-093 ns 
DSM-based (Problems With short!lo!!&_ term memory) U=1521150 0 028* 
D~M-based (Agnosia) U= 15763 50 0 026* 
DSM-based (Aphasm) u = 15982 00 ns 
DSM-based (Apraxia) U-16131050 ns 
D~M-based (Executive FunctiOn) u = 15598 50 002* 
lnformat10n from the careg1ver (memory problems) U= 19000 0 01* 
• Si gm ficant at the 0 05 level (2-tailcd), ** Significant at the 0 01 le-vel (2-tmled), "=Not s1gmficant but 
shows a trend, ns = not s1gmficant, 
5.2.3 Receiver Operating Characteristic Curves (ROC) for more severe problems 
In ROC analyses, areas under the curve d1d not exceed 60% for careg1ver composite 
scmes (agnos1a, aphas1a, aprax1a, executlve functwn, mformatwn from the careg1ver), 
and save for 'agnos1a', were all not S1gn1ficant 'Agnos1a' had msuffic1ent 
d1scnmmatory capac1ty w1th a sens1hv1ty of 69% and spec1fic1ty of 53%, usmg a cut-
off score of 2 5 Th1s md1cates that care giver ques!lons may not d1scnmmate 
significantly between those w1th estabhshed Cl and controls 
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5.3 Estimated Dementia Percentage in an Indonesian Sample 
Of the sample (n=719), 39% (n=215) were cogm!lvely Impaired as assessed by the 
cogm!lve algonthm alone (Cl) Takmg the functiOnal measures (Cl+ FI) mto 
considera!lon 8% (n=58) also had Impaired IADL Combmmg IADL to the cogm!lve 
algonthm as well as caregiver or self-reported confirma!lon of cogmtiVe problems, 
7 6% (n=55) partiCipants were considered to have possible dementia However, this 
percentage mcluded those younger than 60 years of age The percentage of people 
with possible dementia m those over 60 years of age (n=634) was 4 1% (n=26) In 
those over 65 years of age (n=434), this was htgher at 5.8% (n=25). 
5.4 Estimated Percentages of Possible Dementia Types 
Table 16 descnbes some of the partiCipant and caregiver responses that may mdicate 
possible dementia/Cl subtypes m this sample 
Table 16- Participant and caregiver cognitive complaints to assess possible 
dementia sub-types participants 60 years or older 
This table focuses on partiCipants over the age of 60 years with either cogml!ve Impairment (Cl) alone, 
based on the cogmtive algonthm (n=213), or cogm!Ive and functwnalimpmrment (Cl & Fl) based on 
the cogm!Ive algonthm cut-offs as well as an IADL score of <9 (n=5l)) Care giver and participant 
responses that may have giVen an mdicatwn of types of cogm!Ive problems are shown The table gives 
the frequency and percentage [n(%)) of partiCipants With both Cl alone and Cl &FI whom report these 
problems Percentages reported refer to the percentage of the whole sample whom are over the age of 
60 years (n=705) and are reportmg these cogmt1ve problems 
CaregtHr &. P'arhc1pant ReJlOnses Cl alone CI+FI 
n(%) n(%) 
Poor health 0 78 (ll I) 36 (5 I) 
Dcclmc from a prcv•ous Jc...,tJ (C) 12 (I 7) 11 (I 6) 
Worse than before (P) 54 (7 7) 54 (7 7) 
Gradual on~et (P) 91 (129) 45 (64) 
Abrupt onset (P) 10 (I 4) 6 (0 9) 
Cogmtl\e problems are fluctuatmg (C) 12 (0 I) 7 (I 0) 
Affects datly life 
parttcJpant response + 116 (16 5) 29 (4 I) 
caregJVcr response • 16 (" 3) 13 (1 8) 
0 Self rtported poor health ba~cd on < mean of 67 86 on SF 36 OR self reported proxy measure of hcal!h (secmg doctor 
at present anendmg an outpatients department and med1catmn use) 
• Do these problems make 11 difficult for you to funcuon socJall}, work or part1c1pate m splntual/mental or soc1al 
3C\JVI!yl 
• Does Ins or her cogmt1ve problems affect h1slher d.u!y actlVllles'' 
(P) = Parttctpant response, (C)"' Caregwer response 
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Usmg the bas1c cntena to detenmne poss1ble dementla/CI as descnbed m the methods 
chapter, percentages of poss1ble dementla/CI sub-types were add!twnally assessed m 
th1s populatwn (usmg avmlable data) 
Poss1ble AD Percentage 
To be d1agnosed w1th poss1ble AD, the bas1c prevalence estnnate cntena used were 
Cl plus FI and confirmatwn by self-report or careg1ver report of cogn1t1ve problems 
In add1hon, cogmt1ve problems should be gettmg worse ( careg1ver or part1c1pant 
reported), show a declme from a prevwus level29 and have started gradually and not 
suddenly (part1c1pant report30) 
Based on the cntena outhned above, for those aged 60 years and over (n=705), the 
percentage ofposs1ble AD was 3 I% (n=22) The percentage ofposs1ble AD for those 
aged 65 years and above (n=482) was 4 4% (n=21) 
Poss1ble V aD or Other Dementias31 
Part1c1pants w1th V aD or other dementms were hkely to have Cl, FI, and at least one 
other careg1ver or part1c1pant reported cogn1t1ve complamt Furthermore, 1f Cl was 
sudden/abrupt (part1c1pant reported) th1s could md1cate V aD (n=6, 0 8%), cogmtlve 
problems wh1ch are fluctuatmghncons1stent (careg1ver reported) could md1cate LBD 
but also perhaps mfechous d1sease (n=ll, I 5%) There were 34 part1c1pants w1th Cl 
and FI and poor health32 wh1ch could also md1cate secondary demenhas (4 7%) and 
th1s was the largest group of those w1th Cl However, as further mformahon was not 
avmlable, 1t would have been d1fficult to d1fferent1ate between V aD and other 
dementlas and hence for the current phase ofth1s study, these were formed mto one 
category separate from AD 
Usmg th1s cntena the percentage ofposs1ble V aD or other dementla cases m th1s 
sample (n=719) was 54% (n=39) The whole age range (52- 98 years) was mcluded 
29 The caregnrer report of 'problems happen conSIStently' was not use(! as 11 would have falsely reduced the frequency of 
partJc!pants Only 9 7% careg1vers answered thts question Tl11S vanable was based on the partJctpant answenng 'yes' to "have 
cogmtJve problems been gettmg w01se'> 
Jo No careg1ver response \\as available for th1s \anable 
31 Percentage reported 1s percentage of the whole sample (n:7J9) 
32 Poor health= score below the means (67 86) for self·reported health as measured b the SF-36 
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for this category as these types of dementlas can occur m early or later hfe (see 
sectwn 2 l 3) 
These analyses suggest that AD 1s less common than V aD or other demenhas 
combmed m Indones1a, w1th the largest group cons1stmg of those w1th possible 
reversible health related cogmtlve 1mpa1rment 
5.5 Factor Analysis to Assess Possible Dementia Types 
5.5.1 Preliminary analysis summary 
5.5.1.1 Suitability of data for FA (Part 1 summary) 
Imlially the factorab1hty of eleven vanables was exammed Vanables were self and 
careg1ver reported (separately) problems w1th long/short term memory, agnos1a, 
aprax1a, apraxm and execulive functwn, as well as an addJtJOnal composite score of 
mformatwn from the careg1ver pertammg to memory problems and the1r effect on the 
partiCipant The analyses showed adequate sample s1ze for ten out of the eleven 
vanables (rangmg from n = 202- 214) However, the composite score of cogmlive 
mformatwn (CSCI) (composite score based on a range of care giVer responses about 
the partiCipants' memory complaints- see general methods sectiOn 4.1 4.5) from the 
careg1ver had a much small sample s1ze of Just n=58, wh1ch accordmg to factor 
analysis rules may have been meffic1ent Histograms showed vanables were 
adequately normally d1stnbuted and scatterplots showed no s1gmficant out hers m the 
correlatiOns between vanables 
The determmant (= 006) md1cated there was no detnmental mullicollmeanty amongst 
vanables InspectiOn of the correlatiOn coefficwnt matnx between vanables showed 
that nearly all vanables were SJgmficantly correlated w1th each other Furthermore, 
there were an adequate number of absolute values above r= 3, and none above r= 9, 
md1catmg good correlatwns w1th little multJCollmeanty. However, two van abies did 
not have correlatwnal absolute values over r= 3 With any other vanables These 
vanables were the previOusly mentwned CSCI, and the partiCipant self-reported 
problems w1th agnosm However, the CSCI was sJgmficantly correlated w1th 
participant self-reported aphasia and execulive problems Furthermore, the other 
potentially problemahc vanable of self-reported agnosia problems was also 
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sigmficantly correlated With self-reported problem with aphasia, apraxia, and 
executive functwn, as well as caregiver reported problem with agnosia and apraxia 
Therefore, the decisJOn to remove these two potentlally problematlc vanables was not 
made at this pomt 
The KMO ( 694) was medwcre but acceptable, and a sigmficant Bartlett's test of 
sphencity (X2 (55)= 180 43, p<O 05) mdicated there was a significant correlatwn 
between the vanables Assessmg the Ant1-1mage matnces, all KM Os for mdlVldual 
vanables were above .5 (although self-report agnosia and CSCI were every close to 
the cut-off at 528 and 553 respectlvely) 
Communahtles before rotatwn were all well above 3 (between 698 and 833 for most 
vanables) which mdJCates that a high proport10n ofvanance m the mdlVldual 
vanables was explamed by the extracted components However, both self-reported 
agnosia and CSCI had much low communahtles ( 407 and 444 respectlvely) 
Three components ( eigenvalues over the value of I) were extracted from the analyses 
and cumulatJvely explamed 63 79% of the vanance m the data Component one 
explamed 37 67% of the total vanance by Itself, makmg It a very strong component 
compared to component two with 13 36% of the total vanance, and component three 
with 12 49% of the variance. Scree plot analysis further suggested retammg three 
vanables 
Based on the checks for smtabihty of the data, self-reported agnosia problems and the 
caregiver CSCI were classified as problematic van abies However, although there 
were some reasons to keep them m the analyses (e g Significant correlallons With 
other vanables), the low correlallon coefficient absolute values and poor 
communahtles meant they may have been havmg an effect on the overallloadmgs of 
the other van able and hence the vanabihty explamed by the extracted components 
Prehmmary analysis was then re-run removmg one then the other of these two 
vanables to assess If their mcluswn affected the cntlcal values and tests assessed The 
removal of CSCI alone resulted m a stronger determmant (= 008) and overall KMO (= 
702) Interestmgly the mdividual KMO of self-reported agnosia was now under the 
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cnt1cal value of 5 (KMO = 476) Most communahlles were shghtly stronger (closer 
to 1 ), but self-reported agnosia was very weak The three extracted components 
explam more of the total vanance (68 15%), with three factors extracted 
The removal of the self-reported agnosia problems van able resulted m shghtly 
stronger determmant (= 007) and KMO (= 699) than the ongmal analyses and most 
communahl!es were shghtly stronger (closer to 1) However, for CSCI the 
communahlles was weak and close to the cut-off(= 386) Similar to above 68 30% of 
the total vanance m the data was explamed by the three extracted components 
5.5.2 Suitability of data for factor analysis (Part 2) 
Based on the poor correlatiOns with other vanables, low KMO values, low 
communaht1es values and stronger model m the absence of the two problematic 
vanables, It was decided that the vanables of self-reported agnosia and composite 
score of carer reported informatiOn about memory problems would be removed and 
the analyses run finally m exclusiOn of them. 
5.5.3 Sample Size & Variables left in the analyses 
The remammg vanables assessed were self-reported problems with short/long term 
memory, aphasia, apraxia and executive functiOn, and careg1ver report of problems 
with long/short term memory, agnosia, aphasta, apraxia and execu!Ive functiOn Usmg 
the pmrw1se deletiOn option, the sample size for all nme vanables assessed were 
between n=202 and n=214 (mean n = 207), prov1dmg a ratio of23 cases per vanable, 
which IS adequate for PCA However, as the mean sample size IS not very large, 
communal! ties before extractiOn were assessed. Field (2005) suggests that for a 
sainple size between 100 and 200 participants, communahties before extractiOn of 
each vanable should be> 5 The communahties before extractiOn for the nme 
vanables were all greater than 5 and therefore the sample size was not considered 
problematic 
5.5.4 Normality of Data 
Distnbution histograms were analysed and demonstrated that the vanables were 
normally d1stnbuted and had no extreme outhers that skewed the d1stnbutwn curve 
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5.5.5 Correlations between variables 
The analyses output was checked for multicollmeanty which was deemed to not be 
problematic (determmant = 009) On mspectwn of the correlatiOn matnx between 
vanables, all vanables were significantly correlated with each other and for most 
vanable correlatiOns, the absolute value was adequate (r > 3) without bemg too high 
(r> 9) hence no smgulanty was observed (see appendix 6 for correlatiOn matnx) 
5.5.6 Factorability of the data 
Bartlett's test of spheric1ty was statistically s1gmficant (X2 (36) = 883 33, p<O 05) and 
the KMO cntical value (KMO = 712) was 'good' (Field, 2005), both md1catmg good 
factorab1hty Assessment of the antHmagmg matnces shows that the KMO for each 
vanable was above the cntical value (> 5) In fact all were very h1gh (> 7) apart from 
both the self-report and care giver report on executive function problems ( 559 and 
691 respectively) although even these two vanables were adequately high The 
negative partial correlatiOns had values close to zero md1catmg the high hkehhood of 
a factor structure underlymg the vanables Communal! ties after extractiOn (and before 
rotation) were all above .3, with most above 7 Fmally, there were 13 (36%) residuals 
with absolute values greater than 0 05 This figure IS less than 50% and mdicated that 
PCA was a good method for this data set and the vanables assessed 
5.5. 7 Factor Extraction 
The Initial e1genvalues showed that the first three components (with e1genvalues 
greater than I) explamed 45%, 15% and 14% of the vanance respectively, with a total 
vanance of74% The fourth to mnth components all had e1genva!ues less than one 
and m total only explamed 26% of the vanance Therefore, only the first three factors 
were considered On further exammation of the scree plot, the extraction of three 
components was supported (figure 5) The component matnx (which was sorted to 
show the loadmg vanables of each factor m order of strength showed that all vanables 
loaded onto the first component Although the van abies that loaded onto the two other 
components also overlapped with the first component, they d1d not overlap with each 
other, 1 e component two and three had different vanables which loaded onto them 
This suggests that there may be some relatiOnship, or correlatiOn, between the 
extracted factors and suggested an oblique rotatiOn for the next stage of analyses 
Parallel analysis usmg Monte Carlo parallel analysis generated random data (see 
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appendtx 7)33 was run to further confirm the number of extracted components The 
analysts confirms the extractiOn of three components 
Figure 5- Scree Plot to determine the number of extracted components 
In the scree plot, the honzontal dotted !me shows the components above and below the cut-off of 
etgenvalue = 1, the component numbers on the x axis refers to the number of extracted components 
which are plotted on the graph agamst the e1genvalue 
Scree Plot 
1 ------------- --------------------- - ------------ --------- ----------------- ---- -- ----------- -----------
5.5.8 Factor Rotation 
' ' Component Number 
Under the assumptiOn that the components extracted may be correlated wtth each 
other, obhque rotation was used ( dtrect obhm method) However, the correlatwns 
between all three components were all below the theoretically based value of .3 (a 
value of 3 or above mdtcates a strong correlatwn) Based on previOus dementia 
theory, some dependence of components on each other would have been expected 
Interestmgly, and suspected from exammat10n of the component matnx m tm!Ial 
component extraction analysts, although the components were not stgmficantly 
correlated to warrant oblique rotatiOn, component I had a stronger relationship to 
components 2 and 3, whtlst the correlatiOn between component 2 and 3 was weaker 
Upon later exammat10n of the component loadmgs, thts relatwnshtp between the 
components could asstst m gtvmg some mdtcatwn of the posstble underlymg 
33 E1genvalues generated from Parallel AnalySIS should be lower than actual generated e1genva\ues from PCA 
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structures that make the components However, m the current sample, the analyses 
were md1catmg that the overlap was not substantlal, and the components were, 
largely, mdependent Theoretlcally, th1s a1ds m d1fferent1atmg between the sub-types 
of dementla m th1s populallon Therefore, 1t was dec1ded that as the correlatwns were 
not strong enough to assume components were s1gmficantly correlated w1th each 
other, orthogonal rotatlon would be used for the final stages of the PCA 
5.5.9 Extracted Components 
Vanmax orthogonal rotahon was conducted on the nme remammg vanables m the 
final stage of analyses34 The three extracted components (see table 17 for e1genvalues 
after rotatwn) explamed a total of74% of the vanance (wh1ch 1s same as before and 
after rotatwn), w1th the first component explammg 34%, and the second and th1rd 
both explammg 20% of the vanatlon each It 1s mterestmg to note that after rotatwn, 
the vanance 1s more evenly shared between the three extracted components All 
vanables m the analys1s had pnmary loadmgs much greater than 5, apart from 
careg1ver reported aprax1a problems wh1ch was h1ghly loaded onto the first 
component, but not as strongly on the second component ( 379). Th1s vanable along 
w1th careg1ver reported aphas1a problems were the only vanables to load onto more 
than one (two) extracted components See table 18 for the factor loadmg matnx after 
th1s final solutwn 
Table 17- Total Variance Explained Before and After Rotation35 
Total Vanance Ex[!lamed Before RotatiOn Total Vananre Ex)11amed After Rotat1on 
Component 
E1genvalue % ofVanance Cumulatn•e% E1genvalue %of Cumulatne Vanance % 
1 4 062 45 128 45 128 3 054 33 936 33 936 
2 1 314 14 600 59 728 I 817 20 193 54128 
3 1 259 13 989 73 717 1 763 19 <88 '3 717 
4 0 701 7 789 81 506 
5 0 621 6 901 88 406 
6 0 422 4 685 93 091 
7 0 288 3 195 96 287 
8 0 206 2 286 98 572 
9 0 128 I 428 100000 
Only cases for wh1ch cogmttve 1mpa1red vs controls based on MMSE (AND) HVLT cut-offs (HVLT < 14 5 & MMSE < 24 5) 
are used m th1s analyses phase 
34 At th1s stage, as suggested by Pall ant (2005b), the number of components to be extracted was defined SPSS was mstructed to 
extract three components 
35 Pnnc1pal Component Analysts, Rotatton Method= Vanmax, Analyses \\as only for cogmttve 1mpaued vs controls cases 
based on the coglllttve algonthm 
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Table 18 - Pattern/Structure Coefficients36 
Thts table shows the vanable whtch load onto the three extracted components The htghest loadmg 
vanables wtth absolute values greater than 3 are htgh!tghted 
Vanable Entered 
( omponent t Communal•t•c~ 
I 2 3 After ExtractiOn 
Agnosia (careg•ver report) 890 195 063 835 
Apraxm (caregJVer report) 823 379 028 821 
Aphas1a (careg1ver report) 622 -045 632 788 
ExecutiVe function (careg1ver report) 771 288 177 708 
Long/short term memory (careg•ver report) 718 -036 148 538 
Apraxta (self-report) 246 873 032 823 
Aphasm {self-report) 085 193 815 708 
Executive Functwn (self-report) 116 861 258 822 
Long/short term memory (self-report) 084 089 758 590 
The strongest loadmg variables (greater than .3) on the components and the poss1ble 
underlymg theoretical structure they measure were as follows -
Table 19- The component found by the principal component analysis and the 
loading variables 
Vanables are hsted m descendmg order based on the strength of the component loadmg 
Component I 
Agnosia (careg1ver report) 
Apraxia (careg1ver report) 
Execut1ve FunctiOn (careg•ver report) 
Long/short term memory (caregJver report) 
Aphasta {caregiver report) 
Component 2 
ApraxJa (caregJVer report) 
Apraxm (self~report) 
ExecullVC runctmn (self~report) 
Component 3 
Aphasta (self~report) 
Long/short tenn memory (self~report) 
Aphasia (careg1ver report) 
Usmg the vanables that load onto each component (table 19) the followmg poss1ble 
categones were suggested Component one could be named moderate/severe 
dementia, component two V aD or stroke and component three some other type of 
early or mild dementia or possible Cl See sec(! on 2.1 3 for a dtscusswn of these 
possible underlymg constructs In a follow-up study, these structures and the1r 
usefulness pertammg to actual d1agnos1s will be further mves!igated 
36 Pnnc1pal Component AnalysiS, Rotat10n Method= Yanmax, Analyses was only for cogmt1ve 1mpa1red vs controls cases 
based on the cogmtl\ e algonthm 
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5.6 Demographic Risk Factors 
5.6.1 Correlations between Demographic Variables 
5.6.1.1 District with Education, Profession, Gender and Age (see table 20) 
Participants of an older age were more likely to live m the rural areas ofSumedang 
and Borobudur than m urban Jakarta A significant associatiOn was also observed 
between districts m levels of educatiOn attamed This IS because very small 
percentages of partiCipants hvmg m the rural areas of Sumedang and Borobudur had 
obtamed a high school level education and none had umversity level educatiOn, whilst 
those m urban Jakarta showed markedly higher frequencies of people With educatiOn 
at these levels The maJority of those m Sumedang and Borobudur had either no 
formal educa!Jon or only elementary level educatiOn 
Similarly, a sigmficant associatiOn was observed between district and professiOn 
before retirement. In Jakarta, the maJOrity of participants were either not workmg 
before retirement or were m white collar professiOns However, m Sumedang and 
Borobudur, the maJOrity of partiCipants were previously employed m blue-collar 
professiOn 
Gender was significantly associated with d1stnct m this sample The proportiOn of 
men was qmte evenly spread across the districts. However, a greater proportiOn of 
women was observed m Jakarta than m Sumedang or Borobudur 
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Table 20- Demographic Risk Factors Stratified by District 
Table 20 shows the frequency and percentage of partiClpants m each cogmtlve group as well as 
potential demographic nsk factors stratified by hvmg district Differences between districts m these 
vanables were assessed usmg chi-square analySis (X2) analyses for categoncal vanables and ANOV A 
(F) for contmuous vanables 
Demographic R1~k Factors Jakarta Sumedang Borobudur Cnt1cal p Value Value 
N •vu of total sample 298 (41) 207 (29) 214 (30) 
- -
C.ogmtlve Group N (%) 
Cl Ca~es 34 (114) 88 (42 5) 93 (43 5) 129 38 <0 001 * 
Pos~1ble Cl Ca\es 140 (47 0) 98 (47 3) 97 (45 3) 
Control Cases 124 (41 6) 21(101) 24(112) 
Age mean± SO 682(77) 691 (77) 713(79) 
10 55 <0001* 
mm - max (range) 52- 90 (38) 46-52 (98) 60- 90 (30) 
Age Groups N (%) 
< 65 years 139 (46 6) 79 (3~ 2) 67 (31 3) 
65-70 \'tars 71 (23 8) 54 (261) 44 (20 6) 24 72 <0 001 * 
71 - 80 years 60 (20 I) 61 (29 5) 75 (35 0) 
>80 years 28 (9 4) 13 (6 3) 28(131) 
Gender N (%) 
Men 85 (28 5) 81 (391) 89 (416) 10 10 0 004** 
Women 213 (71 5) 126 (60 9) 125 (58 4) 
Educatton N (%) 
No Formal 39 (134) 38(1~4) 98 (460) 
Elementary 122(418) 165 (79 7) 109 (51 2) 248 98 <0 001* 
ll•gh School 83 (28 4) 4 (I 9) 6 (2 8) 
A eadem)/ Unrver'ilty or higher 48(164) 0 (0) 0 (0) 
ProfessiOn N (%) + 
No profc!lsmn 181 (62 8) 28 (13 8) 17 (8 0) 
355 91 <0 001 * 
Blue Collar 9 (3 I) 149 (73 4) 154 (72 3) 
Wlute Collar 98 (34 0) 26 (12 8) 42 (197) 
+ Blue Collar= fisherman, labourer), Wh1te Collar= c1v1l servant, anny/pohce, entrepreneur, employee m a 
pnvate company, doctor, lawyer 
"'S1gmficant at the 0 01 level {2-taJled), "'* S1gmficant at the 0 005 level (2-tat\cd) 
5_6,1.2 Age with Education, Gender and Profession 
Age (m years as a contmuous vanable) was associated w1th number of other 
demographic vanables A s1gmficant d1fference was observed between educatton 
groups m mean age (F=l1 50 (3,708), p<O 001) Part1c1pants w1th no formal educat1on 
(mean 71 35 ± 8 01 years) were sigmficantly older than the other educattonal groups, 
whereas part1c1pants w1th at least a h1gh schoo1level educatton had the lowest mean 
age (66 31 ± 6 50 years)37 A s1gmficant age d1fference was observed between men 
and women (F= 3 72 (I, 717), p=O 05), w1th men bemg on average older (70 14 ± 7 68 
years) than women (68 38 ± 7 92 years) Part1c1pants who had blue collar professions 
37 For elementary level educatton, the mean age was 68 96 ± 7 80 anrl for academv/umvers~ty or h1gher level educat1on 11 was 
6919±781 years 
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or no employment before relirement were also s1gmficantly older than those m wh1te 
collar Jobs (F=3 16 (2,701), p=O 04)38 
5.6.1.3 Profession and Education 
A h1ghly s1gmficant assocJatJOn was found between educatwn and professwn before 
retmng (x2 = 138.34 (6, N=698), p<O.OOI) There was a relatively even spread of 
those from all four educatiOn groups who d1d not work before retmng (no formal 
educatiOn= 20 5%, elementary educatiOn= 30 6%; h1gh school= 52 2%) umvers1ty 
or h1gher = 45 7%) However, the maJonty of those w1th no formal educatiOn (67 3%) 
and elementary level education (49 4%) went on to do blue collarprofesswns whJ!st 
only a small proportiOn of those w1th h1gh school level (1 3%) and umvers1ty level 
(2 2%) educalion worked m blue collar professwns The oppos1te was found for wh1te 
collar professwns m wh1ch the greater maJonty havmg obtamed at least a h1gh school 
(43 5%) or umvers1ty (52 2%) level educatJon Similarly, only 12.3% of those w1th no 
formal educatwn and 20 I% of those w1th elementary level educatiOn worked m wh1te 
collar professwns. 
38 Mean age for profess10n categones before rettrement were as follows -'Not WorJ...mg' = 69 65 ± 8 35, 'Blue Collar'= 69 98 ± 
7 66, 'Whtte Collar' = 68 13 ± 7 46 
158 
Figure 6 - Education levels attained stratified by profession before retirement 
This graph shows the frequency participants with either no formal, elementary, high school or 
academy/university level education that had no profession or worked in blue or white collar profession 
before retirement. 
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5.6.1.4 Profession and Gender 
A significant association was observed between gender and profession before retiring 
(x2 = 11 .89 (2, N=704), p=0.003). A much higher proportion of those not working 
were women (73%) as was the case for white collar professions (64.3%). Almost 
double (51 .4%) the number of men were working in a blue collar profession as 
opposed to a white collar (24.3%) or no profession (24.3%) before retiring. 
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Figure 7 - Profession before retirement stratified by gender 
This graph shows the frequency of men and women who had no profession or worked in blue or white 
collar professions before retirement. 
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5.6.1.5 Education and Gender· 
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A significant association was observed between education level and gender (x2 = 
22.67 (3, N=7 12), p<O.OO 1 ). A greater proportion of women than men had either a 
low (no formal education) or a high (high school or university or above) level of 
education. 
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Figure 8 - Education level stratified by gender 
This graph shows the frequency of men and women with no formal, elementary, high school or 
academy/university level education. 
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5.6.2 Logistic Regression 
A logistic regression analysis was performed using the enter method with cognitive 
group (Cl or control) as the dependent variable and demographic factors as predictor 
variables. These included age, gender, education, ethnicity and profession. In the 
second step of the regression analysis, district was added to assess whether district 
mediated the possible effects of demographic variables on CL Finally, functional 
ability (lADL) and heath (SF-36) were added into the regression analyses to assess 
whether health and functional ability explained the variance in Cl by district. 
A total of352 cases were analysed and the fuii model significantly predicted cognitive 
status. See appendix 10 for model summary. 
In step 1 (see Table 21 for values) the variables added were age, gender, education, 
profession and ethnicity. The model significantly predicted cognitive status and 
accounted for between 51% and 68% of the variance in cognitive status, with 86.4% 
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of accurate pred1ct10ns and 91 8% of Cl cases successfully pred1cted In accordance 
w1th th1s 79 5% of the control group were successfully pred1cted An older age, no 
formal educatiOn and blue collar professiOn before retirement were all s1gmficant 
pred1ctors of Cl However, gender and ethmc1t/9 were ms1gmficant nsk factors for 
Cl 
In step 2 (see Table 21 for values), d1stnct was added mto the regressiOn model The 
model s1gmficantly pred1cted Cl and accounted for between 52% and 70% of the 
vanance m cogmtlve status, w1th 85 5% of all cases successfully pred1cted (Cl cases= 
91 3% and control cases =78 2 %) The vanables of age, educatiOn, professiOn and 
d1stnct were s1gmficant and mdependent pred1ctors of Cl Th1s md1cated that 
differences between d1stncts m age, educatiOn and professiOn d1d not explam the 
d1fference m percentage of cases w1th Cl. 
The th1rd and final step of analyses (see Table 21 for values) controlled for functwnal 
ab1hty and health Th1s final model successfully pred1cted cogmtlve status Between 
56% and 75% of the vanance m cogmtlve status was accounted for by the model w1th 
88 6% of cases successfully predicted In add1t10n, 92 9% of Cl cases and 83 3% of 
control cases were successfully pred1cted 
Age, educatiOn, professiOn and d1stnct remamed s1gmficant predictors of Cl m the 
th1rd step Age was a s1gmficant pred1ctor of Cl m th1s sample w1th older age 
mcreasing the odds of Cl by a factor of 7% per year EducatiOn was also a s1gmficant 
pred1ctor of Cl, w1th no formal education showmg an mcreased nsk of Cl (87%) 
compared to elementary level educatiOn, and 95% compared to h1gh school level and 
above ProfessiOn before retirement was also a s1gmficant pred1ctor of Cl m th1s 
populatiOn w1th specifically blue collar professiOn before retirement increasmg the 
odds of Cl by more than a factor 3 LJVmg m the Borobudur d1stnct (when compared 
to Jakarta) s1gmficantly mcreased the odds of Cl by a factor of9 75 Tlus md1cated 
that people who !JVed m rural areas had almost a ten times h1gher nsk of Cl than those 
hvmg m urban areas wh1ch was five times h1gher for rural Sundanese Furthermore, 
these associatiOns were not med1ated by d1fferences health or poor funchonal ab1hty 
39 Ethmctty \\as not a stgmficant predtctor of Cl but was left tn analyses as a cont10l 
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Table 21 -Logistic Regression Analyses to assess possible demographic risk 
factors for cognitive impairment 
Table 21 show the logis!lc regressiOn analyses to mvestigate potential nsk factors for Cl m this 
populatlOn The table shows only stgmficant vanables at each step At Step 1, age, educatton, 
professiOn, gender and ethmcity were mcluded m analyses At the second step, district was added and 
at the final third step, IADL was mcluded The 'Enter' method was used and simple (first) contrasts for 
categoncal vanables 
Vanable [ntcrcd B SE Exp(B) Sog 95"/o C I for Exo(B) 
S1gmficant Vanables 111 Step 1 
Age I 3 03 I 14 <0 001 1083-1195 
Education Group <0 001 
No formal education vs Elementary level educatton -I 94 48 0 14 <0 001 0 056-0 366 
No formal educatiOn vs h1gh school level educatiOn -4 36 75 0 01 <0 001 0 003-0055 
No formal educatton vs umvers1ty and above level education -36 11 7961 42 0 00 ns 0 000-
ProfessiOn <0 001 
No professiOn vs blue collar professiOn I 63 40 5 10 <0 001 2309-11275 
No profession vs whtte collar professwn -34 47 071 ns 0 282 - I 806 
Constant -17 56 2478 68 000 <0 001 
S1~mficant Vanables In Step 2 
Age 12 03 I 13 <0 001 I 069-1183 
Education Group <0 001 
No formal education vs Elementary level education -1 97 50 0 14 <0 001 0 052-0370 
No formal education vs h1gh school level education -3 93 79 0 02 <0 001 0004-0092 
No formal educatiOn vs umvers1ty and above level educatiOn -36 14 7900 78 0 00 ns 0 000-
ProfessiOn 0003 
No professiOn vs blue collar profess1on 87 51 2 38 ns 0 869- 6 523 
No professiOn vs wh1te collar profcssmn -82 53 044 ns 0156-1239 
D1stnct 0 038 
Jakarta vs Sumedang 1 33 77 3 79 0 08* 0 845-16949 
Jakarta vs Borobudur 148 0 685 4 41 0 03 1153-16872 
Constant -16 30 2478 75 0 00 0 995 
S1gmficant Vanablcs m Step 3 
Age 07 03 1 07 0016 1013-1136 
Education Group 0001 
No formal educatiOn vs Elementary level educat1on -1 79 54 0 17 0 001 0058-0474 
No formal education vs h1g.h school level educatiOn 
-2 99 87 005 0 001 0009-0274 
No formal educatmn vs umverstty and above level education 
-31 20 7786 59 0 00 ns 0 000-
ProfessiOn 0 004 
No profess10n vs blue collar professiOn 1 19 58 3 28 0 039 1063-10113 
No professiOn vs wh1te collar professiOn -63 60 0 53 ns 0166-1723 
D1stnct 0 Oil 
Jakarta vs Sumedang I 58 94 4 86 ns 0 778-30 377 
Jakarta vs Borobudur 2 28 83 9 75 0 006 1908-49766 
Constant 
-6 21 2518 09 0 00 0 998 
SE =standard error, S1g = s1gmficance level, Exp(B) =change m predicted odds of Cl for each change m predictor vanable, 
95% CI= 95% confidence mterval for Exp(B), ns =not s•gmficant, • =not s•gmficant but trend observed 
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5.6.3 Logistic Regression Stratified By District 
Log1st1c regress10n analyses were then strallfied by d1stmct (Jakarta, Sumedang, 
Borobudur) The Enter method was used for the analyses, and the categoncal 
vanables were contrasted usmg the s1mple (first) method The same groupmg of the 
dependent vanable as above was used (Cl vs controls on the bas1s of cogmllve test 
scores). In the first step of the analyses, the pred1ctor vanables added mcluded age, 
educatwn, profess10n and ethmc1ty Health (SF-36) and funct10nal ab1hty (IADL) 
were added m the second step to test for medmtmg effects 
In Jakarta 143 cases analysed (see table 22 and append1x 11 for model summary), 
mcreasmg age was a s1gmficant pred1ctor of Cl, mcreasmg the odds of Cl by 19% a 
year (p<O 001) Furthermore, educat10n was a s1gmficant pred1ctor of Cl (p=O 01) 
Spec1fically, no formal educallon was a s1gmficant nsk factor for Cl mcreasmg the 
nsk by 99% (p=O 006) when compared w1th elementary levels educatwn and to h1gh 
school level educahon. The other demograph1c vanables of professwn and ethnlClty 
were not s1gmficant pred1ctors of Cl m Jakarta The second block of analyses m 
Jakarta controlled for health and functwnal status The model successfully pred1cted 
cogmhve status. At the second block the model accounted for between 52% and 782% 
of the vanance m cogmhve status Furthermore, the model correctly pred1cted 93 7% 
cases accurately (82 8% of Cl cases, and 96 5% of control cases) Increasmg age, as 
well as lower educatwn, was sllll s1gmficant prediCtors of Cl when controlhng for 
functwnal ab1hty and health, wh1ch were mdependent and s1gmficant contnbutors to 
the model 
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Table 22 - Logistic regression analyses to predict cognitive impairment from 
demographic risk factors in the Jakarta district 
Vanable Entered B SE Exp(B) Sog 95% ('I for Exp(B) 
S1gmficant Rcmammg Vanables- Mep 1 
Age 017 005 119 0 001 I 068-1317 
EducatiOn Group 0 002 
No formal vs Elementary level educatiOn ·4 46 I 41 0 01 0 002 0001 "1184 
No formal vs h1gh school level education ·6 9 I 8 0001 <0 001 0000-0034 
No formal vs umvers1ty and above level educ:~llon ·39 I 7582 7 0 ns 0000" 
Constant -15 28044 0 0 996 
S1gmficant Rcmammg Vanables- Step 2 
Age 0 15 006 I 12 0058' 0996-1264 
Education Group 002 
No formal vs Elementary level educatiOn -4 91 I 73 0 01 0004 0000-0218 
No formal vs h1gh school level educatwn ·6 29 I 97 0 002 0001 0000-0087 
No formal vs umvers1ty and above level educatJon ·39 3 7449 0 ns 0 000" 
Constant -15 28044 0 0 996 
B- standardised beta, SE -standard error, S1g- sJgmficance level, E"-p(B)- change m pred1cted odds ol Cl for CdCh change m 
predictor vanable, 95% Cl= 95% confidence mterval for Exp{B), ns =not S1gmficant, *=trend level S1gmficance 
In Sumedang40 n= 99 cases were analysed (see Table 23 and appendix 11 for model 
summary) Age, gender, educatiOn and professiOn were added to the model m the first 
step Age and profession were sigmficant predictors of Cl m Sumedang Older age 
mcreased the odds of Cl by 12% (p=0.01) ProfessiOn was a predictor of Cl, however, 
this was only trend level significant (p=O 06) 
In the second step of analyses controlling for health and functiOnal ab1hty the model 
s1gmficantly predicted cogmtive status and accounted for between 27% and 42% of 
the vanance m cogmtive status The model correctly predicted 87 9% of cases 
correctly, with specifically 96 2% ofCI cases and 55% of controls predicted 
Although functional abihty was not a predictor of Cl m Sumedang, health was 
sigmficantly negatively associated With Cl 
40 lt must be noted that m Sumedang, although ethntcJty was entered m to the model, 11 was not m eluded by SPSS as 11 would 
have been a constant, due to the fact that there \\BS no vanatwn m ethmc1ty m the Sumedang sample Furthermore, for the 
number of cases selected, compansons for educat10n could only be made between no fom1al educat1on and elementary level 
educatiOn because m the Cl group there were no cases wtth h1gh school or umverslly level educatton 
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The same two demographic van abies were mdependent s1gmficant predictors of Cl, 
w1th older age mcreasmg the odds of Cl by a factor of I 12 (p=O 01) and professwn 
s1gmficantly pred1ctmg Cl (p=O 04) However, as m the first step of analyses, the 
md1v1dual compansons between no professiOn and blue collar or wh1te collar 
professwns were ms1gmficant pred1ctors of Cl 
Table 23 - Logistic regression analyses to predict cognitive impairment from 
demographic risk factors in the Sumedang district 
Vanable Entered B SE Exp(B) S>g 95% C I for Exp(B) 
S1gmficant Rcmammg Vanables- Stepl 
Age 0 13 0 05 I 13 0 014 I 026- I 253 
ProfessiOn 0059* 
No professiOn vs blue collar professiOn I 07 076 2 91 ns 0652-12996 
No professiOn vs whtte collar profession -1 15 I 19 0 32 ns 0 031-3 223 
-Constant 14 69 1339767 0 0 999 
S1gmficant Rema1mng Vanables- Step 2 
Age 0 11 0 55 I 12 0 04 I 006 - I 249 
Profess10n 0 04 
No professiOn vs blue collar professiOn I 38 0 87 3 96 ns 0721-21766 
No professiOn vs wh1te collar professwn -2 19 I 81 011 ns 0 003-3 886 
Constant -6 19 13397 66 0 002 I 00 
B- standardtsed beta, SE -standard error, ~tg- s1gmficance level, Exp(B)- change m predtcted odds ol Cl for e.1ch change m 
predictor vanable, 95% Cl= 95% confidence mterval for Exp(B), ns =not stgmficant, • =trend level Slgmficance 
In Borobudur4 \ n=ll 0 cases were analysed by the model (see table 24 and append1x 
!I for model summary) Age, educatwn and professiOn were successful predictors of 
Cl Older age mcreased the odds ofCI by a factor of I 13 (p=O 01) Educatwn was 
also a s1gmficant pred1ctor of Cl (p=O 05), and low educatwn (when compared to 
elementary level educatiOn) s1gmficantly (p=O 02) m creased the odds of Cl by a factor 
0 20 ProfessiOn was also a s1gmficant predictor of Cl (p=O 04) 
41 In Borobudur, no cases had umvers1ty or above level education, therefore, compansons for educatwn were only made for no 
formal, elementary and h1gh school level educatwn Furthermore, all partiCipants m Borobudur \\ere Ja\anese and therefore 
ethmc1ty was not assessed by the model as 11 would have been a constant 
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When controlling for functiOnal abihty and health m step 2, the model sigmficantly 
predicted cogmtlve status and accounted for 33% and 52% of the vanance m 
cogm!lve status, successfully predictmg 85 5% of cases (93 2% Cl cases and 54 5% 
control cases) 
Age and professiOn were no longer sigmficant predictors of Cl Educatwn level s!lll 
predicted Cl, but agam was only trend sigmficant (p=O 089), With no formal educatiOn 
(as opposed to elementary level educatiOn) mcreasmg the odds ofCI by a factor of 
0 22 (p=O 02) In Borobudur, health did not explam the vanance but poor functwnal 
abllity did have an mdependent, sigmficant associatiOn With Cl 
Table 24 - Logistic regression analyses to predict cognitive impairment from 
demographic risk factors in the Borobudur district 
Vanablc Entered B SE E>p(B) S•g 95°/o C I for J:>p(B) 
S1gmficant Rcmaamng Vanables ·Step 1 
Age 0 12 004 I 13 0 006 i 036- I 233 
Educat10n Group 0 05 
No formal vs Elementary level education -i 63 0 66 02 0 02 0 053-0 728 
No formal vs h1gh school level educatton -I 58 I 58 0 21 ns 0009-4542 
Profess10n 0 05 
No profcss10n vs blue collar profe~~10n -0 86 I 22 043 ns 0039-4 608 
No professiOn vs whtte collar profess10n -2 23 I 24 0 11 0 07* 0009-1220 
Constant -7 i2 3 07 0 0 02 
S1gmficant Remammg Varmblcs- Step 2 
Education Group 0 089* 
No formal vs Elementary level education -1 54 07 0 22 0 03 0054-0847 
No formal vs h1gh school level education -i 21 I 6i 0 36 ns 00i5-8332 
Constant -2 2 6 0 li 0 71 
B standardised beta, S E standard C!TOr, S•g s1gmficance level, Exp(B) change m pred1cted odds of Cl for each change m 
pred1ctor van able, 95% Cl= 95% confidence mterval for Exp(B), ns =not s1gmficant, * = t1end level s1gmficance 
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5.7 Hormone Therapy Use in an Indonesian Sample 
5.7.1 Descriptives (see Table 25) 
5.7.1.1 Demographics 
In this lndonesmn sample, 54% of the entire sample (n=719) reported usmg HT 
Analyses was stratified by users and non-users of HT as well as by gender 
No significant difference between male HT and non-HT users was observed m age 
(mean age and age group split) or m level of educatiOn Furthermore, no significant 
difference was also observed m house ownership However, a Significant difference 
was observed between groups m professiOn before retirement, as none of the HT users 
was unemployed before retirement age Although no significant difference between 
groups was observed for rural or urban hvmg, a trend significant difference was 
observed m distnct, with a greater percentage of men usmg HT livmg m Sumedang 
than Jakarta or Borobudur. Similarly, significantly more women usmg HT lived m 
Sumedang There were no female HT users livmg m Borobudur m this sample No 
significant difference was observed m age (mean or age group split) between women 
m both groups as well as no significant difference m level of education, home 
ownership and profession before retirement 
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Table 25- Demographic differences between male and female hormone therapy 
users and non-users 
Table 25 shows the demographic differences between hormone therapy users and non-users for both 
men and women (separately) Chi-square analyses were used for categoncal vanables and the 
Independent Sample T test was used for contmuous vanablcs 
Women Men 
liT Users non~ HT p Value HT Users non~HT p Value Users Users 
N (''/o) 21 (4 5) 440 (94 8) - 18 (7 I) 235 (92 2) -
Age, mean± SD 6833(741) 696(796) 68 33 70 22 ns (7 99) (1 65) ns 
Age Groups,!\ (%) 
<65 years 9 (42 9) 197(425) 8 (44 4) 81 (34 5) 
65-70)ears 5 (23 8) 106(241) ns 4 (22 2) 52 (22 I) ns 
71 - 80 years 6 (28 6) 102 (23 2) 5 (25 8) 81 (34 5) 
>80 years I (4 8) 45(102) I (56) 21 (8 9) 
L1vmg Area, N (%) 
Urban 8 (38 I) 187 (42 5) ns 5 (27 8) 74 (31 5) ns 
Rural 13 (61 9) 253 (57 5) 13(722) 161 (68 5) 
LIVIng D1~tnct, N CYo) 
Jakarta 8 (38 I) 203(461) 5 (27 8) 80 (34 0) 
<0 001* 0063 
Sumedang 13(619) 113(257) 10 (55 6) 70 (29 8) 
Borobudur 0 (0) 124 (28 2) 3(167) 85 (362) 
Education, N (%) 
No Formal 5 (23 8) 129 (29 4) 2 (I I I) 37(162) 
Elemental") 15 (71 4) 214(487) ns 14(778) 151 (659) ns 
H•gh Sthool I (4 8) 63 (14 4) 2 (I I I) 26 (I I 4) 
Academy/ Umvers1t) or 0 (0) 33 (7 5) 0 (0) 15(66) hiJ!:her 
Profcsl!JOn, N (%) 
!'one 7 (33 3) 157(336) 0 (0) 61 (263) 
ns 0016 
Blue Collar 10 (47 6) 172(401) 9 (52 9) 118 (50 9) 
Wh1te Collar 4(190) 100(233) 8 (47 I) 53 (22 8) 
House Ownersh1p, N (%) 
Own House 17(810) 343 (78 0) 16 )88 9) 217(923) 
Rcntmg I (4 8) 23 (52) 0 (0) 3 (I 3) 
ns ns 
L1ve m other's house I (4 8) 21 (4 8) 0 (0) 2 (0 9) 
Soc•al Inshtut•on 0 (0) 25 (57) 0 (0) 3 (I 3) 
Other I (4 8) 12 (2 7) 0 (0) 6 (2 6) 
• S1 nlficanl at the <0 01 level (2 1 nled) ns- not SI mfic1n1 
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5.7.1.2 Functional Ability & Health42 
No Sigmficant difference was observed between female HT users and non-users m 
functwnal ability (ADL and IADL) as well as health as measured by the SF-36 
However, a sigmficantly greater proportiOn of women usmg HT were also usmg other 
medicatwn, currently seemg a doctor and had attended an outpatients climc m the last 
two years (see table 26) On the other hand, none of the men usmg HT had been 
admitted to hospital m the last two years which was sigmficantly less than those not 
usmg HT Male HT users also reported s1gmficantly better functwnal abi11ty than non-
HT users In !m ear regresswn analyses, h1gh mstrumental functwnal abiht/3 was 
sigmficantly associated With HT use for men (J3 =- 123, p = 0 052, 95% Cl -3 817-
0 020) However, this associatiOn was medJated by age (p =- 492, p < 0 001,95% Cl 
-0 313 - -0 200) as the assocJatwn between HT and mstrumental functwnal ability was 
no longer s1gmficant when controllmg for age CP = -.092, p = 0 094, 95% Cl -3 103 -
0 245) 
5.7.1.3 Mood 
No sigmficant difference was observed between men usmg HT and non-HT users for 
feelmgs ofhappmess and feehng down (see table 27) However, a larger percentage of 
men usmg HT reported less feelmgs of stress when compared to others then non-HT 
users, although this was only trend Sigmficant 
For women, no s1gmficant difference was observed for feeling down or m self-
reported feelings ofhappmess compared to others. However, a greater percentage of 
women usmg HT, reported sigmficant more feelings of stress compared to others, did 
not feel as full of life, were more nervous than those not usmg HT 
5.7.1.4 Cognitive Function 
For women, scores on the MMSE and HVLT (DR) were not Sigmficantly different 
between HT users and non-users (see table 26) However, a trend Sigmficant 
difference was observed for the HVLT w1th HT users havmg a worse verbal 
4
' The proxy health measures (use of medJcatton, currently seemg a doctor, attendance of an outpat1ents department m the last 
two years, and adm1ttance to hosp1t:J.l m the last two years) were assessed v1a the partJclpant report only The data md1cated that 
usmg careg1ver responses would reduce power even further due to the low number of participants whom had a careg1ver present 
43 As measured by the Instrumental Act!Vlltes of Da1ly LlVlng (IADL) scale only No stgmficant assocJatJOn between HT use and 
bas1c actJvJ!IeS of da1ly hvmg (as measured b) the ADL) were found 
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unmed1ate recall memory score However, s1gmficant d1fference m MMSE and 
HVL T scores was observed for men usmg or not usmg HT 
Table 26 - Cognitive function scores, functilmal ability, and health differences 
between hormone therapy users and non-users 
Table 26 shows the cogm!Jve functiOn scores, functwnal ab1hty scores, and health (SF-36 and proxy 
health measures) vanables for male and female HT users and non-users Cht-square analyses 
(categoncal vanables) and the Independent Samples T test (for contmuous vanables) were used to 
assess dtfferences between HT users and non-users for these vanables However, non-parametriC 
Mann-Wh1tney U was used to assess the differences between HT groups for cogmt1ve scores Vahd 
percentages are reported for categoncal vanables 
Women Men 
HT Users non-HT Users p Value HT tJsers non-HT Users p Value 
"("!..) 21 (4 5) 440 (94 8) - 18 (71) 235 (92 2) -
CogmbH Function 
HVLT (IR) Score, mean± SD 12 14 (7 84) 15 42 (8 20) 0 077 1347(554) 13 82 (6 78) ns 
HVLT (DR) Score, mean± SD 381(258) 511(358) 
"' 
5 35 (3 30) 4 55 (2 92) ns 
MMSE Score, mean± SD 23 50 (5 59) 24 17 (5 71) 
"' 
24 13 (4 94) 24 28 (5 38) ns 
Cl Cases 9 (69 2) 133(520) 
"' 
5 (83 3) 67 (62 0) ns 
funcllonll1 Ab1hty & Health 
ADL, mean ± SD 1938(120) 1965(128) 
'" 
1994(024) 19 58 (1 16) 0014* 
IADL, mean± SD 13 0 (4 0) 13 56(3 75) 
'" 
14 67 (I 19) 12 77 (311) <0 001** 
SF~36, mean± SD 6133(180) 68 42 (15 32) ns 67 83 (12 24) 67 31 (16 16) ns 
Current!) on med1cat1on 
Yu 18 (85 7) 205 (46 8) <0 001** 10 (55 6) 95 (40 4) ns 
No 3(143) 233 (53 2) 8 (44 4) 140 (59 6) 
Con5ultmg a doctor (at present), 
N(%) 
Yos 14(667) 170(38 8) 001 J· 9 (50 0) 83 (35 3) ns 
No 7 (33 3) 268 (61 2) 9 (50 0) 152 (64 7) 
Allendmg an outpalients 
department or health centre (m 
the la~t t"o Hars), N(%) 
002)• ns 
Yes 15 (71 4) 200 (45 8) 10 (55 6) 120 (51 I) 
'o 6 (28 6) 237 (54 2) 8 (44 4) I 15 (48 9) 
Been adm1tted to hosp1tal (10 the 
last I\\O \ears), 1\(%) 
V os 3 (143) 47(107) 
'" 
0 (0) 42 (17 9) 0 05* 
No 18 (85 7) 392 (89 3) 18(1000) 193 (:82 I) 
• S1gmficant at the <0 05 level (2-ta!led), ** S1gmficant at the <0 01 level (2~talled), ns- not s1gmficant 
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Table 27- Differences in mood between hormone therapy users and non-users 
for both men and women 
Table 27 shows the vanables that md1cate mood for the HT users and non-users for both men and 
women Cht-square analyses were used to assess the dtfferences between HT users and non-users m 
these vanables Vahd percentages are reported 
Women Men 
HT Users nun-HT p Value HT Users non-HT p Value Users Users 
N(%) 21 (4 5) 440 (94 8) 
-
18 (7 I) 235 (92 2) 
-
Compared to others do \ ou feel 
happ'" N (%) 
L<" 2 (9 5) 40 (9 1) I (55) 16 (6 8) 
"' "' The same 7 (33 3) 242 (55 0) 9 (500) 139 (59 I) 
More 12 (571) 158(359) 8 (44 4) 80 (34 0) 
Comp.tred to others do you feel 
stressed" N (%) 
More 4 (19 0) 22 (52) I (5 6) 11 (50) 
0 023• 0 078 
The same s (23 8) 158(372) 3 (16 7) 97 (43 7) 
L<" 12 (57 I) 245 (57 6) 14 (77 8) 114 (51 4) 
Have vou felt ~o doVIn noth1ng could 
cheer \DU up" N (%) 
All of the t1me 0 (0) 4 (09) 0(0) 2 (09) 
Most of the tune 0 (O) 4 (0 9) 
A good hit of the time I (48) \I (2 6) 
'" 
0 (0) 4 (I 7) 
'" 
Some of the t1me 3 (14 3) 59 (13 7) 4 (22 2) 25(108) 
A httle of the lime 8 (38 I) 94 (21 8) 5 (27 8) 51(220) 
None of the ttme 9 (42 9) 259(601) 9 (50 0) !50 {64 7) 
Do lOU feel full of hfe N (%) 
All of the tLmc 11 (52 4) 269 (61 7) 13 (72 2) 146 (62 9) 
Most of the t1me I (4 8) 106(243) I (56) 58 (25 0) 
A good b1t of the t1me 5 (23 8) 42 (9 6) <OQQ]U 4 (22 2) 22 (9 5) 
"' 
Some of the tune 2 (9 5) 13 (3 0) 0 (0) 6 (2 6) 
A httle of the tune 0 (0) 3 (O 7) 0(0) 0(0) 
None of the tlme 2 (9 5) 3 (0 7) 0 (0) 0 (0) 
Are \OU a nenous person" N (%) 
All of the ttme 0 (0) 2 (0 5) 0 (0) I (04) 
Most of the tune 2 (9 5) 9 (2 1) 0 (0) 5 (2 2) 
A good h1t of the lime 2 (9 ~) 8 (1 8) 0 034• I (56) 4 (I 7) 
"' 
Some of the t1me I (4 8) 72(165) 4 (22 2) 42(181) 
A httle of the lime 5 (23 8) 124 (28 4) s {27 8) 62 (26 7) 
!'.one of the ttme 11 (52 4) 221 (50 7) 8 (44 4) 118(509) 
. S1gm!icam at the <0 OS level (2-tat\ed), ** ~tgmficant at the <0 01 level (2-tatlcd), ns- not stgntficant 
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5. 7.2 Linear Regression 
Result ofhnear regression analyses discussed refers to the relationship between HT 
use and verbal memory (HVLT) for women alone44 
5. 7.2.1 Hopkins Verbal Learning Test- Immediate Recall 
Lmear regressiOn analyses (see table 28) showed that HT use m this Indonesian 
sample had a trend level negative association With verbal memory as measured by the 
HVLT-IR m women The (trend) association between HT use and verbal memory 
remamed when the demographic mediators of age and educatiOn were entered mto the 
model An older age and low education were sigmficantly associated with poorer 
verbal memory m this sample In the presence of other possible mediators and 
covanates ofhvmg distnct, house ownership (mdicator ofSES) and mood the 
associatiOn of HT use With Immediate verbal memory became clearer, suggestmg that 
the relatiOnship between HT use and Immediate verbal memory was not mediated by 
these factors. Owmng your own home, feelmg happy and urban hvmg were 
significantly associated with better Immediate verbal memory ( controlhng for age and 
educatiOn) When health was added to the model, HT use remamed only trend level 
significantly associated with worse Immediate verbal memory. However, feelmgs of 
happmess were no longer significantly associated with better memory m this model 
and were apparently mediated by better health These findmgs could mdicate that 
women usmg HT were m general of poorer health which was m turn associated With 
how unhappy they felt. However, power Issues (with small numbers of HT users) may 
confound the associatiOns found 
44 Results for the assoc1atton between HT use and global cogml.lve funct10n (as assessed by the MMSE) as well as usmg the 
cogmt1ve algonthm are not shown because these analyses did not yteld any Slgmficant assocJat10ns These results w1th the 
MMSE are Similar to findmgs from our meta-analyS!S (sect10n 7 3) as well as other studies (e g Greenspan, Resmck, & Parker 
(2005) AddJbonally, verbal memory (HVLT) ts shown for women only as Jmear regress10n onalyses w1th men had no s1gmficant 
assocmt10n of HT use As reported m our meta-analySJS (sectwn7 3), effects of HT on cogmttve functton are usually seen on 
verbal memory tests (Hogervorst, De Jager, Budge,&. Smtth, 2004) whtch ts a sex senslttve cogmttve functiOn that usually 
favours women Thts could addttwnally explam why m th1s sample, no relat10nsh1p between HT use and verbal memory \\as 
observed for men 
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Table 28 - Linear Regression Analyses assessing the relationship between 
hormone therapy use and immediate verbal memory for women 
Hopkms Verbal Learnm Test -lmmedtate Recall 
Un~tandardlstd Standardized 
Coeffic1cnh Cocfficu~nts p Value 
8 SEB 8 
Step I 
liT 340 I 82 09 0063 
Step 2 
HT 2 48 I 45 07 0 088 
Age -0 22 0 04 - 21 <0 001*"' 
tducatlOn 5 11 0 40 53 <0 001*"' 
~tep 3 
HT 3 10 I 44 09 0032"' 
Age -0 20 0 04 - 19 <0 001 "'* 
EducatiOn 4 18 0 47 43 <0001*"' 
L1vmg D1stnct -1 66 0 48 - 17 0 001 
Steo4 
HT 3 18 I 44 09 0 027* 
Age -0 20 004 - 19 <0 001 ** 
Educatwn 410 047 43 <0 001** 
L1vmg D1stnct -I 96 0 50 -20 <0 001 ** 
Home Ownersh1p -0 50 0 23 -09 0 03* 
Step 5 
HT 3 34 I 43 09 0 02"' 
Me -0 20 0 04 -19 <0 001*"' 
EducatiOn 4 02 047 42 <0 001 ** 
LlVlng DJ">tnct -I 66 0 52 - 17 0 001* 
Home Ownership -0 44 0 23 -08 0055 
Do you feel happy? I 32 0 59 10 0026* 
Step 6 
HT 2 66 I 39 07 0057 
Age -0 16 0 04 - 15 <0 001** 
Educat•on 3 56 0 47 37 <0 001 ** 
L1vmg D•stnct -2 30 0 52 -24 <0 001** 
Home Ovvnersh1p -0 43 0 22 -08 005* 
SF-36 011 0 02 21 <0 001 ** 
1\.ote At final step R 446, AdJUS!i.d R 436 p<O 001 
Step 1-2 usmg the Enter method, all other steps usmg the stepw1sc backward method ofehnunJtton 
Only stattsttcally stgmficant vanablcs were kept m the model 
95% Cl for B 
-0179-6974 
-0374-5331 
-0309--() 137 
4 333 - 5 886 
0 263-5 935 
-0290--0118 
3249-5113 
-2 611--0709 
0 356-6 002 
-0 286--() 116 
3165-5027 
-2 943- -0 975 
-0952-0048 
0530-6155 
-0284--0115 
3094-4951 
-2671--{}641 
-0 896-0 009 
0157-2490 
-0 080-5197 
-0 240 - -0 072 
2638-4473 
-3317--1288 
-0 872- 0 005 
0068-0153 
B= unstandardtsed beta SE B =standard error of beta P = standardtsed coeffictents, p Value= stgmficance level Exp(B)-= change 
111 predtcted odds ofpo~s1ble dementia for each chan)!.e m pred1rtor \ an:tblc, 95% Cl= 95"to confidenLC mtcrval for un~tand:trdtsed B 
* Stgmfil.mt at the <0 05\evel (2-taded), ** Stgmticant at the <0 0\ level (2-tmled), ns ::o not stgmficant 
5.7.2.2 Hopkins Verbal Learning Test -Delayed Recall 
HT use was not Significantly associated w1th delayed verbal memory when other 
demographic factors and happmess were taken mto cons1deratwn See Table 29 for 
cntlcal values However, m analyses controllmg for age educatwn and negative mood, 
the assocwtlon between HT use and delayed verbal memory emerged agam as 
s1gmficant As found w1th 1mmed1ate verbal memory, HT use was associated w1th 
worse delayed verbal memory Feehngs of more happmess and less stress were 
mdependently s1gn1ficantly assoc1ated w1th better delayed verbal memory Th1s 
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associatiOn With happmess and stress was still sigmficant when controllmg for health 
(SF-36) although health apparently mediated both the associatiOn of nervousness and 
that of HT with worse delayed recall SES and distnct were removed from the model 
as there were not sigmficantly associated with delayed verbal memory 
Table 29- Linear Regression Analyses assessing the relationship between 
hormone therapy use and delayed verbal memory for women only 
Hopkms Verbal Learnmg Test (Dela)ed Recall) 
Unstandard1~ed Standard1.ted 
Coefficients Cocffic•cnts 
B SE B p 
Step I 
HT 0 37 0 79 09 
Step2 
HT 0 97 0 62 06 
Age -0 12 0 02 -25 
Education 2 23 0 17 53 
Step 3 
HT I 12 0 61 07 
Age -0 ll 0 02 -25 
Education 210 0 17 50 
Do you feel happy" 074 0 25 12 
Step 4 
HT I 20 0 61 08 
Age -0 11 0 02 -24 
EducatiOn 2 16 0 17 51 
Do vou feel happy? 0 90 0 26 15 
Do you feel stressed? -0 51 0 24 . 09 
Step 5 
HT I 12 0 61 07 
Age -0 11 0 02 -24 
Educatton 2 18 0 17 52 
Do you feel happy" 0 86 0 26 14 
Do you feel stressed" -0 55 0 24 • 10 
Arc you a nervous person? 0 28 0 14 08 
Step 6 
HT 0 89 0 61 06 
Age -0 10 0 02 • 22 
Educat10n 2 13 0 17 51 
Do you feel happy" 0 78 0 25 13 
Do you feel stressed" -0 57 0 24 • 10 
Are you a nervous person" 0 18 0 14 05 
SF-36 0 03 0 01 14 
"' 44 7 
_., 1\ote At fin1l step R 6 Adjusted R 3 p<O 001 
Step 1 2 usmg the Em er method, all other steps usmg the stepwrse back\\ard method of ehmmauon 
Only stattsucally stgmficant vanab!es were kept m the modd 
p Value 95 1% Cl for B 
0084 -0184-2933 
0 118 -0247-2181 
0001** -0154--0081 
0001** 1898-2559 
0069 -0 087-2 324 
<0001** -0 151--0 078 
<0 001** I 759-2 436 
0003* 0 260 -I 229 
0 05* -0 003-2 402 
<0 001** -0148--0075 
<0001*"' I 816-2499 
<O oot•• 0 400- I 407 
0 032* -0 985. -0 043 
0 067 -0081-2320 
<0 001** -0 146.-0 074 
<0 001•• I 842-2 523 
0001* 0 351- I 359 
0022* -I 022--0 081 
0 05' 0000-0552 
"' 
-0 298-2 083 
<0 001""" -0 137--0 065 
<0 001 ...... 1797-2471 
0 002' 0 277 -I 275 
0016* -I 035.-0 107 
ns -0 099-0 456 
0001* 0014-0051 
B~ unstandard•sed beta SE B =standard error of beta,~ .. standardtsed coeffictents p Value= s•gmficance level Exp{B) =change 111 predtcted odd> of 
poss•ble dementta for each change m predtctor vanable 9.5% Cl= 9.5% confidence mterval for unstandardtsed B 
• Stgntficant at the <0 05 le, cl (:2 tatled) •• S•gntficant at the <0 Ollevel (2-tmled) ns =not stgmlicant 
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5.7.3 Interaction between Age and Hormone Therapy Use 
GLM ANOV A was run to assess the interaction between age and HT for verbal 
memory. As can be seen in figure 9, age had an overall negative association with 
immediate verbal memory (HVLT-IR). 
In analyses stratified by gender, a trend level interaction between age and HT was 
found for men for immediate verbal memory (HVLT-IR) (F = 1.751, p = 0.072). For 
men, also a significant interaction between age and HT use was found for delayed 
verbal memory (HVLT-DR) (F = I .924, p = 0.044). As can be seen in figure 10, a 
decline in delayed verbal memory can be observed with increasing age. However, 
what is of interest is that this decline is of a lesser extent for men using HT compared 
to men whom are not. For women, no significant interaction was observed for 
immediate or delayed verbal memory, although worse delayed verbal memory was 
observed with increasing age (main effect of age) (see figure 9). 
Figure 9 The association between age and delayed verbal memory for 
women using and not using hormone therapy 
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Figure 10 The association between age and delayed verbal memory for men 
using and not using hormone therapy 
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5.8 Phytoestrogens and Cognitive Function in an Elderly Indonesian Sample 
5.8.1 Whole Sample Descriptives45 
5.8.1.1 Foods 
The maJonty ofpart1c1pants (71 %) consumed some form of soy (tofu/tempe/soy ml1k) 
at least once day Only 5% of the whole sample ate no tofu or tempe at all, w1th the 
maJonty (65%) consummg both tofu and tempe at least once a day (also the med1an 
spht of m take of e1ther soy product) Tempe was eaten at least once dally for 68% of 
the sample (mean weekly mtake = 9.5 ± 6 8), and tofu was eaten at least once dmly by 
67% of the sample (mean weekly mtake =9 3 ± 6 9) A very small proport10n (6%) of 
part1c1pants consumed soy m1lk or other soy products, therefore these data were not 
mcluded m the analyses Frmt or frmtJmce (a part of the d1et for 39% of the sample) 
was consumed an average of 4 9 (± 5 6) tlmes per week S1m1larly, orange/red 
coloured vegetables were eaten (by 31% of the sample) on average 4 4 (± 5 4) tlmes a 
week Green vegetables were more frequently consumed (49% of the sample) w1th an 
average of 7.2 ( ± 6 6) t1mes a week F1sh consumptlon was low (21%) at 3 1 ( ± 4 5) 
tlmes per week Unfortunately there was no data on other protems or foods. 
5.8.1.2 Isoflavone Levels 
H1gh tofu and tempe mtake were mdependently s1gmficantly correlated w1th h1gher 
sahvary levels of da1dzem, w1th only a trend level assoc1atwn found for h1gher 
gemstem and no s1gmficant assocmt10n w1th glyc1tem levels (see methods sect1on 
58 6) 
See table 30 below for the mean quantltles of soy eaten per week and levels of 
sahvary isoflavones for the sample (n=719) 
45 For an extensive descnptmn of the demograph1cs, cogmt1ve scores, health and funct10nal measures for the full study sample 
(n=719) please see sect1on 5 1 
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5.8.2 Stratified by Cognitive Algorithm46 47 (see Table 30) 
5.8.2.1 Foods 
No s1gmficant d1fference was seen between cogmtJve groups m tofu and tempe 
consumptiOn (whether th1s was measured as at least once da1ly, or a weekly amount) 
However, h1ghly s1gmficant differences were found between groups m both weekly 
frmt mtake (p<O 001), orange/red coloured vegetables (p=O 008), and fish (p<O 001) 
Results were sJmJlar for weekly mtake measured as for whether the food was eaten or 
not at all (usmg a bmary yes/no answer) 
5.8.2.2 Isoflavone Levels 
S1gmficant differences were found between Cl cases and controls m the levels of 
aglycone 1sof1avones found m sahva sample for gemstem (p<O 001) and da1dzem 
(p=O 005), but not for glyc1tem (p=O 48) On average, Cl cases had h1gher levels of all 
three 1sof1avones than control cases 
46 NB In chapter 52 assessmg dement1a nsk factors, the sample ''as stratified accordmg to the cogmnve algonthm and grouped 
m to Cl, poss1ble Cl and controls However, m the current section, only the Cl and control groups were assessed m analyses 
47 See sect10n 56 for means and SD!> for cogmt1ve scores 
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Table 30 - Descriptive Analyses of Soy Foods and Isoflavone Levels Stratified by 
Cognitive Impaired and Control Groups 
Table 30 shows the m take of soy foods, fruits and vegetables as well as the mean salivary I so flavone 
levels for the whole sample and the Cl and control cases Chi-square analyses, for categoncal data, and 
ANOV A analyses, for contmuous data, were used to assess the differences between cogmtive groups 
for these vanables The figures show the number and percentage [N(%)] of partiCipants whom eat these 
foods at least once a day The table also shows the mean number of times the food are eaten a week 
The mean salivary Isoflavone levels are also displayed 
Whole Cl Cases Control Cases Group 
Type of rood eaten da1ly or 
more, N (0A,) 
Soy of any type 511 (71) !52 (71) 121 (72) 
Tofu (da1ly or more) 479 (67) 142 (66) 110 (65) 
Tcmpe (da1\y or more) 491 (68) 143 (67) 119(70) 
FrUJUFrmt Jmce 276 (39) 46 (21) 104 (62) 
Orange/red colour vegetables 219 (31) 47 (21) 66 (39) 
Green colour vegetables 351 (49) 94 (44) 87 (52) 
F1sh 148 (21) 24 (I!) 51 (31) 
Mean Weekly Intake, mean± 
~D 
Tofu 9 3 (6 9) 9 4 (6 8) 9 I (7 0) 
Tempe 9 5 (6 8) 9 5 (6 8) 9 7 (6 8) 
Frult/frult Jmce 4 9 (5 6) 3 2 (3 8) 7 5 (6 3) 
Orange/red colour vegetables 4 4 (54) 4 (57) 56 (56) 
Green colour vegetables 7 2 (6 6) 72 (6 8) 7 4 (6 3) 
F1sh 3 I (4 5) 2 6 (4 4) 4 7 (52) 
Sahvary Phytoestrogen Levels 
(ppm), mean ±SO 
Gemstem 0 021 (0 009) 0 024 (0 OIO) 0 019 (0 000) 
Datdzem 0043(0016) 0 046 (0 018) 0040 (0 016) 
G\yc1tem 0 041 (0 027) 0 044 (0 018) 0041 (0044) 
•• + ppm part per mLlhon, S1gmficant at the <0 01 level (2-taJ\ed), ns not s1gmficant 
5.8.3 Stratified by District48 (see Table 31) 
5.8.3.1 Foods 
p Value 0 
ns 
ns 
ns 
<0 001*"' 
<0 001 *"' 
0 07 
<0 001** 
ns 
ns 
<0 001 ** 
0 008"'* 
ns 
<0 001** 
<0 001 *"' 
0 005** 
ns 
Although no stallsttcally stgmficant difference was found between distncts m the 
quantity of soy foods eaten (note a trend stgmficant difference was observed for 
weekly tempe consumption), a highly sigmficant difference was seen m whether soy 
was reported to be eaten at all (p=O 002 for tofu and tempe combmed), and separately 
for tofu (p=O 001) and tempe (p<O 001) eaten more than once daily, with higher 
proportwns seen m Jakarta for both food types Furthermore, partiCipants m Jakarta 
ate more fruit and all assessed vegetables than m the other two distncts (p<O 001) 
4
s See sectiOn 5 6 I for means and SDs of cogmt1ve scores stratified by d!Stnct 
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5.8.3.2 Isoflavone Levels 
S1gmficant differences were observed between d1stncts m gemstem levels (p<O 001), 
da1dzem levels (p=O 04) and glyc1tem levels (p<O 001) 
Table 31 -Descriptive Analyses of Soy Foods and Isoflavone Levels Stratified by 
Living by District 
Table 31 shows the mtake of soy foods, frmts and vegetables as well as the mean salivary Isoflavone 
levels for the whole sample stratified by hvmg diStrict Chi-square analyses, for categoncal data, and 
ANOV A analyses, for contmuous data, were used to assess the differences between districts for these 
vanables The figures show the number and percentage [N(%)] of partiCipants whom eat these foods at 
least once a day The table also shows the mean number of times the food are eaten a week The mean 
salivary tsoflavone levels are also displayed 
Jakarta Sumcdang Borobudur 
Type offood eaten da1ly or more, N 
(%) 
Soy of any type 229 (77) 128 (62) I 54 (72) 
Tofu (da1ly or more) 215 (72) 116 (56) 148 (69) 
Tempe (da1\y or more) 223 (75) 114 (55) 154 (72) 
FrUJt!Frutt Jlllce 205 (69) 49 (24) 22 (I 0) 
Orange/red colour vegetables 152 (51) 49 (24) 18 (8) 
Green colour vegetables 182 (62) 67 (33) I 02 (48) 
F1sh 112(38) 30(15) 6 (3) 
Mean Weekly Intake, mean± SD 
Tofu 9 4 (6 8) 8 8 (7 3) 9 5 (6 4) 
Tempe 9 7 (6 7) 8 6 (7 3) 10 I (6 4) 
frmt/Frmt JUJce 7 4 (5 9) 3 8 (56) 2 5 (3 0) 
Orange/red colour vegetables 6 I (58) 4 I (5 6) 25(37) 
Green colour vegetables 7 7 (6 5) 4 6 (5 I) I 3 (2 2) 
F1sh 4 6 (5 I) 2 9 (4 5) I 3 (2 2) 
Salivary Phytoestrogen Levels (pp m), 
mean± SD 
Gem stem 0 019 0021 0 023 (0 008) (0 008) (0 009) 
Da1dzem 0 041 0 040 0 045 (0 015) (0 013) (0 018) 
Glyc1tem 0 037 0 058 0 041 (0 015) (0 094) (0 027) 
•• + ppm part per million, S1grilfic:mt at the <0 01 level (2-tmled), ns not s1gmficant 
5.8.4 Stratified by Gender (see Table 32) 49 
5.8.4.1 Foods 
p Value 
0 002** 
0001** 
<0 001** 
<0 001** 
<0 001** 
<0 001** 
<0 001** 
ns 
007 
<0 001 ** 
<0 001** 
<0 001** 
<0 001 ** 
<0 001 ** 
0 04* 
<0 001 ** 
No s1gmficant differences were observed between genders m the amount or regulanty 
of soy foods consumed Furthermore, women ate sigmficantly more frmt both 
measured as daily or more ((p<O 001) and as a weekly amount (p=O 02), and 
orange/red coloured vegetables (p=O 03 and p=O 001 respectively for dichotomous 
49 See <;ectJOn 5 6 I for means and SDs of cugnmve scores stratified by gender 
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da1ly or more or contmuous weekly amount) No s1gmficant gender differences were 
found for consumptiOn of green vegetables or fish 
5.8.4.2 Isoflavone Levels 
S1gmficant differences were observed between men and women m da1dzem levels 
(p=O 04) and glyc1tem levels (p=O 003) w1th a trend seen for gemstem levels (p=O 06) 
Men had on average h1gher aglycone Jsoflavone levels than women. Th1s was not 
unexpected as although no stal!stJcal difference was found m tofu/tempe consumptiOn 
between the genders, men reported eatmg more tofu and tempe than women on a 
weekly bas1s 
Table 32 -Descriptive Analyses of Soy Foods and Isoflavone Levels Stratified by 
Gender 
Table 32 shows the m take of soy foods, frutts and vegetables as well as the mean salt vary tsoflavone 
levels for the whole sample strattfied by gender Cht-square analyses, for categoncal data, and 
ANOV A analyses, for contmuous data, were used to assess the dtfferences between dtstrtcts for these 
vanables The figures show the number and percentage [N(%)] ofparttctpants whom eat these foods at 
least once a day wtthm each gender The table also shows the mean number ofttmes the food are eaten 
a week The mean sahvary tsoflavone levels are also dtsplayed 
Men (n=255) Women (n'"'464) p Value 
Type of food eaten da1ly or more, 
N (%) 
Soy of any type 180 (71) 331 (72) ns 
Tofu (da1ly or more) 173 (68) 306 (66) ns 
Tempe (da1ly or more) 172 (68) 319(69) ns 
rrultlfruJt Jutce 73 (29) 203 (44) <0 001 •• 
Orange/red colour vegetables 65 (26) 154(33) 003* 
Green colour vegetables 125 (49) 226 (49) ns 
f1sh 51 (20) 97 (21) ns 
Mean WceiJ) Intake, mean± SD 
Tofu 9 5 (6 9) 9 I (6 8) ns 
Tempc 9 6 (7 0) 9 4 (6 7) ns 
FrUJtlfrull Ju1ce 4 3 (5 I) 5 3 (5 8) 0 Q21t 
Orange/red colour vegetables 3 5 (4 5) 4 9 (58) 0 001 ** 
Green colour vegetables 7 2 (6 4) 7 2 (6 7) ns 
F1sh 3 I (4 6) 3 I (4 4) ns 
Sahvar) Phvtoestrogen Levels 
(pp m), mean± SD 
Gemstem 0 022 (0 008) 0 020 (0 009) 0 06 
Dmdzem 0045(0017) 0 042 (0 015) 0 04* 
GlycJtem 0 046 (0 041) 0 039 (0 016) 0 003** 
-ppm part per m1lhon,,... S1gmficant at the <0 01 level (2-talled), ns not stgmficant 
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5.8.5 Stratified by Median Age 50 (see Table 33) 
5.8.5.1 Foods 
No significant d1fference was observed between groups spht by median age m soy 
food consumptiOn, and consumptiOn of orange/red and green coloured vegetables 
However, although the weekly mtake offrmt/frmtJUice was not sta!Is!Ically 
significantly different between groups, whether fruitlfrmt JUice was consumed or not 
was significantly different (p=O 008), With more participants younger than 68 years 
reportmg mtake offruitlfruitJUICe This group also ate significantly more fish 
(p=O 001) 
5.8.5.2 Isoflavone Levels 
Although no significant d1fference was observed m gemstem and glyc1tem levels 
between groups, participants younger than 68 years had higher levels of dmdzem than 
those over 68 years of age (p=O 05) 
so See section 5 6 2 for means and SDs of cogmt1ve scores stratified by med1an age 
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Table 33 - Descriptive Analyses of Soy Foods and lsoflavone Levels Stratified 
Median Age 
Table 33 shows the mtake of soy foods, fruits and vegetables as well as the mean salivary !So flavone 
levels for the whole sample stratified by median age (less than or greater than 68 years) Chi-square 
analyses, for categoncal data, and ANOV A analyses, for contmuous data, were used to assess the 
differences between districts for these vanables The figures show the number and percentage [N(%)] 
of partiCipants whom eat these foods at least once a day withm each group The table also shows the 
mean number of times the food are eaten a week The mean salivary Isoflavone levels are also 
displayed 
Mcd1an Spht for Age 
< 68 Years Old > 68 Years Old p Value 
(n=371) (n=348) 
Type of food eaten, N ('Yu) 
Soy of any type 259 (70) 252 (73) ns 
Tofu (da1ly or more) 243 (66) 236 (68) ns 
Tempe (da1ly or more) 248 (67) 243 (70) ns 
frmt/Frmt Ju1ce 160 (43) 116 (34) 0 008** 
Orange/red colour 
117(32) 
vegetables 102 (30) ns 
Green colour vegetables 175 (47) 176 (51) ns 
F1sh 87 (24) 67 (18) 006 
Mean Weekly Intake, mean 
±SO 
Tofu 9 3 (7 0) 9 2 (6 7) ns 
Tempe 9 5 (6 9) 9 5 (6 8) ns 
F1 UJtlfrutt JUJr.e 5 (5) 4 9 (6 2) ns 
Orange/red colour 4 6 (54) 
vegetables 4 2 (54) ns 
Green colour vegetables 7 I (6 5) 7 3 (6 7) ns 
F1sh 3 6 (5) 2 6 (4 5) 0001** 
Salivary Ph) !oestrogen 
Levels (pp m), mean± SD 
Gem stem 0 021 (0 009) 0 020 (0 008) ns 
Dmdzem 0044(0017) 0041 (0015) 0 05' 
Glyc1tem 0042(0017) 0041(0035) ns 
. ppm part per nulhon, • S1gmficant at the <0 01 level (2 tailed), ns- not s1gmficant 
5.8.6 Correlation between salivary phytoestrogen levels and self-report on soy 
FFQ in the current study 
Self-reported weekly tempe mtake was sJgmficantly positively correlated w1th 
da1dzem levels {r= I 0, p=O 026) Furthermore, weekly tofu mtake was sJgmficantly 
posJtJvely correlated w1th both dmdzem {r= 12, p=O 007), and glyc1tem (r= I 0, 
p=O 03). Ne1ther tempe nor tofu was s1gmficantly correlated with gemstem levels 
However, when tempe and tofu were added together total weekly soy mtake was 
stgmficantly correlated with gemstem {r= I 0, p=O 018) However, these correlatwns 
are very weak Appendix 4 shows the Pearson's correlatiOns between sahvary 
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phytoestrogen levels of gemstem, dmdzem and glyc1tem and weekly mtake of soy 
foods as measured by the FFQ (see append1x 4) 
5.8.7 Associations between Demographics, Food intake, Isollavones and 
Cognitive Function 
Spearman rank correlatiOnal analyses (see table 34 for correla!Jon coefficient cn!Jcal 
value and s1gmficance levels) assessed a vanety of assoc~a!Jons between vanables 
F1rstly, the relatwnsh1ps between Cl/controls, cogmt1ve scores and demographic 
vanables (age, gender, educatwn, urban/rural hvmg) are d1scussed m sectwn 5 1. To 
summanse, Cl and a lower score on the cogmhve tests was mdependently associated 
(correlatwnal analyses) w1th older age (trend level), male gender, poorer educatwnal 
attamment and hvmg m a rural area, but not Socweconom1c Status (SES)51 
Furthermore rural hvmg was assoc1ated w1th older age, the male gender and havmg 
obtamed less education In the current analyses Cl was not s1gmficantly associated 
w1th mtake of any type of soy However, usmg the HVLT mdependently of the 
cogmhve algonthrn, h1gh weekly tofu mtake was s1gmficantly assoc1ated w1th lower 
HVLT IR and DR scores Tempe mtake was not associated w1th any cogmt1ve 
measure Both tofu and tempe (eaten da1ly or more) were associated w1th rural hvmg, 
although no assoc1atwn was found between weekly soy mtake and urban/rural hvmg 
Tempe and tofu were s1gmficantly pos11Jvely associated w1th each other Intake of 
fru1t, all vegetable types and fish were pos1!Jvely assoc1ated w1th tofu and tempc 
mtake and w1th each other suggestmg an ex1stence of healthy food patterns m those 
w1th h1gh educatwn hvmg m urban areas 
Interestmgly, men had h1gher gemstem and glyc1tem levels. Those who hved m rural 
areas and had low education or ate httle fru1t and vegetables were also hkely to have 
high Jsoflavone levels 
As these factors are thus mter-related, log1s!Jc regressiOn was performed to assess 
mam determmants and mediators of Cl 
sJ As assessed by home ownersh1p and profess10n before ret1rement 
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Table 34- Suearman's correlations bet" een demograQhics. food m take and salnarl' isofla\one le\els 
6 10 11 12 ll 14 
" 
16 17 18 19 
I Cl vs Control C'ases 
2 HVLT(IR)Score r= 86 p<OOO[U 
31\VLT(DR)Score r= 84 r= 84 p<O 001"" p<OOOioo 
4 MM<;E Score r=- ~6 r= 70 r=72 p<O 001 p<OOQ[OO p<OOOIU 
5 Age r-''6 r= '0 r33 r= 29 p<OOOI"* p<0001"* p<000\ 00 p<OOQJU 
6 Gender r-- 09 r= 07 NS NS ~09 p=-0 07t p-oo~· p=O 02° 
7 EducJtlon r-- 64 r= 48 ~" !""'56 1""'-19 r= 07 p<0001"* p<OOOI 00 p<OOOI 00 p<OOOI"* p<OOOI 00 p---o os• 
8 Llrll.1niRura\ 
!""' ~8 !""' 49 r" r39 rl5 r- 11 r- 45 
p<OOOI 00 p<000\ 00 p<0001°0 p<OOOI"* p<OOOI 00 J>"'000200 p<000\ 00 
9 Tofu ("eddy) NS p 08 r os 
" 
NS 
" 
NS NS p-o 04° p-o os• 
\0 Ternpe("eel.\y) NS NS NS NS NS NS NS NS rSS p<0001° 0 
11 Tofu (d:u\y or NS NS NS NS NS NS NS r= 09 r-82 ~69 more) p~02° p<O 001° 0 p<0001* 0 
12 Ten1pe(da1lyor NS NS NS NS NS NS NS 1""'10 ~69 rSI r86 ~u) p---0009 .. p<O oot•• p<0001*" p<O 001° 0 
11 FnlllfFrull JUICC r" r- '3 r27 r27 NS r- 11 r- 34 r- 44 1""09 rl2 r=-13 r- \6 (\\CCkl•) p<OOOl** p<000lu p<0001°* p<OOOiu p---o 00~"* p<0001"* p<0001° 0 p---0 02° 
J>"'000\ 00 p<O 001* 0 p<O 001** 
14 Orange/Red Colour !""' 23 r= 17 r I< rl8 NS ~12 !""' 20 P-32 r= 20 Vcget1hlcs ("cell>) p<O 001u p<OOOI 00 p<OOOI 00 p<OOOiu p=OOOI"* p<OOOI .. p<O 001 p<O 00\* 0 rl9 r2l r- 23 r= 39 
p<OOOI"* p<O 001° 0 p<O 00\ 00 p<0001 00 
I<; (iT(en C'ok>ur 
" 
NS N< NS NS NS NS r-09 r29 ~28 r2Z r= 21 rl6 r= 40 Vc~ct1t>les ("cclly) p---o 02° p<O 001° 0 p<OOOJU p<OOOI 00 p<O 00! 00 p<0001 .. p<O 001u 
16 F1~h ("cell;) r ~2 r" 23 r= 22 I""' 22 r 12 NS rlS !""' 33 rl3 rl6 r--13 r-16 r= 36 r= 32 r= 19 p<OOO\ .. p<"0001u p<"000\ 00 p<OOOiu p"OOO!u p<OOO!"* p<000\ 00 p<000\"0 p<000\ 00 p<OOOlu p<OOO!"* p<0001 00 p<O OQ]U p<OOOI .. 
17 Gcmstem Le\e\ r= 30 r=- 2' !""' 18 r= 26 r=\2 r-25 r= 19 r= os r- 08 r=- 20 r-- 18 
p<OUOI,.. p<O 001 p<OOOI .. p<O QOin NS )>"0 006** p<OOOin p<O 001*• P"0 07t p"o 08t NS NS p<ooot•• p<O 001 .. 
" 
NS 
r= 19 r=- IS ~ ll r- 19 r-19 rl2 r- 11 r-11 r= 08 r= 69 
18 Da1d1em Le\ cl p<OOOiu p=OOOI*" p~o oo4•• p<OOOiu NS NS p<O 00\u NS p<OOOlu p"O 01 ~ NS NS p"00! 00 p=O 07t NS NS p<O 001u 
19 Ghc1tem Le\ cl !""' 20 r=- 16 r= 10 rl8 r-- 09 r--16 r-- 22 r= 14 r09 r-- 22 r= 1~ r=77 dO 
p<OOO!u p<0001u p-O 02* p<OOOI** p-0 03* p<OOOiu o<OOO!u p=0001° 0 !Rl o~· 
"' " 
~s F(O oou• p-OOC!u 
" " 
f!'-0001 .. p'-0001*" 
• Correblton t<; <;Jgm!ic:~nl atlhe <0 OS le\ cl (2-lalled) 
** Corre!atton t~ qgmlicm1t at the <0 01 le\ cl (2-talled) 
• Not '>1gm!icanL hut trend ohc;cncd 
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5.8.8 Logistic Regression Analyses 
5.8.8.1 Non-Stratified 
A total of269 cases were analysed and the model successfully predicted Cl status m 
step 152 However, m this analyses neither tofu nor tempe mtake were Sigmficant 
predictors of Cl This was s!lll the case m the second step 53 m analyses which also 
assessed aglycone iSoflavone levels of gemstem and dmdzem which were also not 
Sigmficant predictors of er (see table 35) In the third step 54, other food mtake was 
added to the analyses Similarly, tofu and tempe mtake as well as isoflavone levels of 
gemstem and daidzem were not sigmficantly assocmted With er status However, low 
frmt mtake was found to have an mdependent Sigmficant assocmt10n With Cl 
Table 35 - Logistic Regression Analyses to assess soy food intake and isoflavone 
levels as risk factors for cognitive impairment 
Table shows the results of regressiOn analyses usmg tbe 'Enter' method wh1ch assesses soy food mtake 
as a pred1ct1ve factor for cogmt1ve 1mpa1rment In the first step of analyses, only tofu and tempe were 
entered In the second step, 1soflavone levels were entered, and m the thtrd step m take of fruits, 
vegetables and fish were entered See append1x 12 for model summary 
Vanable Entered 8 SE [ Exp(B) p Value 95 1Yo C I for Exp(B) 
Step 1 
Tofu 09 08 i 09 ns 0 787- i 056 
Tempe -0 09 0 08 9i ns 0 939- 1 263 
Constant -4 50 2 24 0 01 0 03 
Step 2 
Tofu 08 08 i 09 ns 0933-1261 
Tcmpe -09 08 92 ns 0 788- 1 062 
Da1dzem 2 32 i8 13 59 ns 0 000 -3E+016 
Gemstem 3 48 31 64 32 46 ns 0 000- 3E+028 
Constant -4 81 2 27 01 0 034* 
Step3 
Tofu ii 08 iii ns 0945-i312 
Tempe - 10 08 91 ns 0 774- i 060 
Da1dzem -i 22 18 78 30 ns 0 000- 31:+015 
Gem stem 8 37 32 18 4307 52 ns 0 000 -iE+031 
Fru1t - i3 06 88 0 044* 0782-0997 
Orange/Red Vegetables -0 067 05 94 ns 0 842- 1 038 
Green Vegetables 05 05 1 05 ns 0961-1146 
F1sh -05 05 95 ns 0860-1044 
Constant -5 90 2 50 00 0 Oi8 
8 standard1sed beta, SE standard error, Exp(B) change m pred1cted odds of Cl for each change m pred1ctor \an.tble 
also knov.n as the odds ratio, p Value= Slglllficance le\el, 95% Cl for Exp(B)"' 95% confidence mtenal for Exp(B) 
• Stgmficant at the <0 05 level (2-tutled) ns= not stgmficant 
s2 Model successfully predicted 86 6% of cases correctly (84 I% of Cl cases and 89 I% of controls) 
SJ Model successfully predtctcd 87 4% of cuses correctly (86 4% Cl cases and 88 3% controls) 
s4 Model successfully pred1cted 88 1% of cases correctly {86 4% CI cases and 89 8% controls) 
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As has been d1scussed m sectwn 5 6, the demographic vanables of age, educa!Jon, and 
hvmg dlstnct and professiOn all Slgmficantly predicted er classJficatJon Gender also 
showed some trend level mdependent assoc1a!Jons m these analyses It 1s poss1ble that 
effects of soy consumptiOn on cogm!Jve functwn are masked by some of these strong 
demographic pred1ctors Therefore, for a number of reasons, the dec1s1on was made to 
run further regresswn analyses stra!Jfied by med1an age, gender, and hvmg d1stnct 
F1rstly, part1c1pants m Borobudur were overall older (71 years) than those m 
Sumedang (69 years) and Jakarta (68 years) Therefore analyses were stratified for 
age usmg a med1an spht (at 68 years of age) Secondly, although no s1gmficant 
correla!Jon was observed m earher analyses between gender and er, analyses was also 
stral!fied by gender because prevwus hterature has found gender d1fferences m 
cogmt1ve ab!l1!Jes, as well as d1fferences m the effects of phytoestrogen consumptiOn 
on cogml!ve functwn, specifically m postmenopausal women Furthermore, earher 
analyses showed a s1gmficant d1fference between CI cases and controls m the 
proportiOns of men and women As no s1gmficant d1fference was seen between men 
and women m the amount of soy eaten, the relatwnsh1p between gender, soy, and Cl 
would be an mterestmg one to mves!Jgate. Th1rdly, h1ghly s1gmficant d1fferences were 
found between s1tes m the amount of tofu and tempe they consumed weekly, mtake of 
fru1t, vegetables and fish as well as s1gmficant d1fferences between s1tes m poss1ble 
demographic nsk factors for demcn!Ja such as age and educatwn Therefore, analyses 
were also stral!fied by s1te 
5.8.8.2 Stratified by District 
In analyses stratified by hvmg d1stnct, soy foods and sahvary 1soflavone levels were 
assessed m separate analyses. Th1s was because the low numbers of sahva samples m 
Sumedang (n=29) (see d1scusswn 111 sectwn 7 4 5 for poss1ble reasons) wh1ch resulted 
m msigmficant or no computed results for ALL vanables m log1sl!c regressiOn 
analyses hence a reduc!Jon m statls!Jcal power wh1ch m1ght have lead to a type 2 
error Therefore, hvmg area was dlVlded up mto urban (Jakarta) or rural (Sumedang 
and Borobudur) when assessmg sahvary 1soflavone levels, and mto hvmg d1stncts of 
Jakarta, Sumedang and Borobudur when assessmg soy food m take 
188 
5.8.8.2.1 Analyses of Soy Foods (see table 36) 
Analyses assessmg soy foods could be stratified, as m other analyses, by Jakarta, 
Sumedang and Borobudur as the power was suffic1ent In the first step of analyses, 
weekly tofu and tempe mtake were assessed, and m the second, mtake of other foods 
were added All analyses controlled for the other demographic vanables of age, 
gender, educatwn and professwn 
In Jakarta, a total of 145 cases were assessed. However, both tofu and tempe mtake 
were not s1gmficant predictors of cogmt1ve ab1hty m Jakarta. In the second step of 
analyses controlhng for other foods of frmt, orange/red vegetables, green vegetables 
and fish weekly mtake, agam ne1ther tofu nor tempe were s1gmficant mdependent 
predictors of er when controlhng for intake of other foods 
In Sumedang, a total of 106 cases were analysed. However, tofu and tempe mtake 
were not s1gmficant pred1ctors of Cl m Sumedang, wh1ch was also the cases when 
controllmg for other food mtake 
In Borobudur (n=l14), h1gh tofu mtake was mdependently assoc1ated (trend level) 
w1th Cl m analyses controllmg for age, gender and education, and professwn 
mcreasmg the odds of Cl by a factor of 1 19 However, m further analyses w1th m take 
of other foods also assessed, h1gh tofu mtake was no longer assoc1ated w1th Cl On the 
other hand, low orange/red vegetables mtake was also mdependently assoc1ated w1th 
Cl and reduced the odds of Cl by 81% 
5.8.8.2.2 Analyses of Isoflavone Levels (see table 37) 
Due to msuffic1ent power caused by a small number of sahva samples m Sumedang, 
analyses assessmg sahvary 1soflavone levels strahfied by hvmg area was spht by 
urban and rural hvmg areas only, w1th urban cons1stmg of Jakarta, and rural of 
Borobudur and Sumedang 
In urban areas (Jakarta), 131 cases were analysed and ne1ther da1dzem nor gemstem 
were s1gmficantly assocmted w1th cogmtive group wh1lst controllmg for other 
demographic vanables as well as w1th or w1thout also assessmg other food mtake. 
Th1s was also the case m rural areas (Borobudur and Sumedang) for the 143 
189 
part1c1pants analysed However, m rural areas, h1gh green vegetable mtake was an 
mdependent s1gmficant pred1ctor of Cl and mcreased the odds of Cl by a factor of 
I 14. 
Table 36- Logistic Regression Analyses to assess the relationship between soy 
food intake and cognitive impairment (stratified by Living District) 
Table shows the results of regressiOn analyses usmg the 'Enter' method wh1ch assesses soy food mtake 
as a pred1ct1ve factor for cogml!ve tmpa~rment m analyses strattfied by hvmg dJstrtct In the first step of 
analyses, only tofu and tempe were entered In the second step, mtake of frmts, vegetables and fish 
were entered See appendtx 13 for model summary 
D1stnct Vanable Entered I 8 I SE I Exp(B) I p Value I 954Yu C I for Exp(B) 
Step 1 
Tofu . 02 33 0 96 ns 0514·1888 
Tcmpe . 04 33 0 96 ns 0 503- 1 849 
ConsWnt -6 55 3 91 0 00 0 094 
Step 2 
i! Tofu 00 49 1 00 ns 0380-2623 
• Tempe os 50 1 05 0 396-2 767 
" 
ns 
•.., FrUit - 18 12 0 84 ns 0665-1059 
Orange/Red Vegetables -09 11 092 ns 0745-1123 
Green Vegetables -07 09 0 93 ns 0782-1108 
F1sh - 10 09 0 90 ns 0753 -I 082 
-Constant 11 44 5 88 0 00 0 052 
Vanable Entered B SE Exp(B) p Value 95% C I for Exp(B) 
Step 1 
Tofu 03 07 I 03 ns 0906-1170 
Tempe -04 07 0 96 ns 0 842-1 095 
Constant -6 18 3 84 0 002 0 107 
" Step 2 c 
• 
"' Tofu 03 08 I 03 0891-1198 • ns E 
0 Tempe -04 08 96 ns 0823-1120 
"' Fru1t -08 06 93 ns 0 824- I 044 
Orange/Red Vegetables 06 07 I 06 ns 0 924- I 224 
Green Vegetables -04 06 96 ns 0864 -I 072 
fish 06 07 I 06 ns 0918-1227 
Constant -5 59 3 88 004 015 
Vanable Entered B SE Exp(B) p Value 95% C I for Exp(B) 
Step 1 
Tofu 17 09 I 19 0 066 0 989- I 430 
Tempe - 10 08 90 ns 0765- I 066 
Constant -6 85 3 68 00 0 062 
" 0 Step 2 
"' 0 Tofu 17 ~ 
0 
11 I I 9 ns 0960-1473 
" Tempe 
- I I 0 90 0749-1076 0 09 ns 
"' Fruit -06 12 94 ns 0741-1199 
Orange/Red Vegetables -22 ID 81 003 0665-0 975 
Green Vegetables 11 08 I 12 ns 0956- I 311 
Ftsh - I 4 11 87 ns 0 697- I 089 
Constant -7 17 3 83 00 0 06 
. . . B standardised beta S E standard error, Exp(B) change m predicted odds of Cl for each change 111 predictor ~anable also kno" n a:~ the odds rauo p 
Value~ S1gmficance level 95% Cl !Or Exp(B) ~ 95% confidence mtenal for bp{B) 
• Stgmficant at the <0 05 level (2-tatled), llS"' not stgmficant 
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Table 37- Logistic Regression Analyses to assess the relationship between 
isoflavone levels and cognitive impairment (stratified by nrban/ruralliving area) 
Table shows the results of regressiOn analyses usmg the 'Enter' method which assesses salivary 
1soflavone levels as a predictive factor for cogmt1ve Impairment m analyses stratified by urban or rural 
l!vmg area In the first step of analyses, only daHizem and gemstem were entered In the second step, 
mtake of fruits, vegetables and fish were entered See appendix 14 for model summary 
Area Vanable Entered I B I SE Exp(B) Slg I 95°/1, C 1 for Exp(B) 
Step 1 
Da1dzcm 410 34 13 60469 ns 0 000 • 7E+030 
Gemstem 62 19 52 83 I E+027 ns 0 000-9 3E+071 
Constant -13 02 407 00 0 001 
Step 2 
= Da1dzem -17 45 37 95 00 ns 0 000- 5E+024 • .,
" Gemstem 7341 5741 8E+031 ns 0 000- 5 6E+080 ;, 
Frmt -06 12 94 ns 0 742- I 192 
Orange/Red Vegetables - 12 12 88 ns 0702-1110 
Green Vegetables -09 11 91 ns 0 731 - I 137 
F1sh -06 13 62 ns 0737-1200 
Constant -4 44 5377 23 012 0999 
Vanable Entered B SE Exp(B) S•g 95% C I for Exp(B) 
Step 1 
Da1dzem 30 71 28 55 2E+OI3 ns 0 000- 4E+037 
Gemstem -36 17 49 06 00 ns 0 000- 6E+024 
Constant -5 82 3 37 00 0084 
.. 
Step 2 
" Dmdzcm 17 50 29 48 4E+007 ns 0 000- 5E+032 = 
" Gem stem -47 20 50 66 00 0 000 - 4 E+022 ns 
Frult -06 10 94 ns 0 771 -1149 
Orange/Red Vegetables -11 08 90 ns 0775-1043 
Green Vegetables 14 07 115 003 1016-1309 
F1sh -09 07 92 ns 0 808 -I 042 
Constant -5 57 3 50 004 011 
. 
-
. U Sldndard>sed beta. SE standard error Exp{BJ chilllge m predu;ted odd!; of Cl for each change m prediCtor 'armble also knuwn as the odds r.auo 
S•g = s•gnllicancc level 95% Cl for Exp(B) m 95% confidence mter\al for hp(B) 
"'S1gmficant at the <0 05 level (2-talled), ns"' not stgmficant 
5.8.8.3 Stratified by Median Age (see table 38) 
In analyses stra!Jfied by medJan age of younger than (n=l45) or older than (n=l24) 68 
years of age, ne1ther soy foods of tofu or tempe were s1gmficantly assocJated w1th CI 
w1th or w1thout controllmg for mtake of other foods However, m those younger than 
68 years of age, h1gh mtake of green vegetables was trend level assoc1ated w1th CI, 
mcreasmg the odds of CI by a factor of 1 14 Furthermore, low orange/red vegetable 
mtake had a trend level s1gn1ficant assocmtwn w1th CI Salivary 1soflavone levels 
were not s1gmficantly assoc1ated w1th CI 
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Table 38 - Logistic Regression Analyses to assess the relationship between soy 
food intake and isoflavone levels with cognitive impairment (stratified by median 
age) 
Thts table shows the results ofregresswn analyses usmg the 'Enter' method wh1ch assesses soy food 
mtake and sahvary tsoflavone levels as predtctlve factors for cogmttve Impairment stratified by median 
age (less than or great than 68 years of age) In the first step of analyses, only tofu and tempe were 
entered In the second step, 1soflavone levels were entered, and m the th1rd step mtake of frmts, 
vegetables and fish were entered See append1x 15 for model summary 
l\1ed1an 
A" \'anab\e Entered B SE E>n(Bl p Value 95% C I for Exn(Bl 
Step t 
lofu -0 02 0 13 098 
'" 
0768-1261 
Tempe 006 0 13 I 06 
'" 
0822-1359 
Constant -28 724 006 0 699 
S« 2 
Tofu -0 02 013 098 
"' 
0768- I 261 
Tempe 0 06 013 1 06 
"' 
0822-1359 
Da1Cl7em -7 77 23 28 0 
"' 
0000-3E+0\6 
r Gemstem 26 65 38 17 4 OOE+Jl 
'" 
0 000 - I 2£+044 
• Constant -3 93 741 002 0 595 ~ 
~ Step 3 ~ 
' 
Tofu -0 \I 019 09 
"' 
0624-1299 
Tempe 011 0 19 Ill 
"' 
0771-1600 
Da1dzem -20 02 26 84 0 
"' 
0000-1E+Ol4 
Gcmstem 48 98 42 28 200E+21 
'" 
0 000- I 8E+057 
FrUit -0 22 015 08 
"' 
0599-1066 
Orange/Red Vegetables -0 15 0 09 0 86 0 09 0724-1025 
Green Vegetables 013 0 07 114 0 06 0994-1302 
Ftsh -0 1 0 07 09 
"' 
0791-1034 
Con~tant -2 71 8 26 0 067 0 743 
Vanable Entered B SE Fxp(Bl pValue 95% c 1 for Exo(m 
Step t 
Tofu 0 06 0 09 I 06 
'" 
0885-1272 
Tempe -0 11 0 09 09 
"' 
0749-1078 
Constant -9 19 559 0 
"' Step 2 
Tofu 0 08 0 09 1 09 
"' 
0904-1304 
Tempe -0 13 0 09 0 88 
"' 
0728-1052 
Datdzem 55 22 41 86 5 OOE+23 
'" 
0000-21E+058 
0 Gemstem 109 39 69 05 0 
'" 
0 000 • 2E+011 
• ~ 
~ 
Constant -8 47 5 05 0 009 
~ Si< 
' A Tofu 014 011 115 
"' 
0 926 • I 433 
Tenme -0 17 011 0 85 
"' 
0690-1042 
Datd7em 71 09 45 68 7 OOE+3-0 
"' 
0 000 - 5 7E+069 
Gem~tem 135 58 72 28 0 
'" 
0 000-439 264 
Frmt -0 11 0 09 09 
'" 
0749-1069 
Orange/Red Yel!etables -015 163 0 87 
"' 
0692-1081 
Green Vel!:ctablcs -0 Ot 0 09 I 
"' 
0833-1189 
Ftsh 0 07 013 I 08 
"' 
0831-1395 
Con~tant -15 52 698 0 0 03 
8- standardtsed beta, SE -standard error, Exp(B)- change m predtcted odds of Cl for each change m predtctor 
\anable also known as the odds ratto Stg = stgmficance level, 95% Cl for Exp(B) = 95% confidence mterval for 
Exp(B) 
• Stgmficam at the <0 OS le\el (2-t.u\cd) ns= not stgmficant 
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Table 39- Logistic Regression Analyses to assess the relations between soy food intake and isollavone 
levels with cognitive impairment (stratified by gender) 
This table shows the results of regressiOn analyses usmg the 'Enter' method which assesses soy food mtake and salivary 
Isoflavone levels as predictive factors for cogm!Ive Impairment stratified by gender In the first step of analyses, only tofu and 
tempe were entered In the second step, 1soflavone levels were entered, and m the thtrd step rntake of fnuts, vegetables and fish 
were entered See appendtx 16 for model summary 
Men Women 
Vanable Entered B I SE I Exp(B) I S1g I 95% C I foc Exp(B) 8 SE E<p(B) Sog 95% C I for Exp(B) 
Step 1 Step 1 
Tofu -22 23 80 ns 0515-1248 28 12 132 0018 1049-1661 
Tempe 23 22 I 26 ns 0813-1957 -27 12 77 002 0611-0959 
Constant -7 71 4 86 000 0 112 -4 26 2 46 01 0 083 
Step 2 Step 2 
Tofu -23 23 80 ns 0 505 -I 255 27 12 I 31 0021 I 042 - I 655 
Tcmpe 24 23 127 ns 0809-1994 -26 12 77 0 022 0613-0964 
Datdzcm 34 17 40 78 7 OOE+t4 ns 0 000- 3 5E+049 -I 62 2145 199 ns 0000-4E+OI7 
Gem stem -56 32 70 20 00 ns 0 000 - 2E+035 18 12 37 24 7 OOE+07 ns 0 000- 4E+039 
Constant -10 32 6 31 0 00 0 102 -4 93 2 79 01 0 077 
Step3 Step 3 
Tofu -35 34 71 ns 0361-1390 38 15 146 0010 I 095 - I 954 
Tempc 52 37 I 69 ns 0814-3505 - 32 14 73 0 021 0 552- 0 952 
Da1d1em 146 12 94 85 2 90E+63 ns 0000-16E+I44 -9 90 22 70 0000 ns 0 000- IE+OIS 
-Gem stem 313 10 185 10 00 ns 0 000 - 4E+021 30 42 39 29 2E+OI3 ns 0 000- 4 5E+046 
rnut -I 17 51 31 0023 0114-0852 -07 08 93 ns 0795 -I 086 
Orange/Red Vegetables -24 19 79 ns 0539-1150 - 11 07 90 ns 0808-1026 
Green Vegetables 24 17 I 28 ns 0 922 -I 767 -03 06 97 ns 0 855- I 095 
fish 13 19 I 13 ns 0 789- I 630 -08 06 92 0 19 0820-1041 
Constant .J I 16 13 94 0000 0025 -647 3 38 002 0 06 
B• stand.nd,sed beta. SE "'St;lndard error Exp\B)"' ch1nge m predtctcd odds of Cl for each change m pmhctor•anab\e also known as the odds ratlo Stg"' stgmlicance le\e\ 9~% Cl for Exp(B) '"'Q~•. confidence 
mtcn:ll for [,p(B) 
• Srgmficant at the <0 05 \c;el {2-tatkd) ns-= not Sll!ntficant 
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5.8.8.4 Stratified by Gender (table 39) 
Analyses stratified by gender assessed both soy food mtake and salivary !so flavone 
levels, controlhng for age, educahon and d1stnct and professwn For men, Cl was 
not s1gmficantly associated w1th e1ther soy food mtake However, low frmt mtake 
was mdependently s1gmficantly assoc1ated w1th Cl wh!lst controlhng for other 
demographic vanables (OR= 0 56) S1gmficant assoc~atwns pertammg to soy mtake 
were only seen for women m analyses spht by gender, w1th and Without controllmg 
for other foods Low tempe mtake was s1gmficantly associated w1th Cl for women 
even when controlhng for other food mtake (OR= 0 73). AddJtJOnally, h1gh tofu 
m take was mdependently associated w1th Cl for women (OR= I 46) However, for 
both men and women, sahvary 1soflavone levels were not s1gmficantly 
mdependently assoc1ated w1th cogmtJve group (trend observed for an assoc1atwn 
between lower gemstem levels and Cl for men) See appendix 16 for model 
summary 
5.8.8.5 Stratification by Median Age and Living Area 
5.8.8.5.1 Analyses of Soy Foods 55 
In these analyses the sample was stratJfied by hvmg d1stnct (Jakarta, Sumedang, 
Borobudur) as well as by med1an age (less than or greater than 68 years of age) In 
Jakarta and Sumedang, and Borobudur for both those under and over the med1an 
age of 68 years, soy intake of tofu and tempe were not s1gmficantly associated with 
cogmhve group In Borobudur m those under 68 years of age, h1gh mtake of green 
vegetables showed a s1gmficant association w1th Cl (OR=! 30) 
5.8.8.5.2 Analyses of Salivary Isollavone Levels 55 
In urban areas for those both under and over the med1an age of 68 years, neither 
observed sahvary gemstem nor dmdzem levels were sigmficantly associated With 
CL In rural areas (1 e Sumedang and Borobudur), th1s was also the case for those 
younger than 68 years of age 
5.8.8.6 Stratified by gender and median age 55 
In these analyses, no s1gmficant assoc1atwns between soy mtake and sahvary 
isoflavone levels With cogmtJve group were observed for men, both over and under 
~ 5 See Table I - 7, append1x 17 for model statJsttcs summary and the number of partiCipants m each stratified group 
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68 years of age as well as for women under 68 years of age For women under 68 
years of age, low fish m take was s1gmficantly assocJated With Cl (OR=O 84) 
Furthermore, there was a trend for low orange/red vegetable mtake was also 
associated w1th Cl (OR= .769, 95% Cl 0 571- I 035, p=O 083) For women over 
the age of68 years, low tempe mtake (OR= 0 64) was s1gmficantly associated w1th 
Cl However, when other foods were added mto the analyses, th1s assoc~al!on 
between soy intake and Cl was no longer s1gmficant wluch could relate to reduced 
power of these analyses 
5.8.8.7 Stratified by gender and living district 55 
5.8.8.7.1 Analyses of Soy Foods 
For both men and women hvmg m Jakarta and Sumedang, no s1gmficant assoc1atwn 
was observed between soy mtake and cogmt1ve group However, m Borobudur, for 
women only, a trend level assocJal!on was observed between low tempe mtake (OR 
= 0 80) and h1gh tofu mtake (OR= 1 29) and Cl Th1s assoc1at10n was not found 
when controlhng for other foods Furthermore, low orange/red vegetable mtake was 
s1gmficantly assoc~ated w1th Cl for women m Borobudur (OR= 0.75) 
5.8.8. 7.2 Analyses of lsoflavone Levels 
No s1gmficant assoc~al!on was observed between sahvary 1sof1avone levels and 
cogmtJve group for e1ther men or women hvmg m an urban or a rural area 
However, for men m rural areas a trend s1gmficant assocJatJOn was observed 
between low fru1t mtake and Cl (OR= 0.38) Add1l!onally, a trend s1gmficant 
negatiVe assoc1at10n was also observed between low orange/red vegetable mtake 
(OR=0.73), and h1gh green vegetable mtake (OR= I 26) and Cl for women m rural 
areas 
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CHAPTER 6- THE EFFECTS OF ISOFLAVONES ON MEMORY IN 
POSTMENOPAUSAL WOMEN (RANDOMIZED PLACEBO 
CONTROLLED TRIAL) PRELIMINARY RESULTS 
6.1 Introduction 
Previous research has suggested that the effects of phytoestrogens on cogmtive 
function may be dose dependent This can be seen by companng the findmgs of 
observatiOnal studies m different populations with varymg m take of phytoestrogens 
(see literature review sectiOn 2 3 2) For example, negative effects of high 
phytoestrogen when compared to lower mtake was observed m Japanese-Amencan 
samples (White et al, 2000) Conversely, no significant effects of phytoestrogen 
consumptiOn on cogmtive functiOn have been found m populations whom consume 
a much lower doses than m Asian countnes, e g between 0 14 mg and 15mg per 
day eqmvalent of phytoestrogens compared to 30 mg m Asian countnes 
(KreiJkamp-Kaspers et al., 2007, Franco et al , 2005) Ammal studies have reported 
positive effects on phytoestrogens on workmg memory, for example, m 
ovarectomized (OVX) rats (Lund et a! , 2001; Pan et al , 2000). See also appendix 8 
Similar findmgs reported m a human RCT (File et al, 2001) winch found a positive 
effect of a high soy diet (I 00 mg/day) compared to a low soy diet (0 5 mg/day) on 
long and short term memory and mental flexibility for pre-menopausal women and 
young men Additionally for women only, a positive effect was also observed m 
frontal functwnmg and plannmg ability (see appendix 8) It IS possible that specific 
optimal levels are needed m order to have a positive effect on cognition, which may 
mteract with age, gender and menopausal status Possible optimal levels of 
phytoestrogen mtake were also found m our earlier observatiOnal work for women 
younger than 68 years of age (see section 5 8) PreviOus studies mdicate that the 
dose should not be too low (no effect will be found) or to high (possible toxic 
effects on neurons) We mvestigated the dose dependent associatiOn between 
phytoestrogen supplement m take and verbal memory and speed of mformatwn 
processmg m postmenopausal women younger than 65 years of age m 
Loughborough, lfl( 
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6.2 Methods 
6.2.1 Design 
In th1s p!lot random1zed, double-bhnd, placebo controlled des1gn, part1c1pants were 
allocated to one of three treatment cond1t1ons 
A Placebo (v1a two sugar p1lls) 
B Phytoestrogen supplementatiOn- 30 mg (v1a two 15mg p1lls) 
C. Phytoestrogen supplement- I 00 mg (v1a two 30 mg p!lls) 
Ail testmg was done m the mommg (8-11 am) to avmd dmmal vana!Jon The 
dependent vanable bemg measured was verbal memory v1a cogml!ve tests To 
control for expenmenter b1as, detmled standardised mstructwns for mves!Jgators 
were prov1ded. Expenmental group were ass1gned m a random1zed double-bhnd 
fashwn usmg a computer algonthm 
See appendix 18- 20 for capsule analys1s from the manufacturer 
6.2.2 Participants 
Healthy women w1th an age range between 49- 65 years old took part m th1s p!lot 
study See Table 40 below for mcluswn and excluswn cntena The part1c1pants 
were approached v1a advertisement (flyers, emml, umvers1ty mmlmg hsts, posters, 
newspaper adverts) Etlucal approval was granted through the local eth1cs 
committee at Loughborough Umvers1ty 
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Table 40 -Inclusion and Exclusion Criteria for pilot RCT 
Inclu~;~wn Cnter1a ExclusiOn Cntena 
Aged 45- 65 years old Use of supplementary hormones (mcludmg 
hormonal contraceptiOn w1thm the last 3 
Good health as assessed by self-report months) 
questwnna1re 
Use of antibmtiCS m prevwus SIX months 
Post- menopausal (women): last menses 
longer than 6 months ago Prevwus hiStory of thromboSis 
Surgical or natural Menopause Demgn or malignant growths 
H1story of breast, ovanan or endometnal 
cancer 
Psyclnatnc diSorder (for example chmcal 
depressiOn) 
Pregnancy 
Dementia (e.g. Alzheimer's diSease) 
Epilepsy 
VISion I ear I heanng problems 
Dyslexia 
Pre-menopausal women 
Regular soy food consumer 
6.2.3 Procedure 
This study consists of3 stages (see Figure 13)-
Stage I: Telephone mterview and prehmmary screenmg 
Stage 2. Baselme- (further screening, milia! testmg for baseline data) 
Stage 3 Expenmental CondJ!ion- 6 weeks (cogmlive testmg after phytoestrogen 
mtake) 
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Figure 11- RCT Procedure 
Telephone Interview and 
Preliminary Screening 
A B c 
BASELINE BASELINE BASELINE 
Placebo Phyto Low Dose (30 m g) Phyto High Dose (100 mg) 
Heallh Screen + Demographics Heallh Screen + Demogrephlcs - Heallh Screen + Demogrephics 
Cognitive Testing Cognitive Testing -Cognitive Testing 
Saliva Sample Saliva Sample -Saliva Sample 
6wee ks----'--·-------t--- -----1-·---
A B c 
EXPERIMENTAL CONDmON EXPERIMENTAL CONDmON EXPERIMENTAL CONDmON 
Placebo Phyto Low Dose (30 m g) Phyto High Dose (100 mg) 
-Cogmtive Testing -Cognitive Testing -COgnitive Testing 
-Saliva Sample -Saliva Sample -Saliva Sample 
Stage 1 - Telephone Interview and Preliminary Screening 
Participants were spoken to on the phone for a brief introduction to the study and its 
aims (see appendix 21). They are then asked a short list of questions designed to 
check inclusion and exclusion criteria. If successful, a date for Stage 2 was made. It 
was explained to the participants that sensitive data are kept confidential. Although 
the nature of the study did not put the participants at any physical or mental risk, nor 
discomfort/distress, they were made aware that they and their data could be 
withdrawn from the study at any time without having to give a reason and without 
fear of any repercussions. 
Stage 2 - Baseline 
Participants were instructed to arrive at the Human Sciences Department, 
Loughborough University in the morning at a fixed time between 8 - 11 am where 
they were met by the researcher. This test time remained the same throughout the 
period of the study. They were instructed to refrain for drinking alcohol on the 
previous night and not eat anything the morning of the testing. Participants were 
guided though the information for volunteers details (see appendix 22) and signed 
the informed consent form (see appendix 23). They were instructed on what foods 
and supplements to avoid before the next testing session (a list ofphytoestrogen 
containing foods), as well as the procedures they are expected to follow. 
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Participants completed a health and demograph1cs questwnna1re (appendix 24) 
wh1ch provided mformatwn on demograph1cs, lifestyle, fam1ly med1cal history and 
a detailed account of potential mediCal and health particulars He1ght and we1ght 
measurements were taken to later calculate Body Mass Index (used as a covanate) 
After nnsmg the1r mouth w1th clean water (to cleanse the mouth), partiCipants also 
prov1ded a saliva sample wh1ch was frozen at- 20°C for later analys1s56• After the 
saliva sample was g1ven, a s1mple standardised breakfast of toast, Jam and tea, 
coffee or orange jmce was eaten 
Three tests of verbal memory were completed for baselme data. The Hopkms 
Verbal Leammg Test (HVLT) 1mmed1ate recall (IR) and delayed recall (DR) 
(see sectwn 4.1 4 2) The Category Verbal Fluency Test (CVFT) (Ben ton & 
Hamser, 1978) (appendix 25). Th1s task reqmres the partiCipant to verbally generate 
as many words as poss1ble that belong to the category 'Ammals' m a lime span of 
60 seconds The CVFT (Ammals) has the advantages ofbemg qmck, cross-
culturally valid, educatwnal msensJ!ive, and used in a w1de vanety of 
neuropsychological test battenes (Ardila, Ostrosky-Sohs, & Bemal, 2006) The 
effects of soy consumptiOn on th1s test are unclear and mcons1stent (Duffy et al , 
2003, Kntz-SJlverstem et a!, 2003) However, there 1s a female-spec1fic gender b1as 
on tests ofth1s nature (1 e. verbal memory) (K1mura, 1996). The East Boston 
Memory Test (EBMT) (appendix 26) was first used m an observatwnal study 
(Scherr et a!, 1988) It IS a short story w1th three sentences wh1ch mclude 12Jtems 
The partiCipants were read the story and asked to JmmedJately repeat 1t They were 
allocated one pomt for each of the twelve pomts remembered. Delayed recall of the 
EBMT was also assessed at the end of the test sesswn (approximately 30 mmutes) 
Scherr et a! (1988) reports that the EBMT IS sensitive to changes m memory as well 
as age The EBMT has also been reported to correlate h1ghly w1th the MMSE (see 
section 4 1 4.2.1 for a descnp!ion ofth1s test) and to be sensitive m detectmg Cl 
(Gfeller & Horn, 1996) 
~6 Assays wlll be performed usmg HPLC or Mass Spectrometry method at the 8JOchem1stry laboratory at Loughborough 
Umvcmty Unfortunately, both spectrometry methods are st11l bemg vahdated at Loughborough Umvers1ty, therefore analySIS 
of the sahva samples was not ready m t1me for th1s thes1s and Will therefore be used for future pubhcatJOns after more data has 
been co\1ocated See sect10n 4 1 4 3 for senslt!Vtty and speclficlly of the HPLC spectromctry method 
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Speed of mformation processmg (both simple and complex) has been found to be 
sensitive to the effects of non-successful cognrt1ve agemg (Jolles. 1986) for 
complex information process111g. exercise( van Boxtel et al , 1997), and HRT 
(Hogervorst et al , 2000) The Symbol digit modalities test (SDMT) (Smith, 1982) 
(appendix 27) IS a test of Simple information p10cess111g which assesses attentiOn 
and concentratiOn us111g VIsual scaimmg and track111g A key show111g n111e 
geometnc symbols each labelled with a number from 1 - 9 was shown, and 
partiCipants were reqmred to label a random hst of >ymbols With the correct 
correspondmg number After a few guided examples to ensure a clear understanding 
of the task, pm1Icipants had 90 seconds m which to perform and were told to work 
as qmckly, but as accurately as they could without missmg out m1y symbols The 
total nUinber of symbols attempted, total number of 111correctly Identified symbols, 
and the final number (mmus the errors) are recmded 
Mood can affect cogmtive funct10n111g and was assessed on the day of cogmtive 
testmg via two qucstiOI111aJres, Moo's Distress QuestJOI111aJre (Moos, 1968) (see 
appendix 28) and the COPE daily diary (Morto1a, Girton, Beck, & Yen, 1990) 
(appendix 29) 
Stage 3 -Experimental Condition 
Participants had been 111structed to take one of the allocated pills the mornmg before 
test111g (24 hours before), Immediately upon wakmg, and the other Immediately 
before going to bed on the mght before (I 0 hours before) testmg to obtam maximal 
levels and mvestigate potential24 hour dendntlc sproutmg effects of estrogen 
(Woolley & McEwen, 1993). Upon their return to the laboratory, participants 
followed the same procedure as 111 stage 2 and completed the same cogm!Jve tests 
6.2.4 Compliance 
In order to ensure the participants consumed the supplements as duected and were 
comfortable and happy With the procedure, participants were contacted by letter I 
week before Stage 3 (which reqmred pill consumptiOn) to remmd them of the 
procedure to follow and confirm the test time and day Compliance will also be 
momtored via assay assessment of anomalies 111 phytoestrogen levels found 111 the 
saliva samples (not completed at time of pnntmg) 
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6.2.5 Statistical Analyses 
Descnp!Ive analyses were performed to assess any dtfferences between treatment 
groups on a number ofvanables Cht-square analysts was run for categoncal data 
and AN OVA for contmuous data The vanables assessed were the demographtc 
vanables of age, educatton, professton and ethmctty, health behavtours (smokmg 
and exerctse), mood, and performance on the cogm!Ive tests (sesston I, sesston 2 
and change from basehne 
In order to control for posstble leammg effects, cogmttve test performance was 
measured as change from baselme Therefore, umvanate ANOV A was used to 
assess the dtfferences between treatment groups m cogmttve test performance 
Analyses controlled for age, mood (Moo's and Cope), and BM! Bonferrom 
correcttons were used due to multiple compansons 
6.3 Results 
6.3.1 Sample Demographics (see table 41) 
In thts ptlot study, fifteen parttctpants successfully completed the study Due to 
subject drop out, cells were unbalanced and there was an uneven number of 
parttctpants m each treatment group (placebo n=6, 30 mg n=5, 100 mg n=4) The 
mean age of the parttctpants was 55.47 ± 5 74 (range 49- 65 years) Most 
parttctpants had achteved secondary or umverstty level educatton (n=6 and n=8 
respecttvely), and one parttctpant only had a pnmary level educatton The maJonty 
ofparttctpants were Caucastan (n=12) Nearly half the sample was currently usmg 
medtcatton (n=7) and the maJonty ofparttctpants dtd not smoke (n=14) and 
exerctsed on a regular bases (n=l4) mdtcatmg a healthy hfestyle 
Parttctpants m the 30 mg group were stgmficantly older (61 ± 4 30) than 
parttctpants m the 100 mg group (50± 1.16) and placebo (54.50 ± 4 60) groups 
(F=9 I 0, p=O 004) No stgmficant dtfference was observed between treatment 
groups m educattonal attatmnent, ethmctty, medtca!Ion use, smokmg and exerctse 
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Table 41- Sample Demographic Variables 
Table 41 displays the differences between groups m demographic vanables Umvanate ANOVA 
analyses were used to assess the differences between groups m age and cht-square analyses for all 
other categoncal vanables 
Demographic Vanables Whole Placebo 30 mg 100 mg Cnt1cal df Groun Value 
N 15 6 5 4 
Al!e, mean± SD 55 47 (5 74) 54 60 (4 59) 61 00 (4 30) 500(115) 91 2 
Education, N (%) 
Pnmary I (6 7) I (16 7) 0 (0) 0 (0) 2 82 4 
Secondary 640 0) 2 (33 3) 3 (60 0) I (25 0) 
Umvemtv or hll!hcr 8 (53 3) 3 (50 0) 2 (40 0) 3 (75 0) 
ProfessiOn 
H1gher- Manager, ad mm, 
I (6 7) 0 (0) 0 (0) I (25 0) professiOnal 
lntermedtate- Manager, ad mm, 5 (33 3) 2 (33 3) I (20 0) 2 (50 0) 
professmnal 
6 83 8 
SuperviSory or clencal, Jumor 5 (33 3) 2 (33 3) 2 (40 0) I (25 0) 
manager, ad mm or professiOnal 
Student I 67) 1(167) 0 (0) 0 (0) 
State Pens10ner, no other earner, 
causal or lowest ~rade worker 3 (20 0) I (167) 2 (40 0) 0 (0) 
l:.thmc1ty 
Caucaswn 12 (800) 4 (66 7) I (16 7) I (16 7) 2 58 4 
As1an 2 (13 3) 4 (80 0) I (20 0) 0 (0) 
Black I (6 7) 4 (100) 0 (0) 0 (0) 
On medJcatwn at present 
Yes 7 (46 7) 2 (33 3) 4 (66 7) I (25 0) 3 42 2 
No 8 (53 3) 4 (80 0) I (20 0) 3 (75 0) 
Do you smoke? 
Yes I (6 7) 0 (0) 0 (0) I (25 0) 2 95 2 
No 14 (93 3) 6 (lOO 0) 5(1000) 3 (75 0) 
Do you exerctse on a regular 
bas1s? 
Yes 14 (93 3) 6 (lOO 0) 4 (80 0) 4(1000) 2 14 2 
No I (6 7) 0 (0) I (20 0) 0 (0) 
p Value 
0 004* 
ns 
ns 
ns 
ns 
ns 
ns 
Cnt1cal value refers to f = ANOV A, x2 = ch1·square, p Value= sJgmficance, df= degrees of freedom, • CorrelatiOn 1s s1gmficant at the 
0 Ollevel (2-ta~led), ns =correlatiOn 1s not s1gmficant 
6.3.2 Verbal Memory (see table 42 and see appendix 30 for SPSS statistical 
output) 
A trend level difference was observed between groups m HVLT- IR (change from 
baselme score) (F=3 152, df=2, p=O 087) The placebo group had a greater mcrease 
m HVLT- IR score than both the aclive treatment groups Furthermore, a trend 
level difference was observed between groups in change from baselme for the 
HVLT (DR) (F = 3 01, df=2, p = 0 087) m analyses not controllmg for age and 
BMI The placebo group agam had a greater improvement than both treatment 
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groups even when controllmg for BMI and age Furthermore, we found that women 
who mgested a total of30 mg ofphytoestrogens over 24 hours previOusly scored 
worse m sesswn 2, although baselme scores were not s1gn1ficantly d1fferent from 
the control or 100 mg groups (p=O 20). However, when BMI and age were 
controlled, th1s trend assoc1atwn was no longer observed Th1s could be related to 
the fact that women m the 30 mg group were s1gn1ficantly older than those m the 
other groups wh1ch may have medJated the 1ml!al results 
A s1gn1ficant effect of treatment (F = 4 057, df=2, p =0 05) was observed for the 
change from baselme on the CVFT (BM! and age entered as covanates) Th1s was 
specifically observed m compansons between placebo and I 00 mg, w1th placebo 
part1c1pants havmg s1gn1ficantly worse performance m the second test sess10n and 
I 00 mg treatment showmg the largest Improvement. Agam, baselme scores were not 
s1gn1ficantly different between groups The placebo group performed worse m the1r 
second test sesswn and effects remamed s1gmficant and mdependent from age and 
BMI (see figure 12) 
Table 42- Change from Baseline in Cognitive Function Scores for Treatment 
Groups 
Table 42 shows the change f10m baselme means scores m the cogml!ve tests used for the whole 
sample and stratified by treatment groups ANOV A analyses were used to assess the drfferences 
between groups m these scores 
Change from 
Basehne Whole Placebo 30 mg 100 mg F df p Value Score mean± Group value 
SD 
HVLT (IR) -2 60 (7 59) -2 50 (1 64) 0 80 (1 10) -1 00 (0 82) 3 15 2 0 087 
HVLT (DR) -0 80 (I 52) -I 83 (I 72) 0 (I 23) -0 25 (0 50) I 50 2 ns 
EBMT(IR) I 53 (I 64) 217(172) 060(167) 175(126) 0 42 2 ns 
EBMT(DR) -I 40 (2 23) -2 17 (2 32) -I 20 (I 92) -0 05 (2 65) 0 91 2 ns 
CVFT 0 87 (3 70) -150(259) 0 80 (2 77) 4 50(3 70) 4 06 2 0 OS* 
SDMT 3 27 (5 92) 050(459) 3 0 (6 36) 7 75 (5 68) I 80 2 ns 
F value for ANOV A analyses cnttcal value, df= degrees of freedom, p Value= stgmficancc level, *CorrelatiOn Js SJgntficant at the 
0 01 level (2~taJled), ns =correlation 1s not stgmficant 
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Figure 12- Changes from baseline score for the Category Verbal Fluency Test 
(CVFT) 
IOOiaJ;botliVonc: 
No significant effect of treatment was observed for the EBMT (IR and DR) as well 
as the SDMT. 
6.4 Preliminary Conclusion of RCT 
The results of this small pilot study indicate that better (when compared to placebo) 
semantic memory (verbal fluency) was associated with high (as opposed to lower) 
phytoestrogen intake and that this association was independent of age57. This 
association has been previously reported (File et al., 2001 ), but was not found in 
other studies (File et al., 2005; Howes et al., 2004; Duffy et al., 2003; Kritz-
Silverstein et al., 2003). 
A limitation of this study is that due to subject drop-out, treatment groups were 
unbalanced. In addition, participants in the 30 mg group were significantly older 
than the other two groups. However, in ANOV A analyses, age was entered as a 
covariate and was also not significant in these analyses, indicating that the 
relationship between phytoestrogen treatment and verbal fluency was not mediated 
by older age. 
51 For both episodic verbal m:mory and semantic verbal Oucncy. 
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The mam hmitatlOn of this study IS the small number of participants Post hoc 
power analyses usiDg effect size as a measure ofvanance58 gave a suggested power 
of 0 954 revealed that 66 partiCipants {n=22 per group) would be needed to obtam 
this Our current analyses had 0 582 power. However, while the results reported are 
prehmiDary, they are similar to ear her reports findiDg positive effects of 
phytoestrogen IDtake on category fluency (Kntz-SI!versteiD et a! , 2003) ID women 
younger than 65 years of age Also reflective of this study, (Kntz-SiiversteiD et a!, 
2003) did not find any significant effects on other types of verbal memory For 
example, story recall (the EBMT assessed this ID our study), logical memory (the 
current study used the SDMT to assess this), and complex processiDg speed (not 
reported ID this thesis) This 1Dd1cates that, Similar to findiDgs With Es, 
phytoestrogens may have a test specific effect InterestiDgly, studies IDVestigatiDg 
menopausal change also show the largest differences on the verbal fluency task 
(Fuh, Wang, Lee, Lu, & Juang, 2006) 
To our knowledge this IS the first study findmg positive effects of phytoestrogens 
after 24 hours F1Dd1Dgs may 1Dd1cate that once a day IDtake of phytoestrogens could 
have a positive effect on cogmtwn This IS especially relevant to Asian populatwns, 
such as Indonesia, whom consume phytoestrogen nch foods at least once a day (or 
more than once a day as was found m our observatiOnal study (see sect10n 5 8) 
We expected a significant difference m cognitive functiOn after 24 hours due to 
previous findmgs reportmg that OVX-mduced reduction m dendnt1c sp1De density 
was revered after 24 hour estrogen exposure (Woolley & McEwen, 1993) 
However, and reflective of the Indonesian sample prev10usly descnbed, the effect of 
regular consumption through the day m diet as opposed to a once a day dose needs 
to be taken IDto cons1derat10n (Setchell et a! , 2003). In the current study, It was 
hypothesized that participants would have optimal levels at the time of testiDg This 
was based on findiDgs by (Setchell et a!, 2003) who reported the termmal half-hfe59 
of da1dzem and gemstem IS approximately 8-10 hours Therefore, the current study 
58 An average partml eta-squared (1)2) from ANOY A analyses of all the cogmt1ve tests assessed (mean 1)2"" 0 2006667) was 
entered m to G Power" h1ch calculated the effect stze as 0 5010415 G Power was used to calculate actual power and sample 
stze needed 
http //www psycho unJ-duessc\dorf delaap/prOJCCts/gpower/ 
59 The term 'half-hfe' m phannacokmetJCS refers to the mterval requtred for the quantity to decay to half of tts mlttal value 
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potentlally ach1eved optlmallevels at the pomt oftestmg as partiCipants consumed 
the Jsoflavones 24 hours before and 10 hours before cogmtlvc testmg 
Although a poss1ble mfluence of dose was found m the current study, confuswn stlll 
ex1sts as to whether a lmear relatwnsh1p ex1sts between bwavaJ!abJ!Jty and 
mcreasmg dose (Setchell et a!, 2003, Setchell et a!, 2003, Bloedon et a! , 2002, 
Busby et al., 2002) Setchell et a! (2003) and Setchell (2000) reported a posJ!Jve 
concentratiOn between Jsoflavone mtake and peak concentrations of da~dzem and 
gemstem, although th1s was non-lmear The same relatwnsh1p has been seen 
between bwavaiiabJ!Jty and mtake, w1th unne analyses showmg that over a 4 day 
penod a doub!Jng of the dose of1soflavones d1d not double the total recovery 
(Setchell et a! , 2003) Further stud1es assessmg dose of Jsoflavones m tandem both 
bwavaJ!abJ!Jty di!d cogmtlve functiOn are reqmred m order to have a clearer 
understandmg about the relatwnsh1p between these 1mportant factors 
As we have prevwusly reported, cross-cultural differences have been observed m 
phytoestrogen intake (see chapter 2.3.2) Observatwnal stud1es assessmg !JfetJme 
h1gh m take of phytoestrogens reported a negatlve effect on cogm!Jve functlon (R1ce 
et a!, 2000, Wh1te et al, 2000) Therefore, the effect ofhab1tual mtake of 
phytoestrogens (as m our Indonesian sample) on cogmtive functwn JS an area that 
warrants further mvestlgatwn Hab1tual mtake may have Jmp!Jcatlons for 
bwavaJ!abJ!Jty of isoflavones [for exaJnple Slavm, Karr, Hutchms, & Lampe (1998), 
Hutchms, Lampe, Martm1, Campbell, & Slavm (1995), Adlercreutz et a! (1993); 
Adlercreutz et a! (1982)] In a soy treatment study, Wiseman et a! (2004) assessed 
bwavaJ!abJhty as a result of chrome exposure to soy isoflavones over a ten week 
penod No difference was found between midpomt and endpomt concentra!Jons of 
1soflavones m plasma, unne and faeces wh1ch suggests there were no sigmficant 
effects of habitual mtake However, Woolley & McEwen (1993) reported that the 
mcrease m dendnt1c sproutmg as a result of estrogens peaked at two and three days 
and actually decreases over the precedmg 7 days Takmg these findmgs mto 
cons1deratwn, 1t could be suggested that mtenmttent mtake may be the most 
favourable regime to render positive effects on the bram of women who are younger 
than 65 years of age 
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It IS recommended that future studies also take other factors mto cons1deratwn For 
example, duratwn of soy consumption (Lu & Anderson, 1998; Slavm et a!, 1998, 
Lu, Grady, Marshall, RamanuJam, & Anderson, 1995), and genetically determmed 
metabolism rates affectmg d1gestwn and hence bwavmlab1hty of 1sof1avones (Boker 
et a!, 2002, Duncan, Merz-Demlow, Xu, Ph1pps, & Kurzer, 2000, Row land, 
W1seman, Sanders, Adlercreutz, & Bowey, 1999, Thompson, Robb, Serramo, & 
Cheung, 1991) 
To conclude, th1s pilot study observed that a h1gher dose of soy 1sof1avones was 
assocmted w1th better semantic verbal fluency 111 women under 65 years of age In 
order to 1mprove the power of the study, more partiCipants are reqmred It may be 
poss1ble that other mterestmg effects of phytoestrogen consumptiOn Will be 
observed on other cogmhve functwns when s1gmficant power has been ach1eved 
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CHAPTER 7- DISCUSSION 
7.1 Dementia Screening in Indonesia 
7.1.1 Reliability of the Test Battery Used in the Current Study 
One of the mam mms of this study was to evaluate the use of the cogmt1ve 
algonthm m a diverse populatiOn m order to assess If future adjustments are needed 
for demographic nsk vanables of age, educatiOn, gender and SES As previously 
discussed, the cogmtive algonthm used m this study has been found to be a 
sensitive and reliable way ofdetectmg dementia (Folstem, 2007, SchriJnemaekers et 
a!, 2006, De Jager et a!, 2003, Hogervorst et a!, 2002) Although both tests have 
mdlVldually been found to be valid m a multi-ethmc population (Kuslansky et a! , 
2004), a combmatwn of the tests as an algonthm has not been validated in a 
populatiOn with mixed ethnicity and depnved economic status The results of this 
study md1cated that adJustments to the cogmtive algonthm may not need to be made 
m future for educatiOn but assessmg readmg ability may be beneficial for the 
specificity of the MMSE and HVLT However, education should be adjusted for m 
an environment such as this with a high frequency of people With low educatiOnal 
attamment This IS of noticeable Importance as lower educatiOn was found to be a 
nsk factor for rural areas but only when not controlling for health and functiOnal 
ability, and thus may have been overshadowed by the possible effects of low SES 
and the consequences of that, 1 e poor health and disability (see sectiOn 2 2) Better 
measurement than 'professiOn before retuement' IS needed m order to ascertam 
whether adJustments also need to be made for SES m developmg countnes These 
factors are currently bemg evaluated for the second validatiOn stage of this study 
and are also discussed m sectiOn 7 7 
7.1.2 Participant and Caregiver Reported Cognitive Complaints 
Participant and care giver report of cogm!Ive complamts as well as other problems 
were used to corroborate er classificatiOn usmg the formal cogmtive algonthm The 
partiCipant report d1d not appear to be a reliable md1cator of er m this sample There 
IS a possibility ofunder-reportmg by the participant (when compared to the 
careg1ver) This could be due to demal of cogm!Ive problems It IS also hkely that 
askmg participants with possible memory problems to remember and report their 
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memory problems may not be the most accurate method of assessment By the very 
nature of the Impmrment, memory and agnosia problems may not be well reflected 
by mdividuals affected with these problems Although partiCipants and caregivers 
had httle correspondence for severe problems, the caregiver report60 did prove to be 
useful for some of the less severe cognitlve complamts possibly related to stroke 
type Issues ( execullve functwn, apraxia etc) Furthermore, the care giver report of 
memory problems had good correspondence With Cl as assessed by objectlvc tests 
The care giver report also showed possible dtscnmmatory abihty for assessmg 
different types of Cl m this populatwn 
Overall, the caregivers reported fewer cognttlve problems than the participant self-
report This could have Imphcatwns m dementla diagnosis This could be partly due 
to the methodological Issue ofhavmg few caregiver reports However, careg1vers 
were suspected to under-report cognitive problems of both cases and controls, to a 
somewhat similar magnitude which Implies that another factor may be mfluencmg 
this Specifically m this sample, caregivers were not always close relatives who 
hved with the participant and may not have had accurate mformatwn about health 
and other Issues For the Cl cases, the maJonty of carcrs (78%) were classified as 
'other', I e. a commumty centre volunteer or residentlal home carer, whilst only 
17% was a child and m even smaller (2%) was a spouse Therefore, the length of 
tlme they may have witnessed cogmhve detenoratwn should be taken mto account, 
but we were unable to do so at the llme oftestmg 
It IS common, and may be the case m an Indonesian populatwn, for memory 
problems and behavwural problems which are usually associated with demenha to 
be 'expected' m the elderly and hence be viewed as part of normal agemg and less 
as an abnormahty (Yu et al., 1993) This has benefits when reportmg cognitive and 
health problems of their elderly as caregivers are less hkely to over-emphasismg 
Issues due to feelmgs of burden and stress However, the Idea that these problems 
are part of normal agemg may also lead to a delay or reductwn m reportmg 
symptoms of demenlla to health authonhes, and therefore an artificially low 
prevalence rate as well as later dementla detection This IS particularly problematic 
60 It must be noted that a caregtver was avatlable for only 43% of the total sample (n=719) 
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m an Indonesian populatwn as the culture IS one of respect toward the elderly and 
hence careg1vers could have been under-reportmg cogmuve problems for th1s 
reason These pomts need to be taken mto account when corroboratmg patient's self 
report and cogmt!Ve test results 
In communities such as th1s, the fam!ly umt vanes considerably from that of a 
Western soc1ety In As1an commumtles, due to the nature of the fam1ly umt and the 
role the fam1ly play m canng for the elderly, careg1vers do not have the same 
d1stress responses as Western careg1vers (and even As1an-Arnencan careg1vers) 
(Patterson et a! , 1998) and the same can be seen m Indonesian populatlons (Kaneda 
& Z1mmer, 2007) Pang et al. (2002) found that depresswn-related careg1ver d1stress 
was less m Chmese careg1vers than US careg1vers (although 1t must be noted that 
the authors d1d not study duratwn of AD and the physical health of careg1vers m 
relation to careg1ver d1stress) Indonesian culture IS similar to Chmese culture, and 
m fact Chmese 1mm1grants make up a noticeable factwn of the Indonesmn 
populatiOn and are called 'Chmese Indonesians' (Asrun, 2001) Ch1ldren m South-
East Asmn cultures are brought up w1th the expectatiOn of canng for the1r elderly 
when older, as well as placmg great emphas1s on close mterpersonal relatwnsh1ps 
and mterdependence (Patterson et a! , 1998) Th1s m1ght affect the ab!l1tles of the 
elderly. For example, Swanw1ck et a! (1999) found that the relatwnsh1p to the 
careg1ver was associated with functwnal ab1hty scores Participants w1th AD who 
hved w1th a son or daughter scored lower on functwnal tests than those who hved 
w1th a spouse or alone The findmgs from th1s Indonesian populatwn support th1s 
w1th a s1gn1ficant association found between lower performance on the IADL 1fthe 
partlClpant hved w1th a ch1ld or a ch!ld and a spouse than 1fthey hved on the1r own 
or With a spouse (F=3 02, p=O 008) However, 1t IS worth notmg that partiCipants 
m1ght have been hvmg w1th the1r children as a result of low IADL. 
Still, as stated by T1emey et a! (2003), the careg1ver, or mformant, report has some 
use m 1mprovmg accuracy of cognitive screenmg measures such as the MMSE for 
probable dementia diagnosis Furthermore, self-reported cogn1hve problems also 
hold some value and may flag up problems that m1ght otherwise have gone 
unnoticed, especially m the early stages of the disease (T1emey et a!, 1996) 
Questwns asked of both certamly help m addmg credence to formal diagnostic 
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measures as well as helpmg to d1fferentlate between different dementia types m this 
populatiOn However, It may be useful m future research to mclude a measure 
assessmg careg1ver rehabihty/burden (Marvard1 et al , 2005) The careg1ver report 
will be assessed and compared m future studies usmg the CDR (Hughes et al , 
1982) 
7.1.3 Dementia and Dementia Types in an Indonesian Sample 
Investigations such as this are Important m the current chmate as 70% of the 
world's elderly are predicted to hve m developmg countnes, such as Indonesia, and 
are thought to be at h1gh nsk of dementia (Kalache, 2002) This Imtwl cogmtlve 
screenmg process served the purpose of1dent1fymg mdividuals who are cogmtlvely 
Impaired and hence have or are at nsk of developmg dementla m a country where 
dementla percentage IS currently unknown 
In this populatiOn (n=719) the percentage of people with cogmbve 1mpamnent 
based on cut-offs usmg the MMSE and HVLT, was 30% Evidently, this IS mflated 
when compared to actual dementla prevalence figures around the world 
Furthermore, dementla was not chmcally diagnosed by cognitlve functiOn test 
measures alone Therefore, Impairment m mstrumental actlvitles of daily hvmg and 
self or careg1ver reported cognitlve complamts of one or more of agnosia, apraxia, 
aphasia, executlve function or problems with long/short term memory were added to 
the cntena Our data m the current cohort suggest that possible dementla prevalence 
could be estlmated at 4 I% for those over 60 years of age and 5 8% for those over 
65 years of age m this Indonesian sample This estimate could further be specified 
to be 3 4% and 4 8% for AD specific dementia m those over 60 years of age and 
over 65 years of age respectlvely Of the whole sample of all ages, 5 4% could have 
V aD or other types of dementla Due to the similar demographic pyramid structure 
and hfe expectancy, comparable dementla prevalence was expected m Indonesia as 
m India, which IS 5% m those over 60 years of age (B1swas et a!, 2005) We found 
similar dementla percentage m our Indonesian sample ( 4.1 %) However, vahdatmg 
the chmcal dementia diagnostics was not possible (partly due to opportumty 
samplmg) and follow-up IS necessary to assess dementia m suspected cases by 
tramed neurologists usmg standardized cntena (Hogervorst et a! , 2002) 
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Factor analysts, PCA, was used to mvestlgate whether self and carer reported 
cogmtlve problems were m fact measunng specific cogmtlve aspects by assessmg 
the way the cogmtive complamts grouped together Hence PCA gave an mdtcatwn 
of what possible types of Cl were Identified by the questionnaire m this populatiOn 
PCA resulted m three components m this dataset based on both the caregiver and 
self reported problems With long/short term memory, agnosia, aphasia apraxia and 
executive functiOn The clustenng of these vanables adds some support to the 
validity of these vanables m assessmg different types of Cl m an Initial, non-formal, 
screenmg phase 
The vanables that loaded onto component 1 could be classified as measunng 
moderate/severe dementza The vanables that loaded onto the second component 
mdicated possible V aD or stroke (data was not avazlable to dzscount stroke) The 
thtrd component was not as clear as the first two, but still accounted for a large 
proportiOn of the vanance (19 6%) It could be classified as MC! or early or nuld 
dementza, for example FTD. However, as further data were not available to 
differentiate between other types of dementia, this possible component would need 
to be explored further m the second phase of this study as do all the possible 
dementia groupmgs found m this phase of study 
This suggests that, as found m previOus research (Zhao & Bnnton, 2007) other 
types of dementia may be more prevalent than AD m Astan populatwns However, 
It 1s possible that m these populatwns very few people will reach the age where AD 
mcidence and nsk increases dramatically For example, the current life expectancy 
for men m Indonesia IS 66 years and for women 1t 1s 69 years (World Health 
Orgamsatlon, 2009) Other South-East Asian countnes have much higher life 
expectancy at birth, for example Japan and Smgapore (approx 82 years) which are 
m the top 5 countnes for life expectancy (Central Intelligence Agency, 2008) 
Regardless, AD prevalence has still been found to be lower m South-East As tan 
countnes than m Western countnes (Zhao & Bnnton, 2007) Furthermore, m the 
current sample, a substantial 36 9% of the sample was over 70 years of age 
Therefore, the Issue of significantly fewer people at older ages could not have fully 
accounted for the low percentage of possible AD cases m this sample The possible 
reasons for this lower AD prevalence m a developmg country such as Indonesia are 
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stlll unclear Therefore, th1s thes1s then went on to mvestlgate poss1ble demographic 
nsk factors for dementia wh1ch could explam vanance m results between stud1es 
7.2 Demographic Risk Factors for Dementia 
7.2.1 Overview 
There 1s some ev1dence that the prechmcal phase of cogmtlve declme precedes the 
appearance of d1agnosed dementla by at least I 0 years w1th vanous stud1es 
supportmg the theory that AD progresses, mostly unnotlced, for decades (Kawas et 
a!, 2003; Ehas et a!, 2000, Braak & Braak, 1997, Lmn et al., 1995, La Rue & 
Jarv1k, 1987), and can even be detected by lmgmst1c ab1ht1es as young as 22 years 
of age (Snowdon et a!, 1996). Th1s suggests that by havmg the knowledge to 
categonse poss1ble nsk factors, and puttmg mto place mterventwns that combat the 
pathologJCal expresswns of the d1sease, 1t may be poss1ble to 1dent1fy these 
md1v1duals before AD 1s symptomatlc Unfortunately, apart from mcreasmg age, 
nsk factors for AD are not completely understood and the aspects that may 
contnbute to the accelerated declme of cogmhve function m dementla are yet to be 
well charactenzed. It 1s of cnt1cal1mportance that the reasons for the vanatlon m the 
causes of pathological cogn1t1ve dechne are evaluated, categonsed and understood 
m order to reach the ultimate goal of full knowledge about the poss1ble mechamsms 
that dnve dementm 
In th1s thought provokmg arm of the study, we mmed to d1scuss and assess potential 
demographic nsk factors (and the1r mteractlons) for the development of dementia m 
order to be able to mdlVlduals w1th spec1fic markers that may put them at nsk of 
developmg dementia We found that the vanable of older age, no formal educatiOn 
and blue-collar professiOn were s1gmficant demographic nsk factors for cogmtlve 
1mpmrment Statistically, these van abies were mdependent nsk factors for Cl (other 
demographic vanables were controlled for). Interestmgly, these van abies (although 
s1gmficantly correlated With each other) were not strongly correlated (see table 34) 
Therefore, although 1t 1s hkely that there IS some mter-dependence and a 
relat10nsh1p between these demographic vanables, 1t could be sa1d that these 
vanables had an mdependent and s1gmficant affect on cogmtlve status The effects 
of these nsk factors vaned by hvmg area w1th the maJonty of cogmtlvely 1mpaued 
cases hved m rural areas Furthermore, these demographic nsk factors were not the 
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same across different districts Whilst controlhng for health and functwnal abihty, 
m urban Jakarta, an older age and low educatwn were sigmficant nsk factors for CI, 
whilst m rural Sumedang, although professwn was a predictor, an older age 
remamed the only sigmficant nsk factor for CI In rural Borobudur, low educatwn 
and an older age were the only sigmficant demographic nsk factor for CI However, 
when controlhng for health and functwnal abihty, this associatwn was no longer 
statlstlcally sigmficant m Borobudur suggestmg that poor health and functwnal 
abihty explamed the association of age With cogmtive impairment These findmgs 
are discussed below 
7.2.2 Age 
Agemg has been suggested as the mam nsk factor for AD and prevwus research 
reports that mcreasmg age iS associated With poorer cogmtlve functwn m a vanety 
of countnes m both the developed and developmg world [ e g Ogunmyi et a! 
(2006), Zhang et a! (2006); Zhou et a! (2006), Lobo et a!, (2000)] This study iS no 
different, findmg a highly sigmficant associatwn between mcreasmg age and global 
cogmhve function and verbal memory (as tested by the MMSE and HVLT) 
Consequently, the CI group was significantly older than the control group Older 
age also mcreased the odds of CI, and therefore could be considered a nsk factor for 
demenha Older age was m turn associated lower levels of educatwn and older 
partiCipants were also more hkely to hve m a rural area than an urban one 
Furthermore, age was a Significant predictor of CI whilst controllmg for health and 
functwnal abihty which suggests that the age as a possible predictor iS not JUSt 
reflechve of the physical disabihty but iS mdependently associated With cogmtlve 
functlon. 
7.2.3 Education 
Vanous observatlonal studies have reported an associatwn between low educatwn 
and mcreased dementta prevalence and nsk m both developed and developmg 
countnes [for example Zhang et al (2006), Zhou et al (2006), Herrera et al (2002), 
Callahan et al (1996), Katzman (1993)] This study found that those With er had 
significantly lower educatwnal attamment than controls, With the maJonty havmg 
no formal education and none having educatwn above a high school level Livmg m 
a rural or an urban distnct was also associated with educatlon Those m the rural 
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areas of Sumedang and Borobudur were more hkely to have lower educatiOnal 
attamment In fact no participants m these areas had umverslly level educallon and 
hardly any had a high school educatwn, whilst m urban Jakarta, a higher proportwn 
of participants were educated to a high school and university level We found that 
lower education was a nsk factor for Cl m urban d1stncts which may md1cate that 
adJustments need to be made for educatiOn m any further testmg ofth1s 
demographic. The findmg that educatwn was not a s1gmficant mdependent nsk 
factor m rural areas suggests that there are other vanables (such as professiOn see) 
whiCh may be more of a nsk m these areas and might overshadow the effects of 
educal!on by Itself as a predictor 
The role of educatiOn m exacerbatmg or protectmg cogml!ve functiOn has not 
always been a clear one as can be seen from the hterature (Zhang et a! , 2006; 
Fral!gliom et a!, 1991) as well as from the results of the current mvesl!gatwn. In 
this study, educa!Jon level was measured not by a lmear assoCJal!on with years of 
educatiOn, but by assessmg differences in reachmg certam levels w1thm the 
educatiOn system, 1.e no formal educatwn, elementary school (combmed fimshed 
and unfimshed), high school, umvers1ty or above However, a disadvantage of this 
method IS that It IS not mdical!ve of mtellectual ability (Letenneur et a! , 1999) For 
example, reachmg elementary school level and no further, does not mean that the 
mdJvJdual did not possess the mtellectual ability to go further This IS especially true 
m an environment such as rural areas of Indonesia where It may be socially 
acceptable, or even expected, for most people to stop educal!on and contnbute to the 
mcome of the household Therefore, statmg simply 'high school level' for example, 
and not divJdmg It up mto fimshed or unfimshed (or better sl!ll diploma attamed or 
not) may not be the best way of assessmg cogml!ve ability and IS a potential flaw of 
this studl1 
As late as the Jmd-1980s, esl!mates suggest that two thirds of the Indonesian 
populatiOn had never attended school (Suhartmah, 1991 ), although at the lime of 
data collectwn, this was only found for a quarter of our sample However, even 
61 Elementary school was d!vJded up m to 'fimshed' and 'unfimshed' m th1s sample, however, the other categones \\ere not 
and hence a composite category for elementary school was computed 
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now, educatwnal attamment m Indonesia IS overall very low, and defimtely 
noticeably lower than m developed countnes wh1ch may have an effect on other 
med1atmg factors affected by educatwn Th1s could lead to poorer performance on 
the screemng tools used to detect cogmtlve 1mpmrment, an mflated detect10n rate 
and consequently the problem of false positive detection rates for those who have a 
lo~ level of education Therefore, cross-culturally apphcable tests which are 
educatwn msens1t1ve are needed to accurately 1dent1fy possible cases at nsk of 
dementia. 
In the current sample, more women than men had no fom1al educatwn This was not 
unexpected as 1t IS reflecl!ve of the h1stoncal m1d pohhcal trends of the country. 
Th1s parhcular cohort would have been educated at a lime of Dutch occupatwn of 
Indonesia Mass educatwn mihahves d1d not begm until after Indonesia's 
mdependence m 1945, With educatwn pohcy not bemg formed unl!l the early 1970s 
(Oey-Gardmer & Suprapto, 1996). These cha11ges are especially 1mportm1t for 
women, a11d the younger elderly educated after mdependence are hkely to have 
better educatwnal attamment than the current cohort tested m th1s study (Kaneda & 
Z1mmer, 2007) However, more women also had h1gh school level and umvers1ty 
level educatwn (89% of all umvers1ty educated participants were women) wh1ch 
does not support the earher findmg reportmg only 6% of women w1th a pumary 
level educatwn or above (Kaneda & Z1mmer, 2007) This suggests that the effects 
of educatwn on cogmhve functwn m later hfe are not mediated by gender, and are 
the same for both men and women m this populatwn 
7.2.4 Profession 
Of the whole sample, a h1gher percentage of participants worked m blue-collar 
professwns as opposed to white-collar professwns before rehrement which could be 
reflec!Jve of the h1stoncal economic chmate oflndones1a when the common 
profess10n for th1s cohort would have been more hkely to be manual or farmmg 
work However, most Cl cases (68%) were prevwusly employed m 'blue-collar' 
professwns (farm/labour work) before rehrement Th1s supports the theory that 
environmental factors synonymous w1th a rural settmg, such as access to 
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healthcare62 and educatwn, more chance oftakmg up a manual or labour JOb, and 
consequent poverty, can have a long term effect on cogmtive functiOn (Hall et al , 
2000) Th1s assertiOn was confirmed m the current sample, as although blue collar 
professiOn was a s1gmficant nsk factor for Cl although when the sample was 
stratified by d1stnct, th1s only pertamed to a rural area lnterestmgly, th1s was not the 
case for those w1th no professiOn before retirement. However, we must remember 
that those w1th no professiOn m th1s sample were more hkely to be women, and 
poss1ble housew1ves, and not men, who were most hkely to have blue collar 
professwns Zhang et al (2006) reported h1gher dementia prevalence m farm 
labourers and housew1ves when compared to offic1als and professwnals S1m1lar to 
Zhang, th1s study found the same assoc1at10n for manual labour wh1ch mcluded 
farm labourers However, the same was not found for housew1ves A poss1ble 
reason for th1s difference m findmgs may be because there were more women m 
Jakarta and although a great proportiOn ofthese women d1d not work, they also had 
higher levels of educatiOn Conversely, blue collar professiOn was also associated 
w1th rural hvmg, an older age, and a lower educatiOn Additionally, only 10% of 
those who had a wh1te collar professiOn were class1fied as Cl cases Therefore, 
takmg these pomts mto consideration 1t IS clearer to see why blue collar professiOn 
as opposed to no professwn and espec1ally wh1te collar professiOn m1ght have been 
a nsk factor for Cl m th1s sample 
It has been hypothesized that the use of peshcides (often m rural agricultural work) 
IS a poss1ble nsk factor for neurodegenerative disease (Keefover et al , 1996) and 
th1s could account for the difference seen m AD prevalence rates between farm and 
non-farm labourers, e g Zhang et al (2006) However, m populatwns such as those 
observed m th1s sample, pest1c1des are too expens1ve and rarely used Therefore, 
other factors related to soc10econom1c status (such as hm1ted access to health care, 
poor nutntwn and other poverty-related factors) may be responsible for th1s 
d1fference (Zhang et al , 2006) 
62 In post-hoc analys1~. access to the hea\thcare was assessed to see tfthts medtated the relat10nshtp bet\veen demographic nsk 
factors and Cl per d1stnct The assocJatwn of demographiC factors to Cl was mdependcnt of the proxy measures wh1ch 
assessed access to healthcare However, the quest10n "are you currently seemg a doctor, health prov1der or tradttlonal" was 
mdependently assoc1ated wtth Cl Not seemg a doctor mcreased the odds of Cl m urban Jakarta (OR= 18 043, p = 0 029, 95% 
Cl= I 340- 259 414) as well as m rural Borobudur (OR= 11 276, p = 0 045, 95% Cl= I 059- 120 059) Thts md1cates that 
although access to healthcore may be mdependcntly associated w1th Cl nsk, there was no urbon/rural d1stmctlon 
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The assoc1at1on between educatiOn and professiOn suggests that early hfe educatiOn 
can affect later hfe chmces of professiOn However, professiOn was an mdependent 
pred1cl!ve factor for possible cogmt!Ve 1mpmrment when controlhng for educatiOn 
m th1s populatiOn wh1ch suggest that the effects of professwn on dementla nsk may 
be mdependent of educatlon 
7.2.5 I>istrict 
lnterestmgly of those w1th Cl, a great maJonty (87%) hved m the rural areas of 
Sumedang and Y ogyakarta Th1s IS similar to prevwus findmgs m Chma (Zhang et 
al., 2006), Indm (Rajkumar & Kumar, 1996) and Japan (Sh1bayama, Kasahara, & 
Kobayash1, 1986) and could be reflectlve of several possible mfluentlal factors 
caused by hvmg m rural areas, such as educatwn, professiOn, and access to 
healthcare 
In Jakarta, older age and no formal educatiOn were nsk factors for Cl when 
controlhng for functlonal ab1hty and health Interestmgly, Jakarta had the youngest 
mean age of the three d1stncts as well as the h1ghest level of educatwn w1th much 
h1gher proportwns of 1ts participants havmg a h1gh school or umvers1ty level 
educal!on Regardless of th1s, educal!on was still a s1gn1ficant predictor of Cl in 
urban Jakarta 
In Sumedang, older age was a s1gn1ficant nsk factor for Cl and professwn was a 
s1gn1ficant predictor of Cl, although th1s was not s1gn1ficant when companng 
different types ofprofesswns However, the great maJonty of partiCipants, (73%), 
had blue collar professwns which may explam why no s1gn1ficant assoc1atwns were 
seen when analysing the d1fferent professiOn categones It was mterestmg to see that 
educatwn d1d not mdependently pred1ct cogn1l!ve funchon m th1s populatiOn 
However, most of the sample had low levels of educatwn and hence there may have 
not been enough vanance m educatiOnal attainment to show 1ts pred1ct1ve value 
Blue collar professiOn may also md1cate poverty and low SES wh1ch IS more 
extreme m developmg countnes such as Indonesia (Z1mmer & Kwong, 2004, L1ang 
et al, 2001) 
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The assoc1ated health nsks resultmg from hvmg m a rural area m a country wh1ch 
h1gh poverty hke Indonesia may be a reason for the urban/rural differences 
observed Add1twnally, the percentage of poss1ble secondary dementms due to poor 
health was qmte large Poor health was mdependently associated w1th cogmt1ve 
1mpamnent m Sumedang and Jakarta, although 1t explamed the vanance due to 
agmg, low education and SES m Borobudur As stated by Lmk & Phelan (1995), 
SES IS the "fundamental cause of health", therefore those With poss1ble low SES (a 
h1gh proportion ofth1s sample also had blue collar professwns before retuement) 
may not recogn1se the1r symptoms m time to seek help, or understand hfestyle 
hab1ts necessary to stay healthy and hence have a h1gher nsk of demen!Ja In the 
next phase of th1s study, we mm to assess SES m a more ngorous manner that the 
d1screte categones used for professwn and home ownership For example, when 
assessmg professiOn before re!Jrement, questiOns could be assessed that prov1de 
much more deta1l. As suggested by Carlson et al (2008) questions could mclude 
longest-held job, JOb title, spec1fic JOb duties, type of mdustry, beg1nnmg and endmg 
years for the JOb, reason for stoppmg work Other measures of SES could mclude 
prevwus mcome and financml assets. 
In Borobudur, before controllmg for health and functwnal ab1hty, older age and no 
formal education were s1gn1ficant nsk factors for Cl It 1s also noteworthy that 
although Borobudur had the h1ghest mean age, the relatwnsh1p between Cl and age 
was no longer s1gn1ficant after controlhng for functwnal status and health wh1ch 
were ev1dently medmtmg th1s relatwnsh1p Therefore, older age may have reflected 
poorer health and d1sab1hty m th1s sample relatmg to Cl. Th1s could md1cate that 
these part1c1pants w1th Cl have had some form of (secondary) dementJa Th1s 
assoc1a!Jon w11l be looked at m further detml m the second vahdatwn wave ofth1s 
study No formal educatiOn was a nsk factor for Cl m both rural areas of Borobudur 
and Sumedang w1th few cases havmg more than bas1c educatwn, 1f that 
The use of cogmtlve screenmg tools has been prevwusly d1scussed m reference to 
the1r apphcab1hty for areas w1th low educatwnal attamrnent It may also be of 
mtcrest to mvest1gate an extensiOn of the theory assoc1atmg early hfe rural hvmg to 
educatiOn (Hall et al , 2000) found that rural res1dence m ch1ldhood m combmatwn 
w1th less than SIX years of educatwn was assoc~ated w1th mcreased nsk of AD m an 
220 
Afncan-Arnencan populatiOn The researchers suggest that the relatwnsh1p between 
educatiOn and AD IS actually med1ated by socweconom1c and environmental 
influences m ch!ldhood, a theory that may be apphcable to th1s study 
7.2.6 Gender 
PreviOus research spannmg many decades has mdJCated that men and women excel 
at different types of cogml!ve tasks (Ge1ser, Lehmann, & E1d, 2006, Martm, W!ttert, 
Bums, & McPherson, 2008; Cooke-S1mpson & V oyer, 2007, Herhtz, N1lsson, & 
Backman, 1997, K1mura, 1996) A poss1ble disadvantage, and genderb1as, of the 
cogml!ve tests used IS that they may, to some extent, favour abJ!il!es performed well 
by women ( e g HVLT- verbal memory) and not men (Letenneur et a! , 2000) 
Contrary to some previOus hterature (Hebert et a!, 2001, Lobo et a!, 2000) gender 
was not a s1gmficant pred1ctor of cogml!ve functiOn m th1s study The theory of the 
female gender as a nsk factor for demenl!a IS h1stoncally a controversml w1th many 
stud1es findmg no mcreased nsk for AD m women (Lm et a! , 1995), as well as 
bemg a complex one, appeanng to be med1ated by non-mod1fiable vanables such as 
age Theory has extended the assoc1at10n between the female gender and mcreased 
nsk of AD by attnbutmg the relatwnsh1p to the fact that although a large proportiOn 
of AD sufferers are women, th1s IS due to the longer hfe expectancy of women 
compared to men Hence women are more hke to reach the age where AD IS fully 
mamfested (Hebert et a!, 2001) Interestmgly, equally h1gh proportwns of both the 
Cl and control groups ahke were women Furthermore, th1s study d1d find an 
assoc1atwn between older age and the male gender, although th1s was not the case 
when analyses was stratified by d1stnct and may both explam why no s1gmficant 
associatiOn was found between gender and cogmtive functwn m our analyses Some 
suggested that the h1gher nsk for women m some stud1es 1s related to the1r lack of 
sex hormones such as estrogens after menopause (HalbreJch et a! , 1995) The 
poss1ble protecl!ve role of estrogen on cogml!ve funcl!on was explored m meta-
analyses of estrogen treatment tnals 
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7.3 Hormone Dependent Modifiable Risk Factors 
7.3.1 M eta-analysis of Estrogen Randomised Controlled Trials 
(RCTs) 
In the nmetJes, most stud1es reported that estrogens have benefiCial effects on the 
human bram (Tang et al, 1996, Henderson et al, 1994) However, more recently 
observatiOnal stud1es have shown that women With Alzheimer's disease actually had 
h1gher levels of estrogens than controls (Paolett1 et al , 2004, Cunnmgham et a! , 
1994) Furthermore, stud1es such as the Women's Health lmtJatJve Memory Study 
(Shumaker et a!, 1998) reported that Hormone Replacement Therapy (HRT) 
actually mcreased the nsk of dementia m postmenopausal women over the age of 65 
years 
Many other stud1es were discussed m our published meta-analys1s (Yesufu, 
Bandelow, & Hogervorst, 2007), all reportmg qmte vaned effects ofHRT on 
vanous cogmhve functiOns It showed that estrad10l (E2) had a positive effect on 
selected tests of episodic verbal memory mamly- a cogmtJve functiOn that has 
prev10usly been reported to show gender differences and favounng high estrogen 
environments However, th1s effect appeared to be modified by age as HRT was 
only beneficial for recently menopausal women (the 'wmdow of opportumty' 
theory) Addihonally, not all cogmtlve domams were equally affected by HRT as 
the same positive effects were not as clear for v1sual memory, and even when 
present, were agam modified by age As well as differences m effect based on 
treatment reg1me and type, mterestmgly, duration of treatment was a factor wh1ch 
appeared to be of some Importance Usmg HRT for a long penod of lime(> 1 year) 
could actually mcrease nsk of dementia It has thus been hypothesised that short 
penods ofHRT use are better than contmuous use for cogmtlve functiOn 
7.3.2 Hormone Therapy use in Indonesia 
Our data on hormone therapy (HT) use m Indonesia, although hm1ted, y1elded very 
mterestmg results reflective of findmgs discussed m our meta-analys1s Hormone 
therapy use was associated With worse verbal episodic memory m the current 
sample which pertamed m stratified analyses to women only Th1s assocJatJOn has 
been prev10usly reported m the largest RCT to date, the Women's Health ImtlatJve 
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Study of Cogml!ve Agmg (WHISCA) (Resmck et a! , 2006) There are several 
lim1tatwns to the current analyses Firstly, only a small proportwn of women used 
HT which Is reflec!Jve of prevwus findmgs m Indonesia (Hememann et a! , 2008) 
We also d1d not know what type, duratwn or dose of HT was used, which could 
addillonally have been plant based or formal med1cat10n However, the associatiOn 
between HT and poor cogml!on could reflect results of prevwus research also 
reportmg negative effects of estrogen on cogmtlon m women (see Shumaker et a!, 
2004 etc) In contrast to earlier findmgs that differences m the type of effect 
(positive or negative) may be mediated by age for women, this was not found m the 
current sample and mteracl!ons of HT with age were also not s1gmficant (see 
scatterplots figure 9 & 10 for age by HVLT-IR for men and women separately) 
Interestmgly for men, HT use and age showed a significant mteracl!on for verbal 
memory with older men showmg more benefits of HT use This IS Similar to what 
has been found m some earher observatiOnal studies (Th!lers, Macdonald, & 
Herhtz, 2006, Muller, Aleman, Grobbee, de Haan, & van der Schouw, 2005), but 
not others (Hogervorst et al , 2004). Treatment studies with T supplementatiOn also 
reported positive effects on verbal memory (see for example Chemer et al., 2001 
and Yesufu et al , 2006) Differences m health status, tests used and compounds 
may explam differences between studies, as well as the average age of men mcluded 
(Hogervorst, Bandelow, & Moffat, 2005) For mstance, m the present study, 
associations of self reported functwnal ability and HT use m men were explamed by 
differences in age A possible wide diVersity of possible HT use m men of the 
current study (from plant based med1cme to androgens) may be responsible for a 
lack of clear effects found and needs to be mvestigated m more detail m the follow-
up study 
In women, other factors appeared to mediate the relatwnsh1p between HT use and 
verbal memory Prevwus reports (Hogervorst et al , 2000) had surmised that effects 
might be mediated by differences m educatiOn or age However, age and education 
were mdependent contnbutors m the analyses of the relatwnsh1p between HT use 
and verbal memory m the current study, m which negative associatiOns were 
mediated by health related factors Imtially, LeBlanc et a! (2001) reported that the 
effects of HT on cognitive function were m all likelihood mediated by Improved 
223 
mood and better sleep However, partiCipants performmg poorly on the test of 
1mmed1ate verbal memory m the present study were actually more hkely to be 
unhappy and less healthy Th1s IS Similar to findmgs m Maastncht m a Caucasmn 
populatiOn (Hogervorst, Boshmsen, R1edel, W1lleken, & Jolles, 1999) Also similar 
to the current study, m that study, only 7% of m1ddle-aged women reported to use 
HT. Wh1le m the Maastncht study (similar to the present study) HT users had h1gher 
levels of educatiOn, they also reported more memory complamts (although there 
was no d1fference on an obJectJve memory compound score) These women also 
reported worse health and h1gher anxiety and depressiOn than non-users In the 
current sample, female HT users also reported more feelmgs of stress, wh1ch was 
also assoc1ated with worse delayed verbal memory However, as th1s m 1tself 
appeared to be med1ated by health, th1s could reflect low mood and 
stress/nervousness as a result of poor health This IS substantiated by the facts that 
more women HT users reported bemg on medJca!Ion, seemg a doctor and attendmg 
an outpatients department. The profiles of HT users m these low frequency user 
populat10ns may reflect a different group of users than that ofprev10us other US 
user populat10ns. Possibly poor health and low mood reported are related to havmg 
undergone hysterectomy/oophorectomy for whJCh HT was then prescnbed to reduce 
menopausal symptoms In prev10us work, undergomg oophorectomy (Rocca et al , 
2007, Napp1 et a! , 1999; Sherwm, 1988) mduced lower cogmt1ve functiOn 
However m these studies, when mcluded, HT could reverse these effects On the 
other hand, one study mves!Jgatmg long duratiOn use of HT use(> I 0 years) m 
women who had undergone surgical menopause also reported negative assoc1at10ns 
with ep1sodJC memory and mental flex1bihty (File et al., 2002) As we d1d not have 
data on medical status and duration of use (Hogervorst et a!, 2009, Baum, 2005) 
this could not be further mvestigated 
Other factors that will be assessed m the second phase of th1s study thus mclude 
type, form, duration of HT use and route of admm1strat10n However, It w1ll be 
mvestigated m greater detml m the second phase of tlus study Data will be collected 
on aspects such as type, form and duratiOn of HT Furthermore, as we found 
associatiOns between low mood and HT use, the psychological profile of the users 
will also be assessed usmg a standardised mood assessment scale assessments of 
menopausal symptoms. Cons1denng the profile of female HT users m the present 
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study, morb1d1ty (usmg a physician's report) and reasons for use need to be 
mvestigated m more detml m future study Type of menopause, 1 e whether surgical 
and or natural, and years smce menopause w1ll also be evaluated as our meta-
analysis found that sigmficant effects of menopause were strongest for women who 
had undergone surgical menopause Other cogmtive tests will be employed to assess 
a wider range of cogml!ve functions, for example, simple and complex processmg 
speed InvestigatiOn of these vanables will allow a more direct companson With 
other studieS reportmg both a protective and detnmental effect of HT on cogml!ve 
function Interestmgly regwnal differences m use were reported with the highest HT 
use reported m rural Sumedang Th1s could reflect the use of plant based med1cme 
which is mterestmg from an anthropological perspective Possible ethmc/cultural 
associations w1th HT use also need to be further mvesl!gated m future analyses 
In conclusiOn, results of this prelimmary study are mtngumg and fit w1th some 
earlier research m women of low user frequency populatwns This findmg may g1ve 
strength to the 'healthy user' bias (Hogervorst, 2006) m higher HT user frequency 
populal!ons (e g observatiOnal USA based findmgs) While results are limited by 
the lack of knowledge of the type of HT used and underlymg morbidity, they reflect 
that HT use certamly IS not always associated with positive effects on cogml!ve 
function despite the multitude of ammal and cell culture studies md1catmg that this 
IS should be the case 
7.3.3 Observational Study Assessing the Relationship between 
Phytoestrogens and Cognitive Function in Indonesia 
7.3.3.1 Overview 
Soy consumption IS very high IS East Asian countnes (Murkles et a! , 1998) 
Although 1t IS a mche food predommantly eaten by vegetanans, It IS becommg more 
popular m Western countnes. Furthennore, with the mcrease m suspicion regardmg 
HRT, many postmenopausal women have turned to this natural fonn of estrogen (E) 
and regularly use 1soflavone health supplements However, the effects of 
phytoestrogen consumption on cogml!ve functiOn are by no means clear Some 
observatiOnal studies have reported no effects of phytoestrogen consumptiOn on 
cogmt1ve functiOn (KreiJkamp-Kaspers et al, 2007; Franco et al , 2005). However, 
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these were m low-mtake populatiOn S1m1lar to the findmgs w1th E, other 
observatiOnal stud1es m populat10ns that consume a h1gh quantity of tofu have 
reported a negative assocJatJOn w1th cogmtlve functiOn D1scussed here are the 
results obtamed pertammg to the relatwnsh1p between soy foods and other foods 
eaten, salivary phytoestrogen levels and Cl class1ficatwn only, wh!lst controlhng for 
the demographic vanables of age, gender, educatiOn, hvmg d1stnct, and professiOn 
Please refer to sectwn 5 6 for a full descnptwn of the assoc1at10ns found between Cl 
classification and the demographic vanables controlled for. 
We hypothesized that h1gh mtake ofphytoestrogens would have negative effects on 
cogmtlve functiOn in older part1c1pants (>65 years of age) wh1ch IS s1m1lar to the 
effects ofEs where a 'wmdow of opportumty' IS thought to ex1st for pos1t1ve effects 
on the bram m the m1ddle-aged, but not m the old (G1bbs, 2006a, Hogervorst, 2006, 
Henderson, 2004) In non-stratified regressiOn analyses, we d1d not find an 
assocJatJOn between soy m take of tofu or tempe and sahvary 1soflavone levels w1th 
cogmtlve impa1rment group However, the sample was further stud1ed usmg 
stratificatiOn by demographic nsk factors for CL 
Interestmgly, and reflective of prevwus research findmg negat1ve effects of Es on 
cogmtlon m older women, th1s study found m analyses stratified by gender that h1gh 
tofu consumption and low tempc consumptiOn were Significantly associated w1th Cl 
m women, and specifically m women over 68 years of age63 However, m further 
analyses, the assoc1at10n w1th tempe and tofu was no longer s1gn1ficant when other 
foods were controlled for Regardmg the small numbers left m these analyses, 
power 1ssues could be responsible for th1s. However, these data were stratified as 
descnbed m order to mvestlgate hterature dnven assoc1at10ns between 
phytoestrogens and cogn1t1ve functiOn for d1fferent factwns of the populatiOn Our 
data on tofu could substantiate the theory that tofu had a negative association w1th 
cogn1t1ve function, m particular for women older than 68 years of age Th1s IS 
s1m!lar to findmgs of the HAAS and the Kame stud1es m that high tofu consumptiOn 
was assoCiated w1th a h1gher nsk of Cl m those over 65 years of age (R1ce et a! , 
2000; Wh1te et a! , 2000) However, th1s assoc1at10n was not observed for men m 
63 Assoc1atmn for women over 68 years of age was for low tempe only, wh1ch was no longer s1gmficant when controlhng for 
other foods 
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the current sample as was found by the HAAS study The current study only found 
an assoctatiOn between low fru1 t m take and er for men. Some of the women m the 
current study were younger than 60 years of age and may still have had mtact 
menstrual functiOn With fluctuatmg high levels of E, which could have mteracted 
with the effect ofphytoestrogen on the bram (M1shra, D1ckerson, & NaJm, 2003) 
The Kame proJect found associatiOns between high tofu mtake and poorer cogmtive 
functiOn m women specifically those who were usmg HRT (Rice et a!, 2000) The 
current study did not assess HT m an m-depth manner and only 5 5% of the whole 
sample reported to have used HT m the previous 6 months No significant difference 
was seen between the control and er groups m the percentage of HT users Post-hoc 
analyses found significant associatiOns between Cl and low tempe m take (p=O 0 16) 
and high tofu mtake (p=O 048) for women not usmg HT Insufficient power meant 
the same analysis could not be run for women who were usmg HT (n=l2) 
Furthermore, subsequent m depth follow-up studies will hopefully enable us to 
mvestigate whether serum and salivary endogenous or exogenous Es mteract with 
phytoestrogen levels However, as results mamly pertamed to those over 68 years of 
age (of whom virtually none would have been pre- or penmenopausal), m the 
present study, negative assoctatiOns of tofu are not expected to be explamed through 
their antagomst1c effect on endogenous Es (see Boettger-Tong et a!, 1998) In 
addition we found that tempe may off-set this effect, as It only had significant 
associations with er m tandem with tofu havmg a negative effect. 
In this sample, 71% of the populatiOn at soy at least once a day (which was also the 
median spht), and of these, mean mtake per week was on average 9 times a week 
for both tofu and tempe This IS reflective of other studies assessmg soy mtake m 
native South-East Asian populat10ns For example, m a Shanghai based ehmese 
populatiOn, 96 7% ate soy at least once a week (Chen et a! , 1999) Furthermore, 
only 6% of this Indonesian sample consumed soy m the form of soym1lk or other 
soy based products This difference between soy foods m phytoestrogen content has 
been previOusly discussed (sectiOn 2 3 2 3), and reflects previOus assertiOns that 
East Asian populatwns consume more soy m traditional forms, 1 e tofu and tempe, 
rather than second-generatiOn soy foods Whilst m western populatwns, Jsoflavone 
mtake IS low, hgnan mtake IS much higher (Boker et a! , 2002, de KleiJn et a!, 
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2001) For example, m a Dutch sample, only 5% ofgemstem and da1dzem mtake 
was from tradJtJOnal soy foods, such as tofu and tempe, (Boker et al., 2002) 
Several foods and different types of soy foods were mvestigated simultaneously m 
the current study, unlike the HAAS and Kame ProJect who focused only on tofu 
consumption Therefore, the assocmtion between Cl and soy could be mvestigated 
m more detail by assessmg the type of soy consumed Furthermore, assessmg soy 
m take as not JUS! a categoncal vanable (median spht) but as im-estimated amount 
per week enabled an assessment of the amount of soy eaten The fact that tempe and 
tofu show more of a differential effect m analyses when measured weekly (as 
compared to analysis usmg median spht) mdicates that JS Jt not simply whether soy 
JS eaten or not, but the quantity of soy eaten which may be of some Importance 
(wh1ch was also stipulated m the Kame ProJect). 
The regulanty of Jsoflavone consumphon could be of some Importance Significant 
effects, protechve or detnmental, have been reported m populatwns who consume 
large and regular amounts of1soflavones (e g the HAAS and Kame project). 
Whereas no associatiOns have been found m other sample populatwns whom 
consume very low and m frequent quantihes of Jsoflavones through d1et ( e g 
(Franco et al , 2005)). 
As stated by Setchell et al. (2003) -
"state-ready serum levels are more /zkely to be achzeved by multzple zntakes 
of soy foods through the day on the baszs of analogy to many drugs wzth 
szmzlar pharmacokmetzcs a portfolzo of soy foods that can be eaten 
throughout the day zs lzkely to be more effectzve than a once a day zntake" 
The current study found assocmtwns between high tofu mtake and Cl, as well as 
low tempe mtake and Cl, m particular m women over 68 years of age and those 
hvmg m rural areas However, 1f we take m to consideratiOn recent theones 
assoCJatmg high Jsoflavone m take and nsk for impaired cogmhve functiOn over a 
certam age, th1s findmg may appear contradictory. Tempe has h1gher Jsoflavone 
level than tofu (Wang & Murphy, 1994) wh1ch would not explam why high tempe 
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mtake would be associated with better cognitive functiOn As discussed ear her there 
IS an Important difference m the processmg of the two soy products which may 
alternatively explam results Wh1le tofu does not undergo fermentatiOn, tempe does, 
and this differentiatiOn may have important consequences (Gmtmg & Arcot, 2004) 
reported that a remarkable mcrease m folate content was found after fermentation, 
which was 52-fold higher than that of the boiled soybean (ofwh1ch tofu IS made) 
This may be due to de novo formation of folate by Rhzzopus olzgosporus, the 
pnnc1pal mold m tempe fermentatiOn (Gmtmg & Arcot, 2004). Earlier work m 
Oxford md1cated that women w1th dementia had higher levels of endogenous Es 
when sensitive assays were used (Hogervorst et al, 2001), and that women who had 
high endogenous Es, but who also had h1gh levels of serum folate d1d not perform 
below the 25 pomts performance cut-off score of the MMSE, which IS sensitive to 
dementia (Hogervorst & Smith, 2002) Folate has protective effects on bram 
functiOn and been associated with lower levels ofhomocysteme, an Important 
modifiable nsk factor for dementia (Smith, 2002) Future studies need to mvestigate 
the mteractwn between serum (phyto )estrogens and folate levels m determmmg 
dementia nsk 
This line of th1nkmg IS one explanation for the findmgs of the current study, but 
other explanatiOns could be possible. For example, a study with rats showed that 
tempe had significant antioxidatiVe, antJ-mflammatory and antithrombotic effects, 
all factors which are potentially Important m cognitive decline and dementia 
(R1lantono, Yuwono, & Nugrahad1, 2000) Similar effects have been found for fruits 
and orange/red vegetables m mediatmg and reducmg nsk for Cl, and might be an 
explanatiOn for why no associatiOn was sometimes seen m stratified analyses 
between soy and Cl when controlling for anti-oxidant nch fruits and vegetables 
mtake as the fruits and vegetables which may be actmg as mediators m this 
relatiOnship. This could also explam why significant associatiOns were observed 
between high orange/red vegetable mtake and better cognitive function m the 
current sample. It IS possible that compounds, other than folate m tempe, could be 
responsible for the protective associatiOn found between tempe consumptiOn and Cl 
nsk (as found for vegetables and fruit) 
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Furthermore, the associatiOn between Cl and h1gh tofu mtake could be explamed by 
additional human factors. Accordmg to the Departments of Public Health at the 
Umversities of Jakarta and Yogyakarta, formaldehyde IS often added to tofu to 
preserve Its freshness which IS toxic to the bram (Gurel, Coskun, Armutcu, Kanter, 
& Ozen, 2005) With age the blood bram barn er IS less efficient at keepmg out 
toxms and can start to show leakage (Kleme & Hackler, 1994, Tuomanen, 1994) 
Defence mechamsms, such as endogenous anti-oxidant effects, are no longer as 
efficient and damage can thus be expected to more easily ensue m the older bram 
(Kleme & Hack! er, 1994, Tuomanen, 1994) This could perhaps exp1am why effects 
were mamly found m those over 68 years of age Tempe IS not known to contam 
formaldehyde as It IS made from fermented soybean which keeps fresh for longer In 
logistic regressiOn analyses mcludmg both tofu and tempe as well as 1soflavone 
levels, with or without controlling for other foods, the associatiOn of between low 
tempe mtake and Cl was only significant m analyses m concurrence with tofu64• 
This suggests that h1gh tempe consumptiOn may modify the negative effects ofh1gh 
tofu consumption More m depth analyses of foods consumed, the toxms that might 
affect the bram negatively, and the association between levels and types of 
protective agents, such as folate and anti-oxidants should be mvesl!gated 
7.3.3.2 Bioavailability of Isoflavones 
The VIew as to the biOavmlabihty of1soflavones m different forms (aglycone vs 
glucoside) and of the two mam 1soflavones (da1dzem and gemstem) IS still a dlVlded 
one (see appendix 8) In the current study, correlatiOns were found between soy 
mtake and dmdzem and gemstem (gemstem was not significant). However, analyses 
also revealed a gender difference m da1dzem and gemstem levels Gemstem and 
dmdzem levels were s1gmficantly higher m men There are numerous possible 
explanations for this Firstly, as descnbed by MacDonald & Folk (1996), m 
women's unne, da1dzem IS the most abundant 1soflavone found and suggests that 
gemstem (at least m women) may be utilized differently It may be less well 
absorbed, excreted qmcker, and metabolized or retamed by the body much more 
than da1dzem Hence, the Jack of s1gmficant correlatiOn between gemstem and soy 
mtake for women may not be a surpnsmg one Secondly, the sigmficantly (p=0.02) 
64 Apart from m stratified analyses w1th those oveJ 68 years of age and m a rural Borobudur, '' h1lst controlhng for other foods 
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greater number of women than men m the sample may be of some consequence and 
may have had an effect on the mean levels of gemstem and dmdzem extracted In 
additwn, the termmal half -life (which affects bwavaiiabihty) of dmdzein IS lower 
m men than m women (Bioedon et al , 2002) This might explam why sigmficantly 
(p=O 04) higher salivary dmdzem levels were observed m men than m women, as 
more da1dzem IS bwavmlable m men than m women m the current sample 
Furthermore, as discussed by de Pascual-Teres a et al (2006) the composition matnx 
of the soy product consumed may have some Importance m the bwavmlab11Ity of 
Isoflavones m the human body and affect the metabolism of specifically gemstem 
For the whole sample, dmdzem levels were double the amount of that found of 
gemstem which could be attnbuted to the greater ability of gem stem to bmd to ERs, 
reducmg the bwavmlab11Ity of gemstem and resultmg m higher levels of da1dzem m 
saliva samples. Furthermore, m the current sample, gemstem levels were not 
significantly different between men aJJd women This could be explamed by a 
combmatwn of two factors Firstly, there are more ERs m women than m men, and 
gemstem's greater ability than da1dzem to bmd to ERs could result m lower levels 
of free gemstem found m saliva sample m women Secondly, the ability of gem stem 
to also bmd to the progesterone (P) and androgen (e g testosterone) receptors 
(F1tzpatnck, 2003) could additiOnally result m low levels of free gemstem m men. 
Hence, combmatwns these factors may have resulted m similar levels of free 
salivary gem stem, which are sigmficantly lower than dmdzem, m both women and 
men 
It must be noted that people may or may not have eaten soy on testmg days, and 
therefore, these data are perhaps not surpnsmgly It 1s thus unclear whether we 
mvestigated short (levels) or long-term, lifetime habitual mtake, effects of soy 
mtake, although th1s population were habitual soy consumers Our follow-up study 
Will mvestigate consistency m dietary mtake and the long term effects ofth1s on 
cognitive change 
7.3.3.3 Salivary Isoflavone Levels and Cognitive Function 
Assessmg differences between groups (see descnptives table 30 for ANOVA 
statistics), I so flavone levels of gemstem and dmdzem were significantly different 
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between controls and Cl cases (they were higher for Cl cases) As logistic 
regresswn analyses was not s1gmficant, and the d1fferentml effects based on type of 
soy have been observed (regardless ofphytoestrogen level), 1t 1s unclear why h1gher 
levels (as found m correlatwnal analyses and ANOVA) ofphytoestrogens would 
mdependently have negative assoc1atwns with bram functwn It 1s possible that th1s 
relatwnsh1p IS similar to that found between E and dementia. Several studies have 
found that E treatment and h1gh E levels were associated w1th dementia 
(Hogervorst, 2006, Paolett1 et al, 2004, Cunnmgham et a!, 2001, Hogervorst et al, 
2001) and markers for dementia, such as bram atrophy and accelerated cogmtlve 
dechne (den HeiJer et al, 2003) Da1ly mtake of large quantities of1soflavones may 
have a detnmental effect on bram functions and tissue as found m prevwus rat 
studies For example, Cho1 & Lee (2004) reported that m the rat bram, 20 mg/day 
gemstem caused DNA fragmentation and mcreased LDH (a h1gher toxic enzyme 
found m tandem w1th diseases such as cancer and HIV), wh1ch was not found for a 
low dose of2 mg/day gemstem. It must be noted that these relative amounts of 
gemstem g1ven to rats m these studies would far exceed the normal amount of 
1soflavones that are g1ven to human participants m treatment tnals or eaten m a 
normal da1ly d1et For example, assummg a rat weighed approximately 300 mg and 
the average Indonesian human we1ghs approximately 60kg A rat g1ven a dose of~ 
mg/day IS the eqmvalent of gtven the human 1200 g/day of gemstem As we have 
prevwusly dtscussed, even m populatwns where Jsoflavone consumption IS very 
htgh (for example 100 mg/day = O.Jg/day) th1s is over 12000 times the quanhty of 
normal dmly consumptiOn 
7.3.3.4 Fruit/vegetable intake & cognitive function 
It 1s possible that a dwt of phytonutnent nch foods could help to protect the agemg 
bram from cogmtive dechne For recent reviews, see Head (2009), Wilhs, Shukltt-
Hale, & Joseph (2009) and Ktdd (2008). In analyses controllmg for age, gender, and 
educahon, an mdependent assoctallon was found between low frmt mtake and Cl. 
Low mtake of orange/red coloured vegetables was also assocmted w1th Cl 
specifically m those under 68 years of age and those hvmg m a rural area 
(Borobudur) Although not novel, th1s 1s an mtngumg findmg and fits m w1th results 
from other studtes (Barberger-Gateau et a!, 2007, Frank & Gupta, 2005) suspectmg 
a hnk between anti-oxidant mtake and better memory Perhaps th1s assocmtwn 1s 
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only found m those who are not too old to have expenenced substanl!al bram 
damage and mevers1ble loss Interestmg, and needmg further exploratwn, was the 
negal!ve assoc1atwn between frmt mtake and orange/red coloured vegetables w1th 
1soflavones levels (wh1ch were h1gher m cases w1th Cl) The assoc1at10n between 
ant1ox1dants and cogml!ve functwn 1s beyond the scope of th1s thes1s However, m 
the second part of th1s study, we mtend to have a more extens1ve FFQ wh1ch w1ll 
prov1de more m depth mfonnatwn on a w1de range of frmt and vegetables, allowmg 
a more thorough mvesl!gatwn mto th1s findmg 
Interestmg trends for negal!ve assoc1at1ons w1th Cl were found for consumpt1on of 
green vegetables for those younger than 68 years of age Many part1c1pants ate 
green vegetables at least once a day (49% of the sample) It 1s poss1ble that 
aggress1ve spraymg w1th weed and msect klllers and subsequent accumulatwn of 
toxms m fat l!ssue (mcludmg the bram) may be respons1ble for th1s findmg Hence, 
human factors could alter potenl!ally healthy foods ( e g green vegetables do contam 
h1gh levels of folate) to negal!vely affect cogml!ve functwn. Th1s 1s worth explonng 
m future research 
7.3.3.5 The association between soy consumption and rural living 
An urban/rural d1fference was observed m the relatwnsh1p between tofu mtake and 
Cl, w1th mcreased nsk assoc1ated w1th h1gh tofu mtake m rural Borobudur 
However, for rural Sumedang, s1gmficant assoc1al!ons could not be found poss1bly 
for a number of reasons (see hm1tatwns, sectwn 7 4) Apart from the 
methodolog1cal1ssues d1scussed m the hm1tations ofth1s study, the d1fferences m 
socweconom1c and educatwnal status or m regwnal and ethmcal/genet1c 
compos1l!on ofpart1c1pants (Sundanese m Sumedang vs mamly Javanese m 
Jakarta) could explam results Soy consumptwn was also shghtly lower (for both 
tempe and tofu) m Sumedang wh1ch may explam results for the stral!fied data. 
Notably, m contrast to the stratified analyses, post hoc ANOV A d1d not reveal 
s1gmficant mteractwn effects of soy consumptwn (whether a compos1te amount or 
separately as tempe and tofu) w1th s1te on cogmtive functwn class1ficatwn m 2, 3 or 
4-way mteractwns w1th educatwn and age (output not shown) Due to the p1lot 
nature oftlus study, 1t 1s poss1ble that power 1ssues are respons1ble for findmgs of 
the unplanned stratified analyses for age and s1te combmed and therefore 
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systematically mvestigatmg all mteractJOns or stratlficatJOns was not possible due to 
hm1tcd numbers of partiCipants per cell However, these findmg needs to be 
mvestigated m more deta1! m future stud1es w1th a larger sample s1ze 
7.3.3.6 Comparisons with previously published results of this sample 
As prev10usly discussed, data from th1s sample has prev10usly been reported 
(Hogervorst et a!, 2009, Hogervorst et a! , 2008) However, differences can be 
found m the results between the current data m th1s thes1s, and prev10usly reported 
data, specifically m reference to the book chapter (Hogervorst et a! , 2009) (m 
press) 
In mJtial analysis ofth1s sample (n=297) (Hogervorst et a!, 2009), we assessed the 
relatJOnsh!p between tempe and tofu mtake and er (usmg the cogmtive algonthm), 
as well as separately for the HVLT and the MMSE Furthermore, the assocJatJOn 
between salivary gemstem levels w1th er and well as the HVL T and MMSE 
separately was mvestigated m d1fferent analyses to soy food mtake S1milar to the 
current analyses descnbed m th1s thes1s, the data revealed associations between h1gh 
tofu and low tempe mtake and er (as well as w1th verbal memory alone wh1ch was 
not assessed m the current thes1s), especially m those over 68 years of age, and for 
women (on the MMSE) 
The m1tial analys1s also found assocJatJOns between h1gh gemstem levels and Cl 
(and the MMSE alone but not the HVL T by Jtself) for those over 68 years of age In 
addition, assessmg the curv1lmear term, we also observed that lugh gemstem levels 
were assoc~ated w1th better verbal memory m those younger than 68 years As 
discussed m the book chapter, thiS suggests a possible optimal dose for a protectJve 
effect m those younger than 68 years of age However, m the current analyses, no 
associations were found between salivary 1soflavone levels and er usmg the same 
analyses assessing er (cogmtive algonthm) We speculate that the differences 
between StUdieS may be related to differences m Cohort SIZe Jnvestigatmg only eJ 
versus controls sJgmficantly reduced the sample s1ze when compared to the 
populatiOn used m the art1cle (wh1ch had mcluded all) In add1hon, SES was entered 
wh1ch may have mediated effects found m the article Th1s was suggested to be a 
possible mediator as poor people eat more tofu and could have a h1gher nsk ofei 
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for other reasons In analyses descnbed m the book chapter, the cohort mamly 
consisted of participants from Borobudur and Jakarta while those from Sumedang 
had not been tested In the first article, participants from Sumedang had no 
associatiOn with tofu and cogmt10n Lastly only very few participants from 
Sumedang had data on gemstem and other phytoestrogens rendenng the models 
unstable 
7.4 Study Limitations 
7.4.1 Cognitive Screening Measures 
The cogmtive tests used m this study are currently also used m memory climcs m 
the UK and have shown to have good validity and reliability for dementia at follow-
up (SchriJnemaekers et a! , 2006) 
The HVLT has been found m many prevwus studies to be an effective measure of 
cogmtive Impmrment, more so than some global measures of cogmtive function 
such as the MMSE (de Jager, MI!wam, & Budge, 2002; Swamson et a!, 2001; 
Fowler, Salmg, Conway, Semple, & Loms, 1997) Ep1sod1c memory can be 
mdicatlve of current or future memory Impairment (Bennett et a], 2002, de Jager et 
al , 2002) and as such the HVLT successfully differentiates between poss1ble AD 
cases, MCI cases and controls (SchnJnemaekers et al, 2006) This was useful m this 
study m makmg sure groupings of control and Cl cases were unlikely to include 
possible Cl cases 
The MMSE 1s a useful tool m pred1ctmg dementia for those who screen positively 
for Cl However, It has not been established as havmg predictive valid1ty for 
emergent AD m a normal populatiOn (T1erney, Szalm, Dunn, Geslan1, & McDowell, 
2000), which IS likely to be needed for actually pred1ctmg and addressmg dementia 
that may not have already manifested Itself m climcally dJagnosed symptoms It has 
also been cnticised for not bemg sensitive enough to detect cases of MCI However, 
although this may be the case, 1t 1s of no consequence to this study which only 
focused on healthy subjects at one extreme, and those w1th probable Cl at the other, 
and not the borderlme or possible Cl cases Furthermore, m combmatwn w1th the 
HVLT, cases w1th possible Cl were likely to have been screened out of Cl and 
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control groupmgs The MMSE has been cnllcised for havmg floor effects m 
severely demented cases (Choo et al, 2007) It has also been Sdid to be too sensitlve 
to educatiOnal effects, which IS especially evtdent m populat10ns with h1gh 
Illiteracy Therefore, tt may have been more appropnate to use the Chmese Mim-
Mental State Exammat10n (C-MMSE) (Katzman et al, 1988) The best cut-off 
pomts to assess possible dementla have been established and validated m a Chmese 
populatiOn (Zhang, Hong, L1, & et al, 1999) Cut-offs were based on three levels of 
educatiOnal attamment, :S 19 for those w1th no formal educatiOn, :S 22 for those w1th 
:=; 6 years of educatiOn, :S 26 for those w1th 7 years of educatiOn and above U smg 
such cut-offs may have reduced the confoundmg effects of educatiOn on the ability 
to perform on the MMSE However, as we d1d not have data pertammg to the 
number of years of educatiOn, th1s post-hoc analysis could not be performed The 
use of the C-MMSE will be considered for the next phase ofth1s study 
Advantageously, th1s study did follow the recommendatiOn that the MMSE should 
be used w1th other cogm!ive tests of delayed memory, with adJustments for age and 
educatiOn m analysts (Malloy et al, 1997) 
A different type of problem m a cultural settmg such as Indonesia 1s that 
standardised methods of assessment need to be modified m order to be apphcable to 
the cultural settmg Furthermore, lugh levels of Ilhteracy, especially m rural 
settmgs, may result m underest1mat10n of cogm!ive ab!II!les when usmg culturally 
b1ased (to the western world) assessment tools and measures wh1ch place great 
Importance on literacy and numeracy (Parker & Philp, 2004). 
Like other studies u!Jhsmg the MMSE m developmg countnes ( e g. Ganguh et al , 
1995) modificatiOns of some Items of the MMSE were made m the current study to 
make 1t more applicable m the cultural settmg These modificatiOns are nearly 
always necessary to make objec!Jve demen!Ja ratmg scales of mental status, such as 
the MMSE or other neuropsychological assessments, applicable to a w1de vanety of 
settmgs. Subjectlve, or global, scales such as the MMSE are used to assess changes 
m behaviour and everyday funchonal ability which could be a direct result of 
cogmtJVe functiOn decline They do this by usmg a withm-partJCipants companson 
bases, companng the mdJvJdual with him or herself, and hence are less suscephble 
to cultural and educatiOnal differences (Sahadevan, Rockwood, & Moms, 1999) 
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They also allow assessment usmg mformant reports for those participants who may 
be unable to answer some questiOns due to other Issues such as sensory 1mpamnent, 
severe dementia or acute Illness as well as for deceased mdividuals (P B Dav1s, 
Wh1te, Pnce, McKeel, & Robms, 1991) 
7.4.2 Functional Measures 
PreviOus research has reported a hnk between cogmtive dechne and poor functional 
ab1hty (Perry & Hodges, 2000, M1tmtsk1 et a] , 1999) and even between functwnal 
ab1hty and scores on the MMSE (Mok et al, 2004) However, questiOns have been 
rmsed about the sensitivJty of the IADL specifically. Firstly, Cromwell et al (2003) 
suggest that the gradmg structure of the questions 1s too hm1ted and may be 
Improved by usmg more extensive numbers, e g 1-5 as opposed to 0-1 m order to 
get a more accurate representatiOn of the level of Impairment m the tasks Secondly, 
as IADL IS already 1mpmred m MCI, the IADL scale may not accurately 
differentiate between MC! and AD (Pemeczky et al , 2006) In the present study, 
statistically significant differences were found between control, possible Cl and Cl 
cases for both the lADL and the ADL Th1s contradicts Pemeczky's assertion as 
functwnal1mpamnent may have differentiated between MCI and Cl cases m th1s 
populatwn65 
Functwnal1mpamnent has been 1dentJfied as a growmg problem m As1an countnes 
such as Indonesia (Ofstedal et al , 2007). FunctiOnal ab1hty measurement was found 
to be associated with objeclively measured cognilive Impamnent (v1a the cogmt1ve 
algonthm) m th1s sample However, this pertained to more advanced mstrumental 
actlVllies of dmly hvmg (IADL) and not basic aclivilies of dmly actlVllies (ADL). It 
1s recommended that functiOnal measures, such as the lAD L, can be used for 
demenlia screemng m similar populatwns However, as was the case here, 
modificatiOns to functwnal ab1hty scales need to be made m order to make these 
cross-culturally applicable. 
65 Based on cut-offs used m a Hong Kong sample assessmg Cl m deml.lltla (Mok, Chu, Chung, CIMn, & HU!, 2004) 
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7.4.3 Health Assessments 
When mves!Igatmg dtfferent types ofposstble dementla, It IS Important to assess 
health, albeit to a more m-depth level than the current study allowed, as 11 ts a 
valuable tool m the diagnosis of dementias For example, poor health can be 
mdtca!Ive of secondary dementias, or an mc1dence of stroke can be used to rule out 
V aD. In this cohort, Cl was significantly associated wtth poorer general health (SF-
36), supportmg prevtous research findmgs [for example see Vellas et a! (2008); 
Azad, AI Bugarm, & Loy-English (2007)] It must be noted that the SF-36 IS a self-
reported health questwnnmre and does not mm to replace a formal medical 
dtagnosis of health status. However, as 64% of those With Cl and FI reported poor 
health66, secondary preventable dementias (mfectwus disease etc.) may well be the 
mam diagnostic group As th1s could be treatable, economic analysts should be 
earned out to mvestigate cost-benefits oftreatmg those at an early stage and 
preventmg long term cogmtive disability 
Full health mformatwn was not collected on aspects suspected to be nsk factors for 
dementia such as CVD, cholesterol, blood lipid levels, hypertensiOn, dtabetes, 
stroke, homocysteme, obesity, and blood pressure Health mformatwn was only 
assessed vta the SF36 and proxy measures such as medication use, seemg a doctor, 
and hospital attendance Furthermore, It ts unknown whether memory problems 
were caused by other CNS conditiOns or depressiOn which we should have assessed 
usmg a standardised depressiOn scale, such as the Genatnc DepressiOn Scale 
(Shetkh & Y esavage, 1986, Yesavage et a! , 1982) Th1s could potentially be a 
problem m light of the findmg that depressiOn sometimes mimics dementia 
(pseudodement1a) (Gamotti & Marra, 1994, Came, 1981) It would also have been 
beneficial to know If the partiCipants had any psychiatnc problems, treated or 
untreated, as they can affect the presentatiOn of dementia These methodological 
tssues w1ll be addressed m the follow-up part ofthts mvestiga!Jon 
7.4.4 Data Collection and Sampling Methods 
The method of data collectiOn was through self-report wh1ch relies on retrospective 
memory and IS not necessanly the best form of mformatwn gathenng, especially 
66 Self reported poor health based on< mean of 67 86 on SF-36 OR self proxy measure of health (seemg doctor at present, 
attendmg an outpatients department .md medlcatlOn use) 
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when assessmg possible demenlla Furthermore, an aspect of recall bms may be 
mvolved from both the partiCipant (not wantmg to g1ve an 1mpress10n of cogmllve 
problems) and from the carer (not wantmg to cause offence to the participant), 
therefore the mformalion obtamed should be collaborated w1th standardised 
dmgnosllc tools 
Furthermore, the opportumty samplmg method and cross-sectwnal nature of the 
study, methods often used m th1s area, 1t 1s possible that levels of educatwn could 
affect part!C!palion rates People w1th a h1gh level of educatiOn who may expenence 
early s1gns of demenlla and are aware that th1s may be the case as a result ofbemg 
more health-conscwus and knowledgeable, m1ght refuse to participate m stud1es of 
th1s nature and hence an artificially mf1ated proportion of those who are more 
poorly educated are identified as cases. However, the eslimated prevalence of 5 8% 
m those over 65 years of age 1s similar to what was expected m th1s populatiOn (5%) 
due to 1ts sJmJ!anlles w1th Indm (B1swas et a! , 2005) wh1ch could md1cate that the 
sample 1s random and 1s therefore ref1eclive of the target Indonesian populatiOn 
AddJtwnally, one of the most important Jssues faced when undertakmg populatiOn-
based studies relates to samplmg methods and possible selectwn b1as Furthermore, 
any survey popula!ion-based mvesligatwn wh1ch mvolves the elderly runs the nsk 
ofhavmg reduced response rates and h1gh drop-out rates due to 1llness, mortality 
etc. Although th1s was not a problem for the current study due to the p1lot nature, 
attnlion Will need to be taken mto cons1deratwn m the follow-up study and ngorous 
methods put m place to m1mm1se attntwn rates, for example mamtammg regular 
contact and keepmg up-to-date contact detmls However, th1s not only affects the 
findmgs w1thm a particular study such as th1s, but also needs senous cons1derat10n 
when comp1hng results from vanous populatwn-based stud1es. 
The mcluswn (or cxcluswn) ofmslitu!Jonahsed mdiv1duals IS an example of where 
great vanat1on can lead to maccuracy (Berr et al , 2005) Over- or under-
representatiOn of the elderly res1dmg m nursmg homes can mf1ate or underes!Jmate 
prevalence rates to a great extent, especially cons1denng that although demenlia 1s 
the mam cause of mslitutwnahsatwn, th1s vanes across different populatwns as well 
as there bemg cross-cultural (and cross-natiOnal) vanatwns m the cntena for 
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nursmg home adm1ss10n (Berr et a!, 2005) A hm1tatwn of the current study 1s that 
all ms!Jtutwnahsed part1c1pants res1ded m Jakarta However, no sigmficant 
difference (data not shown) was observed between the cogml!ve groups (controls, 
pOSSible er and er cases) m the number of partiCipants hvmg m !llS!JtUtiOnS or m 
the commumty Furthermore, Jakarta, when compared to Sumedang and Borobudur 
wh1ch had no partiCipants hvmg m an mst1tut10n, also had the lowest percentage of 
those with Cl 
Different studies have varymg standards m reference to the1r mcluswn (and 
exclusiOn cntena) For example, some studies may mclude those with M Cl, or for 
some, funchonallmpairment IS reqmred for d1agnos1s wh1lst for others 1t IS not In 
the current study, poss1ble Cl cases were evaluated separately m order to ensure 
reduced heterogeneity and to have more certamty that Cl cases were, more than 
hkely, not borderhne cases 
7.4.5 Limitations in the assessment of the relationship between phytoestrogen 
intake and cognitive function 
There were several hmitatwns when assessmg the relationship between 
phytoestrogens and cogml!ve functiOn m this sample Firstly, self report may not be 
a rehable measure of soy intake However, the FFQ (on wh1ch these questiOns were 
based) has m previous studies ( e g Frankenfeld et a! , 2003) shown to give a vahd 
reflectiOn of Isoflavone levels, wh1ch were relatively rehable over time (see sectiOn 
4 I 4 3) Cases w1th poss1ble or probable dementia may have under-reported m take 
of foods (see Petittl, Buckwalter, Crooks, & Chm, 2002) due to the nature oftheu 
morb1d1ty. However, 1fth1s were the case, one would have expected lower mtake of 
both soy products, and not h1gher quantities of one and lower quantities of the other 
to result m higher nsk of Cl ConfimJation of m take will be done by phytoestrogen 
assays and follow-up FFQ data m future study 
Unfortunately, and a hm1tation of the current study, 1s that data was not available on 
m take of other foods such as protems or carbohydrates (other than nee) 
Furthermore, more detailed mforma!Jon on the data that was avmlable would have 
also been beneficial For example, types of fish consumed (fresh water or fatty sea 
fish) vary m levels of omega 3 wh1ch may have been worth mvestigatmg (for a 
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rev1ew see Solfnzz1 et al , 2005) However, th1s was due to lime constramts and the 
p1lot nature of th1s study A full FFQ adm1mstered and blood samplmg by expert 
staff m our follow up study will resolve th1s 1ssue Even though complete dietary 
profiles could not be calculated, frmt and tempe were shown to have mdependent 
pos1t1ve associations w1th Cl, wh1ch md1cates that future studies further 
mvestigatmg dietary mtake and cogmlive functiOn m th1s populatiOn are both 
des1rable and feasible wl!hm a relatively short time span (6 month data-collectiOn) 
Data on frmt and vegetable mtake are mtngumg and fit With results from other 
stud1es as the current study observed h1gher mtake of frmt and vegetables was 
associated With less Cl nsk m the urban participants (who were also unfortunately 
relatively younger and better educated w1th higher SES, wh1ch are all also 
associated w1th reduced dementia nsk m other cohorts) It IS unclear whether 
Westernized dietary patterns (h1gher fat and protem mtake assoCiated w1th both 
cardiovascular disease and dementia) have already emerged m urban and/or rural 
areas (we d1d not ask quest10ns mto these aspects), m wh1ch soc1al strata, and how 
th1s affects nsk for age-related morb1d1ty. 
Although 1mportant poss1ble demographic nsk factors of dementia were controlled 
for (1 e age, gender, educatiOn and profess10n), th1s was not so for all theoretically, 
or otherwise, based nsk factors For example, 1! IS of course possible that these 
relatiOnships between soy mtake and Cl could just be reflectmg other mdependent 
nsk factors For example, soy 1s the cheapest forms ofprotem available to buy m 
Indonesia and therefore, we may be actually seemg an associatiOn between SES and 
nsk ofCI (asSES IS a nsk factor for AD- Karp et al, 2004) Th1s study only 
ob tamed fnnge mformat10n to assess SES ( e g house ownership, professiOn) It IS 
possible that the results found are therefore a reflectiOn of poverty m th1s sample 
and although results found were mdependent of SES, further analyses w1th more 
ngorous measures of SES than house ownership and professiOn before retirement 
are needed to fully exclude th1s as a med1atmg varmblc We could not mves!igate 
the extent of depnvat10n due to systematic differences between s1tes However, th1s 
was not expected to play a role m the current results as more and not less tofu was 
associated w1th CL In add!l!on, graphs (not shown) showed s1milar trends m 
demographic, SES-related vanables between the older and poorer rural participants 
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ofBorobudur and of those of Jakarta (who, as a group, were somewhat younger and 
had better SES and higher obtamed educatiOnal levels) 
It must be noted that the 1soflavone collectiOn via saliva samplmg (Judged to be the 
most prolific and non-mvas!Ve method of choice m this populatiOn) IS m Its early 
stages and the assay method (HPLC) IS a novel one We are currently assessmg the 
validity and reliability of salivary assay methods and HPLC phytoestrogen 
extractiOn as compared to blood standards and GC-Mass Spec m follow-up study 
However, one cannot Ignore the realisatiOn that the result of this study are reflecllve 
oftheones and findmgs put forward from a wealth of previous research with 
ammals, ex1stmg cell cultures and human observal!onal studies usmg both plasma 
and unne samplmg methods and hence, may hold some ment Although 1ssues have 
been vmced m comparmg the findmgs from studies which have used different 
bodily flmds for measurement, as stated by Franke et a! (1998), salivary Jsoilavone 
levels reflect 1soflavone levels found m other bod1ly ilmds such as plasma or unne. 
The cross-cultural applicability of the cogni!ive tests used may also be a pomt of 
contentwn However, results obtamed were mdependent of educatiOn m sp1te of the 
large vanallon m these vanables across th1s particular popula!ion Furthermore, 
similar dJstnbutwns have been observed m test performances m Oxfordshire 
(Hogervorst et a! , 2002) The cognJI!ve tests were adapted to local knowledge after 
a pilot (see methods sectiOn 4.1 4 2 for adaptallons) and m general were well 
tolerated (see Figure 13) 
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Figure 13 Cognitive test distributions in Indonesia & Oxford, UK 
Indonesia Oxford 
TOT_REC 
MMSE 
Source: Professor EefHogervorst, ART Midlands invited keynote talk. HY' June 2008. Indonesian data circa published article 
(Hogervorst et al, 2008). 
Totrecall ffOT _REC= Hopkins Vernal Learning Test - total Immediate Recall Score; MMSE =Mini Mental Status 
Examination 
There were also power issues as a result of the analyses performed. Analyses 
stratified by variables such as gender, living district and age were advantageous as 
they allowed for in-depth assessment of the relationship between soy intake and Cl. 
However, such stratification resulted in reduced power and a general lack of 
significant associations found for the Sumedang site in particular. This could be for 
a number of reasons. Firstly, there were only a limited (n=29) number of saliva 
samples taken to measure isoflavone levels in Sumedang due to financial reasons 
and hence in analyses including isoflavone levels, the number of participants in each 
cell was insufficient to make meaningful comparisons. Therefore the statistical 
package could not compute any associations or, as in some analyses, simply no 
significant associations were found. This indicates that potential methodologically 
differences confounded results between sites. Alternatively, differences could be 
due to different test procedures, e.g. translations to Sundanese not sufficiently 
comparable to Bahasa (for Jakarta) and Javanese (for Borobudur) or additional 
variance caused by different testers between sites. 
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7.5 Dose Effect of Phytoestrogens in a Pilot RCT 
In a random1sed placebo-controlled tnal (RCT) p!lot study, the current thes1s 
assessed the 24 hour dose effect of phytoestrogens on verbal ep1sodJc and semanl!c 
memory m postmenopausal women. The prehmmary results found a benefic1al 
effect ofh1gh (as opposed to low or placebo) !so flavone consumptiOn on verbal 
seman!Jc memory (verbal fluency) However, 1! must be noted that these women 
were on average younger (mean age 55 years) than those m prev1ous stud1es 
reportmg no effect or detnmental effects of phytoestrogen consumptiOn Due to 
sJm!lantJes between the sex hormone estrogen and naturally occurrmg 
phytoestrogens, th1s pos1!Jve effect on cogmt1ve functiOn was expected as th1s IS m 
!me w1th the 'wmdow of opportumty' theory for estrogens (G1bbs, 2006b, 
Henderson et a!, 2005; Pmkerton & Henderson, 2005), showmg benefic~al effects 
m recently menopausal women less than 65 years of age Due to the small number 
ofpartJc!pants, 1t is difficult to generahse the findmgs ofth1s study as many more 
partiCipants are needed Recrmtment for th1s 1s ongomg 
7.6 Implications of Key Findings 
In people aged 60 years and above, ahead of stroke (9 5%), musculoskeletal 
disorders (8.9%), cardiOvascular d1sease (CVD) (5%) and all forms of cancer 
(2 4%), demenl!a accounts for 11 2% of years hved w1th dJsab1hty (World Health 
Orgamsatwn, 2003) and JS the most common d1sease and major cause of dJsabJhty 
and mortahty m the elderly popula!Jon (RJtchJe & Lovestone, 2002) It not only 
1mpacts h1ghly on the quahty ofhfe of an mdlVIdual, often to a devastatmg level, 
but also places a h1gh 'cost' on soc1ety as a whole The nsk ofnursmg home 
dependence IS notably mcreased by demen!ia mc1dence (Wancata, Wmdhaber, 
Krautgartner, & AlexandrowJcz, 2003), and the most duect and substantial costs 
from people w1th dementJa 1s through heavy use of commumty and resJdenhal care 
(W1mo, Karlsson, Sandman, Corder, & Wmblad, 1997) For example, m the USA, 
the annual cost of mformal care m 1998 was $18 bill! on dollars for that year alone 
(Langa et a!, 2001) There IS an undemable need for therapies and pracl!ces that 
pnmanly prevent but also defer onset, slow progresswn, or g1ve some resp1te from 
the symptoms of demenha To try to mm1m1ze the human and econom1c cost ofth1s 
potent1al epidemic, 1t 1s Vital that preventa!ive and treatment mterventwns for 
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dementia are put m place which mvolves a more comprehensive understandmg of 
both modifiable and non-modifiable nsk factors 
This thesis has thus far assessed the non-modifiable demographic and hormone 
dependent potential modifiable nsk and predictive factors that might mfluence 
cogmtive 1mpmrment m Indonesia which IS of great value for a country m which 
dementia prevalence IS currently unknown However, a multitude of other nsk 
factors have been reported m previous research (outside of the scope of this thesis) 
and the data presented IS only a screenmg phase from which the local health care 
system can get a better Indication of possible at nsk cases m specific areas that may 
reqmre additional testmg, care and support It does not claim to formally 
defimtively diagnose dementia prevalence and possible dementia types or to state 
that these demographic nsk factors are the only nsk factors for an Indonesian 
populatiOn On the contrary, It IS the first part of a two part study m which the 
findmgs will be validated usmg formal dmgnostic methods as well as prov1dmg a 
base from which other possible nsk factors m an elderly Indonesian populatiOn can 
be thoroughly assessed (see sectiOn 7.7 for details of the second wave of this study) 
As can be seen from previous research, dementia prevalence and mc1dence rates 
vary greatly cross the world This variatiOn could be attnbuted to methodological 
differences However, we may be (m error) attnbutmg too much vanance between 
studies and countnes to methodological problems, when there truly IS a vahd and 
mtngumg reason for the differences seen Although some of the vanance must be 
attnbuted to this (Corrada et a! , 1995), explammg the differences m dementia 
prevalence between the developed and developmg countnes, or even w1thm these 
broad categones, IS not a straightforward task and could be attnbuted to a number of 
factors that are not methodologically based It IS believed that differences m 
ethnicity, culture, and sociOeconomic vanables could mtroduce nsk factors that 
moderate the development of AD (see sectiOn 2 2) There may also be 
environmental factors mvolved in the development of dementia and especially AD 
that are not discussed m the current thesis These factors could mclude aspects such 
as lifestyle nsk factors associated with differences m nsk of AD ( e g body mass 
mdex, hypertensiOn, and cholesterol (Kivipelto et a!, 2002) which are all related to 
lifestyle chmces, such as diet, smokmg and alcohol consumptiOn (Hendne et a! , 
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2001; Ogunmy1 et a!, 2000) However, the pnmary d1fference observed between 
these countnes and commuml!es are demographic differences for factors such as 
levels of educa!Jon, professiOn, health and SES whiCh can affect cogmhve functiOn 
and also have an mfluence on the nsk of developmg demen!Ja Furthermore, these 
factors vary w1thm countnes and can be mfluenced by rural or urban hvmg areas 
(also md1rectly affectmg SES), depnvat10n!poverty, as well as health and access to 
healthcare Differences m these demographic factors could explam the vanance m 
demen!Ja prevalence seen between the developed and developmg countnes 
Demographic factors could mfluence whether an mdlVldual develops dementia or IS 
at nsk of demenha, and may help m pred1ctmg poss1ble dementm mc1dence 
It 1s now established that d1et and nutnt10n play a part m health 1ssues such as some 
cancers and cardiOvascular factors, and more recently cogml!ve functiOn and AD 
(Amencan Institute for Cancer Research, 1997). In th1s modem day and age we 
have turned to d1etary supplements as a qmck and easy way to obtam the nutnt10n 
we believe maintams and promotes good health Therefore, the d1etary supplement 
mdustry 1s now a mult1-b1lhon dollar busmess based on stud1es such as those 
dcscnbed in th1s rev1ew A worrymg mcrease m hormone-dependent health 1ssues 
has been observed Consequently, soy 1soflavones have been suggested as a natural 
altema!Jve to manufactured hormones, such as E, and have already been endorsed as 
protec!Jve of cardiOvascular health (US Food and Drug Admm1strat10n, 1999) The 
labellmg of a product as 'natural' does not necessanly confirm 1ts safety (Emst, 
2002) and worrymgly httle 1s known about the b10log1cal behav10urs of soy 
1soflavones m the human body. Furthermore, the effects of a plant hormone m 1ts 
natural state 1s not necessanly the same as that of when 1t 1s capsulated or has been 
extracted to create a tablet form (F1tzpatnck, 2003) 
Data from the current study w1th phytoestrogens are consistent w1th previOUS 
findmgs for Es, assocmtmg h1gh E levels w1th poorer cogm!Jve functiOn and 
mcreased nsk for AD m women over the age of 65 years (see sectiOn 2 3 I for full 
detmls) Th1s study suggests that what IS thought to be a healthy pattern of 
consumptiOn IS not necessanly translated to all strata of the populatiOn, particularly 
to those over 68 years of age Whether results are explamed through negal!ve effects 
ofh1gh estrogemc compounds on the bram or toxms added to tofu remams to be 
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further mvesllgated Soy consumptiOn has mcreased m the West It was stated to be 
a "superfood" accordmg to data from the Food Standards Agency Further research 
needs to focus on the possrble effect of opllmal dose consumed to mvesllgate when 
phytoestrogen consumption begms to be a nsk factor for cogml!ve declme 
Addrtwnally, we need to mvestrgate factors whrch can off-set these nsks Human 
factors could alter poten!!ally healthy dretary patterns to negal!vely affect cogml!ve 
functwn More m depth analyses of foods consumed, potential toxms and levels of 
protecl!ve agents should be studred m more detarl. 
Thrs research 1s an Important step towards our collccl!ve attempts to understand Cl 
and dementia and rts causes usmg cross cultural assessments Although a focus 
specifically on psychogenatncs has only been a recent development m South-East 
Asra, without contmumg mterest, Indonesia could face problems m the future The 
Indonesian populatwn has been agemg rapidly and IS expected to contmue to grow 
m the next few decades As a consequence oftlus, a greater demand w1ll be placed 
on the country's economy, health care system as well as the commumty and 
farmhes of the elderly Changes m educatwnal pohcres m Indonesia w1ll also mean 
the next few decades wrll bnng about a different category of elderly, who may be 
better educated than the cohort we have today It rs of paramount Importance that 
nsk factors for dementia are assessed, Identified and understood across Indonesia m 
order to be ready for the mevrtable mcrease m those With demenlla that wrll be seen 
m thrs population m the near future. 
7.7 Further Research: Dementia Validation in Indonesia (Wave 2) 
Our Indonesran study IS a welcome step m understandmg the profile of the elderly 
populallon m Indonesia and w1ll ard m mformmg the relevant medrcal authonl!es of 
the scale of cogmllve and functwnal1mparrment currently m Indonesia 
Furthermore, the data collected is of crucral1mportance as rt is the first screenmg 
part of the study from whrch the findmgs will be vahdated usmg formal dragnostrc 
method Suspected cases wrth possrble demenlla wrll be mv1ted to attend health 
centres m whrch each mdlV!dual suspected case will have three controls matched for 
age (w1thm a 5 year band) At the health centre, participants will be tested usmg a 
test-battery developed by the 10/66 Dementia Research Group (a dragnostrc panel 
247 
effectJve across educatiOn levels and across cultures) P1lot stud1es usmg the test-
battery have been completed worldwide, successfully Jdent1fymg 94% of demenha 
cases correctly The panel worked equally well m Indian, Chmese and Latm 
Amen can countnes, demonstratmg effectiveness With language and cultural 
divemty Tests of the I 0/66 group were found to have excellent cross-cultural 
validity m the assessment of demenha (Pnnce et a! , 2003) Suspected dementia Will 
be deterrnmed usmg the Demenha Questwnnmre (DQ) cut-off score and the 
combmatwn ofMMSE score< 24 and HVLT<l9 Cases Will then be assessed m 
more detml m a third wave at the Umvers1ty of Jakarta hosp1tal usmg a validated 
computenzed standardized diagnoshc cntena (DSM-IV, NINCDS-ADRDA) system 
(Hogervorst et a!, 2003) m a follow-up study 
At the health centre participants Will also undergo a phys1cal exam mcludmg we1ght 
and he1ght and blood pressure measurements by tramed research nurses Sufficwnt 
blood will be taken to assess lipid profiles, glucose, sex hormones and other 
bwchem1stry assoCiated w1th cogn1hve Impairment Buccal swaps will be done to 
obtam DNA for later analyses (e g to assess APOE genotype) In add1hon 
partiCipants Will undergo a full nutnhonal questionnmre by a tramed nutntwmst 
Bone mass and metabolism will also be measured Bone metabolism 1s a proxy 
measure ofhfe hme exposure to oestrogen as well as achv1ty levels, v1tamm D and 
sunlight exposure therefore we are assessmg th1s as a secondary measure Full 
medical h1story Will be taken obtammg mforrnatwn pertment to d~agnos1s of 
demenha type and assessmg nsk factors for demenha For exmnple, diabetes, head 
mJury, neurological problems, Parkmson's disease, mob1hty, psych1atnc problems 
such as depresswn, thyro1d problems, CVD, stroke and many more Fam1ly history 
of health complamts and demenha will also be obtamed 
7.8 Future Research 
7.8.1 Dementia Research at Mid-Life and In Those Over 85 Years of Age 
Prevwus research has already suggested that symptoms of demenha can be seen m 
m1d-life and before they are climcally ev1dent (Launer, 2005, Braak et al, 1998) 
SJmJ!arly, some nsk factors for dementm can mamfest m m1d-life wh1ch mcrease 
the chance of developmg demenha m later life, e g. blood pressure, cholesterol, and 
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other cardwvascular nsk factors resultmg m mflammatwn (Launer, 2005) It ts 
posstble that treatment of these nsk factors m mtd-hfe, the momtonng ofbram 
pathologtcal changes from mtd-hfe, as well as cautwn m the use of medtcatwn for 
smd nsk factors could all have tmphcatwns for the preventiOn and treatment of 
dementia by mcreasmg knowledge about the nature of treatments as well as the 
tlmmg ofmterventwns 
A wealth of prevwus research has tdenttfied age a maJor nsk factor for dementia 
and thts has also been continued m thts study The oldest old age group (those over 
age 85 years) ts growmg at a faster rate than others However, data ts sparse for thts 
cohort In the UK for example only a small number of studtes have reported 
mctdence figures for the very old (for example Boothby, Bhzard, LlVlngston, & 
Mann, 1994, Paykel et al., 1994, Paykel et al, 1994, Jagger, Clarke, & Anderson, 
1992, and Mann, L!Vmgston, Boothby, & Bhzard, 1992) Due to such small 
numbers, mctdence figures of the oldest old are, m the most part, a comptlatlon of 
several small and vaned studtes m order to get adequate stattstlcal power (Launer et 
al , 1999) However, screenmg and dtagnosts 1s harder m those over 85 years of age 
because of the large confidence mtervals due to small sample stzes, sensonmotor 
defictts (bhndness etc ) and htgh mortahty rates, as well as the mfluence of survtval 
btas Regardless, 1t ts worth mvesttgatmg cognttlve functwn further m thts strata of 
the elderly populatiOn 
7.8.2 Further Recommendations for Phytoestrogen Research 
Undemably, there ts a huge gap m knowledge about the effects of phytoestrogens, 
partly due to the lack of chmcal studtes The optimal dose at whtch a posttlve effect 
wtll be observed 1s unknown as well as the toxtctty ofhtgh doses oftsoflavones m 
humans The duratiOn of consumptiOn needed m order to see any effect and at what 
pomt long tenn duratwn becomes detnmentalts also unclear. Other factors such as 
genetic, ethmc and environmental vanables, tsoflavone metabohsm and equal 
productiOn (whtch may affect the efficacy of soy tsoflavones), gender, age, and 
menopausal status, all need to be taken mto constderatwn Therefore, future studtes 
should aim to address these tssues, as well as commg to some consensus about 
methodologtcal standards that should be used across the board m order to make 
studtes more duectly comparable Takmg all these pomts mto constderatlon, 1t ts 
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belteved that the evidence to date IS not sufficient to make any recommendatiOns 
about the use of dietary m take of soy Isoflavones to address any human health 
Issues and present and further focused research needs to be conducted m order to 
come to any sort of defimtive conclusiOns 
7.9 Concluding Remarks 
Pubhc consumption allocatiOn between a developed country and a less developed 
one show marked differences For example, the USA assign 29% of public 
consumptiOn allocatiOn to the youth (<20 years old) and 42% to the elderly (65+ 
years old) However, m Indonesia for example, this allocatiOn was 50% to the youth 
and a greatly reduced 3.8% to those over 65 years of age (1996 figures) (Ogawa, 
MahkJ, & Matsukura, 2006) Similar figures can be seen m other less developed 
countnes such as India, Ph1hppmes and Thailand (Ogawa et al, 2006) 
The way forward m dementia research on the whole should be takmg on a 
preventative, proactive approach rather than a reactive one, focused purely on cure. 
We need to ask If the general pubhc m developmg countnes, such as Indonesia are 
well mfonned about symptoms to be aware of As this was bemg wntten, there IS 
currently a large NHS and media campmgn to mcreasmg awareness of dementia, 
possible nsk factors, and potential costs to society (BBC News, 2008a, BBC News, 
2008b) Is this same knowledge accessible to those m developmg countnes and 
those m rural areas who may not have easy access to health mfonnat10n? If not, 
dementia prevalence IS hkely to mcrease to unmanageable levels m the next few 
decades m both the developed and the developmg world Even small preventiOn 
methods could delay dementia onset, and hence reduce dementia prevalence This 
thesis has attempted to address this by focusmg on the Important elements of 
analytical epidemiOlogy It mmed to assess the predictive value of Important nsk 
factors suggested by previous research m an attempt to Identify a profile of an 
mdiVIdual who might be at nsk of dementia due to these nsk factors However, this 
IS JUSt the first step Further assessment IS needed m order to assess the relative 
Importance of these nsk factors, assess other nsk factors that have not be covered as 
well as assess the mteract1ve effects of these nsk factors, and how this mteractiOn 
mamfests Itself This will lead to a proactive approach m the understandmg of 
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dementia w1th a focus on 1dent1fymg md1v1duals at nsk before 1t lS too late to turn 
back the hands of time 
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APPENDICES 
APPENDIX 1 -INDONESIA TEST PACK 
J Quest1onna1re 
Relationship of Salivary Phytoestrogens to Age- Related Cogn1t1ve Decline 
and Possible Dementia m Indonesia 
2006 
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1 Dlstrtc.i-tl'-iC:C'":ttv '::.::-------------------------------,---,----, 
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sumedang-----~-~---- --- -----~~------------ --~2--
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-RT _____ RW 
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4 Location r71n~s7tl7tu~t~,o~n-------------------------------.--1~-. 
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10 
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~In ISh 
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---2-
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f
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13 Complet1on and consistency of answers to th1s auesttonnatre 1s mspected bv 
Name Status Examtnatton Date SI nature 
Interviewer I 
---------
-lntervleWertt --- -- ---------- --- -~- -- -----
~-- ------
-SupeNis~- ----------~-- ----- ------ --- --
F21a How old are you (age from your last birthday) ? 
Age (If any doubt about the answer/doesn't rememberldoesn1 know, check Yrs old 
_ respEndenCs}D cardL ________ ___________ _ 
-- ---- --- --
Doesn't know/ doesn't remember 96 
No anSwer - -- - -- ---- ----~---- 99 ___ _ 
F21b FS~ex~--------------------------.--~---. I ~~e------------- ------------ ----~-- -/---~----/ 
F2 1c What was the htQhest educatton level vou Qraduated from? 
No formal educatton 1 
--El~~~n~~~chQ.~1~-nfi~~h-edi-==. _ -~=- -- --------- -------- -- -----2 --
_ Eleme!'_!a__!Y~S:hq~Ho!!?nd~ lnlandtsct:J..~~-~.Q9!_1~q_~~~l_9~t---- ----- ----- ---3 ---
-----
Pnmary school/ Mtddelbaar Uttgebretd Lagere OnderwtJs/domesttc gtrls 4 
-~c~~I/~~Y'~le_£1.!_ __________________________ 
------
!"1.!_9~~hg~/_!-i__Qge Burge!!!Jk~_?choo~egu!'-::a!~I]L_ _____________ __ 5 __ 
Ac~~emy/ Umvers1ty _ 
--- -- -----
--
- --
-- -- ----- -
---
6 
--
_pther, !Jieas~~p_eE'fl' __ -__ 97 
No answer --99--
What's your profess1on before rettre? 
Not worktng 1 
CtvtiS~Jva~~{(t9a~hei11~ctu!~i9~e~r:De!l!_ e-mj)loyee)_ ____ ~~--=----- --- ---- ---2-~-
En_!epceneur (busm~ssr!!anjtrad~l)___ _ _____ --- -~~~~ ~-=--~ ------3---
_F_~plo_xee 1n pnvate compan --4 ---
ArmJipohc~ __ _ __ __ _ _ _ _ _ __ _ ____ __ _ _ _________ 5 __ _ 
_ Docl9!fla"'l'e~--- _ ____ _ ________ 6 __ 
Farmer 7 
Ftshe-nllarl ------- ---- -~--- --- B---
_Lay_Q_liftno-pe!If1cirlj:D_uob- ------- --- ----- --- 9 
Oth_~, pl"a~e_spe_c:!fy ______ _ _ _ ____ ___ __ _ ___ _ ___ 97 ___ -
F2 1e What IS your parent's race? 
F21e1 Father F2 1e2 Mother 
Javanese 1 1 
-sUrldanes9- ---- - ----2--- - -- --- ~~=--=-2-
-M~~an -----3 3----
Batak -- _ _::_-_=--4
5 
__ -__ _:__ ____ -:4~------
~Minjirii]===--- __ __5 _____ ~-
0th_er, please specify --- __ _:: =~ 9i _____ --- --- _ _::_ _:: 97 
F2 1f Your rellgton/fatth 
Islam 1 ProteStant - - - - - -- - - ------2-- -
Catholtc --- -- -- 3 
-HmdUiSm---------- --~4--~ 
-Buddha -- -- - -- 5---
-Confuctari!Sm_____ -- --- 6 ----
-Oiiler, - ---~----:-_ _:: .::.-=:-ei_::-:--
No answer 99 
F2 1g Ltvtng area 
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!-~~~~~-----~---------\---~---I 
F2 1 h With whom do you hve at this moment? 
Alone 1 
Wife/hu-sbc1iid-- -- ------- --2----
W!f81hUsband a-n-d-Ch,Ta-- ---- ----3 ~ --
}:-hlid:(~thoufV,ite)iiu-~band) 4 
Relat1ves 5 fiistliut10n --------------- ___ 6 __ _ 
0therS --- - ----- -- - - --- 97 ___ _ 
F211 House ownershiP 
Own house 1 
-~~;,t~,:;g::__-_ ---------- ------:~-- -
Llve m other's house ----- ____ 3 __ _ 
-Soclal mst1iU-t1-on - 4 Others - -- -- - ---- ---- -- 97 __ _ 
HEALTH STATUS 
Important for respondent 1s they are healthy and never expenenced senous Illness m the past Th1s 1s to 
confmn (1} their own health, and (11) to avo1d poSSibility of health problems as confoundmg factor m study 
result Complete th1s quest1onna1re fully and clearly to assert the ablhty to become a participant Explam 
clearly and comprehenSIVely whether you have health problems, no senous problems, or m good 
mamtenance (controlled) 
F2 2 Health Compta>nt 
I Part1c1 ant 
At present, do you have any health problem for wh1ch you are Yes No 
(1 ( 2) 
a On med1cat1on, prescnbed or otherw1se (trad1t1onal med1cme ask to see 2 
Careg1ver 
Yes No 
(1 ( 2) 
2 
2 2 
boxes etc , wnte down names of drugs and number) 
Attending your doctor, health prov1der or traditional he"a71e"r--,(a:-n:-d"'fo::r-cw-:;:h::a""t:-+--::---t-----o-+-,---i----;;-b 
2 2 
In the past two vears, have you had any Illness wh1ch re~:'."="'"''e"-'-o"u"-'-to"-----t-.--t--c;--il--,--+-,--
c Consult your doctor health provider or trad1t1onal heale"''-------+--'1---t----;c-+-:i-----i-~-
d Attend a hosp1tal outpatient department or health centre 2 2 
2 2 E Be admrtted to hospital ---------t--,---+--coc--ll--,--+--;c--
F2 3 Tobacco, Alcohol Consumption and Other R1sk Factor for Dementia 
F2 3a Have you EVER smoke? 
I ~~5(COntliiUeto-F2 3-e) ______ ----------------- ------- ------f---~-- -- f 
F2 3b Are you a REGULAR smoker? 
f -~ --- I 
F2 3c How much do you smoke? (choose amount of ctgarettes and one ttme frame whtch respondent 
F2 3d 
r~(!le_f!!_bf!re'!~lly]________ _______ ___ ______ _ __ _ _ _____ _ 
- Yes __ Amou~--
~~oun!_per d~y __ __ _____ ____ ______ ____ _ ==~-- ___ -_-~;:~:~::_ 
Amountper_we_ek __ _ __ _ _ _ _ __ _ __ ,., 
Amount per month 1 Cigarettes 
Cigarettes type 
I Kretek _ _ _ . Wh1te 1 i 
F2 3e Have_y~>U EVER dnnk alcoholic beverages? 
Yes 1 
-No -(coiiilnue!o-F2jh) _________ - -------- -- --- -- -- - -- ------- ---- 2 
r2 3f Do you ROUTINELY/ALL THE TIME/OFTEN dnnk alcoholic beve=rac:g:-es:;;,:-------------L----"---
I ~~"'s("c-o=c=-nt",•n~uc-e:-tc:o:oF"'2'3;;;h:c)------------------------------------+ 1 ----2 
F2 3g How much alcohol consufDptlons_y9u have each week? 
~~~-~::::~;~~:.-' __ -~----_-_-_-_-_---_-_--=_-_--_-_ --_-_-_-_-_-:::::-=---_ =----_-}::::=::::-
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1.1 Un1t OfSp1ntS - ---
Other:-pi8as8 sFJeCJfy _____ _ 
F2 3h Do vou dnnk tea? 
GREEN TEA 
Yes 
------------ ----i---
N0(CorltinU~t~E:2)J>-___ ~-~--=--- __=.=__ --=----=-=--~----_-_-_-_--_-_-_-_-_________ _ -~-2- --
BLACK TEA ves--- - -------·-----·------------- ---- -- ---- --
NO (contmueto Fi3j) ------- -- --- - -- -- -- --- -- ------- ---
F2 31 
easily) 
How much tea you dnnk? (confirm the answer to glass amounvt1me frame wh1ch respondent remember 
----- --- --- -- -- - -- --------------~- -yes- -Amount --
_Anl~nlP~i2~--_ --- ---------------___ ____ 1 ------ -gtass--
Amo_~:!n!_p~r wee!___________ 1 glas~ _=_ 
Amount er month 1 lass 
Do you dnnk coffee? F2 3J 
---+ -- -~---I Yes ______________________ _ -No (contmue to F2 4) 
F2 3k How much coffee you dnnk? (confirm respondent's answer to glass amounvt1me frame which 
respondent remember easily) 
------ -- -- -_--_-______ -_--_-_-._-_-_-_---.--~~-= -=-=y--·~-- _An10lJ!l_l -_-
--~~ou-~tnerSJiiy- --- 1 gtass 
- - cor-- ,------------------ f--- - --- ---- --Amount per week 1 _ _ _ _ __ glas_s_ 
A""iilount per month 1 _ _glass 
F2 4 Are you on hormone therapy m the past 6 months? (e g use of hormone (for men), v1agra, plants) 
c1rcle 
1-~~· --- --- ------------ 1----~- ----
F2 5 Compare to others 
More The same Less 
_a_ 0_E_l'OU fe~l happy_?_ _____ 1 2 3 
_ b_ Do _you feel secure~ _ ___ • ___ --- - - -- --1---- ---2-- --- 3-~ 
---~-~--
-1-r----- --3-~ c Do you m stress or anx1ous? 2 
F2 6 Food Consumption 
How much do you consume the folloWing food Do you eat 1t dally? If yes, ask how Days m a Days m a 
1tem many t1mes a day and contmue to the week month next food 1tem 
Yes, how many times a No day 
a R1ce 1 2 
b FrUit/JUice 1 2 
c Orange/red colored vegetables 1 2 
d Green ve etables 1 2 
e FISh 1 2 
f Tempe 1 2 
_g Tahurrotu 1 2 
h Soy milk, other soy roduct 1 2 
I Tumenc as )amu (herbal med1c1ne) 1 2 
J Tumenc as sp1ces 1 2 
k Tumenc as raw veoetables 1 2 
I Wh1te meat (Chicken) 1 2 
m Red meat (beef/lamb/veal) 1 2 
F2 7 Phys1cal, Mental and Soc1al ActiVIties 
F2 7a Your oos1t1on dunno act1v1t1es 
Never Seldom Sometimes Often Very otter 
Pos1t1on (I) (2) (3) (4) (5) 
a S•t I 2 3 4 5 
b Stand I 2 3 4 5 
c Walk I 2 3 4 5 
d Lift heav , thmgs I 2 3 4 5 
E Feel t1red afterwards I 2 3 4 5 
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r Sweat afterwards 2 3 
F2 7b Compared to people of you own age how do you rate your physical actJvJty 
Lighter___ _ ___ _ _ _ _ ___ _ _ _ ______ _ 
-~~eavY. ________________________ -------------
Heavier 
F2 7c Do you play sport regularly? 
I Yes _ No cOnt1nueto F2 a 
F2 7d What k1nd of sport 
K1nd of sport played Frequency (how 
often) 
1 t1mes 
2 t1mes 
3 t1mes 
4 times 
5 t1mes 
F2 8 Mentai/Soc1al ActlvatJes 
F2 Ba f Do you enqaqed m the ollowJnQ actiVItieS 
ActiVIties Never Seldom Sometimes (!) (2) (3) 
a Read I 2 3 
b Wnte letters I 2 3 
c Watch TV I 2 3 
d Talk to fnends, ne1ghbours or fam_!y_ I 2 3 
e Go to gathenngs (soc~a\) I 2 3 
f Pray together I 2 3 
9 Have dmners w1th fnends/fam1ly I 2 3 
h Go to theatre /film (ketoprak, ludruk, reog, topeng, lenong)- I 2 3 
I Go to mus1cal gathenng (la1pongan,gend1ng) I 2 3 
I Involved 1n commun1ty _soc1al act1v1t1es I 2 3 
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Day 
1 
1 
1 
1 
1 
4 5 
F2 
1 
2 
-- :3---
+ 1 2 
T1me frame 
Week Month 
2 3 
2 3 
2 3 
2 3 
2 3 
Often Very ofte 
(4) ill 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
4 5 
-- ----------------------------------------------------------------------------------------~ 
F2 8b the health centre/hosp1ta!? 
1 
---------------2-
F2 Be Acttvtttes you follows 
_Gy_!!l__Qasttc _____________ _ 
Health Educatton 
Promotion - Prev8nttoli-
Trltegfated-Health PoSt (DIVISIOn nl health centre dedtc3t8-d to mothers' toddlefs, and-- ---
elderly) _ 
O~her, pleas~~pectfy ___ _ _______________________ _ 
No answer 
1 1-
1 
1 
- -97 
--99--
F2 8d Do you have hobbtes? 
No 1 
Flower ar-rangemen-tS---------------- ------------- --- -1-
Puzzl6 -- - -- - - - 1 
-co_<>k1n9 _=::::__ -==-=-=:: =-=-:------------:=_-=::-=:: -__ 1 --
Drawmg _ _ __ _ _ _ _ ____ _ _1 
_ Gardentng _____________ ------------ _____________ 1 __ 
_ St!Q~glw_?!!5_!~g_ _ __ _'!_ 
Trav~llln!} ____ _ _ _ __ _ __ _ _ _ _ 
~?~~::.n~ie~~pec1fy ---------=--::_ ;7 _ 
Other, pleas~ spec1fy _ _ ____ __ _ __ _ ___ _ _ __ _ _ _ ____ _ ___ _ 97 _ 
No answer 99 
F29 Memory 
These questions also d1rected to careg1ver and gave the answers m caregtver column 
I C •arhctpant areg1vcr 
F2 9a Problems m forgett•ng Do you remember? Yes No 
1 Names of people you have JUSt met 1 2 
2 Names of people you know a httle (acquamtances) 1 2 
3 Names of people you know well (cousins/nephews) 1 2 
4 Names of people verv close to vou fch1ld/partnerl_ 1 2 
5 Names of th1ngs (ammals, grocery 1tem) 1 2 
6 Way home/way to the shops/way to fnends 1 2 
7 Thmgs you bought from last tnp to grocery 1 2 
8 Remembenng where you put thmgs 1 2 
9 Remembenng what you had for breakfast 1 2 
10 Remembenng what you d1d last week 1 2 
11 Remembenn_q what you d1d last year 1 2 
12 Remembennq what you d1d 10 years aqo 1 2 
13 Remembenr}g vour childhood 1 2 
14 Other, please spec1fy 1 2 
F2 9b Problem~ m reco~mzmg fa cell of people you know 
1 A little 1 2 
2 Verv well (Child/spouse) 1 2 
3 Problems m recogmzmg your way home 1 2 
4 P10blems m recogmzmg thmgs 1 2 
5 Other, please spec1fy 1 2 
F2 9c Problems m understandmg language (ask careg1ver and observe) 
1 Problems m _§_peakl!!.[_ 1 2 
2 Word f1nd1ng problems 1 2 
3 Speakmg m understandable sentences 1 2 
4 Problems read1ng 1 2 
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F2 
Yes No 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
5 Other, please spec1fv 1 2 
F2 9d Problems m domo thm!!S 
1 Combmg ha1r, washmg themselves, dress1ng themselves, gett1ng up 1 2 from a cha1r, eatmg, us1i1g to1let, 1ndoor walkmg 
2 Tak1ng med1c1ne regularly 1 2 
3 Cookmg, shoppmg, cleanmg 1 2 
F2 9e Problems With plannmg and Inhibition 
1 Planmnq (a tno, do1no someth1no, qo1no shopp1nq) 1 2 
2 Counttnq account (bank affa1r) 1 2 
3 Hand!mq money 1 2 
4 Act1ng aggress1vely 1 2 
5 Worry SUSPICIOUS (paranOid) 1 2 
6 Other, please spec1fy 1 2 
If, accordmg to respondent I caregtver, the respondent expenenced the problem(s) above please 
contmue to quesftons F2 10- F2 12 If not contmue to questton F2 13 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
F2 lOa D1d these problems start 
I Slow! Sudd:Le::;nt"y'(e::-:::g-:a"ft;::e7r::;st"ro"k::ce') --------------- ----\-}-
F2 !Ob 
1 
-----
2 
F2 !Oc How long months (1f the answer 1s m years, convert 1t to months or xl2) 
F2 11 Impact of cogmt1ve problems on quahty of hfe 
F2 !la Do these problems make 11 d1fficult for you to function socm\ly or to work or functiOn m your activity 
( spm tu a 1/socmlly/men tally)? 
I ~~ ---~--- ---------------\--~ --
Fl Jib Does 1t make you sad? 
I ~~"'s ___ _ 
F2 lie 
F2 lid Does 11 affect you m gettmg around? 
r2 I le Are there other thm s that 1s mflucnced b the roblems above? 
Yes 
3--~-
1 
2 
--\--~---
1 
No, Please cont1nue to F213 ------ ---------- --
f2 12a Name other thmgs that IS mfluenced by the problems above 
F2 12b What do you thmk ts the reason for these problems (old age, stress, d1sease, sadness) 
Explam 
F213 INFORMATION FROM CAREGIVER 
THE FOLLOWING QUESTIONS ABOUT THE ELDERLY IN LAST COUPLE OF YEARS IS DIRECTED ONLY TO 
CARE GIVER 
F213a Does the elderly you care for (the one concerned w1th th1s quest1onna1re) have memory problems? 
Yes 
If yes wh1ch? explam 
No:Piease cOnt,n-ue to F213 --------- --- ---- ------- --- -- -- ~- --- --
F213b If yes, does 1t happen consistently? 
[ ~~s --------- - ---------- -- - - ----- -
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-- - -
2 
1 
2 
1 
2 
F213c Does the concerned remember and mentton some events correctlv 
Always ________________ ---··· _____ -------- _ _1 __ 
Somettmes 2 
seldom-- -- ----- - 3- ~ 
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F213d 
F2 13e 
FZ 13f 
FZ 13g 
F213h 
F2131 
Is the concerned able to recall some th1ngs (e g shopping hst) 
_81W9JS ------------------------ --------- 1 
--2-K_~d8.!19 __ k_ad~ng-_Som~!l_f'!!8S ___ _ ______ _ 
Seldom 3 
In the last one otten worse? 
Yes 
No 
Does her/his memo roblem affect her/h1s da1l act1v1t1es? 
Yes 
No 
Does the concerned forget b1g and Important events m a few weeks Since the event took place (e g a 
weddmg, led, Chnstmas) 
_!l.lways'=c:-=--------------------------------!---1---Sometlmes 2 Seldom ---- - ---- -- - - --- - -- -- --- 3 
Does the concerned forget the details of Important events? 
A_lv.:ays_____ __ _ _ ___ __ ___ ___ _ _ __ __ __ __ ___________ 1 
Sometimes ---2--
Seldom- - ------ --3--
Does the concerned fully forqet Important events m the past? 
Al\,\lays __ _ _ _ _________ _ ___ _ 
Sometlecm:,es"----·--------------- ______ _ 
Se!dorTI--
1 
2 
--------3-
Observation 
F2 14a Observe and record respondent ohvs1cal condition 
L1e down 1 
-Sit on a wheel cha1r 2 
Need-help walkmQ- --- --- - - - ----- -- --- -- -- ---- - -- 3 
--Other, olease soecllY ____ ---------------------------- --97-
F214b Dunng mterv1ew does the resoondent seem 
Relax 1 
- [f!nse (as 1~ un~! pressl!re)_ ____ __ -------------- -~-2---
--- -- --
-----
--- --
-
--- - --
---
-
--
_ _e..~?_?thetlc or confuse9 3 
Sad 4 
~Other, Diea-sesoecllY ______ --- ---- - ----- -------- --
--97--
F214c Does respondent understand all quest1ons asked? 
F214d How respondent answers or responds to quest1ons asked? 
-~nswer mde~end_~_tlY.==::-:-:===---------------------1---;1~ 
Be:1n1;1 /l~!P~~ a~~91rected by ca~eg1ve~_ _ _ __ ----- _ _ ____ _ _ _ 2 
Other, please spec1fy 97 
Record other observabons made 
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2 
2 
2 
lnstructtons 
Tnal1 
HOPKINS VERBAL LEARNING TEST VERSION A (lndones1an Vers1on) 
~carefully whtle I read a list of 12 words Try your very best to memonze as many of these words as 
you can When 1 stop, you are to say back as many of the words as you can, tn any order that you wtsh 
Ready?' Read the words at the rate of one word every 2 seconds (1 sec between words) After readmg the enttre 
ltst to the pattent, have the pattent recall them Check off the words the pattent recalls on the form If a word ts satd 
that ts not m the ltst, wnte that word on the form but say nothmg to the pattent about the word not bemg on the hst 
If the pattent does not produce any words for 10-15 seconds, ask the patient tf he/she can remember any more 
words If not, move on to tnal 2 Later, you can record the number of words that were correctly repeated on the 
summary fonn 
Tnal2 
'That was a good begmnmg Now, I'm gomg to read the same hst agam When I stop, I want you to tell me 
as many words as you can remember, mcludtng the words you satd the f1rst tJme 1t does not matter m 
what order you say them Just say as many words as you can remember whether or not you satd them 
before Ready?' Read the words at the rate of one word every 2 seconds Then have the pattent recall them 
Check off the words that the pattent recalls on the form If the pattent does not produce any words for 10·15 
seconds, ask the patient tf he/she can remember any more words If not, move on to tnal 3 Later, record the 
number of words that were correctly repeated on the summary form 
Tnal3 
•Very good I'm gomg to read the hst agam Agam, hsten carefully and try to remember as many words as 
you can whether or not you satd them before Ready?' Continue to follow recording procedures from tnals 1 & 
2 Note that each *learmng• and recall tnal should last about 1 m1nute 
Delayed recall 
For researcher Thts part ts asked after all tests are done Do not read the hst agam Check the words the pattent 
recalls 
Delayed Recall (D) PART IS ON THE LAST PAGE 
Words to Mentton 
Tnal1 Trtal2 
Correct (,J) Incorrect word Correct(,)) Incorrect word Correct (,J) 
1 Lion 
2 Emerald 
3 Horse 
4 Tent 
5 Sapph1re 
6 Hotel 
7 Cave 
6 Opal 
9 T1ger 
10 Pearl 
11 Cow 
12 Hut 
TOTAL 
Refused to attempt 
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Tnal3 
Incorrect word 
Respondent number 
Respondent's Name 
Respondent's Age 
Educatton 
Max Elderly 
Score 
5 
5 
3 ( ) 
5 ( ) 
3 ( ) 
9 ( ) 
MINI MENTAL STATE EXAMINATION (MMSE) 
F4 1 Onentatton 
lntervtewer Name 
lntervtew Date 
Fmtsh Ttme 
What IS the (day) (date) (month) (year) (season)? 
Where are we (street) (house number) (town) (v1llage) (prov1nce)? 
F4 2 Regtstratton 
lntervtewer name 3 objects 1 second to say each Then ask the respondent to 
repeat all 3 after you have satd them GJVe 1 pomt for each correct answer If still 
m correct, repeat them unttl he learns all 3 Count tnals and record (House- Ch•ld-
Rtce} 
Tnals ------
F4 3 Attention and Calculation 
Ask the subject to begm wtth 20 and count backwards by 3 Gtve 1 score for each 
correct answer Stop after fJVe subtracttons (20, 17, 14, 11, 8, 5, 2) Other alternatiVe 
ts to spell the word "worldH backwards (d-1-r.o-w) 
For llltterate Respondents 
Ask respondent to name days m week from f1rst day (Monday, Tuesday, Wednesday, 
Thursday, Fnday, Saturday, Sunday) Then ask respondent to name 1t backwards 
(Sunday, Saturday, Fnday, Thursday, Wednesday, Tuesday, Monday) 
F4 4 Recall 
Ask for the three words you previously asked h1m to remember One pomt for each 
correctly recalled 
F4 5 Language 
a What IS the name of these thmgs? (show 2 thmgs, e g penc1l and wnst watch) 
b Repeat the followmg sentence ,If not, and 
but' (1 pomt) 
c Follow a 3 stage command 
• Take this paper m your nght hand, 
• fold 1t m half and 
• put 1t on the floor 
d Read and obey the followmg "Close your eyes~ 
If 1lletrerate JUSt say ,Close your eyes~ 
e Wnte a sentence 
If 1lleterate ask to draw a house 
Copy the followmg draw1ng 
or 
Total ( 
Score 
Mark elderly re w1th an x 
Fully CO 
24 or less 
25-30 
H1gh likelihood of dementia 
Normal agmg or borderlme dement1a 
Fm1sh t1me 
Interview place 
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a 
(2 pomts) 
(3 pomts) 
(1 pomt) 
(1 pomt) 
(1 pomt) 
Observation Column Record cond1tton durmg mtervtew (respondent condtttons respondent reactions to 
_questions or mstructtons) 
Show thts drawmg, then ask respondent to close her/hts eyes then open and copy th1s drawmg 
Close Your Eyes 
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Act1v1t1es of Oa1ly L1vmg 
Respondent number 
Respondent name 
No Funct1on Pomts 1 Cntena 
F51 ; Defecat1on control f _ -~~ _ ~ ~r~;~~~~W~~~;~~:E:mes(OnCeaW€ek)___ _ __ _ _ _ __ _ 
----,---- _______ ----------- --i ____ g_:_jJ:~.O~tul~~~-~-=~~ -=--=---~=-~ --==~~-=-=-- ~ 
F5 2 ' Unnate control 1 0 1_1 ncon!l!:!ence ~~~~~ng c~the~er:_ a~d_~~CO_!!_troll!i!d ________ _ 
______ j _____ _ __________ f~- ; __ ~-f~~~~~j~~~some-limes(:ax =x~~our~::__-:_ ___ -:__::_ __ --
F5 3 1 Ab1l1ty to clean themselves (wash the 1- Q __ t N_eed help_ _____ _ _ _ ~ __ 
___ ~~ _tac'::_~~ eo~~· !'r~~~ ~h~~e~--- -~1---1 __ 11ndepe:~~n!____ _ _ _ __ _ __ _ _ _ ____ ____ _ 
F5 4 : Toilet use To go to and from to1let I 0 1 Dependent 
1
1 (take off and wear trousers, w1pe, I f- I ~j§!d heln -m s-ql"!:l~8cttvltle-s_-but l_ndepenCferlf 1n othBrs ~---- __ _ 
---! flush) :- _2 ___ j lndepe~cl_~~- _____________ :::_-:_ _____ __: ____ _ 
F55 1 Eat _, _o ___ !l __ Unable_____ _ _____ _ 
' I 1 Need someone to cut the food 
___ _ _ -1 ___ _ _ _ _ _ ~~ 1 TrldeP.TideO! - --~ - --_-_ ----_----=- -- -=--:- --
F5 6 1 Change pos1t1on from IJe down to s1t 1 0 1 Unable 
/ up r----1_--,-Need heTpto s~(2 person~f:--~-~=- -~- =-- ~ -~ 
I ~ _ _? __ ,_ ~_!~OJ"!:I_!_pe.I_~~-- ---------
1 ~ 3 }J!:IQ.ep~n9~!_ _______________ ---------
F5 8 I Get dressed (put clothes on) I 0 l Dependent t- -- 1 ~- Pcirtty: dep-endent (e-g -b-Uttomng Shirt) --- - ----------- -
_ ---~;------- ____________ --+-- 2 --r~!lc!epend~~t ____ -=_ ~-~ ______________ _ 
F5 9 
F510 I Take a bath 1 0 1 Dependent 
--r-- --- ---- _________ ~=- -::r--: j lndepe_n~,lnt ______ __:: ___ _::_:: _ _::_- --=- ~:__- --~~ 
ADL Score 
, T a tal score 
20 
12-19 
9-11 
5-8 
0-4 
Independent 
Lightly dependent 
Moderately dependent 
Heav1ly dependent 
Totally dependent 
1 Cntena 
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No ActiVIties 
Instrumental ActiVItieS of Dally LIVIng {IAOL) 
P01nt Crltena If there's matd, wh• 
w111 do these actiVItt 
F61 1 Extendmg ~ _ 0 __ 1 U!!abl~ to extend_ ~~??_9ge _ _(c!Q~~n'!_ have te!ept!on~!!)Clud~) __ J ___ -~ _ 
' message/us1ng 1 , MessageeXtende~. partially (capable of 3nswenng phone but : 
: telephone (there Will L_ __ l_ unable to operate 1t1 _ -----------__ 
I at Mr RT's house at I , , be meet1ng tomorrow ' 2 l Able to operate telephone/message extended completely •1 
----l1oL ______ -----L ---- ------------- - --- ---~- -- -------
I ' 
F
6 2 I Shopping ; ___ ~ __ ·::+-~~;~.of ptJI'c~"SI~g_up_to_:l ~leJT1s,_othe'Y''se-"ee{~EliP~==:; -~ ~-~- :._ _ _::_~ 
_ ~ r- __ __ __ _ ___ i 2 !Independent_ _ __ ___ ___ ___ _ _ _ ____ • ~ __ __ 
F6 3 
---
F6 4 
F6 6 
F67 
---
F6 8 
I Prepanng meal I 
I 
I 
i 
0 1 Unable 1 :_--1 --j A~1e lQ co_9k-lfth_e_mgredlents are- ready or to warm cooked food ,-- ------ -
_________ ;'_ -~2~-1 -"ln,ed;e~det ! ________ _ 
I I I 
' Housekeepmg 
I 
I 
i 
I 
' 
UtlhzatJon of 
I transportation means 
' 0 I Unable to travel w1th any tran~~':!at1on mean , 
1 1 j Travels on public transportat1on/tax1 or pnvate car 1f ) 
I 
-
:___ ___ _h~lp~gt~cE<?!!!e~~~-q_EY ~t~er _____________ 1 ___________ _ 
·---~1 _.=_2 ___j_ir1d~~endent _ I 
I 1 I I 
I 
ResponsJblhty of own 
medJcatJon/prepanng 
own medJcat1on 
I 
1 Ab1l1ty to handle 
finances 
I 
i 
1 T a tal score 
~ __ o __ _J Incapable_ -~ _ _ _ ____ ____ __ _ __________ j 
' 1 I Able to arrange dally purchases, but need help w1th 1 
I --+_ba~~g~2!:.£UrchasJQ_9 ·cc~-.--,---·-c--''--------
r-o-1 2 'I Able to manage financial problems (household budget, pays the 1 
, rent, rece1pt, bank matters) or to momtor 1ncome 
I I 
IADL score 9-16 
1-8 
0 
Independent/doesn't need any help 
Needs help 
Unable to do anyth1ng 
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SF 36 Health Survey 
Instructions Thts set of quest1ons asks for your vtews about your health Thts mformatton Will help keep track of 
how you feel and how well you are able to do your usual acttvtbes Answer every questton by marktng the answer 
as tndtcated If you are unsure about how to answer a questton please gtve the best answer you can 
F71 In general, how would you say your health ts? 
Excellent 1 
::very_goocl :::=::_ ::::::::::-_:- =-= ___ _:::::__~_- --- _____ ~--_-_-_-_--_--_-___ --_-2 
Goo~d~---------------------------------------------------1--~3 
~· 4 -- -- ----
Poor 5 
F7 2 Compared to one vear aqo, how would vou rate vour health tn qeneral now? 
F7 3 
F7 4 
F7 5 
F7 6 
F7 7 
F7 8 
Much betler 1 
-somewhat better ------ --------- ------------------ ---- --2--
AbO-Utthe san:;e------------------------- -------- ----- _3 __ _ 
-=-~QmeWh-a.!_ worSe-- ~----- ______________ ----------- ____ _ ___ -~--
Much worse 5 
The followtng questtons are about actiVlttes you mtght do dunng a typtcal day Does your health now llm1t 
you m these act1v1t1es? If so how much? (Circle one correct answer for each row) 
Act1v1ty Yes, lim1ted Yes, lim1ted a lot (1) a little (2) 
a Vigorous act1v1t1es, such as runn1ng, l1ft1ng heavy objects, 1 2 partlc!patrng m strenuous sports 
b Moderate act1v1bes, such as movrng a table, sweep1ng I pushrng a 1 2 
vacuum cleaner, qymnasbc, mowrnq the lawn 
c Uft1 ng or carrying grocenes 1 2 
d Chmbrng several flights of sta1rs 1 2 
e Chmb1ng one fl_!9ht of sta1rs 1 2 
f Bend1nq, kneelrng, or stoopmQ 1 2 
g Walkrng more than a kilometre 1 2 
h Walkmg several blocks/alleys 1 2 
I Walking one block/alley_ 1 2 
I Bath1nq or dressrnq yourself 1 2 
Dunng the past month, have you had any of the followrng problems w1th your work or other regular dally 
act1v1t1es as a result of your physrcal health? 
Yes(1) 
a Cut down on the amount of trme you spent on work or other act1v111es 1 
b Accomplished less than you would hke 1 
c Were hm1ted rn the kmd of work or other acttvrtres 1 
d Had drff1cul~rform1!.!9_the work or other actrv1tres (for example, tt took extra effort) 1 
Dunng the past month, have you had any of the follow1ng problems w1th your work or other regular da1ly 
I f I I I f d actrv1tres as a resu to any emotrona prob ems e g eelmg epressed or anx1ous)? 
Yes (1) 
a Cut down on the amount of time you spent on work or other act1v1t1es 
b Accomplished less than you would l1ke 
c D1dn't do work or other act1v1bes as carefully as usual 
Dunng the past month, to what extent has your physrcal health or emotronal problems mterfered wrth 
your normalsoc1al act1vtt1es w1th fam1ly, fnends, ne1ghbours, or groups? 
F7 
How much phys1cal pa1n have you had dunnq the past month? 
None 1 
1 
1 
1 
yery miid --- -- ---- - -- -- - -- ---- --- ----- ---- 2 
'-MC;MC:~~0'e::r=at"'e _____ -_-_-_--_-_-_-__ =::_-=::::__=_:::=_: _ _:::::.:_:=~--=::_ --1 _::: 
~~~:v~r~ -~ -~ ----- - -=-~-- ---_:_-_=_=- --~ -~ --==_ - -- - ----- --- -- - -- ~ 
Dunng the past month, how much d1d parn rnterfere wrth your nonnal work (rncludrng both work outsrde 
the home and housework)? 
No\ at all 
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Not l1m1ted 
(3) 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
No (2) 
2 
2 
2 
2 
No (2) 
2 
2 
2 
A little bit 
Moderately 
QUite a b1t 
Extremely 
F7 9 These questtons are about how you feel and how thtngs have been With you dunng the past month 
F710 
Please gtve the one answer that IS closest to the way you have been feelmg for each 1tem Please c1rcle 
one number (code) on each I me All of the ttme 
1 Most of the ttme 
2 A good bit of the t1me 
3 Some of the bme 
4 A httle of the t1me 
5 None of the ttme 
a D1d you feel full of ltfe 
b Have you been a very nervous person 
c Have you felt so down 1n the dU!"QQS that nothmg could cheer you !JP 
d Have you felt calm and eaceful 
e D1d you have a lot of energy 
f Have you felt downhearted and blue 
Q Otd vou feel worn out 
h Have you been a happy person 
I Dtd you feel t1red 
Dunng the past 1 month, how much of the ttme has your physical health or emotional problems 
mterfered w1th vour soc1al acttv1t1es (hke VISibnq w1th fnends, relattves etc ) 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
1 2 
All of the ttme 1 
-MOst Of thet,me------ --------------------- -2--
1~~~:~~~-~~~-:--------~~=------------------------- --- --- -;-
-None Otthe time--- 5 
F7 11 How TRUE or FALSE IS each of the followmg statements for you Please Circle one number (code) on 
each line Def1n1tely true 
1 Mostly true 
2 Don't know 
3 Mostly false 
4 D efin1tely false 
a I seem to get s1ck a little easter than other people 
b I am as healthy as anybody I know 
c I expect my health to get worse 
d Mv health 1s excellent 
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1 
1 
1 
1 
2 
3 
4 
5 
Code 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
3 4 5 6 
Code 
2 3 4 ~ 
2 3 4 ~ 
2 3 4 ~ 
2 3 4 ~ 
HOPKINS VERBAL LEARNING TEST VERSION A (Part D) 
Delayed Recall (Ol 
For researcher ThiS part IS asked after all other tests IS done by respondent/partiCipant Do not read the hst 
agam Check each word that the pat1ent recall, record allmcorrect words on the form 
Tell the patient, 'I read you a list of wordll and )OU pract1ced rememberang the \\Ords 1\o\\ tell me as man) words as 
you remember ' 
Words to recall 
Correct (_,J ~ Record all words not on the ong1nal hst 
1 Lton 1 
2 Emerald 2 
3 Horse 3 
4 Tent 4 
5 Sapphire 5 
6 Hotel 6 
7 cave 7 
8 Opal 8 
9 T1ger 9 
10 Pearl 10 
11 Cow 11 
12 Hut 12 
TOTAL 
Refused to attempt word hst recall Total recall (0- 36) 
r.~-~~~~~~--~~~~~~~~~~~~~~~--~~~--~--~--t End of Interview 
Thank you for your willingness to spare some t1me to answer th1s questionnaire We really apprec1ate 
your help. ~ --------------------------------~~~~-------------------------------1 """"""~>"'-'"•-".4""'~~·· :>.. .... """~,- J 
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APPENDIX2 
- -lnfoimed Consent 
Con~ent from Study Respondent of the 1nfluence of ph~ toestrogen levels on memor)' m men and women m Indonesia 
The purpose and details of thts study have been explamed to me I understand that th1s study IS destgned to 
further sc1enttfic knowledge and that all procedures have been approved by the Faculty of Med1cme Umvers1ty of 
Indonesia Ethical Adv1sory Committee 
1 have read and understood the mformatton sheet and thiS consent form 
l have had an opportunity to ask quest1ons about my part1c1pat•on 
1 understand that I am under no obhgatJon to take part m the study 
1 understand that I have the nght to withdraw from thiS study at any stage for any reason, and that I will not be 
requ1red to explatn my reasons for w1thdrawmg 
I agree that a saliva sample w1ll be taken and used to assess the level of plant hormones m my body 
I understand that all the mforrnat1on I prov1de Will be treated m stnct confidence 
I am happy to prov1de a saliva sample for testing of plant hormones 
I agree to part1c1pate m th1s study 
Your Name 
Your Signature 
Careg1ver Name 
Careg1ver Signature 
Name of lnvestrgator 
S1gnature of lnvestrgator 
Date _____ /2006 
Follow-Up Consent Form 
I don't mrnd be1ng contacted aga1n for another study but I do realize that I don't have to part1c1pate 1f they ask me 
agam and that I can refuse whenever ll1ke Without QIVIng any reason 
Respondent number 
Name 
S1gnature 
Careg1ver name 
Careg1ver s1gnature 
Full address 
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APPENDIX3 
InformatiOn Letter for Volunteers 
The Influence of phytoestrogen le\'els on memory in men and nomen m Indonesia 
Substances m plants called plant hormones or 'phytoestrogens', may affect the body and the bra m 
People m the West consume less of plant hormones than people m the East Some mvesl!gators 
belreve that these plant hormones prevent cancer and heart problems because these diseases are less 
frequent m As1an countr1es It has also been suggested that these plant hormones can 1mprove 
cognltlve funct10ns, such as memory, whtch ts what we want to test m this study Thts study mvolves 
the measurement of plant hormones m sahva and the memory functiOns of women and men older 
than 60 years of age m Jndones1a 
You will be tested on several cogmttve functiOns mcludmg memory and asked several que~tiOns 
about your health and d1et You w1ll be asked about soya contammg products such as Soya beans, 
Soya nulk, Soya nulk desserts, yogurts and !Ce-cream, Tofu, Soya protem and soya protem lSolate, 
M1so and Temp eh and the mtake of vegetables and grams You w!ll be g1ven a ques!Ionna1re about 
the food that you eat and your actlVll!es 
We would hke to take a sahva sample to measure the amount plant hormones m your body and 
substance that may be related to d1sease For the sahva sample you w!ll be asked to nnse your mouth 
With clear water 
The entire sessiOn wlll not take more than 1 hour No nsks are mvolved m thts study as our research 
asSistants are tramed to take the sahva samples safely and hyg1emcally 
All data are str!Ctly confidential, the study 1s anonymous and your name 1s never revealed to 
anybody You can stop w1th the study whenever you hke and you can ask for your mformat10n to be 
Withdrawn from the study wtthout havmg to gtve a reason, at any pomt without any consequences 
Please feel free to ask the research assistant any questiOns that you may have about this 
study 
APPENDIX4 
Pearson's CorrclatJOn"i between o;o, mtake {"eekh) and o;all\an• [!hYtoeo;trogen leH'l"i !£mm) 
2 3 4 5 6 
I Da1dzem (ppm) 
2 Gem stem (ppm) r= 76 
p<O 001** 
3 Glyc1tem (ppm) r- 86 p<O 001** r= 86 
p<O 001** 
4 Tofu (weekly) r= 12 r= 06 r= 10 p=O 007** p"O 14 p=O 03* 
5 Tempe (weekly) r= 10 r= 06 r= 06 r= 87 p=O 026* p"O 21 P" 14 p<O 001** 
6 Total Soy (weekly) r= 10 r- 05 r- 08 r= 95 r- 95 p=O 02 * p"O 21 P"08 p<O 001 ** p<O 001""" 
• CorrelatiOn 1s s1gmficant at the <0 05leve\ (2-talled), *"'Correlation 1s s1gn1ficant at the <0 01 level 
(2-tatled), ppm =parts -per m11l10n 
365 
APPENDIX5 
Landis Kappa Groupings 
<0 No agreement 
00-019 Little agreement 
0 20-0.39 Fa1r agreement 
0 40-0 59 Moderate agreement 
0 60- 0 79 Substantial agreement 
0 80- I 00 Almost perfect agreement 
(Land1s & Koch, 1977) 
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APPENDIX6 
CorrC'Iatlon Coefficu•nt Matnx for Vanable Entered into Factor Analysis ob 
2 3 4 5 6 7 8 9 
Agnos•a (carcgner report) 
r= 77 
2 Aprax•a (carcgn·er report) p<O 001 
3 Aphasra (caregn'CT report) 
r- 53 r= 48 
p<O 001 p<O 001 
4 Executn e Function (caregncr report) r= 69 
r= 73 r= 61 
p<O 001 p<O 001 p<O 001 
5 Longlo;hort term memory (caregn er report) r= 60 
r= 47 r= 44 r= 37 
p<O 001 p<O 001 p<OOOI p<O 001 
6 Aprax1a (<;elf-report) r= 38 r- 54 r= 17 
r= 33 r= 22 
p<O 001 p<O 001 p..O 008 p<O 001 p<O 001 
r= 18 r= 20 t= 54 r= 23 r= 17 r= 23 
7 Aphasia (self-report) p..O 005 p..O 002 p<O 001 p<O 001 p..O 007 p<O 001 
8 Execut1ve Function (self-report) r= 29 r= 34 r= 20 
r= 43 r= 16 r= 65 r= 33 
p<O 001 p<O 001 p=O 002 p<O 001 p<O 001 p<O 001 P,O 001 
9 Long/short tl'rm memory (o;clf-report) r= 19 r= 16 t= 39 r= 20 
r= 20 r= 14 t= 37 r= 26 
p..O 004 p..O 01 p<O 001 p..O 003 p=O 003 p..O 027 p<O 001 p<O 001 
• Only ca<>cs for wh1ch Dcmentta vs controls based on MMSE (AND) HVLT cut-offs (HVLT < 14 5 & MMSE < 24 5) are used m the analySIS phase 
b Detcnmnant == 009 
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APPENDIX7 
Monte Carlo PCA for Parallel AnalvSIS 
Number ofVanables- 9 
Number of Subjects- 207 
Number of Repetitions- I 00 
Eigenvalue 
I 
2 
3 
4 
5 
6 
7 
8 
9 
Random Eigenvalue 
I 3303 
I 2126 
I 1299 
1 0550 
0 9921 
0 9256 
0 8566 
0 7871 
0 7108 
Standard Deviation 
0566 
0405 
0370 
0269 
0261 
0273 
0328 
0341 
0437 
Monte Carlo PCA for Parallel Analysis 
©2000 by Marley W Watkms All nghts reserved 
NB Program InstructiOns 
Select the number ofvanables (3-100), subjects (100-2500), and replicatiOns (1-1000) 
The program then 
(I) generates random normal numbers for the quantity of vanables and subjects selected, 
(2) computes the correlation matrix, 
(3) performs Pnncipal Components Analyses and calculates the eigenvalues for those vanables, 
(4) repeats the process as many times as specified m the rephcatwns field, and 
(5) calculates the average and standard deviatiOn of the eigenvalues across all replications 
For stable results, replicate 40-100 times Use these eigenvalues as the cntena for Horn's Parallel 
Analysts for the number of factors or components to retam for rotatiOn 
APPENDIXS 
Phytoestrogen Background Literature Review 
1. ClasSification of phytoestrogens 
There are three mam categones of phytoestrogens These are ISoflavones (diScussed m the mam 
thests), hgnans and coumestans Ltgnans (secmsolancrresmol, and to a lesser extent matairesmol) are 
found m some bernes, nuts, vegetables and m the aleuromc layer of whole grams close to the fibre 
layer, but m particular m otlseeds, such as flaxseed When mgested, these plant hgnans are converted 
by bactena to mammalian ltgnans (secmsolancuesrnol to enterodtol and matatresmol to 
enterolactone) Coumestans have been less studied (Murkles, Wilcox, & DaviS, 1998, Adlercreutz & 
Mazur, 1997, Kurzer & Xu, 1997, Pnce & FenwiCk, 1985, Bradbury & White, 1954) Coumestrol, a 
coumestan, can be found predommantly m red clover sprouts, alfalfa sprouts and soybean sprouts 
Although highly estrogemc m nature (It has hydroxyl groups at both ends of Its structure), only small 
amounts can be found m the human diet Therefore, coumestans have not been as wtdely mvesttgated 
as other phenolic ( chenucal compounds contammg the hydroxyl '-0 H' group) phytoestrogens 
Isoflavones resemble Em Its heterocychc phenol structure (a nng chenucal structure With direct 
bondmg to one or more hydroxyl '-0 H' groups) and come m vanous forms m plants and 
particularly m soybeans They are predonunantly m the form of glucoSides (a sugar group attached to 
the mam part of the molecule which makes It water soluble) Isoflavones mclude bwchanm A, 
fonnononetm (both mostly m red clover), daidzm, gemstm, and glycltem These ISoflavones also 
occur m other forms, as acetylglucoSides (6"-acetylgemstm, 6"-acetylglyCitm, 6"-acetyldaidzm) and 
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malonylglucostdes 6"-malonylgemstm, 6"-malonylglycltln, 6"-malonyldatdzm) When consumed 
they are metabolised mto a further form wtthout the sugar group attached and form another category 
called aglycones (gemstem, datdzem, glycttem) lsoflavones are low molecular wetght hydrophobtc 
compounds In the maJonty of cases, they extst naturally as glucostdes, acetylglucostdes or 
malonylglucostdes and although free aglycones (whtch are less water soluble) are present, they occur 
m very small quant1t1es Prevtous research has md1cated that the aglycones gemstem and da1dzem are 
the most potent estrogemc compounds and have the greatest effect on hormonal acttvtty, and 
therefore a wealth ofprevwus research (dtscussed below) has focused on these two compounds 
Each category of phytoestrogens affects E-medtated responses m dtfferent ways Although many 
phytoestrogen forms are known, most research has focused on tsoflavones as they appear to have 
estrogemc effects m the mammalian body and are found m abundance m human dtets (Murktes et al , 
1998) Isoflavones, although not closely related chemtcally, are structurally stmtlar enough toE to 
enable them to bmd toE receptors m the same way as E, due to stmtlar polanltes and molecular 
wetghts (Ganora, 2008) In addttton, the locatton of the hydroxyl groups allows bmdmg to theE 
receptor protem Furthermore, the A and C nngs of tsoflavones are stmtlar to the A and B nngs of 
estradtol (Ganora, 2008) Gemstem IS the Jsotlavone of greatest mterest and ts found m soy protem 
It bmds ttself to the ERP receptor With greater affimty than ERa, and mi!tates greater gene 
transcnptton of ERa compared to ERP However, gemstem also has the ability to bmd Itself to the 
progesterone (P) receptor and androgen receptor (Fttzpatnck, 2003) 
Phytoestrogens 
I. lsoflavonolds I I Non flavono1ds I 
I J I Lignans I 
I Coumestans I [ lsoflavones I l Prenylflavono,ds I 
I I I I Matalr&SIOOI I Secolsolancireslr 
I I l I 
Aglucon as Glucos•des Acetylglucosides Malonyglucosldes 
• Da,dze,n • Da1dzem • Acetylda1dzm • Malonylda1d2:1n 
• Gen1sle1n • Gen1stm • Acetylgemstm • Malonylgemsl1n 
• Glye~tem •Giycl!in • Acetylglycltm • MalonylglyCitln 
• Formononelm Ononm 
• B1ochantn A • Srssotnn 
i'1gure I - Uass1ficat10n of ph) tocstrogens 
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Oestradiol 
Aglycone Isoflavoncs Glucostde Isoflavones 
OH 
H ~ 
""" 
OH HQ) """ # .& 0 
OH 
Genstem G er:nstm (genstan glucostde) 
H 
H 0 
""" 
""" 
11 
""" 
# 
""" 
# Q) I # # 0 HO/ H 
HO 
H 
Da.td:r.em Da~dzm(da1dzem glucoSI.de) 
{7 OH OH 
OH 0 
""" I c-'0 
""" 
""-
1-bC..,.....o 
""" 
.& HO H, I I Loo/ # 
HO/ # 0 4 Glyalm(glycrt.em gl.ucoSlde) Glycttem 10 H 
F1gurc 2- Structure of 1 7~-estradiol, aglycone 1soflavoncs (gcmstcm, da1dzcm and glycJtem), and gluco\!de 1~oflavoncs 
(gemstm, daldlln, and glyc1tln) 
Aglycone iSOjlavone stmctures possess the phenolic (A) and liydJoxyl (B) mmet1es as oest1adw! stntctwes With smulm 
distances between/he two gwupj (fSA, 2002) 
2. History of phytoestrogen research 
Throughout htstory, certam plants have been used m traditional medtcme and folklore for thctr 
estrogemc properties The pomegranate, for example, IS associated with fertthty (Pnce & Fenwtck, 
1985) and hops was used by rmddle class German clergy m the rmddle ages to lower hbido (Allen & 
D01sy, 1923) Loewe, Lange, & Spohr (1927) first reported estrogemc properttes and actJVJttes m 
plants followmg the pubhcatton ofthe Allen-Dotsy bwassay for Es m 1923 Loewe's research 
mvolved dose effect-response of ovanan extracts By usmg the Allen-D01sy-test and quantJfymg It, 
Loewe was the first to succeed m measunng E m human blood and unne At the same tlme, Loewe 
and hts eo-worker Voss developed the first specific bwassay for the male hormone The Loewe & 
Voss bwassay served as a fundamental prereqmstte for the Isolatwn and chemtcal charactensatwn of 
the androgens m the eatly thirttes (Kattermann, 1984) Decades later, we arnve at 1975 by w!uch 
time hundreds of plants had been found to ex!ubit estrogemc actJVJty or to contam estrogemcally 
acttve compounds (Famsworth, Bmgel, Cordell, Crane, & Fang, 1975) 
The benefits of estrogemc tsoflavones were ongmally used to promote growth m the ammal feed 
mdustry (Bradbury & Whtte, 1954) In tradttwnal use of herbal remedtes, certam plants have been 
utilised m the treatment of cogrutive dtsorders, mcludmg neurogeneratlve dtseases such as AD Tills 
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has now lead to an ethnopharmacological approach m recent years m Western medtcme to treat AD 
symptomatology, for example galantamme from Galanthus mvalis L used m the Umted Kmgdom 
(for a rev1ew see Howes, Perry, & Houghton, 2003) 
Estrogemc effects of phytoestrogens were first reported m reproductive disturbances m sheep by 
(Bennetts, Underwood, & Shelf, 1946) The sheep, wh1ch grazed on foliage contammg red clover, 
showed S!gns of mferulity and also nuscarned when pregnant The clover m these pastures was h1gh 
m 1soflavones, formononetm, and bwchanm A, wh1ch were some of the first phytoestrogens to be 
diScovered (Ross1ter & Beck, 1966) Gemstem specifically was first ISolated from soybeans m 1931 
(Walz, 1931) and later m 1941 (Waiter, 1941) 
3. Bwlog1cal Mechamsms 
3.1. Pharmacokmetics (the process by wh1ch a substance IS absorbed, d1stnbuted, metabolized 
and elimmated by the body) 
Isoflavones m thClf natural form are found as glucoSldes, acetylglucos1des, and/or 
malonylglucos1des Many ammal and human stud1es have assessed the relatwnsh1p between 
Isoflavone mtake and the biological actiVIty that follows, mcludmg absorptiOn, distnbuhon, 
metabolism, and excret10n forms (glucoSide or aglycones) (lzunu et al, 2000, P1skula, Yamakosh1, 
& Iwa1, 1999, Franke & Custer, 1996, Kmg, Broadbent, & Head, 1996, Hutchms, Slavm, & Lampe, 
1995, Xu, Hams, Wang, Murphy, & Hendnch, 1995, Wang & Murphy, 1994, Xu, Wang, Murphy, 
Cook, & Hendnch, 1994) When 1soflavone glucoSldes are consumed, the enzyme beta-glycoSldases 
found m the small mtestme then hydwlyse and release the aglycone form wh1ch 1s f1ee for absorptwn 
(Day et a], 1998, Ioku et al, 1998, Lampe, Karr, Hutchms, & Slavm, 1998, Setchell, Bomello, 
Hulme, K!fk, & Axelson, 1984) These released aglycones are e1ther absorbed mtact or broken down 
further m the large mtestme by bactenal glycos1dases from gut nucroflora mto other products wh1ch 
mclude equol and 0-desmethylangolensm (metabolites of da1dzem) (Kurzer & Xu, 1997, Joannou, 
Kelly, Reeder, Wanng, & Nelson, 1995), and p-ethyl phenol (metabolite of gemstem) before they are 
fully absorbed (Kurzer & Xu, 1997, Xu et al, 1995) Th1s process lS referred to as deglycosylatwn 
These aglycones are absorbed duectly (gemstem and d8!dzem) or demethylated by colon bactena 
convertmg bwchanm A mto gemstem and formononetm mto da1dzem before absorpt10n (De Rljke, 
Zafra-Gomez, Anese, Bnnkman, & GomJe, 2001, Hur & Rafi1, 2000) The levels ofm!Croflora, and 
hence the amount of free !Soflavones m the body, can vary from person to person (see below) 
Therefore consummg the same quantity of 1soflavones can have varymg estrogemc effects from one 
md1v1dual to another (Ganora, 2008) 
lsoflavones can be measured m a wtde vanety ofbodtly samples, mcludmg unne, plasma, faeces, 
semen, b1le, breast nulk and saliva, as well as m plants, and solid or hqmd foods usmg gas 
chromatography and HPLC (see sectwn 4 I 4 3 m mam thes1s for a descnpt10n ofth1s method) and lS 
usually presented as parts per b1llion to parts per nulhon concentratwns (Karr, Lampe, Hutchms, & 
Slavm, 1997, Lu, Lm, Grady, Nagamam, & Anderson, 1996, Franke & Custer, 1994, Franke, Custer, 
Cema, & Narala, 1994, Adlercreutz et al, 1993, Coward, Barnes, Setchell, & Barnes, 1993, 
Adlercreutz et al, 1991, Adlercreutz et al, 1991, Setchell, Welsh, & L1m, 1987, Goldm et al, 1986) 
However, the maJonty of studies assessmg the metabolism and effects of 1soflavones m the body 
have done so through assessment of1soflavone levels m blood plasma or m unne samples (Mmbes 
et al, 1998, Tham, Gardner, & Haskell, 1998, Adlercreutz & Mazur, 1997) 
3.2. Bwavailabihty 
There lS vanab1lity m the absorptwn and bwava~lab1hty of d1fferent forll!S and structures of 
!Soflavones Knowledge about the bwavadab1hty ofmgested 1soflavones 1s of paramount Importance 
as 1t enables an understandmg of the way m wh1ch the chenucal forms of!Soflavones b1olog1Cally 
affect the human body pos111vely, 1 e the!f efficacy (Zub1k & Meydam, 2003) as well as allowmg 
evaluatwn ofthe!f safety However, th1s knowledge, particularly m reference to the bwavadab1hty of 
gernstem and da1dzem as a result of the form consumed (aglycone or glucos1de), lS m the mam part 
mcomplete, contrad1ctory and mconclustve, parhcularly m human studies Some prevwus research 
has shown no difference m the pattern of plasma appearance and disappearance of gemstem and 
datdzem after consumptiOn of 1soflavones m the aglycone or glucostde form (for example Zub1k & 
Meydam, 2003, R!Chelle, Pndmore-Merten, Bodenstab, Enslen, & Offord, 2002), wh1ch lS reflected 
m the lack of s1gmficant d1fference found m absorptwn of aglycone and glycoSide !Sotlavones m 
am mal stud1es (P!Skula et al , 1999). Th1s suggests that bwava1lab1hty of gem stem and d8!dzem lS 
not affected by the free or conjugated forms they can be consumed m (P!Skula et al , 1999) 
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However, others report that m v1vo aglycone Jsoflavones (m the form of fermented soybean extract) 
are absorbed faster and w1th htghcr quantities than glucoside Isoflavones (unfermented soybean 
extract) (Kano, Takayanag1, Harada, Sawada, & lsh1kawa, 2006, Izurm et al, 2000) Addltwnally, 
Setchell et al (2002) found that, Sirmlar to rat studies (Andlauer, Kolb, Stehle, & Furs!, 2000) 
1soflavone glucos1des can not be d1rectly absorbed mtact by humans across the enterocyte (mtestmal 
absorptive cells found m the small mtestme and colon) 
Other contradictory research has reported that da1dzem and gemstem are more bwavatlable when 
mgested m the glucoside form rather than the aglycone form (Rufer et a!, 2008, Setchell et a!, 2001, 
Setchell, 1998) The authors suggest a reason for th1s could be due to the glucoside mmety, or the 
sugar component wh1ch the aglycone form does not have, actmg as a protecl!ve agent and 
mm1m1smg the metabobsm of the structure (Setchell et al, 2001) AddJl!onally, m the same study 
when equal amounts were consumed, plasma levels of gemstem were sigmficantly and consistently 
h1gher than that of da1dzem The authors stated that tlus difference could be a result of larger 
dJstrJbutwn of da1dzem than gemstem across the whole body and hence lower levels observed m 
plasma samples 
There are a few posstble explanatiOns for discrepancies between studies and reasons why comparmg 
them may be less than 1deal F!fstly, as a methodological Issue w1th far reachmg consequences, 
studies assessmg bwavailabihty of soy tsoflavoncs use soy products m dtfferent forms, e g as 
Jsoflavone extract pharmaceutJCally manufactured or soy food Items such as soy rmlk or textured soy 
protem The compos Ill on of the different soy products could affect the bwavaJ!abJbty and 
metabobsm of1soflavones Furthermore, de Pascual-Teresa et a! (2006) reported lower total urmary 
recovery of gem stem followmg consumptiOn of prepared foods of tsoflavone nch JUICe when 
compared to bars and cookies Da1dzem levels were Sirmlar for all three products This md!Cates that 
the food matrix may mdeed affect the levels of Jsoflavones a !tamed, and parl!cularly that of 
gemstem 
PreviOus research has shown that lifestyle cho1ces such as habitual mtake (Lu & Anderson, 1998, 
Slavm, Karr, Hutchms, & Lampe, 1998, Lu, Grady, Marshal!, RamanuJam, & Anderson, 1995) and 
quanl!ty of1soflavones consumed (Setchell et a!, 2003, Setchell et a!, 2003, Bloedon et a!, 2002, 
Busby et a! , 2002) affect the bwavaiiabihty of 1soflavones Also genetic factors could mfluence 
metabolism of tsoflavones, 1 e differences m mtestmal mtcrofloral populatiOns (Dun can, Merz-
Demlow, Xu, Ph1pps, & Kurzer, 2000, I Rowland, W1seman, Sanders, Adlercreutz, & Bowey, 1999, 
Thompson, Robb, Serramo, & Cheung, 1991) It IS possible that the colomc rmcrofloral 
env1romnents of Amencan participants (Zub1k & Meydam, 2003) may have had h1gher capacity to 
hydrolyze glucos1des than a Japanese sample (Izurm et al, 2000) and hence metabolise glucos1des 
better (Zub1k & Meydam, 2003) Furthermore, the presence of other foods m the digestiVe system 
and the compositiOn of those foods may also be factors to consider (Zub1k & Meydam, 2003) In an 
ammal study It was found that food-depnved ammals absorbed Isoflavones faster than fed ammals 
(Piskula, 2000) In the Izurm et a! (2000) and Zub1k & Meydam (2003) sl!IdJes, partiCipants were fed 
foods wtth a dtfferent compOSition matrix before tsoflavone consumption, whtch may have 
accounted for some of the dtscrepanctes between the studtes mentwned 
4. Equol 
The chmca!Importance of equol1s at the forefront of current research Equol IS a metabohte of the 
Jsoflavone da1dzem produced by gut rmcroflora More specifically, It IS produced by three strams of 
bactena, namely the gram-negative Bacte1 ozdes ovatus spp and the gram-postttve Stepotococcus 
mte1 medzus spp and Rummococcu; productus spp (Ueno & Uch1yama, 2001 m vitro) Equol was 
first Jdenllfied m human unne m 1982 (Axelson et al , 1982) and has the ability to bmd to both ER 
receptors, but with a 10-fold bmdmg affmlty to ERP Equo1's bmdmg ab1hty IS of similar strength to 
gemstem, and It has been found to be three times as estrogemc as tts parent dmdzem m an 
endomelrlal tumour !me (MarhewJCZ, Garey, Adlercreutz, & Gurp1de, 1993) Vanatwns exist 
between ammals and humans as well as between vanous human populatwns m the proportiOn of 
people With the ability to produce equol Monkeys and rodents are able to produce high quanti!Jes of 
equol Due to the vanabiiity m gut rmcroflora, only 20-35% of a western populatiOn can produce 
equol (W1seman et a!, 2004, Setchell, Brown, & Lydekmg-Olsen, 2002, Rowland, W1seman, 
Sanders, Adlercreutz, &. Bowey, 2000, Lampe et a!, 1998, Morton, Wilcox, WahlqvJst, & Gnffiths, 
1994) The proportiOn of equol producers decreases with mcreasmg age (Frankenfeld et a!, 2004) 
As we have already established, metabolism of glucoside Jsoflavones to biOlogically act1ve aglycone 
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tsoflavones rehes on effictent gastromtestmal functwrung Agmg and some medtcation may affect 
the functwnal ab1llty of the gastromtestmal system and therefore 1mpa1r the metabolism of 1sof!avone 
glucos1des Other factors related to th1s need consideratiOn, such as gender Some studies have found 
that men and women differ m their response to chrome Isoflavone exposure (Lu & Anderson, 1998, 
Lu et a!, 1996) Although other studies have not found a gender difference (W1seman et a!, 2004), 
some studies reported that gemstem and daidzem recovery was lower and equal productiOn was 
higher m women after consummg soynnlk daily for I month Interestmgly, three female participants 
developed the ability to produce equol after 2 weeks of daily soynnlk suggestmg that metabolism of 
daHlzem may be altered by chrome soy mtake which may therefore be a cause ofmter-vanab1llty m 
Isof!avone metabolism (Lu et a!, 1996) [this effect was not observed m men (Lu et a!, 1995)] 
Therefore 1t ts possible that the effects of Isoflavones on vanous endogenous systems are mediated 
by bemg an equol producer or not (Zhao & Brmton, 2007) as well as possibly age (Frankenfeld et a! , 
2004) and gender 
5 Pharmacodynamics (the achons or effects of a substance on a llvmg orgamsm) m VItro 
5.1. Estrogemc and Antiestrogemc Activity if Isoflavones 
A wealth of evtdence and previOus research from ammal models and m vttro cell culture studtes have 
Implicated 1soflavones m both direct and mdirect, honnonal and non-hormonal ways that are 
relevant to human health This Is done via two mechamsms, namely estrogemc and anhestrogemc 
actiVIty Isoflavones and coumestans have the ability to bmd to the ERs m the mammalian body, but 
with less affimty than the endogenous E 17P-estradwl Therefore, they can moderately mterfere With 
the endogenous E-responSIVe Signallmg due to bmdmg ability through the phenolic n-rmg, With 
greater bmdmg to the ERP than the ERa receptor Sites However, dependent on the plasma 
concentratiOn of E and the d1stnbutwn of the ERa and ERP receptor sites, phytoestrogens behave m 
the same way as selectiVe estrogen receptor modulators (SERM) (Halbreich & Kahn, 2000, Kmper et 
a!, 1998, Kmper, Shughrue, Merchenthaler, & Gustafsson, 1998, Ho!, Cox, Bryant, & Draper, 1997, 
Kmpcr et a!, 1997, Shughrue, Lane, & Merchenthaler, 1997) They act as an E agomst (estrogemc) 
at only specific tissues or as an antagomst (anii-estrogemc) by competmg with the more portent 
endogenous E for ER sites, m Sirmlar ways to the breast cancer anii-estrogemc drug tamox1fen and 
especially the SERM drug raloxifene (actiVIty may be sex honnone or gender-dependent) (HalbreiCh 
& Kahn, 2000, Murkies et a! , 1998, Ho! et a! , 1997) Phytoestrogens estrogemc properties 
(transcnptwnal actiVIty) are ER-mediated However thm ant1-estrogemc potential do not appear to 
be ER-mediated (Makela, 2001) 
The hypothesis that phytoestrogens behave m an antlestrogemc manner m envuonments Wtth high 
levels of E ( e g premenopausal women) and m an estrogemc manner m low E environments ( e g 
post-menopausal women) IS not a new one and has been supported for qmte some time Antt-
estrogemc actwns were observed m female rats as far back as over forty years ago (Kmper et a! , 
1998) However findmgs are still rmxed mto the ways m which ISof!avones act m an estrogemc or 
antiestrogemc way dependent on the environment to which they are mtroduced, e g the endogenous 
levels of E, ER site placement and effects on specific tissue both m vitro and m VIVO This shall be 
dtscussed as appropnate throughout thts literature review Dose and ttssue-spectfic Issues need to be 
considered when assessmg different types of health benefits of1soflavones behavmg m different 
ways For example, mveshgatmg the effects of tsoflavones on breast cancer prevention, 
anttestrogemc activity ts the destred affect, whereas focusmg on bone mass, cogmtwn, and 
cardiovascular health, It would be advantageous for 1soflavones to exert an estrogemc effect (Folman 
& Pope, 1966) 
5.2 Effects on Biological Mechamsms 
A number of studtes have shown the neuroprotechve effects of tsoflavones on vanous bwlogtcal 
mechamsms For example, gemstem has been shown to mlubtt tyrosme kmests and may also affect 
cell cycle smce It mhibits DNA top01somerases I and 11 (Zhao & Bnnton, 2007) Gemstem mcreases 
the act1v1ty of anti-oxtdant enzymes and thus may act as an antiOxidant as It has been shown to have 
an antiOXIdant effect on neurons exposed to free radical damage (Jonas et a!, 1995) Some suggest 
that phytoestrogens may have the ability to alter the metabolism ofE Itself, for example by mhibitmg 
the enzymes aromatase and Sa-reductase Reports are contradictory wtth some reportmg that 
gemstem mcreases SHBG, while others suggest It mh1bits It (Lee, Lee, & Sohn, 2005) therefore 
affectmg levels of free or bwavailable sex steroids Gem stem and da1dzem have been found to 
protect hippocampal and cortical neurons agamst glutamate-mduced neurotoxiCity (Albertazzi & 
Purd1e, 2002) Gemstem protects SH-SY5Y human neuroblastoma cells from AP-mduced death 
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(Sonee, Sum, Wang, & MukherJee, 2004, Zhao, Chen, & D1az Bnnton, 2002) and suppresses Af3-
mduced apoptos1s Bang et al (2004) mvestigated SIX phytoestrogens (gemstem, gemstm, da1dzem, 
datdzm, formononentm and equal) for thetr neuroprotecttve efficacy agamst two toxms and found 
that all SIX phytoestrogens mduced a small but s1gmficant reductiOn m lactate dehydrogenase (LDH), 
a marker of tiSsue breakdown, m hippocampal neurons Isoflavones have also been found to be 
neuroprotectiVe m human corttcal neurons by exertmg stgmficant and concentratiOn-dependent 
reductiOns m markers of plasma membrane damage (Zhao et al, 2002) For full reviews see 
Occhmto et al (2008) 
6 Pharmacodynamics In V1vo 
Sm11lar toE, soy tsoflavones may also act on cellular mechamsms wtthm the human and ammal 
orgamsm One mechamsm could be as potent neuroprotect1ve agents m am mal models of neuronal 
death In a study by (Bmgham, Atkmson, L!ggms, Bluck, & Coward, 1998, FotSis et al, 1998, 
Murkies et al , 1998, Setchell, 1998, Tham et al , 1998, Adlercreutz & Mazur, 1997), gem stem 
reversed loss of cell v1abihty, DNA fragmentatiOn, mtracellular levels of free calcmm and caspase-3 
activatiOn m the hippocampal cells of rats Zeng, Chen, & Zhao (2004) reported that cerebralleswns 
m mtce caused by smglet-oxygen-mduced cerebral stroke were lessened by 44% wtth gemstem 
treatment compared to controls, hence supportmg the theory of the antiOxidant effects of soy 
ISoflavones In another study (Tneu, Dong, Zheng, & Uckun, 1999), farruhal amyotrophic lateral 
scleroSIS (F ALS) rruce treated With gem stem lowered disease onset and mortality m males but not 
females DISease onset and mortality were also much lower m untreated female FALS rruce than m 
untreated male FALS mtce Thts suggests that E may protect neurons from F ALS and that gem stem 
acts as an E agomst In another study (Tneu & Uckun, 1999) treatment with higher doses of 
gemstem (3 4 mg) protected the eyes ofrats from mduced Ischem1c retmal degeneration by 
suppressmg the mcrease m tyros me phosphorylatiOn However, we must note that although these 
studies d1stmctly show the neuroprotect1ve qualities of gemstem, some have reported It may mduce 
apoptosiS m neurons For example (Hayash1, Wemberger, Knn, & de Juan, 1997) reported that rats 
consurrung a large dose of gemstem (20mg/day) had an mcrease m LDH m the bra m tissue, which 
was not the case for rats on a low gemstem regime (2mg/day) DNA fragmentatiOn was also seen m 
both treatment groups 
7 Effects on endogenous hormones and the premenopausal reproductive cycle 
Although Chm & Lee (2004) reported no effects oflow dose 1soflavones on the fertility of female 
rats, a declme m fertility of cheetahs at North Amen can Zoos has been attnbuted to their diet with 
mcludes 18-35 mg phytoestrogens per kg (Lamartimere, Wang, Srruth-Jolmson, & Eltoum, 2002) 
Addmg further weight to thiS findmg, studies assessmg the effects ofiSoflavone consumptiOn on 
endogenous hormones m premenopausal women have been more conststent For example Setchell et 
a! (I 987) rep011ed a Sigmficant reductiOn m mculatmg levels of E2 (20%) across the menstrual 
cycle, as weii as a reductiOn m P (33%) In women 22-29 years old, Lu, Anderson, Grady, & 
Nagamam (2001) observed decreased serum I 7[3-estradwl and luteal phase serum Pas a result of 12 
ounces of soy rrulk consumed three times a day However Lu, Anderson, Grady, & Nagamam (1996) 
d1d not observe this reductiOn m length of luteal phase w1th I Og flax seed supplementatiOn, but did 
find an mcrease m folhcular phase length across a normal menstrual cycle A 3 month trial of 129 
mg/day tsolated soy protem supplementatiOn m premenopausal women resulted m lower estrone and 
dehydroep1androsterone sulphate (DHEAS) m the fol!owmg menstrual cycle when compared to a 
much lower dose of 10 mg/day (Plupps, Ma11nu, Lampe, Slavm, & Kurzcr, 1993) 
Duncan et a!, 1999, Xu, Duncan, Merz, & Kurzer (1998) reported that a constant d1et ofiSoflavone 
nch soy-protem mcreased the length of the folhcular phase by 2 5 days and mcreased concentratiOn 
m E2 m that part of the cycle, consequently delaymg menstruatiOn m premenopausal women The 
cycles d1d not return to normal until three menstrual cycles had elapsed Furthermore, the nonnal 
mid-cycle surges m the levels of the gonadotrophms lutemlZlng hormone (LH) and folhcle-
stJmulatwn hormone (FSH) were Sigmficantly suppressed The same effects on gonadotrophms were 
not observed w1th a soy protem devoid of 1soflavones The researchers also found that equol had the 
greatest mfluence on the effects of1soflavones on the menstrual cycle w1th highest unnary equol 
excretiOn associated wtth the largest mcreases m folhcular phase length Casstdy, Bmgham, & 
Setcheii ( 1994) reported that soy protem not contammg any ISoflavones d1d not have the same effects 
seen of Jsoflavone-nch soy on endogenous hormones ( e g plasma gonadotrophms or folhcular phase 
and menstrual cycle lengths) CasSidy, Bmgham, & Carlson (1993) mvestigated the dose-response 
toxic effects of 1soflavones on the reproductive development of Immature rats ThiS study found that 
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high doses of ISoflavone suppressed growth Sigruficantly, with a low dose havmg a much more 
modest effect on body weight Furthermore, uterus weight was decreased and ovary weight was 
mcreased m a dose-response manner Although other studies (Guan, Huang, & Chen, 2008) d1d not 
find the same result, Lamart1mere et al (2002) and Galla et al (1999) used much higher doses (at 
least 101 times higher) that that ofGuan et al (2008) Even though E2 suppressiOn effects ofh1gh 
dose tsoflavone was not found, the researchers dtd observe a reductiOn at week 12 and explamed thts 
as an anl!-estrogemc effect of havmg doses 500-1000 limes higher than those given to humans 
Furthermore, and suggestive of a duratiOn effect on antt-estrogemc activity, htgh tsoflavone 
supplementatiOn only reduced P concentratiOns after 12 and not 6 weeks of mtake ThiS same fmdmg 
has been observed m other ammal studies (Lamartm1ere et al , 2002, Gallo et al , 1999) and cell 
culture studies (Lamarl!ruere et al, 2002) (m which P productiOn was actually mh1b!led) and IS 
smular to that of others who report htgh doses of tsoflavones can cause reproductive abnormahttes m 
rodents (Kaplanski, Shemesh, & Berman, 1981) 
Although d!fectly companng rat reproductive behaviOur to humans IS dubwus, as well as the fact that 
human populattons consume varymg quantities of dietary tsoflavones m vanous forms, there are sttll 
apparent toxtc effects ofhtgh doses of tsoflavone consumptiOn These changes m the reproductive 
cycle provide additiOnal evidence for the potential agomst-antagomstic action of dietary Es Puttmg 
these findmgs together, there IS an mdicatiOn that the ISoflavone component of soy affects 
endogenous hormone functwn 
8. Effects of phytoestrogens on health 
It IS Important to highlight researched benefits or potential mcreased nsk of phytoestrogen 
consumptiOn on health As tan and western populatwns show dtfferent prevalence rates for certam 
health conditiOns, with ASian populat10ns havmg lower prevalence of E-related diSeases (Stroheker 
et al, 2003, Hughes, 1998, CasSidy et al, 1994, Setchell et al, 1987) It has been suggested that one 
of the reasons for this, particularly m women, IS the lugh mtake of soy foods m As tan populat10ns 
Differences between these populatlons have been observed m certam hormone-dependent cancers, 
with ASian populatiOn havmg lower prevalence and mc1dence of these cancers (Adlercreutz, 1990) 
For example, lower mcidence of breast cancer has been observed m East Asian countries whtch has 
been associated With high soy mtake (Z1egler, 2004, Henderson & Bemstem, 1991) However, 
concern has recently ansen from the reports of m VItro and ammal studtes findmg an zncrea.sednsk 
of breast cancer with soy ISoflavones (Wu, Yu, Tseng, & Pike, 2008), m particular for 
postmenopausal women (Ju, Allred, Allred, & Helfench, 2006, Ju, Fultz, Allred, Doerge, & 
Helfench, 2006) with a protective effect only found m postmenopausal women under 56 years of age 
(H1rose et al , 1995, Lee et al , 1992) Smularly, lower prevalence of prostate cancer has been 
associated with Asian countries such as Japan (Wu et al, 1996)and Chma (Dhom, 1991) With high 
soy mtake associated with low prevalence of prostate cancer (Parkm, Mmr, Whelan, Gao, & Ferlay, 
1992, Miller, 1988, Zandze, Boyle, & Smans, 1984, Skeet, 1976) Additionally, geographic 
differences m cardiOvascular health have been hnked to soy mtake (Coward, Barnes, Setchell, & 
Barnes, 1993 ), as has osteoporosiS (Azadbakht et al , 2007), and some menopausal symptoms 
(Ch1echi et al, 2002, K1m et al, 2002, Morab1to et al, 2002, Ho, Chan, YI, Wong, & Leung, 2001, 
Me1, Yeung, & Kung, 2001) However, most research mto the health effects of phytoestrogens has 
been on the basiS of ammal models and m vitro cell culture studies but !muted chmcal assessments 
(Maskannec, 2003, Huang et al, 2002, Kwnenberg, 1999, Lock, 1986) The relatiOnship between 
these heath ISsues and soy mtake go beyond the scope of thiS theSis and hence are not diScussed m 
tlus thesiS 
9. Animal Studies 
The health effects of phytoestrogens on the human bram are not fully known and the findmgs to date 
are highly contradictory However, much more has been diScovered about the effects of 
phytoestrogens on the rat bram Although human and rat bram structures differ, the practical 
lmutatwns of these assessments on the human bram mdicate that It IS Important to mvest1gate the 
effects of phytoestrogens on the ammal bram m order to get some baSic understandmg of the 
bwlogical effects of phytoestrogens on bram health 
Studies With female rats have shown an Improvement m cogmt1ve functiOn With the use of soy 
ISoflavones In a study by (Ostatnikova et al, 2007, Celec et al, 2005) ovanectonuzed (OVX) rats 
on a 10 month soy d1et showed a dose-dependent Improvement m performance of the radial arm 
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maze test Tills suggests that soy Isoflavones act as an E agomst m 1mprovmg workmg memory and 
do not block the beneficial effects of E2 on the workmg memory of OVX rats In another study by 
the same group usmg frontal cortex samplmg, (Lu et a! , 1996) reported that E2 and soy 
phytoestrogens mcreased rnRNA (messenger nbonucleiC acid - a copy of the mformatwn earned by 
a gene on the DNA) levels ofbram-denved neurotrophic factor (BDNF) m the frontal cortex which 
could have a posltrve effect by encouragmg dendntic sproutmg (Pan, Anthony, Watson, & Clarkson, 
2000) 
Pan, Anthony, & Clarkson, 1999a, Pan, Anthony, & Clarkson (1999b) reported that a lrfelong high-
tsoflavone diet resulted m better performance on the radml arm maze test than a 1soflavone-free dtet 
In further support when the high-rsoflavone diet was changed to a low one, these rats performed 
worse than those who stayed on the high-rsoflavone diet These effects were found m female rats It 
IS not clear whether there are beneficial effects of soy tsoflavones for cogmtlve functiOn m male rats 
as the mvestigators also found worse visual spahal memory m male rats on the same hlgh-1soflavone 
diet Thts group has supported the theory that m leanung and memory tasks requmng vrsuo-spatial 
memory (VSM), men showed supenor performance to women (a difference attributed to the 
hormonal differences (Scharfman, Goodman, & Sollas, 1999) for example Therr tat and nuce 
studies support thrs assertiOn as dietary phytoestrogens Sigmficantly sex-reversed the normal 
sexually dimorphic expressiOn ofVSM (for example Lund et al, 2001)) Thrs Implies that the 
consumption of dietary phytoestrogens can alter sexually dimorphic bram regwns that affect anxiety, 
leammg and memory Furthermore, Kimura (1996) reported that male rats consummg 
phytoestrogens outperformed male rats on an 1soflavone-free d1et m the spattal delayed matchmg-to-
place task The mvestigators also found that an 1sof!avone nch diet mfluenced the bram chohnergic 
system and reduced age-related neuron loss and cogmtive declme m these elderly male rats 
Although the findmgs of these rat studtes, as a bnef example, are more concluSive than those With 
human participants, there has still been some diScrepancy between study findmgs Thrs may be due 
to a number of factors such as the age of the rats, diet regimen and types of tests used In the male 
rats specifically, the outcome of a protectiVe or detnmental effect may have been mfluenced by 
differences m the treatment duratiOn and/or dose (Lund & Lephart, 2001, Lund, Rhees, Setchell, & 
Lephart, 2001) 
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and Sumedang [thJL.ll .lppl0\JI tUill\efS.Jt~ ol Indonesta. 
jJlarta, ;md Loughborough Utmt'ISit)' UK\, mformed 'onsent, 
~>O\ernment.tl and local permits. \\er(' all obt~med before stud; 
on~t 
In West J,n-J., 1n the litunedJns \lte aU ~0'" elder!; •,•rho resJded 
m th-e YtllJge of Ctten~ah \il 1- to ~-hour dw" trom Bandungt 
weretestedat the\ommumtv htalth center In the BorobuJurstk 
tCentral }aYU. a 2-hour dme lrom )0g)'3kartJJ .lll214 elderh, ~oY­
ered by the Borobudur Nmmuntt} heath .;:enterv.eretested at the 
iocrtl hNlth center.v. htle 1 elderk With lmuttxi mohll!t\ '"''ere 'IS· 
iledJt home f-or Central and ".outh Jakarta IN0rth-\\est hna),;J 
con' emen ... e sJJ11ple of20S.dderl) v.,1s m~luJ.eJ. \\ ho were eilher 
J.ttendtnl!. the lo\al .;:ommumt\- health lentm or h\~d m a LJft 
home 1n 'the area (n = 49) l'f v.err tested at home \ll = l) 
".~5\:'SlfJ.'W/~ 
TestJng_ V.J.S done lr;' tramed .tnd su~n·1sed rt:'seJn:h a~sJ~­
tants. bt'tv.een S Jnd 11 a m to J\Otd ..:mad.Jantntcrft•r.;ond~ rtnd 
the cflt-cts ufheat The p.uuupJnt~ dtd rt mouth ruw. g;ne a s.a-
h\ asamplt• \tO bter rtsSJ)' phrtoestwgen le". elsl J!ld \\ ete surw~ cJ 
for demo~raphtc and othervanJbies, su(h i.ll> health and Ufestvk 
usmg standardtt.ed qucstwnnJlrcs To ... omrollo!neglo:.'\. t of eat-
IllS a proper over .Ill d1et due to memo!'} protlems or demenl1il 
S} mptoms, dt:tJtledquestiQn~based. on the Foc·d rrequenl yQues-
thmnmeabout JJt'tan mtake Ill] \\t'le lJkubtt•J Js \\'t't'(..l) Mal 
fooJ intJ.le l,._akulated from dailv, v.eelly or monthh lOllmmp-
tJon, t g mtJ.ke of J tood onle monthh = 0 ~5·'Y!ee\.... 1x a day= 
2liweel) Thts mduded the mam '.111Jbb l'f Ullt'n::st intJl.e of 
temre. tofu or tahor and other gemstem .;:ontamm~ foods. sulh 
as SO)' milt, as well as questions about mtake of n\e, frwt ~whok 
or as JUke), orJnse or 1rd '•C£:_et.lhles, green 'esetablt::s or tt·.h 
'nhKh had all pre'l<tous.ly been frund to ]o'fler the dement1rt ml 
]12] The anS\\t'fS v.tre subs.tJ.ntwted by a cJrer To o.b.sess memo. 
f) fwKtlon, the Hopbns \ erballearmng T<>tiHI'LTJ [tJ] "" 
used fh1s Js a word \earmng test measunng ep~odtL memory 
Vo'hl ... h .;:onSJStS of 12 v.orJs from 1, Jow-trcqut'Ol )' categNll'S 1f01 
H'fSton A 'hwnan shelter', 'ammals' Jnd 'rrecJ(1usstmlt's) Thi's( 
words\\~reaU ft'J'eated 3 tunes to ottama tota!Jmmedtate Jc~.all 
(1R) measme ('learnmg Jbihtj') -\fter 20 nun a d.cLned Je .. Jll 
(DR) wJt\l(lut L1.l.r:~ ur p1omrtmg WJ~ done \lemon t~ om· oftht 
fust fun\ttons to showadt::dwe m lkmentiJ [14. 15] and thts t~:q 
was found to br senSitJw to d1flerent forms- and the earl) stag-
es- at dernrntla [1\ 16] Some Items to! the predolti st\lne cate~ 
gory) "'re shghtl) ,hang«! to adapt to ha! kno·,,kdze .1fter a 
pilot stuJy The JJstnbutJon c•l performan\e on th15. kst V.JS sJm· 
ilar to th.tt of acompamble gmurot elderh, of O'tfordsh1re Bad,. 
tr.mslalton '\ilS done sucle .. stu!!y tor tests and questtC'!nnatres 
whkh '""all 11ell tolmt.>d 
SthWt~r,;: ~.na:1·sr:s 
Des ... npthe onal) ses v.ere done ustng X: te~ts tfor \Jtt:gon~al 
data) or urn\"J.natt' generallmear rnfldels ( o~,.NQ\.A) to assess dJI-
feien~.esm food mtake rtndothN\JOabJe~ Olmtetest h~t'MCJl tbt 
Mtes Nonparo.metrJL Spearmm's ran\. correlations v:ere earned 
out to ,mes~ as~ocJrtlwns between the\"J.nables LJ.neJI 1 egrcs<.Jflt1 
anal;'l>es were ttsed to !'fl.'dJCt H\ LT IR and DR scoresfrcrm phy-
toestrC<gen mtal.t.> l'>llllllitan~ousl) t-ntenng tempt:' and tolu l<'l1· 
sumptton per V.'t't:'l as continuous data) andm.lud.t1tg the fo!lnw. 
mg.,:(I\~JJJates a::;e Jt the ume of testmg.. sex \C,us of turtllel edu· 
~atkm and study s1te In st\.onJar} analyst's. mtales of othe1 
toods \\ere aho entered. as coY,llli.lte~ l or all e-. Jlu..tll\lnS a p \'alLtt 
ofo o::: v.as used anJ the analpes wcrt' performed ut SP'\S 14 0 
Ho~enorst 'Srtdtmum 'Yesutu ·kreae;t'r: 
R1~1~l~ ~ 
395 
Results 
Tab I~ 1 DemogrJph!c, foodmtal.eand mCJnoz;rvanables acros.~ dmncts 
Dntnct 
~hole group )Jk.lrta SUJ11ed.~t g Borobudur p1~ue 
Pati:JCI}\Ults 719 298 ~o; ~14 
M~J.D age ± 1\D, )CaTS oQ 18±7 s; 682±7'" 6CJ J ±'"t> 71 'l,±79 ··O 0001 
Women, Ov 6' 72 61 58 0004 
U..llll..atwn, Oil <0001 
None ,. ,, 11 t8 46 
llement:ti]' ;; 42 so 51 
H1sh "hool B 28 ' 1 
' Academy/tmlwmty or h1gher 16 0 0 
LtllOKll), 9v ~ 0 0001 
1XI'Jl1t'~t' 47 101) 
Sundanese 17 100 
Other 16 
Profess.Jon, 0{, <00001 
None ll 61 14 8 
Cl\ll sm-rult ; 11 J 
P.us.mess,'tr.hie I\ q 2 14 
-\mnlpoU~e 4 5 \ 
l:~mwr \6 I 60 53 
Lal:>Oft'l' 8 2 19 
T)'pe ol food. o, 
Tolu\dll~ or more) 65 69 16 69 <01106 
T empe ld::ulf (If more) 67 ., ,_ ss 72 •0001 
I rulttttuce '9 69 24 10 ( 0 0001 
Or.mge/red. vegetabks \I SI 24 s '001)01 
Green H·getJbles 49 b2 )\ 48 <00001 
fiSh 21 JS 15 • 00001 
MeJ.n H\'LT s~ore ± SD 
IR 14 i±'i7 197±72 IJ:!±b'l, 121±64 ··0001 
DR 49±>4 67±14 39±28 ~s±~s <,(!001 
~l<m >edJ, so\ mtale ± SD, n-fold 
tofu 9.3±6 9 94±68 88±74 95±64 o:;f. 
Tempe 95±6~ 97±67 8t.±73 1011±64 oo; 
pvalue lor test ot sJgn1fKant d1tferen~~ m means (ANOYA) or rroportwns (X~J Ethnldt) tn JJ.lJrta p.1r-
tb.1pnt~ '\ere ot J mr'\eJ ethnK l't1cl.gmunJ, With 47'1u JJ<!'nlli)Jilg the1r p~r<!nts os J,l\,mes.e \q)o, b1ltb t.llhel 
<1nd mothefJ, 1711v Sundanes.e (921\. both tJther and motl1en. 5'\ \1mang Kebau (rnaml; fmm Sumatm SS~ 
both tat her an.! mother). 2(). '•IJ.lap.n \S69. both (\1TentsJ, 79. PJ.ta~ (6';0" !1oth pawlts.J or other 1e,; Chm, ~tJ 
v.h1~h refhts the 2000 Indone~an porul.tuon censu~ di'lta. 
wm Sundanese and all tn Botobudur wm la,·.tncse. 
11lulelakatta had a nm.ed (IJtntctt) I see table 1 
Dt'l1102rtlp!n-. Chr:rrir!tll~tfC~ of t!:c St:~>1,1 S.w;r!c 
Demogr.tphK ,m,1i)~~s for pattt~..tpants f01 thl.' whok 
s,1mpll' and l0f md1' Jdttal Sill'S .ut! ptt:,?ntt:d 111 tJblt> 1 
fhr sample h,ld J reasonabl\' spt rad m dt-nwgr ·'J1hK \an-
(lhles With Mll'sl,mtt,\1 ~iltfet~nc~s bt:'hH'Cll the ~lit'S, as 
those !11 tng mturalarcas wm oldcr.lud hCIV<d Je>s 
e,itt<ahon and''"' more like!) to hM b«·n ror sttll wod, 
,lS) f.trtnm or J,tbows AllpaJIICtpants 111 Sumedang 
fl1od Int.:~t'lllld .\l.Jntor)' Pcnormancc 
\1o't ptlrtlup,Ult~ consum~d SO) products on :.1 d.ul) 
bas1s Thl'tn t-rageconsumrtwn of ('ttheJ f<,od was9 tmws 
a 11eek Onh 1% of the coltot t .tte no tempe or t,,ru ,,, all, 
\•.hdr o;>Y, of the (OJtott consumed both so1 J'toducts 
on~ I;' or moi.: than l)H~l' dJtl) {h Juch wa' Jiso th~ ffi?(\t,m 
~plit ot mtal-e 01 either so) product per \\f'd~.) -\strung 
H1gh Tofu lntal.e Is A.~"'Ot.Jated With 
\\one Memor) m ElJerh Indunr.:os1.1m 
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Table 2 Spoearman\ r.mkcorrelJttons bt'lwe-:n v;,mJbles 
2 , 4 ; • 7 9 
I Age 
2 Ldu~auon r = -0 10 
p<OOOI 
J HVLT IIR) r=-010 r =0 4S 
p<OOOI p <0001 
4 Tofu NS NS r= -0 os 
p < 004 
5 Tempe N' NI NS r =0 8" 
p <0001 
6 frutt NS r =0 34 r= 0 n r :009 r= o 12 
p <0001 p<OOOI p·:OOI p<OOOI 
7. Orangt'red \-toget.:tblcs NS r =021 r= o IS r =0 21 l =0 1° r=O.W 
p' 0001 r • o oo1 p <0001 p•OOOI p <; 0001 
8 Gr~n \egt>tables NS NS NS r=O 2Q r=Or r =0 16 r=uc~o 
p ,0001 p < 0 001 r.-ooot r, o oo1 
9 fiSh r=-012 r=Ol9 r= 013 r =0 11 r= 016 r =0 ~6 r= 0 32 r =0 19 
p· 0001 p < 0001 p<0001 F •,0001 p<OOOI r, ooot r oout p<tJOOl 
D.1ta are all<~nahzed 111 \ontmuous format N~= Not s1gnlhcant IR Re~ults Y.ere Sirnllo.rfor Dr~ 
poS!.tl\e as~OChlhon '\as ~e-en beh~N!ll the reported \\e-el..-
1) m tale of tofu and tempe tr = 0 ~5. r < 0 001) Tuv fe>1 
p~orle (b%) cono;;tuned "0} tmll or other ~or product'!, )0 
these data wete not mduded m th( ,1nol}'<S All partto-
pants ate nee ,Jt least datl), but fr utt. 1 eget.1bles .md it>h 
11111 not <OOIUtll<d by ?let) One ft.1ble l) There1111e sub-
stantJal re~ton,ll dtttmnces Ill the t) pes oi food con-
~umcd Tutu athl tempt> '~~re more trt.<quently us~d b} 
mw )\lftJO)\tnts 111 Rorol<udut and ),lkJJ ta th.rn Ill 
~umrdang, but the JH'rage comttmptton pel ,,\l'J?l was 
not dJtfeJt'llt bt.'twl'rn the &Ill'& Sttr}'JJSJnglv (With tet,aJd 
to .n atlabiltn ), J~..,s lrtllt and \eg~·tables \\ere wnsumtod 
m botluUJal sttes. 
The nlt~moJy perloJ mance d.1ta \\\~Je-normal!; dJstJJb· 
uted and needed no tt"nslorm,ltton rnor tu "nalyses 
TI1m wm <tgntitc,llll dttfctcnce; b<'th tn!R and DRbe-
tween the SJtes, with the. p.lltiup.lnt'> u1 J.il,,ltta $Conng 
stgmftcant~ lugher th,lll thme tn tl<e rural atw ot 
Suml'dang and Botof.udur ft,1bh: I) Hn\'>t'1t!1,~ partk· 
lj\lnts wr::re O\l'r~lll \(•tmg.et .md ht'ttl'r l'dt~<..at~\i m 1~­
l.atta (tJble l), 1·.lucb np!Jtned the result• ot th,· dtlter-
enc~s Ill [)R 1 hut !lL)t m) pet lorm,lJlu? b-.'tM•en tht' Silt'" 
(p = 0 IOJ Ultng ltno,u regresston an,1lysrs LthnKtt) \Of 
t.nher and mother), soc!Ot'lP110lllK st.ltus [Jl'b beto1 ere-
tuement) ,md SL'\ '"'t'lt? not t~lated to !lJemun pt'IIOI· 
manu.• In the~e analyse~ 
.>\SStKtaftatlsl!£.t1Vt't'1 Dt'mogr,lpl:us, Food lnt,:he, 
J~or:,:l'otJcs twd Cogulili'C F ull{[IO't 
~pearmlm r.Hlt cm relatiOns itahh.' 2i pl'J fornwd on 
tood mta\...e per \he\... s!Jo\,t:d th.lt nge ,,~Js nrt as,onated 
wtth the mtake of an) ol the foods. arart tram the con-
mmptton of fish, \llllch 11 as lo11erJn older pc•opl< Thme 
With lughN bds ot rdtk.lt!On \\'{'[(' tnOl{ hi-.l'h to ha\ e cl 
'he,lltluet' food intJke (eg ltmt, \eg<t.r\,Je,, Jt,h, 11htdr 
11e1e Jll as,octated ll'lth each other, mdtcatmg the pm-
once ot health) dtetarl' patterns) A healthy dt£1ar) pat-
tl!rn,m tmn, was Jt'i,ltrd to b\'ttC'I memmy perlorm.m ... e 
Tofu had a ~n1Jll n::-_g.liJh' .ts~odatJon \Hth nh'11l1\l} l'ttt 
was posJtnel} hnked \\ tth other food 101ctle, ,\, Wi1'- t~lll­
pe, wluch b•, ttsdi was not a<~uctatcd 1\'tth memot 1 pcr-
lorm.rnce Sex id,ltJ not shown) ,,·a 1 not relat<d to II'<Ckh 
soy con,umpttrn 
Lmear tegressJOn ,malJses (t,lble J1 mdtcaled that 
11ccU) totumtake had a neg,rtn c assoctahon 111th mcm-
uJ) 111 ,,n,ll) St:'~ tontrol!nl tor il_ge, sex, education Jnd site 
'I cmt'e \\ '-'" md~ J'd1lknth stgmficJntl} rt'lakd h1 bl'tk'l 
lR memoq lwtth ,, >lllllhr trend tor DRJ pet torm.u''' 
J he anal\,,., were not much altmd 11 henmtenng oth<t 
tood> Ho11<1 er, the int.1ke ol fruit 11as .1llo tound to ha~/ 
.1n ttli1'J'dl\knt posttnr assoct,\tton wtth both JR and DR 
(taole 3) Ana hoes mtng medtan ']'lit> of'") l'toJnctm 
t.lke pet \·.~el ga\ E' sum!J.J r-t>sult.:; to tiHN? .. oncernm~ 
conttnttr'US ~ono::.;um!'tt,,n pet wed,, shC>wmg a ht:'tter 
Hog~n or:-:.t 1S,1Liumun tYesuf u: J...r~.'<lt-~'1 I 
RJh.11Jlo 
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Tabl@ 3 Lmem regressiOn .malv'Ses CL•ntrolled for age, se\. edtL<.atlon and5lte{step ll und,m step 2. l0r mta!..e0t L•ther foods 
HYLT(IR) H\LT(DR) 
step 1 ~ep2 step 1 step 2 
\ge r.= -0.21, }'"' 0 001 ~" -o 2J, r, o oot ~o-021 P' 0(1)1 ~o-026.p<OOOI 
Se't NS NI NS NI 
fduciltlon ~o037,p< 0001 ~" o J4. r, o 001 ~o04l,p<D001 ~oor,p, 0001 
Stte ~ o -018, f" OOD! ~o-014 poOOOI ~o-OlO.poOOJ NS 
Tempd•Aeel.l) 1 ~o012,poODI ~o0!2,p:006' ~=012.p=OW ~=Oll.p:OOY' 
Tolu !lied.~ I ~=-018.p=0005 ~=-Ot;.p:0006 ~=-0 J;,p:0006 ~=-OI7,p:OOD8 
Frwt t weekh J ~=014.p<0001 ~=011 p=OOO! 
Or.mge/red "egctables \M'ei,h) NS NS 
Green vegetables 1,1ee1J)) NS NS 
Fosh 111eel.~) NI NS 
NS =Not stgnih~.ant. Intake of foods ts cuku\Llted o~ contmuous per'\':eel.e£ Jx dally- 21 t1mes1v.eek 
J Not stJttstK.tll} sl£nlfKant but shows a trend. 
m em of\ p<rlor man,e tn those llhochct not comtUne tofu 
dat!l or lll"te than once d.ul). 
To t<st our mtttal h1 poth,•sis, the analyses 11m str.ttt-
l!e,l for age usmg lite medt,tn spltt (at oS years of age) In 
w parttctpants who wete 68 )ms ol age or o!,ler, totu 
"·'"assoCiated w1th wors~ IR mt~moq pe1formana, m-
dependent!) ol ,tge, educ,Jtton and stte (whtclt all contttb-
uteu to the anal)ses "lule sex dtd not have an tnderen-
dent stgmtic,mt assocta tton) In the <a me ami) ses, tempe 
MS tndependentl) rel.ttt'J to l>elter IR memory peifor-
mance \\'hen other foods were added, tn4l< p.trtiCtpants 
over b8 H\lJS of .1ge, t!J~ assocJJtlons for toftt and h~mpe 
\'<'tlf(' nuint1Jn.:d In allj\lrtltlJ\lnts (Je·g-trdlt')Ss of agr}, 
11\llt consumptt,>n was ltnled lltth belter IR petfot· 
man~,e FN DR, the te~ulh> ot thi! anal' ses sho,·.cd suml.1r 
t1 ends (table 4) 
Discussion 
In the present ~lid). the con<utnl'tion oftotu (So) bean 
~.u1d 1 had neg.ttJw assoLJ.ltJOns ,.,Jth memoJ y tttncllon' 
'I he 111l,tle ul kmpe, the termented ,utd pw<cd su)l>e,\ll 
p!OdtKI, '~''" rl'i.ltEd Ill h·.'ttrJ mrnwr} tunctwns m tlh'-:.i."' 
.m.tl)Ses \\'it tie tempe consumpttnn haJ no >tgmJ~c,tnt 
JS'-0llatJons '' Jth m?mon b~ Jt,cif, tl ~t>rmt~d to \:l~rt 
p1otectr~i."' rltl'L ts only wht-n enkitd 1n.t.bf .mah ses w1th 
toiu 'onsumpttun and could rotenwl!l olf<ct some uftts 
negat11~ elkcts 1\'lt<·n otlmfoods 11 ere ad,led, th< mt,\le 
ol t1utt also showed anutdepemlent pos1tt1e .tssoctatton 
H1~h Totu Intalt' Is Jo.~<.ocJJted 'OJth 
\\'o1se Mt>nW) m llderh Indones.Jans 
With bett('f memon pertormJnd~ .\\1 ,tn.th st?:; ,.,t'Jt' con-
trolled for age, se\, cducatwn, stl< JJhitnt,tke <'I othe1 
roods \\.hen the .uta!) ses 1wre str.tttfte<i fi)r age, the re-
sults tor soy pro1htd> prttauung to tlto>e who ,.,m o1er 
oS J earsot .Jge conf01111~ our mtttal il) pothe>t< ba>,d 
on mda-anal} ses ot tht: liter:nure tor l''>tl ogen~ anl1 pht-
to'''trogens (see lnttt'dudton) Stgntft<.lllt coud.tttc>ns 
also e~tsted [>,•tll'<','n memor:. and the we<UJ tntake or 
i1sh and orangelted 1cget.tbles A health) dtet,1r) pattern 
was 0\'I?J,,ll assou.ltl'\.i With ha\ 1ng lud h1gher levels ot 
educ.tl!on ln anal) srsll htch a,iluskd for ag1 and t•duca-
tton, time (OllR~cttoni \•,m subsequmtil no longct stg-
lllf!(ant 
There are >1\Ct.tl mdltodologJcalltn,ttat~<'m to !he 
pre>ent stud). Fusth. tl•e s.unpltng m.-thods do not ,tllol> 
us to genmlm the lfsnlts \\'hik the cthmctt)' ot the 
parttctp.tnts was not rel,tt<d to memory rmornuna tn 
the cut lent anah~es and momtions of tofu ,md tempe 
111th me111oty tunctton \\ete also mdependent of the 
study site, unplanned post hoc analyses straufte,J for age 
,lnd sJte Jewaled thJt assol.l.ltlons m those O\cr os \ears 
of ,tge pertained to l'eorle f10111 Jakart.J, wtth 'tmll,u 
trends tor the P>oropudur ;tte, but not tor Sumedang Po<-
stbh dt!h•t ent te>t procedures I• g tr,mslattons to Sunda-
nese not sutfidenth comJWahle to Bahas.1 Indonesia (for 
!a kat t.t) .md J.n an m (for Borobttdur)J ot Jddtttonal lart-
ancc~vau"ed b) d1lterent teqe1s between the s1tcs could he 
"'J'<>tNble lot the la<k ol >tgntftcant asSO>.J.Jttons ot ;o;. 
product\\\ 1th memot y fut Sumedang Hot> e;er, post ho, 
.tnal)'el dtd 1ho11 that posttlle asiOC!.lttonl betwmt 
Dcm~nt GenJIJ Cog,n DJsord.tbO 5 
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Table 4 Lmear n·g1essJoll analp .. es stiJlitJed for Jg_e UsJilg the med.Im1 spht. ~,ontrolkd for i.'IE.t', sa... t.'\hu.atwn, and stud\ stte and m 
step 2, for other foods 
'68ye;u-s of age ;.68) rors of age 
step l step 2 step 1 sup 2 
HHTIR 
Age NS 
Sex 
Fducatlon 
Site 
Tempo(~edJy) 
Tofu (Me!J) I 
frllit 
NS 
~=01Lp:002 
~=04Lp<OOOI 
~=-02l.p<0001 
NS 
~ = o 11, r= o o' 
~=017,p<0001 
~=-01Y.p:OOOl 
NS 
ll=-U17.p<0001 
NS 
~ =O '7.p = ooo; 
~=-011 p=DOJ 
~=022.p=002 
~=027.p=000' 
[3 = -0 ~0. r •' 0 lln] 
N> 
~=011,p<0001 
NS ltJt:•nJiJ 
~= oz:. r= oooo 
~= 02".p=0002 
~= 017.p:0004 
NS 
NS NS 
Om.n,ge;ft'd wgetables 
Grer!n vegetJbb 
~=0 J6.f=OOOl 
NS 
NS' NS 
fish NS N' 
HHTDR 
'-ge 
s" 
Educatwn 
Site 
l empe (weelJy) 
lotu ("<d.h) 
rrwt 
Oran,gered wgctables 
Green wt:etahles 
NS 
NS" 
~=04l.p<0001 
~=-016.p=0001 
NS 
~=-018,p:Otx;' 
NS 
~=OIO.p=ON 
~=040.p<D001 
~=-01J,p:D02 
NS 
~=-011,p:016! 
~=01Lp=OC4 
NS 
~=-OtS.p<OOOt 
NS 
~=042,p,.0001 
N> 
~ =0 15.p = 0 12' 
1)=-01-,p=OOS~ 
~=-020.p 0001 
NS 
~=OJ7.pd001 
N' 
~=Dt6,p=D11' 
~ = -0 20,p= 0[~ 
~=018 p:OU02 
NS 
NS 
nsh - NS 
NS =Not SJSnJfiCJnt 
a Not St.lttstlc,lll)' Slgn1fJcant but s.hows a trend 
memor}J'etiortn3nce ond th~ tntal-e cl ft uttln th~ Sun-
dant>~e were m.Hnt,Hn~d. tndt'pt'ndcntl) of ,\ge, edu~J­
tton, >rl- .111d the tntal.e of otlJer tuuds I Ius cuuiLI rndr-
c.m thot put~n\t,tl methoLiologtcal dttfmnw wete tn-
sultictrnt to confound th~ re>ults between the sttes. 
Alte1 natn d}, the "'llfteJ<·tKcs m the soctoC'conomJC 
.md educatwnal status, 01111 the tcgton3l and rthmc,tli 
gcndtc composrtton of 1bc partKrp.um (Sundanese ;s 
maml) J ll\ ancse) het\\ren th<' sttes could :.H. count tor tht> 
results +Af.so,consumrtwn 11as sltghth !o11er m Sumed· 
,mg. 11lltch could pcrh,tps cxplatn the fmdmgs 1or tJ,c 
stt .tt tft<J da t.t Nota blv, m , ont r "'t to the str.1ttfieJ a n.tl-
)>el,post hoc A NO\·~ dtd not tew.ll ''gntfJCanttntetac-
tton dl~lh ot soyu:m..,umptJon WJth site on tnl'tlluJ \'pt'r-
toJ mJ.nce (ll1 2-, J-ot 4-way mtN ,KtJons With education 
atHLtge) It JS 1hu' J'l,ttr>tblethaiJ'O'•'• et tNt« ate respon-
sti'lc tot the I tndtngs ot t J,e unplanmd >trattfted ,m,tl) ''s 
tor age and stte Jo sr,trnutllally tnvesttg,tte all mtcm· 
ttons ot stlatJfKJhons W(ls not pos~tble due to lm11ted 
6 
NS 
NS 
mnnrers ot partrctpants per cell Hul'.c\\'r, thts Itndtng 
n<eds to be inw<ttga1ed m more dctatl tn tuture stttdtcs 
wr1h a larger <Jntple me 
Another lmHt.ttton ts tdated to >elt-tcpotl o! !ood 
consurnJ•tton. 11 htch m a) not be a rclt,tblo mwur e ot ac-
tual phrtoestrogcntntal-c In prmous studt<s [11. I"] the 
Food Ftcquencr Qucst10nnarre (on 1\lHch thcse ques-
trons wote b.t<edJ was shown to gtve .1 l~tltd tcfh tton o1 
tsoflamne hnrls1 ''Inch were .llso 1rlatndy 1 ellabll' O't.'f 
ttme [11] Howeur, cases V>tth memory ddtc.tenq ,1Jt-l 
dent<ntt.t m· known to undcmport the tnt.tl-e ot toods 
• Jnd medtc.ttJon 11~1 dttc to the lW)' n:tturc ot thttr mor-
htdtt) Cum. when ptt'>ent (tn 40'~ tlfhotlt the suspect-
ed CN'S ,tnd control<), subst.tnttated the s,·IJ-report ddl.t 
In ,tddtttc•n, 11 thrs aspect plmed J matot wk tn the pres-
ent stttd). one would ha'< e~pected lo1<er mtakes n! buth 
so: pt udtld> to tmJ'Jrt ht~het I!Sl. whil<'for toftt ,tlus:lel 
J t..,J- w,,, detelttd 
Hogcr.orst SJdnnum 'lesufu·hrcager: 
RJh:ud1o 
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~strength ot the rr~sent >tud' ''-IS th,tt lt\?t,ll toods 
~nd drttmnt 1\ pes ot soy food were rmestrg~!t'd srmitl· 
taneoush Unfo1 ttmJtd)', there \\JS ltttlv rntornlJ!ron on 
th1mtake ol other foods and none on theconsumptron 
of potems (pulses, redlwhrte meat, se,lluoL\, etc 1 or ol 
~cJrbohydrates other thm nee, and complete dt· 
et,1ryprofrles includmg c.llone e'.pendJtures could not he 
,,,kulated, On the other hand, frtut and temp< 11ell 
shown to h,\\1 mdependent positM a<>OdJIJons 111th 
nwnor). wh~eh rndK,\tes that future >tudres turther Ill· 
1estrgattng dretm mtake and Logmtne functronrn thr< 
pOJ'Uiatwn are both desrra11le .md te:IS!hk Our d,\ta on 
tnut comsumptron ,\Jt' rntrrgurng and ftt wrth the results 
tr om other stud res lt2, !9J smpectlng a hn k between an· 
tro\ldJnt rnt,1!-e and better me mol y functron 
it 11 undearl'.hyhrgher lml> or phytoestrogens \\ould 
hale neg,\ttw JS;vmtwns 111th brarn function Se1ml 
oth11 studres round that estJOgen tteatment and htgh es· 
tJOgen k1els \lete related to dementla p, c0-c2J and 
markers tor dentt'nthl, such as brain atroph) and accelct· 
ated cognruw dedme I23J Some ot the women rn thrs 
stu,ly wm )Ounger titan 60 years of age and may stlll 
hate had an mtad men;tt ual functron wnh tluctuating 
hrgh le1 els of estl(lgens, whKh could h.we mteracted ll'tth 
the effect ot ph)10estrogens on the br.unj2J. Sub~<>qtwnt 
tn·depth follow-up studres wrll etllble us to mwstrg,\te 
11 hethe~ serum and sa]ll"af) endogenous estrogens are 
lnlhed wrth ph)10estrogen rnt,lke. Howmr, astll<> results 
m ami) rertarned to those om oS yws ot age (ot whom 
Ill tually none Mttld ha'<' been pre· ur penmenorausal), 
m the- pt e'ient ~tud)) n~gatn e assoctattom ol tvfu are not 
elpected to be npl.nned b1 their ar\lagont>tll efll.t on 
endogenuus c~trogt>ns 
Our chta on to!tt tre m 111th the Honolulu ;>t,l Agmg 
)tudy, winch tound that mm ,tnd women 11 ho ,onsumed 
hrgh krels ol tolum mrdhle <I I'd bteJ life h.t.l wrse cog· 
mtrv~ functron Tempe seemed to mTset some ot the neg· 
,\tne ffte,ts ot hrgh totu mt,\ke, as rt had no ,\sso,ratrons 
with mrmorJ functron b) ltl•'lt. Temp< lm hrgl,er genii· 
tell\ k1 d< (the most potrn1J'hl toestJOgenJ than totu ltJ, 
11 h"h does not expl.un why tempe nught otfset the nrg,\· 
tile ertects ol totu, unless thm would be J LLct\1\ r!tneat 
illiSOO.:IatJOn A.nalyst?s mvohmg g~OJ')Ietn lrYeh usmg a 
qu.1dr ,\!re term should answer tht< hnothesrs rn the f0]. 
lo11 up stud) 
1 here rs an rmrortant drtterence ut tlw poCt'>Slllg ot 
the~ SO) ]'JOdUcts WhKh ll\a\ olternath'(h eXp],llll the 
mult> \I'Jule toiu doe' nvt undergo \er mentatror,, tempe 
does One stttlh lc41 showed th.1t a remarkable rnuease 
m lolate \ontrnt \\ ;u h•und .lttt:-1 t?rnlt:ntatiOn~ whJCh '•'a" 
Hlcth Tofu Int.l) t' {<.. A~S.Od,tted V. 1th 
wOrse Memory m rider!} Ind~me.:.wn<-
5.2-tuld lugh<r th,\n that of tlw boiled so) bean !OI wluch 
tOll! IS m,ldt'} Thi"i 11)3\ rt' du~ to d~ 11CI(Iformat10il Ol 
tol,\k' \ly RIII.Ofll> olt~"'P•'rll', the runCI)l.llmold m tcm 
pe tcrment.1tron 12~1 Our e.nlte~ 110rl- rn Ol.ford rndr-
c,tted that (al 11 umen wrth denknttd J,,td lughctlewh ut 
endog~nous estrogem ~ben smsttl\'l' ass a~ s w~t l' us?d 
1221 ,md that (b) \\omen\\ holud lugh etklogcnou, t'>tro-
gens, but who also had hrgh le1 els ot 1erum tolak, ,]rJ not 
perform bdu1•. the 25-pumt per tmmJn,e cutoft ><Oil of 
the Mmr-~lental Statm [\ammauon. llhtdtts sensltlle 
to dem£ntla l25j folatt" Jus ~'JOtc·ltJ\t' drccts on btatn 
function ,md h,l< been JSI0CJatcd 111th loweJ d<mcntra 
m!, l2oJ ruturr 1tudres nord to m~e>ligatr the mtmc· 
uon t'oeh\t:t.1Jli.irtum rph) to\e\tJO_gt.'n-; and lflbtt le\els 
and dementr,\ n <L 
Tlwret1re f:.e\er,ll othet il\l~LlllJIKttl\ tor tht' pott'ntt;J! 
pr(lt~ctJ\~ wk ot ti."mpc mtal..? combHkd \\Jth tlli~ nega. 
tne dfeds ot t0!u ~ccotdmg to tlk Dcp.u tments ot Puh-
lt, Health Jt the llmwrsrucs ot J,\kJrt,1 and Yog;,\l,arta. 
tormaldoh\tk rs ,,tten added to tofu (but not temJ'e) to 
preserve Jts tre>hness 1 ormaldehytlr ,an -Ol.tdJtrw 
d,1mage to tile front,11LOI tex .md IHJ'J'c>camJ\ll \Jssur ,\nd 
\'lt,1min E, a )'v'.l'trfttl ,uJtiOX!dant. \\,\>shown tu rrotl.t 
ag,unst this 111 ws 121 Anothu stud\ 111 rats sl<OIICd that 
tm1pe not onl) had srgnrfic.11lt anlioxrd,\111,' but also 
.1ntHnllanunator y and ,1ntrthr ombotrc cftects, all factors 
',l]uc], aJe potentrall} rmportant 11\ cognrtrw dcdmc .1nd 
dementra [2BJ Pos~bl), other compounds tilan to late m 
temp!? could thus bt JesponsJbk lor the pJot~ctJ\'t as~o­
cratJontdentrfred bctwe<n t< mpe consumptron ,1nd mm-
orr p.·rturmance In condusron, Ill the rrmnt Stlllh 
hrgher mtake of tofu "''s f(,\ltlll to b,• rdakd to ]otl'lr 
m~mor) l'<rtormance, wlnle tempr m.l) oitset tilts l u-
tur! stud res sil0ttld '• ,t!td,lte th~> Jmdrng and 11\1 estl,:ate 
posstble mecliam>ms ut actton. 
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APPENDIX 10- Model Summary for Table 21 which describes Logistic 
Regression Analyses to assess possible demographic risk factors for cognitive 
impairment 
Step I - Model x2 - 251 3 7, df- 11, p<O 00 I, Cox & Snell - 51, Nagelkerke - 68, Hosmer and 
Lemeshow ch1-square ~ 9 19 (df~ 8 p ~ 327), ns vanables ~gender (p~O 262), ethmc!ly (p~O 584) 
Step 2:- Model X2 -258 15, df- 13, p<O 001, Cox & Snell- 52, Nagelkerke- 70, Hosmer and 
Lemeshow ~ 10 62 (df~ 8,_]) ~- 224), ns vanables ~gender (p~O 400), etlmicity (p~O 462) 
Step 3:- Model x2- 291 26, df- 15, p<O 001, Cox & Snell- 56, Nagelkerke- 75, Hosmer and 
Lemeshow ~ 7 87 (df~ 8, p~O 446), ns vanables ~gender (p~O 164), ethmc!ly (p~O 199) 
APPENDIX 11 -Model summary for Table 22 which describes logistic 
regression analyses to predict cognitive impairment from demographic risk 
factors stratified by DISTRICT 
Jakarta:- Rlock 1:- Vanables ~age, gender, education, professwn, ethmc1ty, X2 (Model~ 
92 86, df~ 11, p<O 001, Cox & Snell ~ 48, Nagelkerke ~ 75), Hosmer and Lemeshow ch1-
square ~ 5 31, df ~ 8, p ~ 724, ns vanables ~ gender (p~O 119), professiOn (p~O 629), ethnicity 
(p~O 932) 
Block 2:- Vanables entered~ IADL and SF-36, x2 (Model~ 105 65, df~J3, p<O 001, Cox & 
Snell- 52, Nagelkerke = 82, Hosmer and Lemeshow ~ 4 42, df= 8, p ~- 818, ns vanables ~ 
gender (p~O 246), professiOn (p~O 637), ethnicity (p~O 639), IADL (p~O 281), SF-36 (p~O 186) 
Sumedang:- Block 1:- Vanables entered~ age, gender, educahon, professwn, ethmc1ty, x2 
(Model~ !I 65, df~ 6, p~O 011, Cox & Snell ~ 16, Nagelkerke ~ 24), Hosmer and 
Lemeshow ch1-square ~ I 0 47, df ~ 8, p ~ 234), ns vanables ~gender (p~O 754), educatwn 
(p~O 527) 
Block 2:- Vanables entered= IADL and SF-36, x2 (Model~ 30 43, df~ 8, p<O 001, Cox & 
Snell = 27, Nagelkerke ~ 42, Hosmer and Lemeshow ~ 4 93, df ~ 8, p ~- 765, ns vanables ~ 
gender (p~O 329), educatiOn (p~O 782), IADL (p=O 235), Health as measured by the SF-36 
p=O 01 
Borobudur:- Block 1- Vanables entered~ age, gender, educatwn, professiOn, ethniCity, x2 
(Model~ 33 30, df= 6, p<O 001, Cox & Snell ~ 26, Nagelkerke ~ 41), Hosmer and 
Lemeshow ch1-square = 2 36, df~ 8, p = 968, ns vanables ~gender (p~O 958), Ethnicity was 
not added by SPSS as 11 was a constant 
Block 2:- Vanables entered= IADL and SF-36, x2 (Model= 43 77, df= 8, p<O 001, Cox & 
Snell- 33, Nagelkerke ~52, Hosmer and Lemeshow = 2 39, df= 8, p ~- 967, ns vauables ~ 
age (p~O !53), gender (p=O 717), professiOn (p~O 145), SF-36 (p~O 293), Functwnal ab!hty as 
measured by the IADL p~O 016 
APPENDIX 12- Model Summary from Table 35 which describes logistic 
regression analyses assessing the relationship between soy food intake and 
isoflavone levels and cognitive impairment 
Step I R2 55 (Cox & Snell), 74 (Nagelkerke), Model X2- 216 13, df~9, p<O 00 I, Hosmer & 
Lemeshow ~ 7 59, df~8, Sig ~ 0 474, Demographic Vanables Age (p=<O 001), EducatiOn 
(p<O 001), gender (p~ns), diStnct (ns), profesSion (p~O 00!), 
Step 2 R2 55 (Cox & Snell), 74 (Nagelkerke), Model X2 ~216 22, df~ll, p<O 001, Hosmer & 
Lemeshow = 8 36, df=8, s1g ~ 0 399, Demographic Vanables Age (p<O 001), Educatwn (p<O 001), 
gender (ns), diStrict (ns), professwn (p=O 001), 
Step 3 R2 57 (Cox & Snell), 76 (Nagelkerke), Model x2 ~ 226 06, df=l5, p<O 001, Hosmer & 
Lemeshow = 23 68, df~8, Sig = 0 003, Demographic Vanables Age (p<O 001), Educatwn (p<O 001), 
gender (p~O 062), diStrict (ns), professwn (p~O 003) 
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APPENDIX 13 Model Summary from Table 36 which describes logistic 
regression analyses assessing the relationship between soy food intake and 
isoflavone levels and cognitive impairment stratified by DISTRICT 
Jakarta (n=145):- Step 1 R2 48 (Cox & Snell), 75 (Nagelkerke), Model x2 = 95 18, df=7, 
p<O 001, Hosmer & Lemeshow chi square= 0 80, df=8, sig = 0 999, Demographic Vanables Age 
(p<O 001), Educatton (p<O 001), Gender (p=O 032), profession (p=ns) 
Step 2 R2 52 (Cox & Snell), 81 (Nagelkerke) Model x2 = 106 21, df=ll, p<O 001, Hosmer & 
Lemeshow chi square= 3 32, df=8, sig = 0 913, Demographic Vanables Age (p<O 001), EducatiOn 
(p=O 001), Gender (p=O 012), professiOn (ns) 
Sumedang (n=106):- Step 1 R2 16 (Cox & Snell), 26 (Nagelkerke), Model x2 = 18 71, df=7, 
p=O 009, Hosmer & Lemeshow chi- square= 4 13, df=8, SI£= 0 845, Demographtc Vanables Age 
(p=O 007), Education (p=ns), Gender (p=ns), professiOn (p=O 03) 
Step 2 R2 19 (Cox & Snell), 30 (Nagelkerke), Model x2 = 22 28, df=ll, p=O 022, Hosmer & 
Lemeshow = 3 79, df=8, sig = 0 875, Demographic Vanables Age (p=O 011), Education (p=ns), 
Gender (p=ns), profession (p=O 083) 
Borobudur (n=114):- Step 1 R2 29 (Cox & Snell), 46 (Nagelkerke), Model x2 = 39 12, df=7, 
p<O 001, Hosmer & Lemeshow = 5 01, df=8, sig = 0 757, Demographic Vanables Age (p=O 003), 
Education (p=O 020), Gender (p=ns), professton (p=O 053) 
Step 2 R2 34 (Cox & Snell), 54 (Nagelkerke), Model x2 = 47 59, df=ll, p<O 001, Hosmer & 
Lemeshow = 8 29, df=8, sig = 0 406, Demographic Vanables Age (p=O 002), EducatiOn (p=O 011), 
Gender (p=ns), professton (p=O 032) 
APPENDIX 14- Model Summary from Table 37 which describes logistic 
regression analyses assessing the relationship between isoflavone levels and 
cognitive impatrment stratified by URBAN/RURAL living area 
Urban (n=l31)·- Step 1 R2 46 (Cox & Snell), 77 (Nagelkerke), Model x2 = 81 66, df=7, 
p<O 001, Hosmer & Lemeshow =I 46, df=8, Sig = 0 993, Demographic Vanables Age (p=O 001), 
EducatiOn (p<O 001), Gender (p=O 021 ), professiOn (ns) 
Step 2 R2 50 (Cox & Snell), 82 (Nagelkerke), Model x2 = 89 67, df=ll, p<O 001, Hosmer & 
Lemeshow = I 48 df=8, sig = 0 993, Demographic Vanables Age (p=O 002), Educatton (p=O 002), 
Gender (p=O 049), professiOn (p=ns) 
Rural (n=l43):- Step 1 R2 31 (Cox & Snell), 47 (Nagelkerke), Model X2 =52 63, df=7, 
p<O 001, Hosmer & Lemeshow = 5 77 df=8, sig = 0 673, Demographic Vanables Age (p=O 003), 
EducatiOn (p=O 004), Gender (ns), professmn (p<O 001) 
Step 2 R2 35 (Cox & Snell), 53 (Nagelkerke), Model x2 = 61 28, df=ll, p<O 00 I, Hosmer & 
Lemeshow = 8 74 df=8, sig = 0 364, Demographic Vanables Age (p=O 003), Educatton (p=O 008), 
Gender (ns), professiOn (p=O 001) 
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APPPENDIX 15- Model Summary from table 38 which describes logistic 
regression analyses assessing the relationship between soy foods and isoflavone 
levels with cognitive impairment stratified by MEDIAN AGE 
< 68 years (n=lSl).- Step 1 R2 50 (Cox & Snell), 70 (Nagelkerke), Model x2 = 100 60, df=9, 
p<O 001, Hosmer & Lemeshow = 14 05 df=8, stg = 0 081, Demographic Vanables Age (p=ns), 
EducatiOn (p<O 001), dtstnct (p=ns), gender (ns) 
Step 2 R2 50 (Cox & Snell), 71 (Nagelkerke), Model X2 = I 0 I 13, df= 11, p<O 00 I, Hosmer & 
Lemeshow = 13 87, df=8, stg = 0 085, Demographtc Vanables Age (p=ns), EducatiOn (p=<O 001), 
dtstnct (p=ns), gender (p=ns), professiOn (p=ns) 
Step 3 R2 53 (Cox & Snell), 75 (Nagelkerke), Model X2 = I 01 68, df=l5, p<O 00 I, Hosmer & 
Lemeshow = 8 34, df=8, stg = 0 401, Demographic Vanables Age (p=ns), EducatiOn (p=<O 001), 
dtstnct (p=ns), gender (p=ns), professiOn (p91s), 
> 68 years (n=125):- Step 1 R2 51 (Cox & Snell), 73 (Nagelkerke), Model x2 = 81 18, df=9, 
p<O 001, Hosmer & Lemeshow = 4 99, df=8, s1g = 0 758, Demographtc Vanables Age (p=O 016), 
EducatiOn (p=O 005), dtstnct (p=ns), gender (p=ns), dtstnct (p=ns) 
Step 2 R2 52 (Cox & Snell), 74 (Nagelkerke), Model x2 = 91 75, df=11, p<O 001, Hosmer & 
Lemeshow = 8 71, df=8, s1g 367, Demographtc Vanables Age (p=O 012), EducatiOn (p=O 004), 
dtstnct (p=ns), gender (p=ns) 
Step 3 R2 55 (Cox & Snell), 79 (Nagelkerke), Model x2 = 100 08, df=l5, p<O 001, Hosmer & 
Lemeshow = 5 80, df=8, stg 669, Demographtc Vanables Age (p=O 003), EducatiOn (p=O 019), 
dtstnct (p=ns), gender (p=O 060), professton (p=ns) 
APPENDIX 16- Model summary from table 39 which describes logistic 
regression analyses assessing the relationship between soy foods and isoflavone 
levels with cognitive impairment stratified by GENDER 
Men (n=75):- Step 1 R2 53 (Cox & Snell), 71 (Nagelkerke), Model x2 =56 71, df=8, p<O 001, 
Hosmer & Lemeshow =4 88, df=7, stg = 0 675, Demographtc Vanables Age (p=O 022), EducatiOn 
(p=O 017), dtstnct (p=ns), professiOn (p=ns) 
Step 2 R2 60 (Cox & Snell), 80 (Nagelkerke), Model x2 = 68 08, df=14, p<O 001, Hosmer & 
Lemeshow = 5 76, df=7, stg = 0 568, Demographtc Vanables Age (p=O 024), EducatiOn (p=O 019), 
dtstnct (p=O 164 ), professiOn (p=O 077) 
Step 3 R2 65 (Cox & Snell), 87 (Nagelkerke), Model x2 = 78 77, df=l4, p<O 001, Hosmer & 
Lemeshow = 8 68, df=7, stg = 0 276, Demographic Vanables Age (p=O 014), Education (p=ns), 
dtstnct (p=ns ), professiOn (p=O 079) 
Women (n=201):- Step 1 R2 59 (Cox & Snell), 78 (Nagelkerke), Model x2 = 171 81, df=8, 
p<O 001, Hosmer & Lemeshow = 3 74, df=8, s1g = 0 880, Demographtc Vanables Age (p<O 001), 
EducatiOn (p<O 001), dtstnct (p=ns), professton (p=ns) 
Step 2 R2 59 (Cox & Snell), 79 (Nagelkerke), Model x2 = 172 17, df=IO, p<O 001, Hosmer & 
Lemeshow = 1 64, df=8, s1g = 0 990, Demographtc Vanables Age (p<O 001), EducatiOn (p<O 001), 
d1stnct (p=ns), professiOn (p=ns) 
Step 3 R2 61 (Cox & Snell), 82 (Nagelkerke), Model x2 = 183 00, df=l4, p<O 001, Hosmer & 
Lemeshow = I 50, df=8, s1g = 0 993, Demographtc V artables Age (p<O 001 ), EducatiOn (p<O 001 ), 
dtstnct (p=ns), professiOn (p=ns) 
404 
APPENDIX 17 
Model Statistics Summary in Stratified Logistic Regression Analyses 
Table 1 - Stat1'ihcallnformat10n Sum man for LogJ-.tlc Regre-~'iiOn analvscs o;trat•fied h' LIVIng l>i'itr•ct and MedJan Age 
(a'i"c"" ov foods onlvl mg'i 
Jakarta Sumedang Borobudur 
"' R2 46 (Cox & Sne\1), 83 • R2 28 (Cox &. Snell), 40 * R2 28 (Cox & Sncll), 38 
(Nagelkerke) Model X2 = 61 06, df= (Nagelkerke) Model x2 = 15 90, df (Nagelkerke) ModclX2"'1398,df=7, 
7, p<O 001, Hosmer & Lemeshow = = 7, p=O 026, Hosmer & p=O 052, Hosmer & Lemeshow = 
0 17,df=8,s•g= 1000 Lcmeshow= ID 15,df= 8, s•g= 13 60,df=8,sog=0093 
-
0225 
Q, 
* Vanab\es entered= tempe (p==ns) "' Vanables entered= tempe (p""Tls) "' Van abies entered = tempe (p=ns) and 
• Vi and tofu (p=ns) and tofu (p=ns) tofu (p=ns) 
• Demographic van abies entered = "' Demogrnphtc vanables entered= • Demographic van abies entered= age 
age (p=ns), educatiOn (p=ns) & age (p=ns), educatton (p=ns) & (p=ns), educa!Jon (p=O 025) &. gender 
gender (p""nS), profeSSion (p=ns) gender (p=ns), professwn (p=ns) (p=ns), professiOn (p=ns) 
~ 
• • R2 56 (Cox &Snell), I 00 • R2 32 (Cox & Snell), 45 • R2 51 (Cox & Sncll), 69 
• ~ (Nagelkerke) Model X2" 80 38, df= (N<~gelkerke) Model x2 = 18 30, df (Nagelkerke) Model x2 = 30 24, df= ~ 
"' 
11, p<O 00 I, Hosmer &. Lemeshow = = 11, p=O 075, Hosmer & 11, p=O 00\, Hosmcr & Lemeshow= V
0 00, df= 8, sog =I 00 Lemeshow= 7 84, df= 8, Sig = 8 09, df= 8, sog= 0 425 
0450 
.... 
• Van able:. entered= t(.mpe (p=ns), • Vanables entered= tempe "' Van abies entered = tempe (p=ns), 
Q, tofu (p=ns), orange/red coloured (p=O 321 ), tofu (p=ns), orange/red tofu (p=ns), orange/red coloured 
~ 
vegetables (p=ns), green coloured coloured vegetables (p=ns), green vegetables (p=ns), green coloured Vi 
vegetables (p=ns), frUJt (p=ns) and coloured vegetables (p=ns), fr01t vegetables (p=O 045), frUll (p=ns) and 
fish (p=ns) (p=ns) and fish (p=ns) fish (p=ns) 
"' Demographic vanables entered= * Demographic vanables entered= "' DemographiC vanables entered= age 
age (p=ns), educatiOn (p=ns) &. age (p=ns), educatwn (p=ns) & (p=ns), educatwn (p=O 021) & gender 
gender (p""ns), professwn (p=ns) gender (p=ns), professiOn (p=ns) (p=ns), professwn (p""O 084) 
"' R2 54 (Cox & Snell), 74 "' R2 24 (Cox & Snell), 46 * R2 13 (Cox & Sne\1), 32 
(Nagelkerke) Model X2 = 36 08, df= (Nagelkerke) Model x2 = 15 81, df (Nagelkerke) Model X2 = 9 75, df= 7, 
7, p<O 001 , Hosmer &. Lemeshow = = 7, p=O 027, Hosmer & p""O 203, llosmer &. Lemeshow = 5 55, 
2 20, df= 7, sig = 0 948 Lemeshow = 1 67, df::: 7, sig = df= 8, Sig= 0 698 
-
0 976 
" • Van abies entered= tempe (p=ns) • Vanab1es entered= tempe (p=ns) "' Vanables entered= tempe (ns) and " 0 o; and tofu (p=ns) and tofu (p=ns) tofu (p=ns) 
"' DemographiC van abies entered = "' Demographic vanables entered= "' Demographic vanables entered= age 
age (p=O 035), education (p=O 034) & age (p=O 088), educatwn (p=ns) & (p=ns), educatiOn (p=ns) &. gender 
gender (p=ns), protesswn (p=ns) gender (p=ns), professwn (p=ns) (p=ns), professiOn (p=ns) 
~ 
-• "' R2 72 (Cox & Snell), 1 00 * R2 31 (Cox & Snell), 59 * R2 14 (Cox & Snell), 36 • ~ (Nagelkerke) Model X2 ""60 28, df= (Nagelkerke) Model x2 = 21 28, df (NagelkerJ..e) Model X2 = 10 96, df= ~ 
'<> 11, p<O 001, Hosmer &. Lemeshow = = 11, p=O 031, Hosmer& 11, p""O 446, Hosmer &. Lemeshow = A 
0 00, df~ 7, Slg =I 00 Lemeshow= 1068,df= 8, s1g= 7 20, df= 8, sog= 0 515 
0 221 
.... 
"'Yanables entered= tempe (p=ns), • Vanables entered= tempe "' Yanables entered= tempe (p=ns), 
" 
tofu (p=ns), orange/red coloured (p=ns), tofu (p=ns), orange/red tofu (p=ns), orange/red coloured 
" 0 vegetables (p=ns), green coloured coloured vegetables (p=ns), green vegetables (p=ns), green co\oULcd o; 
vegetables (p=ns), frun (p=ns) and coloured vegetables (p=-ns), frUJt vegetables (p=ns), frUit (p=ns) ,md fish 
fish (p=ns) (p=ns) and fish (p=ns) (p=ns) 
"' DemographiC vai mbles t:ntt:rt:d = "' Demograp1Hc vanables entered= * Demographic vanables entered= age 
age (p=ns ), educatwn (p=ns) & age (p=ns), educatiOn (p=ns) & (p=ns), educatiOn (p=ns) & gender 
gender (p=ns), profess10n (p=ns) gender (p=ns) (p=ns), professiOn (p=ns) 
NB Jakarta - <68 years n = 98, > 68 years n = 47, Sumedang < 68 years n = 48, > 68 years n =58, Borobudur < 68 years n = 42, > 68 
years n = 72 
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Table 2- StatlstJcallnformatwn Summarv for Log1st1c Regress1on anah•se~ ~trat1fied b\ Urban/Rural 
L dMd A I I n I I 1\ IVInl:;llfl e 1an ge a'i'ie'i'img sa 1varl: ISO avone eve son v 
Urban Rural 
• R2 49 (Cox & Snell), 89 (Nagelkerke) • R2 28 (Cox 8.. Snell), 37 (Nage!kerke) 
Model x2 ==59 88, df= 7, p<O 001, Hosmer & Model x2 = 17 99, df= 7, p=O 012, 
Lemeshow = 0 558, df= 8, s1g =1 00 Hosmer & Lemeshow = 5 01 df= 7, s1g = 
0 659 
-~ • Yanables entered= gemstem (p""ns) and • Vanables entered= gemstcm (p=ns) and Q 
00 da1dzem (p=ns) da1dzem (p~s) 
• Demograph1c van abies entered= age (p=ns), • Demographic v.J.n.J.bles entered= age 
educatiOn (p=ns) 8.. gender (p=ns), professwn (p=ns), educatiOn (p=O 020) &. gender 
(p-ns) (p=ns), professwn (p=ns) 
• R2 54 (Cox & Snel\), 100 (Nagelkerke) • R2 39 (Cox &Snel\), 53 (Nagelke1ke) 
< 68 Model x2 = 70 68, df= 11, p<O 001, Hosmer & Model x2 = 28 08, df = 11, p=O 003, 
) ears Lemeshow = 0 00, df= 8, s1g = 1 000 Hosmer & Lemeshow = 5 48, df= 7, s1g = 
0 602 
• Yanables entered= gemstetn (p=ns), • Vanables entered= gemstem (p=ns), 
"' 
dmdzem (p=ns), orange/red coloured da1dzem (p=ns), orange/red coloured 
..
0 vegetables (p=ns), green coloured vegetables vegetables (p=ns), green coloured Q 
05 (p=ns), fru1t(p=ns) and fish (p=ns) vegetables (p=O 01 6), fruLt (p=ns) and fish 
(p-ns) 
• DemographiC van abies entered= age • Demographic van.:tbles entered= age 
(p=O 487), educatwn (p=O 074) &. gender (p=ns), educatiOn (p=O 015) & gender 
(p=O 708) (p=ns), professiOn (p=O 077) 
• R2 60 (Cox & Snell), 87 (Nagelkerke) • R2 13 (Cox & Snell), 28 (Nagelkerke) 
Model x2 = 37 53, df= 7, p<O 001, Hosmer & Model x2 = 12 46, df= 6, p=O 052, 
Lemeshow =I 20, df= 8, s1g = 0 997 Hosmer & Lemeshow = 5 975, df= 8, s1g 
= 0 650 
- • Yanab\es entered= gemstem (p=ns) and • Vanables entered= gem stem (p=O 085) 
"' V dmdzem (p--ns) and da1dzem (p=ns) Q 
00 
• DemographiC vanables entered= age (p=ns), • Demographic vanables entered= age 
education (p=ns) & gender (p=ns), profess1on (p=O 034), educatiOn (p=050) & gender 
(p-ns) (p=ns), profess1on (p=O 010) 
> 68 
• R2 69 (Cox & Sne\1), l 00 (Nagelkerke) * R2 28 (Cox & Snell), 57 (Nagelkerke) 
Model x2 = 47 69, df= 11, p<O 001, Hosmer & Model x2 = 28 21, df= 11, p=O 003, years Lemeshow = 0 000, df= 8, s1g = 1 000 llosmer & Lemeshow = 0 73, df= 8, s•g = 
0 999 
* Yanables entered= gem stem (p=ns), • Yanables entered= gem stem (p=O 05), 
"' 
daldLem (p=nl>), orange/red coloured dmdzem (p=ns), orange/red coloured 
" 
vegetables (p=ns), green coloured vegetables vegetables (p=ns), green coloured V 
Q (p=ns), frmt (p=ns) and fish (p=ns) vegetables (p=ns), fruit (p=ns) and fish 
= (p-ns) 
• DemographiC vanables entered= age • DemographiC vanables entered= age 
(p=O 999), education (p=l 000) & gender (p=O 033), educatmn (p""O 054) & gender 
(p=O 999) (p=ns), professiOn (p=O 019) 
NB Urban- <68 years n = 90, > 68 years n = 41, Rural < 68 years n =56,> 68 years n = 87 
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AJ:ti!l 
< 68 years 
Men "'omen 
* R2 51 (Cox &..Snell), 73 (Nagclkerke) Model "'R2 51 (Cox&. Sne\1), 72 (Nagelkerke) Modely2-
xz"" 2 00, df= 6, p=O 001, Hosmer & Lemeshow 81 61, df= 6, p<O 001, Hosmer & Lemeshow = 3 72, df 
~ 097, df~ 8, Slg~O 998 =8,sig=0881 
-.. * Vanables entered =tofu (p::ns), tempe (p~s), * Van.Ibles entt.red =tofu (p=ns), tempe (p=ns), ~ 
,;; 
* Demographtc vanables entered =age (p=ns), • Demographtc van abies entered= age (p,ns), educatton 
education (p=ns), profess ton (p=ns) {p<O 001 ), professiOn (p=ns) 
* R2 52 (Cox & ~nel\), 75 (Nagelkerke) Model * R2 52 (Cox & Snell), 72 (Nagelkerke) Model X2 
x2 = 22 05, df= 8, p=O 003, Hosmer &. Lemesho\\ 82 72, df= 8, p<O 001, Hosmer 8.. Lemeshow= 3 84, df 
~092df~8,Sig~ I 00 :o8,slg=0871 
M 
.. 
• Vanab\es entered= tempe (p=ns), tofu (p=ns), 
• Vanables entered= tofu (p=ns), tempe (p=ns), 
<i5 da1dzem (p=ns), gemstem (p=ns) gemstem (p=ns), da1dzem (p=ns) 
*Demographic vanab\es entered= age (p=ns), • DemographiC vanables entered= age (p=ns), educatwn 
education (p=ns), professiOn (p=ns) (p<O 001 ), professiOn (p=ns) 
* R2 70 (Cox & ~ne\\), 1 00 (Nagelkerke) Model * R2 56 (Cox 8.. Snell), 78(Nagelkerke) Model x2 
x2 = 37 35, df= 12, p<O 001, Hosmer & 93 21, df= 12, p<O 001, Hosmer & Lemeshow = 8 61, df 
Lemcshow = 0 000 df= 8, s1g = 1 000 = 8, Slg = 0 377 
• Vanables entered= tempe (p=O ns), tofu • Vanables entered= tempe (p--ns), tofu (p=ns), 
.., (p=O ns), gemstem (p=O ns), da1dzem (p=O ns), gen1stem (p=ns), da1dzem (p=ns), orange/red coloured 
c. 
orange/red coloured vegetables (p=ns), green vegetables (p=O 083), green coloured vegetables (p=ns), ~ 
,;; coloured vegetables (p=ns), frmt (p=ns) and fish fruit (p=ns) and fish (P"'O 041) 
(p=ns) 
• Demographtc vanables entered= age (p=ns), * Demographic vanables entered= age (p=O 089), 
educatiOn (p=ns), professiOn (p=ns) educatiOn (p""O 003), professiOn (p=ns) 
NB Men n=31, women n = 114 
Table 4 Stah'lt rat InformatiOn Summarv for Lom'\tlc Rcere'\~lOn anal"<;cs '\tratlfied b\• Gender and Mcdmn 
- ', ' ~ 
> 68 years 
-.. 
~ 
,;; 
M 
Men 
• R2 51 (Cox & Snell), 72 (Nagelkerke) Model 
x2 = 36 03, df= 6, p<O 001, Hosmer& Lemeshow 
~ 16ldf~8,sog~0990 
• Vanables ente1ed =tofu (p=ns), tempe (p=ns) 
* Demographic van abies entered= age (p=O 025), 
educatiOn (p=ns), professwn (p=O 077) 
* R2 51 (Cox & Snel\), 73 (Nagelkerke) Model 
x2=31341,df""8,p<0001,Hosmer& 
Lemeshow =7 46 df= 8, stg= 0 487 
E * Vanables entered= tempe (p=ns), tofu {p=ns), 
I'Jl gemstem (p=ns), da1dzem (p=ns) 
.., 
* Demographic van abies entered= age (p=O 037), 
educatwn (p=ns), profess1on (p=ns) 
fr * Not computed due to low power 
<i5 
NB Male n = 44, Female n = 80 
\\'omen 
• R2 58 (Cox & Snell), 82 (Nagel!..erke) Model x2-
69 07, df= 6, p<O 001, Hosmcr & Lemeshow = 0 58, df 
= 8, s1g = I 000 
* Vanables entered= tofu (p=ns), tempe (p=O 056), 
• DemographiC vanables entered= age (p::=ns), educatwn 
(p~o 005), professiOn (p~O 069) 
• R2 59 (Cox & Sncll), 84 (Nagelkerke) Model y) = 
72 \2,df= 8,p<O 001, Hosmcr& Lcmeshow= 0 61, df 
= 8, s1g = 1 000 
• Vanables entered = tempe (p=O 051 ), tofu (p=ns), 
gemstem (p=ns), da1d7e111 (p=ns) 
• Demographtc vanables entered= age (p=O 081), 
education (p=O 005), p1ofess1on (p=O 094) 
* R2 71 (Cox & Snell), I 00 (Nagelkerke) Model x2 = 
97 74, df= 24, p<O 001, Hosmer & Lemeshow= 0 00, df 
= 3, <;lg = 1 000 
• Vanables entered= tempe (p=ns), tofu (p=ns), 
gemstem (p=ns), datdzem (p=ns), orange/red coloured 
vegetables (p=ns), green coloured vegetables (p=ns), frutt 
(p=ns) and fish (p=ns) 
• Demographtc vanables entered= uge (p=ns), educatiOn 
(p~s) 
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~urn mar\ for Lomsttr Rel!ress on analv~e~ stratified h\ lt\ln!! Dt\tnct and Gender (a~~essml! 
' ~ov food~ onh'} 
Jakarta Sumedang Borobudur 
• R2 65 (Cox 8.. Snell), l 00 *R2 08(Cox&Snel!), 13 • R2 40 (Cox & Snell), 62 
(Nagelkerke) Model X2 = 33 62, df= 6, (Nagelkerke) Model X2 == 3 08, df= (Nagelkerke) Model X2 = 19 40, df= 
p<O 001, Hosmer 8.. Lemeshow = 0 00, 6, p=O 799, Hosmer & Lemeshow = 6, p=O 004, Hosmer & Lemeshow = 
-
df== 8, Slg = J 00 13 50 df= 7, sog = 0 061 I 068 df=7, sog=094 
"' 
• Vanables entered= tempe (p=ns) and • Vanables entered= tempe (p=ns) • Vanab\es entered= tempe (p=ns) 
" 0 tofu (p=ns) and tofu (p=ns) and tofu (p=ns) ;;; 
• Demographic vanables entered= age • Demographic vanables entered= • Demographic vanables entered== 
(p=ns), education (p=ns), profess10n age (p==ns), educatiOn (p=ns), age (p=O 063), education (p=ns), 
(p=ns) profeSSIOn (p=ns) professiOn (p=ns) 
c 
• R2 65 (Cox & Snell), I 00 • R2 29 (Cox &. ~nell), 48 • R2 64 (Cox & Sne\1), I 00 
" 
(Nagelkerke) Model x:2 = 33 62, df= (Nagelkerke) Model x:2 == 13 26, df= (Nagelkerke) Modclx2=3911,df= ;;: 10, p<O 001, Hosmer & Lemeshow == I 0, p=O 210, Hosmer & Lemeshow = 10, p<O 001, Hosmer & Lemeshow = 
0 00, df= 8, sog =I 000 24l,df=8,sog=0966 0 00 df= 4, sog =I 000 
.... • Van abies entered= tempe (p=ns), tofu • Vanables entered== tempe (p=ns), • Vanablcs entered= tcmpc (p=ns), 
"' 
(p=ns), orange/red coloured vegetables tofu (p=ns), orange/red coloured tofu (p=ns), orange/red coloured 
" 0 {p=ns), green coloured vegetables vegetables (p=ns), green coloured vegetables (p=ns), green coloured ;;; (p=O 993), fnnt (p=ns) and fish (p=ns) vegetables {p=ns), fru1t (p=ns) J.nd vegetables {p=ns), frUit (p=ns) and 
fish (p-·ns) fish {p=ns) 
• Demographic vanables entered= age • Demographic vanables entered = • DcmogrJ.ph1c van abies entered = 
(p=ns), educatwn (p~s), professiOn age (p=ns), educatiOn (p=ns), age {p=O 171), educallOn (p"'O 712) 
(p=ns) professwn (p~s) 
• R2 47 (Cox & Snell), 74 * R2 29 (Cox & Snell), 46 "' R2 32 (Cox & Snell), 50 
(Nagelkerke) Model ;(2 = 72 08, df= 6, (Nagelkerke) Model X2 = 23 45, df= (Nagelkerke) Model x:2 = 28 871, df 
p<O 00 I, Hosmer & Lemeshow = 2 41, 6, p=O 001, Hosmer &. Lemeshow = = 6, p<O 001, Hosmer &. Lemeshow 
df= 8, sog = 0 966 938,df=8,sog=0312 = 2 70, df= 8, sog = 0 952 
- • Vanables entered= tempe (p=ns) and • Vanables entered= tempe (p=ns) • Vanab1es entered= tempe 
"' 
" tofu (p=n~) and tofu (p=ns) (p=O 091) and tofu (p=O 063) 0 
= • Demograph1c vanables entered= age • Demographic vanables entered= • DemographiC vanables entered= 
(p=O 001 ), education (p=O 001 ), age (p=O 011), educat1on (p~s), age (p=O 055), educatwn (p""O 028), 
professmn (p=ns) profeSSIOn (p"'O 093) professiOn (p=ns) 
c 
• • R2 57 (Cox & Sne\1), 89 • R2 32 (Cox & ~nell), 50 • R2 36 (Cox & Snell), 58 e 
0 (Nagelkerke) Model X2 = 94 97, df= (Nagelkerke) Model x:2 = 25 96, df = (Nagelkerke) Model x:2 == 34 53, df= ~ 10, p<O 001, Hosmer &. Lemeshow= I 0, p=O 004, Hosmer & Lemeshow = 10, p<O 001, Hosmer & Lemeshow= 
0 17, df= 8, SJg=l 000 8 60, df= 8, SJg = 0 378 214,df=8,sog=0976 
.... 
• Vanables entered= tempe (p~s), tofu "'Vanab\es entered= tempe (p~s), • Vanables entered= tempe (p~s), 
"' 
(p=ns), orange/red coloured vegetables tofu (p=ns), orange/red coloured tofu (p=ns), orange/red coloured 
" (p=ns), green coloured vegetables vegetables (p=ns), green coloured vegetables (p-=0 050), green coloUJed 0 
= 
(p=ns), fru1t (p=ns) and fish (p=ns) vegetables (p=ns), fru1t (p=ns) and vegetables (p=ns), fru1t (p~s) and 
fish (p"'"tls) fish (p~s) 
• Demograph1c vanables entered= age • Demographic vanables entered= • Demographic vanables entered = 
(p=O 009), educatiOn (p=O 008), age (p=O 013), educatiOn {p=ns), age (p=O 032), educatwn (p=O 033), 
professmn (p"'O 06) profess10n (p=ns) professwn (p=O 085) 
NB J.1karta. Male n == 32, Female n = 120, Sumedang ·Male n = 38, Female n = 68, Borobudur. Male n == 38, Female n = 76 
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T hi 6 St t t lint a 
' 
- a •~ 1ca o'm at on 'I marv f L ~t1c Reo C'i-~ton analv~e~ st at tied bv llrhan/Ru all IVJn!! and Gender (a<;se~<;ml': 
' 
urn ., ogJ 
' ' ' ' <;ahvan• I<;Oflavone lt>vel<; onlv) 
Urban Rural 
* R2 23 (Cox & Snell), 34 (Nagelkerke) Model r.2 
18 11, df= 6, p=O 006, Hosmer &. Lemeshow = 3 04, df= 
8, Slg = 0 932 
-c. * Not computed due to low power * Vanables entered= gem stem (p=ns) and dmdzcm (p=ns) • 
<ii 
• DemographiC vanables entered= age (p=O 017), 
educat1on (p=ns), professton (0 079) 
c 
* R2 45 (Cox&. Sndl), 69 (Nagelkerke) Model X2-• 
::0 29 09, df= 10, p=O 001, Hosmer & Lcmeshow = 2 54, df= 
8, Slg = 0960 
.... * Vanables entered = gcmstem (p=ns), dmdzcm (p=ns), 
c. 
* Not computed due to low power orange/red coloured vegetables (p=ns), green coloured ~ 
"' vegetables (p=ns), fruit (p=O 08) and fish (p=ns) 
* DemographiC vanablcs entered= age (p=O 026), 
educatiOn (p=ns), professiOn (p=ns) 
* R2 48 (Cox & Sncll), 77 (Nagclkerke) Model X2- 67 91, df * R2 33 (Cox & Sne\1), 51 (Nagelkerke) Model x2-
= 6, p<O 001, Hosmer &. Lcmeshow =0 858, df= 8, s1g = 0 999 38 10, df= 6, p<O 001, Ho<;mer & Lemeshow= 2 74, df= 
8, Slg = 0 950 
-c. * Van abies entered =gem stem {p=ns) and da;dzem (p=ns) * Vanablcs entered= gemstem (p=ns) and da1dzem (p=ns) ~ 
"' 
*Demographic vanables entered= age (p=O 001), education * Demographtc vanables entered= age (p=ns), educatiOn 
(p=O 001), profess10n (p=ns) (p=O 005), pmfessmn (p=O 015) 
c 
• * R2 62 (Cox & Sne11), 1 00 (Nage!kerke) Model r.2 101 83, * R2 40 (Cox & Snell), 62 (Nagelkerke) Model x2-e 
0 df=-c 10, p<O 001, Hosmer & Lemeshow= I 00, df= 5, s1g = 49 19,df= 10, p<O 001, Hosmer & Lemeshow=4 52, df= ::: I 00 8,Sig=0807 
.... 
* Vanables entered= gem stem (p""!ls), dmdzem (p=ns), * Vanables entered= gem stem (p=ns), da1dzem (p=ns), 
c. orange/red coloured vegetables (p=ns), g1een coloured orange/red coloured vegetables (p=O 019), green coloured 
~ vegetables (p=ns), fru1t (p=ns) and fish {p=ns) vegetables (p=O 041), frmt (p=ns) and fish (p=O 043) 
"' 
* DemographiC vanables entered= age (p=ns), educatiOn * Demographic vanables entered= age (p=O 033), 
(p=ns2), profession (p=ns) educatiOn (p=O 009), professiOn (p=O 004) 
NB Urban· Men n = 27, Women n = 104, Rural· Men n =48, Women n = 95 
409 
T bl a • 7- s tatlshca 11 r n ormahon s urn man or og•stlc R tfidhllb/R lt egres'iiOn ana V'ies o;tra 1 1e 
' 
r an urn -Jvmo an dG d ••• er a~'ie~'ilnli:; 
o;a)lvan 1soflavone level'i onlvl 
Urban Rural 
* R2 23 (Cox & Snel!), 34 (Nage!kerke) Model x2-
18 I I, df"" 6, p=O 006, Hosmer &. Lemeshow = 3 04, df = 
8, Slg == 0 9)2 
-c. 
"'Not computed due to low power • Yanables entered::: gcmstem {p=ns) and dmdzem (p=m) !' 
"' 
*Demographic vanables entered= age (p=O 017), 
educatton (p=ns), profess10n (0 079) 
• 
* R2 45 (Cox & ~nell), 69 (Nagelkerke) Model x2 3 
~ 29 09, df= 10, p=O 001, Hosmer &. Lemeshow = 2 'i4, df= 
8, Slg = 0960 
M • Vanables entered= gemstem (p=ns), da1dzem (p=ns), 
c. 
• Not computed due to low power orange/red coloured vegetables (p=ns), green coloured !' 
"' 
vegetables (p=ns), frutt (p=O 08) and fish (p=ns) 
* Demograplm, vanab\es entered= age (p=O 026), 
educatton (p=ns), professton (p=ns) 
"'R2 48 (Cox & Snell), 77 (Nagelkerke) Model X2 6191, df "'R2 33 (Cox & ~nell), 51 (Nagelkerke) M odd t2-
= 6, p<O 001, Hosmer & Lemeshow =0 858, df= 8, stg = 0 999 38 10, df= 6, p<O 001, Hosmer & Lemeshow = 2 74, df= 
8, stg = 0 950 
-c. * Vanables entered= gemstem (p=ns) and datdzem (p=ns) "'Yanab1es entered= gem stem (p=ns) and dmdzem (p=ns) !' 
"' 
"'Demographic vanables entered= age (p=O 001), educatton • Demogruph1c vanables entered= age (p=ns), education 
(p=O 001), professiOn (p=ns) (p=O 005), professwn (p=O 015) 
• 
• "'R2 62 (Cox & Snel\), l 00 (Nagelkerke) Model x2 -101 83, "'R1 40 (Cox & Sne\1), 62 (Nagelkerke) Model x2 e df= 10, p<O 001, Hosmer & Lemcshow= 1 00, df= 5, stg= 49 19, df= 10, p<O 001, Hosmer &., Lemeshow = 4 52, df= • 
... I 00 8, Stg = 0 807 
M "'Vanables entered= gemstem (p=ns), datdzem (p=ns), • Vanables entered= gemstem (p=ns), da1dzem (p=ns), 
c. orange/red coloured vegetables (p=ns), green coloured orange/red coloured vegetables (p"'O 019), green coloured 
~ 
Ji vegetables (p=ns), fru1t (p=ns) and fish (p=ns) vegetables (p=O 041 ), frun (p=ns) and fish (p=O 043) 
"' Demographtc vanables entered= age (p=ns), educatton "' Demographtc van abies entered= age (p=O 033), 
(p=ns2), professton (p=ns) educatiOn (p=O 009), professton (p=O 004) 
NB Urban w Male n = 27, Female n = 104, Rural w Male n = 48, remale n = 95 
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APPENDIX 18 
Cert1f1cate of analySIS 
Acotns Speclalluas Holdmg B V 
Ann Mr R Stmons 
P 0 box 
426) ZG GIESSEN 
$an ple recewed 
LOJGHOOROJG!-- CAPS 1 F .. ,l.,:;;::bO 
04-12-20Ctl 
R~pOI" o:l1tt 
San pi~ (!nte 
013 12 2JC~ 
'"'' 
7e&t 
0 Sanl~kl ;lreolr~toon 
'" 
['ao:lztn (Hf>LC) 
.;n lta'':;nf..Otudzr tHPLCt 
0" heel> ..:!R..:I:t~ (HPLC> 
o37~ Ceod:e1 (HPL:: 
"e~ Tcto.l Oo.-d:ton 
'" 
Total Daldze~ 
"' 
Glyc!tln (HPlC) 
6n ~11lonyl-g\ytM1 (HPLC) 
"" 
Ace1yl.<;~lyatrn (HPLC) 
""' 
Glyc~ejn {HPLC) 
'" 
Total Glyal..., 
"'' 
GeflJStm (HPI..C) 
"'' 
Malonyl..gen~lln (HPLC) 
683 Ate1YI"I!IIOiSir11 tHPLC) 
,, Gen,.ll!l1 
'" 
Total Geooslem 
"" 
Totllllaollavunes BOiucooes 
"'' 
Totalllollavane5 
Order-ne 
R~~· 
.. a os 
c :':5 
'" c :s 
c :s 
.. 0 05 
.. 0 05 
<005 
< 0 05 
< 0 05 
< 0 05 
< 0 05 
"' 0 05 
< 0 05 
c: 0 os 
< 0 05 
<005 
< 0 05 
For....,..d.-on""'""tcnon~.-.-.p~NW~H-....-y......._,. 
Arrt~-.al~..w!tornllflt>OM<Ionlhfo~"-•--•~ol-""_,_ 
O<>ly ,.produ<:bon <JI 0,. .-. c.Mocol• 10 P"""- ""lhol" ••J>Iodl wfithr~ aull>c>n..t.:>n by Nu!nlob BV 
Nuii\IOIJBV 
Bl.ll'g~llalll 12 P 0 6o~ 7 4283 LG G•essen Tl>f' Ne'tlellancls 
•I o-31 (0)183446305 f +Jl (0)163<!4:!597 
• e uu1nllll>®nutnlab nl w.u. nutnlnb nl 
• Trade ReQIII1erTIIbufQ 18114291 
• Banker RABObank LBAN Nll!4RA800101015410 S•VIFTII31C RABONL2U 
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1'11JI<;J 
rtg <;~ 
rtg,g 
rt.J •J 
rlQ 9 
m gig 
mglg 
lllg/9 
mo~ 
11111111 
mg/g 
1119151 
mg/g 
mg111 
mg/g 
m gig 
mwg 
mg~ 
153804 
Plasttc b3Q 
" 
PIIQII 1 /2 
0 ...... -=---
' '"'po<l""""'"""'"-"' I ,..,_.....,.., __,_ 
APPENDIX 19 
Ata.trls Specialities Holding B V 
Attn Mr R Slmons 
P 0 bOK 
4283 ZG GIESSEN 
De~~"P '"'' L0Uf~H60R0Ut-H CAPS 2 2 1~ 1¥~ If 
5ar1pl~ re(elvt'd 
f<t"p((1,]J .. 
Sanpled:lte 
04 12 2'10t> 
0012 2006 
::roe TeSI 
S1mp\t prepar1bon 
'" 
D11dzm (HPLC) 
672 Ma onyl-<Jatdm (HPLC) 
,,, Acetyl.-:li!tdZI>'l IHPLC) 
1>75 O<~odze•" ,.-!Pt.C) 
'" 
real 0d d_e., 
"" 
61ycrJ~ (HPLCI 
,., h\3""'!1-{lly'..J':I~ lt-o?LC, 
'" 
Arel)'l {11yronn •-IPLC1 
"" 
G~CdN'l ( -!PU') 
'" 
To.1l Glyr.le-"' 
'" 
Gem tin 1HPLC> 
"' 
IID<>"')'I<;e"""..l"' (HPLC) 
'" 
Aull'1~en 5~0 !!-'PLC I 
(\a~ "~"' 1~11 
670 To.,IG~n•ll.eon 
'"' 
To.>l ,...,naK>n~. "JI~<X>'..-.; 
~7 To~11o<.Ofla,~ 
F<or ~>vo ~•!.> •~., orrr~l'<>< on""'""""~ n>tr>o<~•p.o~•• <or'> 11'• <Jbcr>'>) "''''"'~~., 
ResJtt 
127 
01 
04 
02 
" 
"' 
" 005 
" 
" 
" 
" 005 
" 
" 
" 
" n 
"'-"> ,.~or•l:ll<>no'><~~f>C..,. ow't>n .. ,.,....,.oorot-.s O"t'>c.1• .. •""'- ""'"'~o'K«<~ 3'>:>' 
C41, rte<:><ott.c-rol IN. ~"'"'e «""""'"" oom>Ota~ ••t>o.J owi.nt"" ~"" o>~~Oo ,.,.,., W 'lu .. ..;t. Bt 
'lu "<ILSV 
1'1 G'lra~tt2 P( flru7 4:l8~zr,c.oc '" TheNelht.rld•<l• 
t ~tp1 t~>.,41f10'• 1•11(i.l1tf!14l?trl 
~ '""'ol.lt ,(!:nu~labnl WNW • ulrll~~ ~ 
Troo" Reqr; tr ljt~rg IBI 1~2'~1 
B.>1kl"f RllS::..t..,.r I BAN t.L.-.l'l;O.BC{IIa IC 1'-1 tC S' IFT BtC RIIBONL;: I 
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Certificate of analysiS 
~"' 
""' 01!:1 !J 
""' 
~" 
lfl<J'Q 
~" 
ffi)g 
""'' 
""' ~' 
""' 
""' lll(li<J 
111!;1 J 
"" mgo 
153805 
Pl~s tct,•[l 
No 
~ ""'~'""" ,,.~ 
... ,~ ........... ., '""""! 
, ....... 0.,. .... .,~,.,.,. 
APPENDIX20 
Df'scnp<on 
Acatrls Specialities Holding 8 V 
Alln Mr R Slmons 
PO box 
4283ZG GIESSEN 
S.:~rtJ~e rece•VPC 
Rep.:>" aate 
Sample date 
04 !.! 200G 
oe 12 2000 
Coo• Test 
S1mple pr~rll!IO'l 
'" 
Omdzm {HPLC} 
672 M.:llonyi.Oatdzln (HPLC) 
073 At!'tyl Cdt<JlJn (HPLC.) 
675 011ilZI!In (rlPlC) 
"" 
To 11 (n.,lzem 
G7G r!ycot•n {HPLCJ 
"' 
M1lonyl O'YCIM {HPLC-r 
"' 
Ac~!yl-gtvcrtEn ,1-lPLC) 
,,, Glycol,..., (~PLCJ 
5109 To ill Glycl etn 
"'' 
G<>t"~Jon (HPLC) 
"' 
Malcmyl~en•~t" (HPLCJ 
'" 
At~IVI-<JPiliSI r (HF'LC) 
685 6<.-wsJe.r 
"' 
Tct-.1 C,.,Hst;,ln 
'" 
Total•sofi.o....,no:::; "'g ~.-cor-es 
'" 
To"' "'"f' ovon~ 
F<>< n....-~ <i<ola ,.,;! •n'co"'~""".,.. ~!+' "'d me1w<l• «u•• o,.-L.o•t !I""'L:>l...-•LC 1 '"-"'>!l"' 
Re~ult 
"' 02 
" 07 
"' 24 7 
01 
OB 
" 
'" 
" 01 
" 02 
" 
" 
" 
A.••l one~"""""'" ol on.:>iylloll •~w~ ""'1\00<1~~ on u,., t••tlo<~t<'l-9• o" 1 ~ u,. ...,.,.,.,. ~ ~ttoe:lol>t.,, 
r.ml, ropmcuc1oon ot th<> ent•~ oon••.-•10 "~'"rm~l"d -.th<.o.U O<PIIt< "'"~"" au1M'"" ~n t>y Nutto ~h f!V 
Nul,llb CV 
BJ< < <r:>:o I~ P (.. &,~ 7 4Z5 ZG (•oe..o;en Th<o- N"'IM l.l~<l· 
•3! 0)1Kl44h20~ I ~~I{(! 1b3442&:07 
e uutnl<>b;.~lr"' 11 ot.o 1~ '"''~' ..,Uinl', rol 
1 ,.,,. R<'"<ll"'""' Tll~u<~ 1!'11 o42"1 
i:!<lr>K~r RAEI(~>.)n~ l~l\N NL&41'.A8(J{)t(J101~41C SW I~ T Ell• Rll.b )hl<U 
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Certificate of analysts 
nr(I><TnJ 153806 
No 
mg g 
myy 
fllll9 
mgg 
mgg 
"'" 
"'" mgo 
mr~q 
mgQ 
mog 
m'g 
nn 'J 
mg'g 
m'g 
m'g 
mog 
f>a<;~ .. I 12 
.......... '"' ,,. 
"A.,""', ......... 
'.,.,_.,.,,.,..,",..,...,e 
E 1oJ..-'"''""''' .... ..__,,.,,"-" 
APPENDIX21 
Telephone Interview and InformatiOn Scnpt 
***** Please note, if you feel the participants level of verbal English does not appear to be 
adequate for thiS study at any pmnt m thiS study please say:-
Thank you for your time, however due to the nature of the study and the cogmllve tests mvolved I 
am afraid your verbal Enghsh level IS not adequate for the study Thank you agam, goodbye 
IF THEY CALL YOU 
Thank you for calhng The study you are calhng about IS takmg place at Loughborough UmvefSlty m 
the Human Sciences Department I am gomg to give you some bnef details over the phone to gtve a 
general1dea and then ask a few questwns to make sure you are nght for the study ThiS w1ll take 
about 10 nunutes Is that okay and have you got lime now? 
(If response 1s no) That's fine When would be the best time to call you back? (arrange a 
convement time to call back and make a note of 1t m the d.ary) 
IF YOU CALL 
Good (mommg/afternoon) My name IS And I am nngmg about the mterest you showed m 
takmg part m a study we are runnmg here at Loughborough UmverSity Are you still mterested m 
heanng about 11? 
(•f response IS no) That IS not a problem Can I ask what changed your mmd'l (answer any 
questions, if Simply not mterested say) That IS fine If you change your nund, have any questiOns 
or know anyone who nught be mterested, you have my number and ema1l address Thank you for 
your ttme 
(If response 1f yes) Excellent This study mvolves lookmg at memory m women over 45 years old 
and whether memory IS affected by plant supplements called phytoestrogens Have you heard of 
them? Good Phytoestrogens are a natural plant hormone that are Slnular to estrogens It IS found m 
soy products, for example tofu, soya m1lk etc It IS perfectly natural and safe and IS m fact sold over 
the counter m a p1ll form and can also be found m soya nulk and many foods It has been suggested 
that the quantity of phytoestrogen you consume m Important m supportmg memory function Some 
beheve thiS quantity IS h1gh and some beheve 1t IS lower We would hke to mvestigate wh1ch of these 
opmwns IS hkely to be correct by seemg 1f a low or h1gh dose of phytoestrogen through a p1ll 
supplement IS better at supportmg memory The dose g1ven IS normally consumed through food on a 
da1ly basis m Astan counties To make sure our results at the end are accurate, you wtll either be 
takmg the phytoestrogen p1ll of low or h1gh level or a placebo which does not contam any active 
mgredtent and ts JUSt a sucrose or sugar pill Also, to be sure there IS no b1as, we wtll not and you 
w1ll not know wh1ch pill you are takmg We w1ll dlfect you on what days to take the supplement and 
are always available tf you need to ask any questions You will need to come m only two times over 
the whole penod When you do, the sessiOn will take about I hour and we Will have a chat to see 
how you are domg, g1ve you the p1lls for the second sesswn and then do the fun part, which IS the 
cogmt1ve tests Although we w1ll take a sahva sample when you come m, you w!ll also need to take 
one yourself the day before you come to se us so that we can measure the level of phytoe<trogen m 
your body Takmg part m thiS study w1ll help the scientific commumty a great deal m findmg a 
potential way of supportmg memory functiOn as we age Arc you mterested m takmg part? 
(If response 1f yes) That's great I w1ll g•ve you lots more mformatwn when I see you But to check 
whether you fit mto the group of people that are takmg part, I need to ask you a few questiOns Some 
of these w1ll be about you mediCally Please be assured the mformatwn you g1ve me IS stnctly 
confidentl31 and w1ll not be shared w1th third parties, whether you take part m the study or not You 
need to be aware that you can also withdraw yourself or your data from the study at any pomt 
without havmg to gtve a reason and wtthout consequences Is that okay? 
(If response If no try to reassure them. If to no avail say) That IS fine If you change your nund, 
have any questions or know anyone who nnght be mterested, you have my number and emat1 
address? Thank you for your lime 
(If response if yes) Thank you (go through the health screen below) 
*************NOTE: If a 'Yes' response they do not qualify. However pay attentiOn to 
astensked notes and then say) Thank you for answenng these questwns I am afraid that because 
414 
of some of your answers, you do not quahfy for takmg part m the study But many thanks for you 
call today 
GENERAL INFORMATION 
I Name 
2 Phone number 
3 Ema1l address 
4 Date ofB1rth 
5 Age 
6 Educatton Level 
7 Ethmc1ty 
8 Is Enghsh first language? Y I N 
I At present, do you have any health problem for whtch you are 
(a) on med1catton, prescnbed or otherwise (mcludmg ant1b10t1cs) 
** 1f used anttbwttcs m LAST 6 MONTHS, not quahfy 
(b) Consultmg your GP, on hosp1tal wa1tmg hstloutpal!ent dept (reason) 
**If senously 1ll do not m elude (consult someone 1f unsure) 
2 In the past two years, have you had any Illness wh1ch requtre you to 
(d) consult your GPiattend a hosp1tal outpatient dept/be adm1tted 
hosp1tal (reason) 
•• if seriously 1ll do not include (consult someone 1f unsure) 
3 Have you ever had any of the followmg 
(a) Hormone medication (corticostermds, thyroid hormone etc) 
(b) ThrombosiS or other blood ( clottmg) d1sorder 
(c) Convuls1onslep1lepsy 
(d) Head tnjuryl Neurological problems 
(e) Allerg1c to soya 
(f) Psych1atnc problems (depresston, psychosiS) 
(g) Dementia (e g Alzhe1mer's d1sease) 
(h) Cancer or bemgn growths (polyps etc ) 
(1) VISion! ear I heanng problems •• okay If corrected 
to 
(J) Thyrmd problems or other endocnne d1smders (Cushmg's, Addmson's 
disease etc 
(k) Other (e g dyslex1a) 
(I) Breast, Ovanan, or Endometrial cancer 
4 Additional Questwns 
(e) Have you used hormonal contraceptive w1thm the last 3 months (e g the 
p11l, tnjectton, 1mplant)? State wh1ch type 
(J) Have you takmg any HRT m the last 3 months? 
(k) Could you be pregnant or plannmg pregnancy? 
(I) Are you lactatmg 
(I) Do you have (had) any gynaecological problems (PMS, endometriOSIS, 
polyps, mahgnant growth/tumors of breast/ovary, problems conceiVIng) 
(crrcle) 
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Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
5 Would you be able to stop eatmg soy contammg foods (e g tofu, tempe, soy products) for the 
penod of the study" YES I NO 
(After the health screen If qualifies, say) Thank you for answenng these que•Uons We would hke 
you to be a part of thts study Can we book m a convement tlme for our first meetmg? (book m a 
time m the diary If possible). Tell them about the saliva sample before they come m and orgamse to 
post I drop off I pick up mformat10n If necessary 
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APPENDIX22 
InformatiOn Letter for Volunteers 
The Relationship between low and high dose phytoestrogen supplementation 
and cognition in women aged 45 - 95 years of age. 
Background 
Some natural substances found m plants are called plant hormones or 'phytoestrogens' (also 
called 1soflavones) These have been hypothes1sed to support cogmt1ve functions, such as 
memory, wh1ch IS what we want to test m th1s study Ammal and cell stud1es suggest that 
oestrogens could mamtam healthy bram functwn However, oestrogens have not always 
been shown to have a pos1t1ve effect on cogmtlve functwn 
A recent, large chmcal tr1al actually reported that contmuous h1gh dose dmly oestrogen 
therapy could mcrease nsk of chrome d1sease such as stroke, dementm, Alzhe1mer's d1sease 
and breast cancer for women Other researchers reported that pos1llve effects of h1gh dose 
oestrogen therapy on cogmtlve functwn wh1lst others have not 
Therefore, some have turned to natural altematlves m the form of PHYTOESTROGENS 
Phytoestrogens are found m plants and are a plant hormone wh!Ch m1m1cs oestrogen hke 
act1v1ty m the bram Phytoestrogens can be found m soya products hke tofu, m1so and 
tempe and some vegetables and grams and are mostly consumed through d1et 
It has been suggested that the level of phytoestrogen consumed may be 1mportant L1ke 
oestrogen stud1es, some phytoestrogen tnals have found that a h1gh level of mtake can 
support memory functwn and others have reported that the same IS poss1ble form a low 
level of m take 
We would hke to mvesllgate 1f takmg a h1gh or low dose phytoestrogen supplement (a 
natural altematlve) on a one-off occaswn can support memory m humans Our m1t1al 
stud1es have shown that phytoestrogen supplements taken for 1 day can support memory m 
young people, so we now want to test th1s m older adults for the same penod oftlme 
Phytoestrogens at the dosage that we ask people to use are very safe, and they are the same 
amount as Asmn people eat m the1r da1ly d1et Asmn people have a lower nsk of cancer and 
heart d1sease than m the West Some researchers beheve that th1s may be related to 
consummg phytoestrogens 
Health Status Questionnaire and exclusion criteria 
In the first meetmg we w1ll ask you a few s1mple quesl!ons to determme 1fyou can take part 
m the study as well as g1vmg us some 1mportant mformatwn You w1ll be asked questwns 
about your age, educatwn, general health and med1catwn use, and menopausal status You 
w1ll also be asked about your d1et and specifically about your mtake of soya contammg 
products such as Soya beans, Soya m1lk, Soya m1lk desserts, yogurts and 1ce-cream, Tofu 
and tofu-contammg foods, Soya protem and Soya protem ISolate, M1so and Tempeh and the 
mtake of vegetables and grams For the duratwn of the study, you w1ll be asked to abstam 
from these For th1s reason you w1ll be g1ven a questwnna1re about the food that you eat and 
your actiVIties Your he1ght and we1ght w11l also be measured m order to calculate your 
body mass mdex (BM!) wh1ch may affect the levels of natural oestrogens m your body 
People who cannot part1c1pate m th1s study 
You cannot partiCipate m th1s study 1fany of the followmg apply to you· 
• Use of supplementary hormones (mcludmg hormonal contraceptwn w1thm the last 
3 months) 
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• Use of antlbwttcs m prevwus stx months 
• Prevwus htstory of thrombosts 
• Bemgn or maltgnant groV>1hs 
• Htstory of breast, ovanan or endometnal cancer 
• Psychtatnc dtsorder (for example clmtcal depresswn) 
• Pregnant or breast feedmg women 
• Dementta (e g Alzhetmer's dtsease) 
• Eptlepsy 
• If you pre-menopausal 
ALL data provtded wtll be kept stnctly confidenttal and wtll not be used for any other 
purpose apart from to detenmne ehgtbthty for the study as well as for use m the group 
analysts 
Experimental Condition 
You wtll etther be m the group who wtll take 30mg phytoestrogen (spltt mto two ptlls of 
15mg each) or m the group who wtll take lOOmg phytoestrogen (spht mto two ptlls of 
50mg each) Thts ts wtthm the range of normal consumptwn m Astan food consumptiOn 
Most studtes done to date have tested twtce thts amount for penods longer than a year 
None of these studtes (wtth a total of 444 parttctpants) found any adverse effects on 
mctdence of breast cancer, adverse symptoms etc Thts means that the nsk of stde-effects ts 
very low 
It may also be posstble that you are chosen by the computer to be m the placebo group The 
placebo group wtll have a ptll of the same stze, colour, texture and smell but tt wtll be not 
contam any acttve mgredtent, tt wtll only contam sucrose The study wtll be double-blmd, 
whtch means that netther you nor the researchers wtll know whtch dose of the 
phytoestrogen ptll you are takmg or tf you are takmg the placebo unttl the results of the 
study are revealed 
Sahva Sample 
You wtll be asked to take a small saltva sample on the day before you come to see us 
(sa!tva tube wtll be provtded) and gtve another one on each occaswn that you come to vlSlt 
us Thts allows us to measure the actual levels of natural oestrogens and phytoestrogen m 
your body For the saltva sample you wtll be asked to nnse your mouth wtth clear water 
The sample wtll not be used for any other purpose, tt ts non-mvastve and wtll not cause you 
any dtscomfort No nsks are mvolved m thts study as the researchers are tramed to take the 
sahva samples safely and hygtemcally 
Cognitive Testing 
You wtll be tested on several cognt!tve functwns whtch measure verbal memory and 
fluency, concentratton, mformalton proce>Smg and mental rotatwn The tests are stmple, 
relattvely qmck to do and hopefully enJoyable They are not tests of IQ and you wtll not be 
judged on your score, so you do not need to worry about the score you achteve These tests 
have been shown m prevtous studtes to be very senstttve to the effects ofphytoestrogens 
Procedure 
You wtll be requtred to attend the Umverstly on only two separate occastons 
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SESSION I 
INSTRUCTIONS FOR SESSION 1 
• DO NOT dnnk alcohol the day before 
• DO NOT eat breakfast they day of the sess1on 
You come m to the test centre at the allocated !Jme Please try to be punctual as we have 
mulllple appomtments m one mommg 
The followmg procedure w1ll occur and should take no more than I hour -
We w11l go through the deta1ls of the study w1th you 
If you w1sh to take part, you w11l then need to s1gn the mformed consent 
form 
You w11l complete the health ques!Jonna1re and 1f no problems anse from 
that you are officwlly a part of the study 
You w!ll then be g1ven a breakfast of toast (Jam opt10nal), tea, coffee or 
orange JU!Ce 
We w1ll then go through the cogn1t1ve tests w1th you 
An appomtment w!ll be made for the next test sesswn 6 WEEKS later and 
you w!ll be g1ven all the thmgs you need 
In the s1x weeks followmg, YOU SHOULD NOT EAT ANY OF THE FOLLOWING 
FOODS DURING THE WHOLE STUDY PERJOD -
• No soy products (beans, flour, m1lk, cheese, as hot dogs or other meat altemat1ves), 
tempe, tofu (bean curd), Shoyu, Fermented soy bean products (e g paste, m1so) 
• No Ch!Ck peas, Black-eyed peas, pmto beans, Black beans, K1dney beans, 
Fenugreek seed, Lent!ls, Alfalfa sprouts 
• No Chmese take-away 
• Also avmd Broccoh, Pumpkm and Bernes Go easy on the nuts 
• If you eat bread, eat no Rye bread, Oat bran, or Rye meal (anythmg contammg flax 
seed) 
• Alcohol should not be consumed the mght pnor to the occas10ns you corn m to see 
us for the cogn1!Jve testmg 
If you thmk that you would have trouble keepmg to tl11S reg1men (memory problems, too 
busy etc ), please d1scuss th1s w1th the expenmenter 
SESSSION2 
The procedure that follows when you come m w11l be the same as the first !Jme you came 
m 
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INSTRUCTIONS FOR SESSION 2 
• THE DAY BEFORE YOU COME IN take deposit a saliva sample mto the tube 
and put 1t in the fndge as soon as you wake up (before you take the supplement) 
• The DAY BEFORE YOU COME IN take one pill as soon as you wake up (after 
you have done the saliva sample 
• THE DAY BEFORE YOU COME IN take the second pill JUSt before gomg to bed 
• DO NOT dnnk alcohol 
• DO NOT eat the soya based food (see I 1st) 
• THE DAY YOU COME IN do not eat breakfast, It will be provided 
Risks, discomfort and your rights 
Takmg the phytoestrogen supplement w1ll have no negat1ve effects on you You Will 
expcncnce no d1scomfort and are not put at any nsk at any lime However, the mvest1gatory 
pill may mterfere With any medicatiOn you are currently takmg so we advise you consult 
your doctor to check 1t does not adversely mterfere w1th medicatiOn before consentmg to 
part1c1pate m th1s study 
Although mforrnatwn gathered from this study may be collectively published or presented 
at conferences, all data are stnctly confidentJal, the study IS anonymous and your name IS 
never revealed to anybody at any lime You w1ll be giVen an ID number wh1ch all data 
documents will have and all health mforrnatwn will be kept separate and locked up Only 
authon;ed research personal will have access to these records You can stop par!Jc1patmg m 
the study whenever you hke and you can ask for your mforrnatwn to be Withdrawn from the 
study Without havmg to g1ve a reason, at any pomt Without any consequences 
Although you may not receive any monetary payment for takmg part m this study, you will 
receive all supplements for free as well as gettmg free memory assessment In addil!on, you 
takmg part m th1s study Will give mvaluable mforrnatwn for science and the public m terms 
ofpotent1al supportmg effects ofphytoestrogens on memory 
Please feel free to ask the research a~~"tant any questions that you may have about this 
study. 
Or you can contact the number below M on- Fn (9 am- 5 pm) -
Amma Yesufu Tel - 01509 223048 or on 07737720962 or ema11 A Yesufu@lboro ac uk 
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APPENDIX23 
Informed Consent 
The effect of phytoestrogen supplementation on cogmt1on 
Please read the following statements and t1ck the box to md1cate you have READ and UNDERSTOOD each 
pomt 
The purpose and deta1ls of th1s study have been explained to me I understand that th1s study IS des1gned to 
further scJent1fic knowledge and that all procedures have been approved by the Loughborough Un1versJty 
Advisory Comm1ttee o 
I have read and understood the 1nformat1on sheet and th1s consent form o 
I understand the nsks and benefits of the study o 
I have not been unduly mftuenced by any researcher to partiCipate 1n the study by any statement or Implied 
statement o 
I have had an opportumty to ask quest1ons about my parliclpatJon o 
I understand that I am under no obligation to take part m the study o 
I understand that I have the nght to withdraw from th1s study at any stage for any reason, and that I Will not be 
reqUired to explain my reasons for Withdrawing o 
I understand that all the Information I prov1de w1ll be treated m stnct confidence o 
I am happy to prov1de a saliva sample at sa1d po1nts 1n the study for test1ng of plant hormones and oestrogen 
levels o 
I agree to partiCipate m th1s study o 
By s1gnmg th1s consent form I have not wa1ved any of the legal nghts that I have as a partiCipant 1n a research 
study o 
Your name 
Your s1gnature 
S1gnature of mvest1gator 
Date 
Contact Deta1ls 
Address 
Tel No Home, _________ Mob. ______ _ 
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APPENDIX 24 
Health Screen For Study Volunteers 
1. Dem<>graph1cs 
(a) Town 
(b) Date ofb1rth Day 
(c) Age years 
Parllc1pant Name 
Refused mterv1ew 0 
County 
Month 
Number 
Year 
(d) Educabon (circle) pnmary I secondary I umvefSlty degree 
(e) Profess10n (Circle) Grade A (h1gher- manager, admm or profess10nal) 
B (mtermedmte- manager, admm or professiOnal) 
Cl (supervtsory or clencal, JUiliOr manager, admm or 
professwnal) 
C2 (skilled manual) 
D (senu and unskilled manual) 
E (state pensiOner, no other earner, causal or lowest grade 
(f) Ethme1ty 
(g) Rehgwn 
workers) 
Father Mother 
(h) Number of chlldren (mcludmg the ones that may have d1ed) 
(I) Ch1ldren still hvmg lJ Children close-by (able to VISit) 
(k) Are you hvmg (cucle) alone with clnldren w1th relatives mst1tutwn 
other 
(I) Your home ( cucle) own rent other 
2. Medical History 
Wetght measurement st Ibs Hetght measurement ft 
At present, do you have any health problem for whiCh you are 
(a) on medicatiOn, prescnbed or otherwiSe (hst) 
(b) Attendmg your general practitiOner (reason) 
(c) on a hospital wa1tmg hst (reason) 
In the past two years, have you had any Illness which reqmre you to 
(d) consult your GP (reason) 
(e) attend a hospital outpabent deparbuent (reason) 
(f) be adnutted to hospital (reason) 
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mches 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Participant 
No 
No 
No 
No 
No 
No 
Have you ever had any of the followmg 
(g) Hormone medicatiOn ( corticostermds, thyrmd hormone etc ) Yes No 
(h) Asthma or other lung disease Yes No 
(1) Thrombosis or other blood ( clottmg) disorder Yes No 
(J) Diabetes Yes No 
(k) Digestive, gastromtestmal problems Yes No 
(I) Heart Problems Yes No 
(m) Convulsions/epilepsy Yes No 
(n) Head InJury/ Neurological problems Yes No 
(o) Intolerance, hypersensttivtty to, or dtsllke of foods contammg soya Yes No 
(p) PsycluatriC problems (depressiOn, psychosis) Yes No 
(q) Dementia (e g Alzheimer's disease) 
(r) Cancer or bemgn growths (polyps etc ) Yes No 
(s) VIsiOn! ear I heanng problems Yes No 
(t) Thyrmd problems or other endocrme disorders (Cushmg's, Addmson's Yes No 
dtsease etc 
(u) Kidney or hver problems Yes No 
(v) Other (e g dyslexia) Yes No 
(w) Allergies (state) Yes No 
(x) Breast, Ovanan, or Endometnal cancer Yes No 
3. Fam1lv HIStorv 
Has any member of your family had any of the above diseases, please state "h1ch diSease and age at 
onset 
Whom 
(a) Father 
(b) Mother 
(c) S1blmg 
4. Health Related Behaviour 
(a) Do you smoke? (cucle) Yes No 
(b) If yes, how many a day 
Cigarettes 40ormore 20-39 10-19 1-9 
Cigars or p1pes only 5 or more or mhaled Less than 5 or non-mhaled 
(c) Do you exercise regularly? (mcle) Yes No 
(d) How many days per week do you spend at least 20 mmutes m moderate to strenuous exerCISe? 
0 2 3 4 5 6 7 days per week 
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(e) Can you walk 4 rrules bnskly without fatigue (cucle) Yes No 
(f) Umts of alcohol consumed per week 
(I~ glass beer, J~ glass wme, 1~ umt ofspmt) 
(g) Number of cups tea/coffee per week 
5 Add 1hona _g_ues wns 
(a) Do you still have your monthlypenod? 
If'yes' answer (b-f + k-1) If 'no' answer (g-1) 
(b) If yes, are yourpenods nonnallregular? 
(c) When was your last menses? 
(d) How long !S your cycle on average? 
(e) Have you used hormonal contraceptive withm the last 3 months (e g the pill, 
mJectwn, Implant)? State which type 
(f) Is It oestrogen, combmatwn or progestagen based? (mcle) 
(g) Are you postmenopausal? 
(h) If yes, what year did your menses stop? 
(I) Are you 'naturally' or 'surgiCally' menopausal? 
(J) Have you takmg an HRT m the last 3 months? If yes, 
name 
(k) Could you be pregnant or planmng pregnancy? 
(I) Are you lactatmg 
(I) Do you have (had) any gynaecological problems (PMS, endometriOsis, 
polyps, mahgnant growthltumors of breast/ovary, problems concelV!ng) (mcle) 
6. Food Questions 
Do you eat? 
(a) White nee 
(b) Brown nee 
(c) FrUit 
(d) Orange/red veg 
(e) Green veg 
(f) Fish 
(g) Tofu 
(tofu products) 
(h) Tempe 
(g) Tahoe 
Times per day Days per week 
(0-4) (1-7) 
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Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Days per month 
(1-31) 
(1) Soy rmlk 
(soy products) 
(J) Tumenc 
(k) M1so soup 
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APPENDIX25 
Category Verbal Fluency Test 
Read out the followmg standardized Jnstruct1ons to the partiCipant 
"For th1s next question I am go1ng to g1ve you a category and I want you to say, as fast as 
you can, names of thmgs that belong m that category You Will have 1 m1nute 
For example, 1f I say the category IS clothes, you could say th1ngs l1ke, 'shirt, sweater, belt, 
and so on' Ready? The category IS ANIMALS Tell me all the an1mal names you can thmk 
of 1n 1 m1nute Any kmd of am mal Will do Start now" 
Start t1mmg for 1 minute and wnte down the answers m the columns below. 
REMEMBER keep watchmg the clock so you can put words mto the nght column 
accordmg to the lime categones below. Answers m the f1rst 15 seconds go m column 
1, 16-30 seconds m column 2 etc 
One prompt 1s perm1tted (e g, "Keep gomg; what other ammal names can you think 
of?'). 
[You can repeat the category 1f requested 1 
[If d1rectly asked, you should conf1rm that birds, f1sh, msects, etc are cons1dered to be 
an1mals 1 
Category nammg: ANIMALS 
0-15 seconds 16-30 seconds 31-45 seconds 46-60 seconds 
I 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
0 Check lw e if pm t!Cipant 1 efwed to attempt the ta'k 
Subtotals, Animals to be score later b research ass1stant) 
0-15 sec 16-30 sec 31-45 sec 46-60 sec No. 
Incorrect 
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APPENDIX26 
East Boston Memory Test 
"Now I WILL READ YOU A VERY SHORT STORY When I am done, please repeat as 
much of the story as you can remember Be sure to g1ve as many spec1f1c detailS as you 
can" 
Read slowly and enunciate clearly The t1me to read the story should be approximately 15 
seconds You cannot repeat the story, 
Three children were alone at home, and the house caught on f1re. A 
brave fireman managed to climb in a back window and carry them 
to safety. Aside from minor cuts and bruises, all were well. 
"Now repeat as much as you can of the story • 
**Delayed Recall -"You heard a story ear her, can you please repeat as much as the story as you 
can remember " 
ESSENTIAL IDEA 
SCORE 
DR 
three [NOT few, several] 
0 Correct 
children kid(s) I youngster(s) I boy (s) I girl(s) /young people 
0 Correct 
[NOT farruly, people] 
alone by themselves I parents gone I unsupervised 
0 Correct 
house home I reSidence I apartment 
0 Correct 
[NOT bmldmg or any nomeSidential structure] 
on fire bummg I m blazes 
0 Correct 
brave heroic I gallant I danng I dashmg 
0 Correct 
fireman firemen I firefighter(s) I fire department 
0 Correct 
[NOT pohce I rescuers] 
chmbed m came m I entered I went m I broke m 
0 Correct 
back rear 
0 Correct 
[NOT side, f10nt, open, outSide J 
wmdow shutters I Sill 
0 Correct 
[NOT entrance, door, openmg] 
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IR 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
~ earned I took I brought I conveyed I transported 
0 
0 Correct 
[NOT led, rescued, saved] 
chtldren ktd(s) I youngster(s) I boy(s) I gtrl(s) I young people I 
0 
0 Correct 
"they" or "them" 1f clear reference ts to chtldren 
[NOT fanuly, people] 
to safetx to where tt ts safe I out of the house I out I out of danger I 
0 
0 Correct 
[saved (them) or rescued (thcm)ts credtted here but 
No credtt IS gtven for carrxl 
mm or small I a few I several I [InJUred] a !tttle I 
0 
0 Correct 
scrapes I scratches I brut~es I cuts 
mmnes lacerations I scrapes I scratches I brmses I cuts I contusiOns 
0 
0 Correct 
everyone all I everybody 
0 
0 Correct 
well OK I all nght I hved happtly ever after I fine 
0 
0 Correct 
[NOT safe, saved, rescued, not hurt, unharmed} 
__ I 17 tdeas (JR- Jmmedtate Recall) __ I I 7 tdeas (DR- Delayed Recall) D Refused 
to attempt story recall 
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APPENDIX27 
Symbol Digit Modalities Test Instructions 
See { { 1260 Smtlh, A 1982, } } 
• Say, "look atthe;e bmes" 
• Pomt at the key at the top of the page "Nollce that each bm has a ;ymbolmthe uppe1 part ofzt and 
a numbe1 below Now look down he1 e" 
• Pomt to the test "Notzce that the boxes on the top have symboh, but the bo>e' on the bollom me 
empty " 
• "!want you to fill m the numbe1 that goes wzth each mm k F01 e:wmple, look at the ji1M symbol then 
look at the key "Pomt "The numbe1 I goes wzth the first ;ymbol So you would Wiz le Ill the number I 
for theji1st box" Pomt out the next 2 answers "As t/us numbe1 goes wzth th" ;ymbol, and tlm 
numbe1 goes wzth thzs ma1 k Please fill m the 1 est of the nwnbe1 s untzl he1 e for p1 actzce " 
"Good, you know how to do them I have jOme m01 e of these 1 want you to do When I tell you to 
begm, W1lte down the numbe1 s JUSt llke you have been domg untzl 1 say stop Do not ~krp any boxes 
and go as quzckly m you can Ready? Begm " 
• Start timer at "begm". allow 90 .;;econds. and then say "stop "Record partlcmant responses 
• *Do not re-mstruct further after you begm, 1fpressed say '';mt do the best you can " 
Scormg: 
• On the test form check for accuracy of each response Note all errors Record on the form the number 
of test 1tems attempted rrunus the number of 1tems mcorrect (Later a total score w11l be calculated 
equal to the number of 1terns attempted rrunus any errors 
• *Do not perform calculations m front of the parttc1pant. 
Number of Items attempted m 90 seconds __ 
Number of mcorrect 1tems dunng 90 seconds __ 
(Do not mclude Items not attempted) 
o Check here lfpartictpant refused to attempt or complete the symbol-d1g1t task 
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APPENDIX28 
Moo's Distress Questionnaire 
Today's Date . . ... 
Dally Health D1ary 
Please read the hst of feelings and behav1ours Please f1tl 1n the blank next to the number 
that best descnbes how you feel today F1ll 1n 0 1f not present 
0 1 
Not present M1mmal 
Abdormnal pam Dtscomfort* 
2 Anger* 
3 Anxiety* 
4 Awakemng durmg the mght* 
5 Backache* 
6 Bloatmg or swellmg of the abdomen* 
7 Blurred or fuzzy vtswn 
8 Burst of energy or actlVlty 
9 Confuswn 
I 0 Cramps-utenne or pelvic 
11 Cravmg for specific food or tastes* 
12 Cravmg for alcohol 
13 Decreased appetite 
14 Decreased sexual desue* 
16 Depiesswn (feel sad or blue)* 
17 Destre to be alone* 
18 Diarrhoea 
19 Difficulty concentratmg 
20 Difficulty gettmg to sleep 
21 Difficulty makmg declSlons* 
22 Dizzmess or hght headedness 
23 Early mommg awakemng* 
24 Fatlgue 
25 Feelmgs of gmlt* 
26 Feelmgs ofwell-bemg 
27 Forgetfulness 
28 General aches and pams 
29 Headache* 
30 Hostihty* 
2 
M1ld 
430 
3 
Moderate 
31 Hot flushes or sweats 
32 Impattent, mtolerant* 
33 Impulsiveness 
34 In control 
35 Increased actlvity 
36 Increased appetite 
3 7 Increased food mtake 
4 
Extreme 
38 Increased sensitlVlty to cold* __ 
39 Increased sexual destre 
40 Increased sleepmg 
41 Intentwnal self·mjury 
42 Imtable* 
43 Lonely* 
44 Lowered coordmahon I clumsmes __ 
45 Lowered desue to talk or move* 
46 Nausea 
4 7 Nervousness 
48 Out of control* 
49 Pamful or tender breast* 
50 Rapid mood changes* 
51 Restlessness or Jittenness 
52 SensatiOn of wetght gam* 
53 Skm disorder* 
54 Smcidalideas or thought 
55 Swelling of hand and feet* __ 
56 Tearfulness, crymg easily* __ 
57 Tenswn* 
58 Somethmg else" ______ _ 
APPENDIX29 
Daily Diary (COPE) Today's Date ...... .. . .... 
Please 1nd1cate how you have felt today Even 1f none of the boxes represent exactly how 
you have felt, please mark the box that 1s most s1m1lar to your expenence 
not at all Slightly moderately severely 
[0] [1] [2] [3] 
1) Fat1gue 0 0 0 0 
2) lmtab1illy 0 0 0 0 
3) Bloating 0 0 0 0 
4) Anx1ety/tens1on 0 0 0 0 
5) Breast tenderness 0 0 0 0 
6) Mood lab1ilty 0 0 0 0 
7) Depress1on 0 0 0 0 
8) Food crav1ngs 0 0 0 0 
9) Acne 0 0 0 0 
1 0) Increased appet1te 0 0 0 0 
11) Over-sens1t1v1ty 0 0 0 0 
12) Swelling 0 0 0 0 
13) Expressed anger 0 0 0 0 
14) Cry1ng eas1ly 0 0 0 0 
15) lsolallon 0 0 0 0 
16) Headache 0 0 0 0 
17) Forgetfulness 0 0 0 0 
18) Gastromtest1nal 0 0 0 D 
symptoms 
19) Poor concentration o 0 0 0 
20) Hot flushes 0 0 D 0 
21) Heart palp1tat1ons 0 0 0 0 
22) DIZZineSS 0 0 0 0 
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APPENDIX 30- SPSS Output for Pilot RCT ANOV A analyses 
assessing the effect ofisoflavone dose on cognitive function 
Tests of Between-Subjects Effects 
Dependent V anable Chanqe from base· HVL T -lR 
Type Ill Sum 
Source of Squares df Mean Square F S1g 
Corrected Model 11 545 4 2 886 1 587 252 
Intercept 391 1 391 215 653 
AGE 1 524 1 1 524 838 381 
BMI 1 391 1 1 391 765 402 
DOSE 11 466 2 5 733 3 152 087 
Error 18 189 10 1 819 
Total 65 000 15 
Corrected T a tal 29 733 14 
a Computed us1ng alpha= 05 
b R Squared= 388 (AdJUSted R Squared= 144) 
Esttmates 
Dependent Vanable Chanqe from base- HVL T-IR 
95% Conftdence Interval 
Dose Mean Std Error Lower Bound Ugper Bound 
Placebo 2 730' 591 1 412 
15mg lsoflavone 206' 864 -1 720 
50mg lsoflavone 1 398' 869 -538 
a Covanates appeanng tn the model are evaluated at the fo!lowmg 
values Age of Parttctpant = 55 47, Body Mass Index ;:: 25 753 
Pa1rw1se Compansons 
Dependent Vanable Change from base- HVLT-IR 
Mean 
Difference 
(I) Dose (J) Dose (1-J) Std Error 
Placebo 15mg lsoflavone 2 524 1 146 
50mg lsoflavone 1 332 988 
15mg lsoflavone Placebo 
-2 524 1 146 
50mg lsoflavone -1 191 1 462 
50mg lsoflavone Placebo -1 332 988 
15mg lsoflavone 1 191 1 462 
Based on est1mated marg1nal means 
a Adjustment for multiple compansons Bonferron1 
Umvanate Tests 
Dependent Vanable Chanqe from base- HVLT-lR 
Sum of 
4 048 
2 132 
3 333 
S1~' 
157 
622 
157 
1 000 
622 
1 000 
SQuares df Mean Square F S1q 
Contrast 11 466 2 5 733 3152 087 
Error 18189 10 1 819 
Partial Eta Noncent Observed 
Squared Parameter Powefl 
388 6 347 327 
021 215 071 
077 838 132 
071 765 125 
387 6 304 474 
95% Confidence Interval for 
D1fferencea 
Lower Bound Upper Bound 
-764 5 811 
-1 503 4167 
-5 811 764 
-5 387 3004 
-4167 1 503 
-3 004 5387 
Partial Eta Non cent Observed 
Souared Parameter Powera 
387 6 304 474 
The F tests the effect of Dose Th1s test 1s based on the linearly m dependent pauw1se compansons among the est1mated 
margmal means 
a Computed us1ng alpha = 05 
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Tests of Between-Subjects Effects 
Dependent Vanable Chanaebase HVLT-DR 
Type Ill Sum 
Source of Squares df Mean Square F S'g 
Corrected Model 13 331' 4 3 333 1 748 216 
Intercept 008 1 008 004 950 
AGE 128 1 128 067 801 
BMI 2 448 1 2 448 1 284 284 
DOSE 5 734 2 2 867 1 504 269 
Error 19 069 10 1 907 
Total 42 000 15 
Corrected T a tal 32400 14 
a Computed using alpha- 05 
b R Squared= 411 (Adjusted R Squared= 176) 
Esttmates 
Dependent Vanable Change base HVLT-DR 
95% Conftdence Interval 
Dose Mean Std Error Lower Bound Upper Bound 
Placebo 1 627a 606 278 2 977 
15mg lsoflavone 222a 885 -1 750 2 194 
50mg lsoflavone 281• 890 -1 701 2 263 
a Covanates appeanng tn the model are evaluated at the followtng 
values Age of Parttctpant =55 47, Body Mass Index= 25 753 
Patrwtse Compansons 
Dependent Vanable Change base HVL T-OR 
Partta! Eta Noncent Observed 
Squared Parameter Powet 
411 6 991 358 
000 004 050 
007 067 056 
114 1 284 177 
231 3007 248 
Mean 95% Confidence Interval for 
Dtfference Otfferencea 
(I) Dose (J) Dose (1-J) Std Error s,g a Lower Bound Upper Bound 
Placebo 15mg lsof1avone 1 405 1173 776 -1 961 4 771 
50mg lsoflavone 1 346 1 011 638 -1 557 4 249 
15mg lsoflavone Placebo -1 405 1 173 776 -4 771 1 961 
50mg lsoflavone 
-059 1 497 1 000 -4 355 4 237 
50mg lsoflavone Placebo -1 346 1 011 638 -4 249 1 557 
15mg lsoflavone 059 1 497 1 000 -4 237 4 355 
Based on esttmated margtnal means 
a Adjustment for multiple compansons Bonferrom 
Untvanate Tests 
D d V bl Ch epen ent ana e ange base HV T D L - R 
Sum of Partial Eta Noncent Observed 
Squares df Mean Square F s,o Squared Parameter Powera 
Contrast 5 734 2 2 867 1 504 269 231 3 007 248 
Error 19 069 10 1 907 
The F tests the effect of Dose Thts test 1s based on the lmearly mdependent pa1rw1se compansons among the esttmated 
margtnal means 
a Computed usmg alpha = 05 
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Tests of Between·Subjects Effects 
Dependent Vanable ChanQe base EBMT·IR 
Type Ill Sum Part1al Eta 
Source of Squares df Mean Square F S1g Squared 
Corrected Model 13 992' 4 3498 1 473 281 371 
Intercept 7 603 1 7603 3203 104 243 
AGE 6 849 1 6 849 2 885 120 224 
BMI 1 972 1 1 972 831 383 077 
DOSE 1 983 2 992 418 670 077 
Error 23 741 10 2 374 
Total 73 000 15 
Corrected Total 37 733 14 
a Computed us1ng alpha- 05 
b R Squared= 371 (AdJUSted R Squared= 119) 
Estimates 
De pen d ent Vanable c hange base E T BM -IR 
95% Confidence Interval 
Dose Mean Std Error Lower Bound Upper Bound 
Placebo 1 804' 676 299 
15mg lsoflavone 1 814' 987 - 386 
50mg lsoflavone 776' 993 -1 436 
a Covanates appeanng 1n the model are evaluated at the followmg 
values Age of PartiCipant= 55 47, Body Mass Index= 25 753 
Palrwtse Compansons 
D~endent Vanable ChaQge base EBMT -IR 
3 310 
4 014 
2 988 
Noncent Observed 
Parameter Powe( 
5 893 305 
3 203 367 
2 885 336 
831 131 
835 100 
Mean 95% Confidence Interval for 
Otfference Otfferencea 
1 (I)Dose (J) Dose (1-J) Std Error S1g' Lower Bound Upper Bound 
Placebo 15mg lsoflavone 
-009 1 309 1 000 -3 766 3 747 
50mg lsoflavone 1 029 1 128 1 000 -2 210 4 267 
15mg lsoflavone Placebo 009 1 309 1 000 -3 747 3 766 
50mg lsoflavone 1 038 1 670 1 000 -3 756 5 832 
50mg lsoflavone Placebo 
-1 029 1128 1 000 -4 267 2 210 
15mg lsoflavone 
-1 038 1 670 1 000 -5 832 3 756 
Based on estimated margtnal means 
a AdJustment for multiple compansons Bonferrom 
Umvanate Tests 
D d V bl Ch epen ent ana e ange base E B MT-IR 
Sum of Part1al Eta Non cent Observed 
Squares df Mean Square F S1o Squared Parameter Powera 
Contrast 1 983 2 992 418 670 077 835 100 
Error 23 741 10 2 374 
The F tests the effect of Dose Th1s test ts based on the linearly mdependent pa1rw1se compansons among the est1mated 
margmal means 
a Computed usmg alpha = 05 
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Tests of Between-Subjects Effects 
Dependent Vanable Change base EBMT-OR 
Type Ill Sum 
Source of Squares df Mean Sguare F S'lJ 
Corrected Model 20 813° 4 5203 1 067 422 
Intercept 5 783 1 5 783 1 185 302 
AGE 8177 1 8177 1 676 225 
BMI 10 837 1 10 837 2 221 167 
DOSE 8 829 2 4 414 905 435 
Error 48 787 10 4 879 
Total 99 000 15 
Corrected T a tal 69 600 14 
a Computed usmg alpha= 05 
b R Squared= 299 (AdJusted R Squared= 019) 
Estimates 
0 epen d V bl C en I ana e hange ba E MT OR se B 
-
95% Confidence Interval 
Dose Mean Std Error Lower Bound Upper Bound 
Placebo 1 571 a 969 - 588 
15mg lsoflavone 2 5983 1 416 - 556 
50mg lsoflavone 
-3543 1 423 -3 524 
a Covanates appeanng m the model are evaluated at the follow1ng 
values Age of Participant= 55 47, Body Mass Index= 25 753 
Pa1rw1se Compansons 
0 d tV bl C epen en ana e hange b a se EBMT OR 
-
Mean 
Difference 
(I) Dose (J) Dose (1-J) Std Error 
Placebo 15mg lsoflavone -1 028 1 876 
50mg lsoflavone 1 924 1 618 
15mg lsoflavol)e Placebo 1 028 1 876 
50mg lsoflavone 2 952 2 394 
50mg lsoflavone Placebo 
-1 924 1 618 
15mg lsoflavone -2 952 2 394 
Based on est1mated margmal means 
a Adjustment for mulhple compansons Bonferron1 
Umvanate Tests 
D~endent Vanable Change base EBMT-DR 
Sum of 
3 729 
5 752 
2 817 
SJq' 
1 000 
785 
1 000 
737 
785 
737 
Squares df Mean Square F S1g 
Contrast 8 829 2 4 414 905 435 
Error 48 787 10 4 879 
Parttal Eta None en\ Observed 
§_quared Parameter Power11 
299 4 266 227 
106 1 185 167 
144 1 676 216 
182 2 221 271 
153 1 810 165 
95% Confidence Interval for 
Dtfferencea 
Lower Bound Upper Bound 
-6 412 4 357 
-2 719 6 567 
-4 357 6 412 
-3 920 9 823 
-6 567 2 719 
-9 823 3 920 
Partial Eta Noncent Observed 
Squared Parameter Powera 
153 1 810 165 
The F tests the effect of Dose Thts test IS based on the lmearly mdependent pa1rw1se compansons among the est1mated 
margmal means 
a Computed usmg alpha = 05 
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Tests of Between-Subjects Effects 
Dependent Vanable Change base CVFT 
Type Ill Sum 
Source of Squares df Mean Square F S1g 
Corrected Model 102 543° 4 25 636 2 874 080 
Intercept 3 311 1 3 311 371 556 
AGE 8 907 1 8 907 999 341 
BMI 13 100 1 13 100 1 469 253 
DOSE 72 378 2 36 189 4 057 051 
Error 89 191 10 8 919 
Total 203 000 15 
Corrected Total 191 733 14 
a Computed usmg alpha- 05 
b R Squared = 535 (Adjusted R Squared= 349) 
Estimates 
Dependent Vanable Change base CVFT 
95% Conf1dence Interval 
Dose Mean Std Error Lower Bound Upper Bound 
Placebo 
- 857" 1 310 -3 775 2 061 
15mg lsoflavone 
- 667" 1 914 -4 931 3 598 
50mg lsoflavone 5 359a 1 924 1 082 9 656 
a Covanates appeanng m the model are evaluated at the followmg 
values Age of PartiCipant= 55 47, Body Mass Index= 25 753 
Panw1se Compansons 
Dependent Vanable Change base CVFT 
Mean 
Difference 
Part1al Eta Noncent 
Squared Parameter 
535 11 497 
036 371 
091 999 
128 1 469 
448 8115 
95% Confidence Interval for 
01fference3 
(I) Dose (J) Dose (1-J) Std Error S1g 3 Lower Bound Upper Bound 
Placebo 15mg lsoflavone 
- 190 2 537 1 000 -7 471 7 091 
50mg lsoflavone 
-6 226 2187 052 -12503 052 
15mg lsoflavone Placebo 190 2 537 1 000 -7 091 7 471 
50mg lsoflavone 
-6 036 3 237 276 -15 327 3 256 
50mg lsoflavone Placebo 6 226 2187 052 -052 12 503 
15mg lsoflavone 6 036 3 237 276 -3 256 15 327 
Based on estimated margmal means 
a Adjustment for multiple compansons Bonferron1 
Umvanate Tests 
Dependent Vanable ChanQe base CVFT 
Sum of Part1al Eta Noncent 
Souares df Mean SQ!:lare F S1g_ Squared Parameter 
Contrast 72 378 2 36 189 4 057 051 448 B 115 
Error 89 191 10 8 919 
Observed 
Power 
561 
086 
148 
195 
582 
Observed 
Power3 
582 
The F tests the effect of Dose ThiS test IS based on the hnearly Independent pa1rw1se compansons among the estimated 
margmal means 
a Computed usmg alpha = 05 
436 
Tests of Between.SubJects Effects 
Dependent V ana b s le c DMT 
Type Ill Sum 
Source of Squares df Mean Square F s,o 
Corrected Model 143 716" 4 35929 1 035 436 
Intercept 7 556 1 7 556 218 651 
AGE 16 380 1 16 380 472 508 
BM! 5 249 1 5 249 151 706 
DOSE 124 871 2 62 435 1 798 215 
Error 347 217 10 34 722 
Total 651 000 15 
Corrected Total 490 933 14 
a Computed usmg alpha= 05 
b R Squared= 293 (AdJusted R Squared= 010) 
Esttmates 
Dependent Vanable cSDMT 
95% Confidence Interval 
Dose Mean Std Error Lower Bound Upper Bound 
Placebo 1 074' 2 584 -4 684 6 832 
15mg lsoflavone 1 118' 3 776 -7 297 9 532 
50mg lsof!avone 9 242' 3 796 784 17 700 
a Covanates appeanng 1n the model are evaluated at the followtng 
values Age of Part1c1pant; 55 47, Body Mass Index; 25 753 
Pa1rw1se Compartsons 
Dependent Vanable cSOMT 
Part1al Eta Noncent 
Squared Parameter 
293 4 139 
021 218 
045 472 
015 151 
265 3 596 
Mean 95% Confidence Interval for 
Difference Otfferencea 
_!!]Dose (Jl_Dose (~J) Std Error S1g' Lower Bound Upper Bound 
Placebo 15mg lsoflavone 
-044 5 005 1 000 ·14 409 14 321 
50mg lsoflavone 
-8168 4 316 263 -20 555 4 218 
15mg lsoflavone Placebo 044 5 005 1 000 -14 321 14 409 
50mg lsoflavone 
-8 124 6 387 697 -26 456 10 208 
SOmg lsoflavone Placebo 8 168 4 :316 263 -4 218 20 555 
15mg lsoflavone 8124 6 387 697 -10 208 26 456 
Based on est1mated margtnal means 
a Adjustment for multtple compansons Bonferront 
Umvanate Tests 
D d V epen ent a nab e c SDMT 
Sum of Parttal Eta Non cent 
Squares df Mean Square F S1g Squared Parameter 
Contrast 124 871 2 62435 1 798 215 265 3 596 
Error 347 217 10 34 722 
Observed 
Powet' 
221 
071 
096 
064 
290 
Observed 
Powera 
290 
The F tests the effect of Dose Thts test IS based on the linearly Independent patrwtse compansons among the esttmated 
margtnal means 
a Computed usmg alpha = 05 
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